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Abstract
Transcription factors are a set of proteins that bind to DNA and regulate transcription. They play a
key role in regulating genes through the developmental process and disruptions to transcription factor
binding have been linked to cancer and other human diseases. This thesis develops a bioinformatic
workflow to identify high confidence transcription factor binding sites and characterise the functional
role of a transcription factor by integrating available genetic and epigenetic data sets.
Chromatin immunoprecipitation followed by sequencing (ChIP-seq) is the assay of choice to
identify where a transcription factor is binding in vivo. The ChIP-seq protocol is known to generate false
positive signals and requires a large cell population resulting in significant biological variance across
experiments. Our workflow addresses these weaknesses in two ways. First, DNase I hypersensitivity
(DHS) accessibility data is used to filter out false positive binding events that are inaccessible as
transcription factor binding is dependent on access to DNA. Second, we built a new tool to identify
reproducible peaks across biological replicates improving our ability to accurately report transcription
factor binding. This tool had marked improvement over available approaches at identifying true
binding sites from ChIP-seq data.
ChIP-seq cannot be used to assay binding across all factors and cell types due to lack of a specific
antibody, inability to extract cells and general infeasibility. To combat this, we built a Bayesian network
model that predicts in vivo binding sites allowing a transcription factor to be characterised without
the need for ChIP-seq data. Our model did not achieve the performance required to be included in
our workflow but it did allow identification of chromatin accessibility, DNA footprints and sequence
patterns associated with binding across different factors and conditions. We also indicate where
improvements can be made in future models and ultimately the need for new biological information to
accurately predict binding events within and across cell types.
After identifying high confidence binding events, our workflow determines where binding events
occur relative to genes and integrates available histone modification data to build epigenetic profiles
that provide insight into how a transcription factor operates. Using these profiles, we demonstrated
key differences in the operation of two transcription factors; showing one to preferentially bind far
from the nearest gene at locations with strong regulatory activity while the other binds closer to genes
at locations with epigenetic patterns linked to weaker or repressive activity. Therefore, including
such profile generation in our workflow successfully provides new insight into the regulatory role a
transcription factor plays.
RNA-sequencing (RNA-seq) experiments provide insight into gene expression patterns and,
through comparison of wild type and transcription factor knock out experiments, can be used to
determine which genes are being regulated by a transcription factor. This information is invaluable
when attempting to characterise the functional role of a transcription factor. However, transcription
factors are capable of regulating multiple genes over potentially long distances making target gene
identification challenging. Our workflow used a combination of existing approaches to predict tran-
scription factor target genes followed by functional annotation to characterise the regulatory role
of a transcription factor and identify novel target genes that were subsequently experimentally vali-
dated. This new knowledge could not have been identified without the application of our integrative
bioinformatic workflow.
While valuable biological insights were gained using available approaches, the task of identifying
transcription factor target genes accurately is yet to be resolved. Approaches to predict long distance
target genes are based on chromosome conformation capture experiments designed to detect long
distance interactions driven by DNA-looping. These experiments have high false negative rates, low
resolution, are difficult to reproduce and only a handful measure interactions genome wide making
them a poor gold standard against which predictive approaches are measured. We reviewed available
approaches identifying numerous limitations, flaws and oversights and conclude that no approach can
predict target genes of transcription factor binding events accurately when learning from low quality
validation data.
In summary, this thesis presents a bioinformatic workflow as a set of methods and techniques
focused on data integration and machine learning that can be adapted to a range of different experiments
and types of data. Specifically, we demonstrate the application of our workflow to regulation across
the genome with a focus on transcription factor biology. Our bioinformatic workflow clearly outlines a
number of approaches to characterise a transcription factor’s regulatory role. This includes an approach
to filter ChIP-seq binding sites using accessibility data, a robust method for combining biological
replicates, a means to build epigenetic profiles of binding events and construction of a transcription
factor targetome linking high confidence binding sites to biologically relevant or misregulated target
genes leading to a better understanding of transcription factor driven regulation in the genome. We
applied this workflow to a number of transcription factors successfully identifying and validating
novel target genes and providing insight into the functional role each factor plays: knowledge that was
inaccessible without the application of our bioinformatic workflow.
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Processing, integrating and analyzing chromatin immunoprecipitation followed by sequencing
(ChIP-seq) data
High throughput sequencing (HTS) technology has contributed to a number of discoveries in the
human genome. One technique which relies on HTS is chromatin immunoprecipitation followed by
sequencing (ChIP-seq); a technique that allows us to identify where proteins are binding in vivo. A
handful of consortiums have generated thousands of data sets using ChIP-seq to describe transcription
factor (TF) binding and histone modifications (HMs). Individual labs are also generating numerous
data sets exploring TFs in specific cell types and cell states using HMs as support. In the last decade,
ChIP-seq has become so popular that although we have a standard way of performing the experiment
in the wet lab, we have seen the development of a staggering number of processing pipelines and
protocols designed to interpret the resulting sequenced reads. This begs the question of which approach
is the ‘best’.
Once you have your ChIP-seq peaks, you will quickly discover that despite the challenges, generat-
ing them was the easy part and now you’re faced with interpreting the data at hand. To fully appreciate
the information stored in your peaks, you have to understand the strengths and weaknesses of ChIP-seq
and the power of integrating your ChIP-seq result with other available data.
This talk aims to guide you through the ChIP-seq processing steps exploring the available tools and
discussing the important considerations that must be made throughout. It will also cover approaches
for analysing ChIP-seq peaks and highlight the importance of data integration in the interpretation of
processed ChIP-seq data sets.
COMBINE 2016, poster presentation
Combining high throughput sequencing data to improve identification of transcription factor binding
Math1 is a transcription factor (TF) which plays a role in neural development and Medulloblastoma.
TFs are known to bind to regulatory regions defined by accessible chromatin detected by DNaseI
hypersensitivity (DHS), and epigenetic features such as histone-3 lysine-4 tri-methylation (H3K4me3)
and histone-3 lysine-4 mono-methylation (H3K4me1) indicating enhancers and promoters respectively.
The genes targeted by a TF can be detected using RNA-sequencing and perturbing the system by
knocking-out the TF of interest, in this case: Math1. By combining these data sets with chromatin
immunoprecipitation (ChIP-seq) data for Math1; we can select high confidence binding sites, identify
epigenetic patterns distinguishing sites and improve detection of Math1 gene targets.
We gathered the above data sets in Cerebellar granule neurons (CGNs) at P5/7 to create a high
confidence set of TF binding sites for Math1. To qualify, we required that Math1 ChIP-seq peaks
overlap a regulatory region defined by DHS, H3K4me3 and H3K4me1. We identified 4,149 high
confidence peaks from 8,804 total peaks and determined that 3,362 were bound to an enhancer
>2,000bps from the nearest TSS indicating Math1’s preference for binding enhancers.
Using our high confidence binding sites we identified 2,283 putative target genes of Math1. By
requiring that a target gene show differential expression based on RNA-seq of a Math1 knock-out,
we reduced this to 743 relevant target genes. These targets are linked to regulatory regions that are
distal or proximal with distinct epigenetic features. Finally, using StringDB, DAVID and KEGG, we
narrowed the genes of interest to <50, 3 of which were selected for experimental validation. Through
combining data sets, we identify a small set of significant target genes for Math1. We can extract
relevant information about a TF and gain insight into why and how it binds, and what influence
different binding ‘modes’ have on target gene expression.
Combining high throughput sequencing data to improve
identification of transcription factor binding
Alex Essebier and Mikael Bodén
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Problem
Identifying gene targets of transcription factors (TFs) is
challenging due to the complex nature of TF binding. In
particular, the ability of a TF to regulate genes over large
distances. Combining high throughput sequencing datasets
adds epigenetic detail to individual binding sites. Using this
detail, as well as a binding site’s location, we can better
distinguish a TF’s binding mode and set of gene targets.
Here, we use Math1 in Cerebellar granule neuron precursors
as an example.
Methods
Data: H3K4me1, H3K4me3 and Math1 processed ChIP-seq
  files and processed RNA-seq from [1]. DHS and H3K27ac 
  processed files from [2]. TSS and gene locations from UCSC.
Explore binding sites: Overlap Math1 peaks with the four 
  marks, isolate peaks of interest and calculate distances to
  nearest TSSs.
Identify targets: Peaks located proximally and within genes
  were assigned the nearest gene as a target. Cismapper [3]
  was used to find distal gene targets using correlation
  between H3K27ac and gene expression across multiple cells.
Outcomes
Grouping peaks by location and applying CisMapper [3] to 
determine distal targets returned 146 extra gene targets. 
DAVID and StringDB allowed exploration of functional
annotation and the literature leading to identification of
<50 biologically relevant target genes that had links to
Math1. Our collaborators were able to explore this list and
extract targets used to generate new hypotheses.
Epigenetic environment
Different combinations of DHS, H3K27ac, H3K4me1 and 
H3K4me3 define regulatory regions as recorded below.
Of interest is Math1’s preference for strong enhancer binding.
As enhancers are known to be more cell type specific than
promoters, it may play a specific role in Cerebellar granule
neuron precursor cells.
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Available data
TFs bind regulatory regions defined by accessible chromatin
detected by DNaseI hypersensitivity (DHS), and epigenetic
features such as histone-3 lysine-27 acetylation (H3K27ac),
histone-3 lysine-4 tri-methylation (H3K4me3) and histone-3
lysine-4 mono-methylation (H3K4me1). 
Math1 peaks can be overlapped with individual marks to
generate epigenetic labels providing detail about its binding
preference.
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A surprisingly small set of target genes show significant 
differential expression (DE) in the RNA-seq data comparing
a wild type mouse to a knock-out of Math1. This is evidence
of indirect interactions and redundancy in the system.
The strong enhancer group has been linked to a greater
number of biologically significant genes than the unmarked
group.
Peaks were assigned to proximal (Peak 3), genic (Peak 1)
and distal (Peak 2) location groups. Proximal and genic peaks
can be annotated to the nearest gene. Distal peaks can
target multiple genes over long distances and require a
different approach to identify targets.
Distal regulation
CisMapper [3] provides a higher confidence set of gene
targets for distal peaks than using the nearest gene.
Peak 2 could regulate G1, G2 or G3. 
G1
G2 G3
2,000bps
Peak 1
Peak 3Peak 2
Locations of Math1 peaks
Math1 binding sites occur
distally, hindering accurate
gene target annotation.
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GenGen 2017, speaker
ENCODE-DREAM in vivo transcription factor binding site prediction challenge: a Bayesian
network approach
This DREAM challenge required participants to develop and apply computational methods that
can integrate multiple data sets to predict in vivo binding maps of a diverse collection of transcription
factors in a variety of cell lines. It required integration of multiple data sets including ChIP-seq,
DNAse-seq and gene expression data. In this talk, I presented my preliminary results and progress in
the challenge.
Winter School 2018, organiser and speaker
Processing, integrating and analyzing chromatin immunoprecipitation followed by sequencing
(ChIP-seq) data
High throughput sequencing (HTS) technology has contributed to a number of discoveries in the
human genome. One technique which relies on HTS is chromatin immunoprecipitation followed by
sequencing (ChIP-seq); a technique that allows us to identify where proteins are binding in vivo. A
handful of consortiums have generated thousands of data sets using ChIP-seq to describe transcription
factor (TF) binding and histone modifications (HMs). Individual labs are also generating numerous
data sets exploring TFs in specific cell types and cell states using HMs as support. In the last decade,
ChIP-seq has become so popular that although we have a standard way of performing the experiment
in the wet lab, we have seen the development of a staggering number of processing pipelines and
protocols designed to interpret the resulting sequenced reads. This begs the question of which approach
is the ‘best’.
Once you have your ChIP-seq peaks, you will quickly discover that despite the challenges, generat-
ing them was the easy part and now you’re faced with interpreting the data at hand. To fully appreciate
the information stored in your peaks, you have to understand the strengths and weaknesses of ChIP-seq
and the power of integrating your ChIP-seq result with other available data.
This talk aims to guide you through the ChIP-seq processing steps exploring the available tools and
discussing the important considerations that must be made throughout. It will also cover approaches
for analysing ChIP-seq peaks and highlight the importance of data integration in the interpretation of
processed ChIP-seq data sets.
GenGen 2019, organiser and speaker
Exploring transcription factor binding and interaction through integration of high throughput
sequencing data
A handful of consortiums have now generated thousands of high throughput sequencing (HTS)
data sets describing different regulatory controls in the human genome. These include ChIP-seq
and DNase-seq to describe transcription factor binding and epigenetic state, RNA-seq and CAGE to
describe gene expression changes and chromosome conformation capture to explore three-dimensional
structure. Together, these data describe the regulatory system in the human genome. The challenge we
are currently facing is how to integrate this information to discover biologically relevant information.
CSIRO Machine learning in genome biology symposium 2019, speaker
A Bayesian Network approach to predicting transcription factor binding sites in vivo
Identifying transcription factor binding sites in vivo is key to understanding regulation in the
genome however, many transcription factors and cell types cannot be assayed by techniques such as
chromatin immunoprecipitation followed by sequencing (ChIP-seq) due to lack of antibody, inability
to extract the cell type and an infeasible number of combinations to assay. Learning from a number
of features including sequence, chromatin accessibility (DNase I hypersensitivity), accessibility
footprinting and gene locations we built and trained a Bayesian network to predict in vivo binding of
transcription factors in a variety of cell lines. Our simple network based on features common to all
transcription factors showed large variation in performance across different transcription factor and
cell type combinations and in this talk I discuss how we queried the network and explored the data to
learn about features of transcription factor binding and how they vary.
Winter School, invited speaker 2019
Extracting knowledge from models trained on biological data to measure performance and
improve understanding of the system
Extracting knowledge from statistical and machine learning approaches is a challenge faced by
many researchers including those in the field of bioinformatics. A large amount of data is now available
that captures multiple aspects of human biology at the cellular level and we are faced with the task of
extracting knowledge, patterns and relationships from this data to assist in our understanding of how
our bodies function at a molecular level and to aid in the treatment of diseases such as cancer.
To explore approaches to extracting knowledge from a model, we built a Bayesian network with a
limited set of features and a relatively simple structure to identify transcription factor binding sites in
vivo, information key to understanding regulation in the genome. While our network did not have the
best performance, Bayesian networks are generative and our aim was to gain a better understanding of
the features that define a transcription factor binding event.
In this talk I will discuss the approaches we used and the challenges we faced in extracting
knowledge from our Bayesian network and linking performance back to the input data to learn about
the features of transcription factor binding and how they vary under different conditions.
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Chapter 1
Introduction
1.1 Background
Transcription factors are a set of proteins with the ability to bind to DNA, recruit RNA polymerase
and regulate transcription [76, 100]. They play a key role in controlling gene expression through
the developmental process and in maintaining homeostasis allowing the existence of more complex
organisms. Transcription factors and their ability to provide fine scale control over transcription of
genes is a topic of significant interest to better understand the regulatory processes that take place
within an organism.
The disruption of transcription factors has been identified as the cause of multiple developmental
diseases due to loss of control of the dynamic, sequential changes that are required for normal
development [160, 97]. Transcription factors are also deregulated in many human cancers where they
can act as oncogenes and tumour suppressors [14, 139]. The immune system’s responses to both
microbial and environmental cues is also controlled by transcription factors [157]. Understanding a
transcription factor’s functional role is essential not only to understand the regulatory system but also
to define disease pathology, and explore their potential as therapeutic targets. Here, the functional role
of a transcription factor is captured through the roles played by target genes of the transcription factor
itself.
This thesis presents a bioinformatic workflow that describes multiple data integration techniques,
predictive approaches and knowledge extraction methods that are broadly applicable to related but
biologically distinct problems. Specifically, we analyse and quantify the performance of each aspect
of the workflow in the context of transcription factor binding and it’s impact on regulation across the
genome. Our workflow has the ability to integrate genetic and epigenetic data to define and quantify all
aspects of transcription factor biology and characterise a transcription factor’s functional role in vivo.
1.1.1 Transcription factors and the regulatory system
In general, transcription factors bind to DNA and recruit other factors including RNA polymerase II to
form the transcriptional machinery that is required to regulate the amount of messenger RNA (mRNA)
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produced by a gene [100]. Binding can have an inhibitory (repressive) or excitatory (activating) effect
on gene expression. Transcription factors must be considered in the wider context of the regulatory
system to better understand how they function. Multiple layers of information influence regulatory
patterns in the genome resulting in a non-linear dynamic system which is dependent on both time and
space, or more specifically, conditions such as cell type, developmental stage or disease status [24].
Improving our understanding of the regulatory system generally and in the context of specific cell
types and tissues is an active area of research that faces many challenges but will ultimately lead to
new methods of treating cancer and other diseases.
The key features that play a role in the regulatory system are represented in Figure 1.1. Together
these features define cis regulatory modules (CRMs); locations on the genome characterized by
clustered transcription factor binding sites, distinct patterns in chromatin state, specific sequence
features and evolutionary conservation. CRMs are broken into three categories: promoters, enhancers
and silencers, and insulators [63]. Identifying transcription factor binding sites, CRMs and patterns of
chromatin state is an area of active research. Detecting the relationships between CRMs, transcription
factors and chromatin state is a secondary, though closely related, field of research. In this thesis,
the focus is on identifying transcription factor binding sites, annotating these sites with a chromatin
state label and linking binding sites across the genome to identify gene targets over long distances.
All aspects of the regulatory system depend on multiple other factors making any attempts to study it
challenging primarily due to lack of sufficient accurate data.
When a transcription factor binds, there are multiple avenues through which it can influence gene
expression, the ultimate outcome being activation or repression. Without an understanding of the
different binding modes of a transcription factor, and the associated effect on gene expression patterns,
it is not possible to determine its functional role. Binding mode here refers to a transcription factor’s
interaction with DNA, the transcriptional machinery, chromatin state and other transcription factors.
Features which influence a transcription factor’s binding mode can be genetic, epigenetic or related
to protein-protein interactions. This thesis includes analyses of factors, where data is available, that
influence binding mode measured as a change in gene expression patterns.
Interactions with DNA
Identifying where a transcription factor binds to the DNA is the first step in understanding its effect
on gene expression. Most transcription factors possess a DNA binding domain that allows them to
bind directly to DNA, often in a sequence specific manner [100]. The DNA sequences recognized by
transcription factors, referred to as motifs, are between 4 and 20 base pairs (bps) and derived from
merging sequences detected by both in vivo and in vitro techniques as bound by the transcription factor
[7, 83, 113]. No ‘gold standard’ exists to represent sequence preferences of a transcription factor and
these preferences are also dependent on other conditions including cell type and transcription factor
interactions making motifs challenging to work with but a reasonable approach to identify binding
events [76, 183].
Transcription factor binding is dependent on an accessible chromatin state as condensed DNA
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Figure 1.1: A simplified representation of the key features in the human regulatory system that
influence one another to control the dynamic and sequential gene expression changes required for
normal development and a healthy life.
prevents transcription factors from binding to DNA [45]. Chromatin state is represented by a number
of epigenetic features including histone marks and patterns of accessibility. Transcription factors can
also, in turn, recruit chromatin modifying factors that alter chromatin state allowing other factors to
bind and alter gene expression [59, 76]. In fact, one group of factors known as ‘pioneer factors’ play
a unique regulatory role being able to bind to inaccessible chromatin regions and open chromatin
structure to regulate gene expression [149, 159, 137].
It is also important to note that not all transcription factors bind directly to DNA but instead bind
to other factors that are in contact with the DNA. Many transcription factors contain effector domains
which can interact with transcriptional machinery, other transcription factors, and indirectly recruit
histone and chromatin modifying enzymes. Effector domains are less conserved than DNA binding
domains allowing a single transcription factor to play a range of roles in regulation depending on its
interactions [53, 156].
Experimental techniques including chromatin immunoprecipitation followed by sequencing (ChIP-
seq) exist to identify transcription factor binding events in vivo however, they are not always applicable
leading to a body of work that aims to predict transcription factor binding events. This work is reviewed
in Appendix E and expanded in Chapter 5.
Knowing that a transcription factor binds at a certain genomic location is not sufficient to define
the role that binding event has on gene expression as it ignores the other aspects of the regulatory
system. This thesis aims to integrate data describing multiple aspects of the regulatory system to gain
a more complete understanding of the regulatory role a transcription factor binding event plays.
Interactions with additional factors
Cooperation between transcription factors allows an increased number of regulatory changes to be
made by a limited number of transcription factors. Cooperation can occur through direct contact of
transcription factors (mutually cooperative), two transcription factors binding to a third transcription
factor (indirect cooperation) and through binding near one another conferring an additive effect without
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Figure 1.2: A hypothetical gene regulatory map. An example of three genes (G1, G2 and G3) and their
active promoters (P1, P2 and P3) characterised by H3K27ac and H3K4me3 markers. The enhancer
E1 is characterised by H3K27ac and H3K4me1 and has the potential to regulate G1, G2, G3 or
combinations of these genes. Available annotation tools would favour P1 and G1 as the target gene for
E1 as it is the closest gene. P1 shows an example of a transcription factor which is bound outside the
promoter region and could therefore be considered a false positive. This would not be realised without
combining histone modification and transcription factor ChIP-seq data sets.
protein-protein interactions [115]. When a DNA bound transcription factor links a second transcription
factor to the transcription complex with no direct binding to the DNA, they are known as co-factors
[165, 138]. A number of transcription factors exist which do not directly bind DNA and only operate as
co-factors while other factors can bind directly or indirectly to DNA. Finally, transcription factors will
compete with one another to occupy a binding site with the outcome dependent on the transcription
factor copy number (or concentration), its binding affinity to an available site and the number of sites
available for binding (controlled in part by chromatin accessibility) [19].
Additionally, a number of transcription factors are known to bind as homo- or hetero-dimers and
even oligomers to DNA [80, 55]. One way dimers can alter transcription is through the recruitment of
different cofactors and transcriptional machinery [152, 90]. Analyses reported in this thesis aim to
determine the level of cooperation between two transcription factors.
Transcription factor target genes
Identifying the gene (or genes) targeted by a transcription factor binding event is challenging. When
an event occurs in the promoter region of a gene (e.g. ±2,000bps of a transcription start site (TSS)), it
is likely that it regulates the nearest gene. When a binding event occurs further away from a gene, it
could be linked to a target gene through formation of a DNA loop. Studies have shown that as few as
7% of DNA loops link a binding event to the nearest gene and it is common to observe a number of
genes within DNA loops whose expression is not influenced by the transcription factor of interest [145,
94]. Using Figure 1.2 as an example, tools currently available to annotate target genes would assign
G1 as E1’s target gene because it is the closest however; E1 could be regulating any or even all three
genes [153]. A full, published review of the literature surrounding this topic and the many challenges
and limitations of existing tools to identify transcription factor target genes is included as Chapter 2
and supplemented with additional analyses in Chapter 6.
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Functional role of a transcription factor
The functional role of a transcription factor is best defined through statistical analysis of the roles
played by target genes of the transcription factor itself. Transcription factor target genes often include
other transcription factors orchestrating multiple, successive and coordinated changes in expression
across the regulatory system [176, 164]. Therefore, both direct and indirect target genes or genes
bound by target transcription factors that form a gene regulatory network must be considered when
defining the functional role of a transcription factor. In this thesis we apply data integration techniques
to classify direct and indirect targets of a transcription factor allowing us to consider functional role in
more detail.
With so many avenues through which transcription factors can influence gene expression, multiple
data sets processed using a robust and informative workflow, such as the one presented in this work,
are required to determine the impact a transcription factor is having on regulation within the genome.
A number of high throughput sequencing (HTS) technologies have been developed that describe the
biological features outlined here making it possible to study transcription factors genome wide and in
vivo.
1.1.2 High throughput sequencing technologies
Chromatin immunoprecipitation followed by sequencing (ChIP-seq), DNase I hypersensitivity se-
quencing (DHS), RNA sequencing (RNA-seq) and cap analysis gene expression (CAGE) are HTS
technologies which play a crucial role in identifying CRMs and deciphering transcription factor
biology. Each experiment explores different components of the regulatory system within a genome
informing our understanding of development, cell differentiation and disease mechanisms. ChIP-seq
identifies protein binding sites in vivo and is applied to transcription factors and histone modifications
allowing us to identify individual features but also putative CRMs [63, 108, 6, 98]. To complement
histone modifications, DHS identifies regions of open chromatin indicative of active regulation [158,
170]. RNA-seq and CAGE reveal the outcome of regulation through expression levels of genes and
transcripts and are often used to identify changes in expression patterns under different conditions.
They are also used to identify gene locations and exon/intron structure with CAGE also able to detect
alternative promoter usage or transcription start sites [169, 173, 162].
The formation of DNA loops which can bring enhancers into contact with target promoters, a key
feature of regulation, are also explored using HTS techniques. DNA contact points can be detected
using a range of chromosome conformation capture techniques including 3C [171], 5C [145], Hi-C
[105, 135, 81], Capture Hi-C (CHiC) [114] and ChIA-PET [101]. All chromosome conformation
capture techniques are known to have high false negative rates (specifically ChIA-PET) and low
resolution [101]. Hi-C and CHiC are genome wide approaches however, interacting regions shorter
than 1 megabase and 40 kilobases are not detected by Hi-C and CHiC respectively [105, 135, 81,
114]. These experimental approaches are currently the gold standard for testing tools which predict
enhancer/promoter pairs (long distance interactions).
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Together, these technologies describe the components that define the regulatory system as shown
in Figure 1.1. In the last seven years, a handful of consortiums [39, 96, 29, 146] and a number of
individual labs have generated thousands of HTS data sets across hundreds of cell types to better
understand regulation in the human genome. In this thesis, these data sets have been used extensively
to better understand functional roles of transcription factors, to explore cell-type specificity given
chromatin state and transcription factor binding, and to identify features defining different epigenetic
states across the genome as well as many other valuable discoveries.
Most HTS data sets describe events across the entire genome resulting in large, information rich sets
of data. Bioinformatic approaches developed to explore these data sets are in their infancy as complex
data mining, feature selection and machine learning approaches are required to extract meaningful
relationships and patterns. Identifying the best approaches to performing data analysis on this scale for
such a complex system is a challenge unto itself.
Currently available tools for processing sequencing data into sites of interest or expression values
are generally limited to analysing individual data sets. Once individual processing is performed,
integration of data sets describing events which are dependent on one another is attempted. Integrative
approaches exist to predict transcription factor binding events in vivo (see Appendix E and Chapter
5), define chromatin state given multiple epigenetic marks [41, 69] and determine gene regulatory
networks [8, 23]. The author was unable to find reference to any approach capable of applying
post-processing integration of data seamlessly across the different stages of defining the functional
role of a transcription factor including identification of high confidence binding events, classification
of binding sites given chromatin state and linking of binding events to target genes.
1.1.3 Summary
This thesis describes the development of a bioinformatic workflow which takes into consideration
all aspects of transcription factor biology described above and characterises the functional role of a
transcription factor based on the available data. Our workflow includes improved data processing
steps, novel data integration techniques and unique knowledge extraction approaches to identify high
confidence transcription factor binding events, determine binding mode and report a refined set of target
genes. The application of individual components of the workflow that apply various data integration,
machine learning and knowledge extraction techniques is not limited to the study of transcription
factor biology but is applicable to other areas of research where multiple data sets are available that
describe different aspects of the same system. Through a number of case studies we show that our
workflow accurately characterises transcription factor biology providing new, specific knowledge of
each tested transcription factor and ultimately a better understanding of regulation in the genome.
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1.2 Research hypotheses and aims
1. Transcription factor biology can be characterised by applying data integration techniques across
genetic and epigenetic data.
a) Review available approaches for defining transcription factor binding sites, combining
transcription factor binding with epigenetic data and predicting transcription factor target
genes to identify limitations, weaknesses and flaws (Chapter 2 and Appendix E).
b) Build an accessible bioinformatics workflow that identifies high confidence transcription
factor binding sites using available replicates, RNA-seq and epigenetic data (Chapter 3).
c) Evaluate this workflow on available data and generate new insights into transcription factor
biology (Chapter 3).
2. Transcription factor binding sites can be further defined using available genetic and epigenetic
data (Chapters 4 and 5).
a) Develop and evaluate a tool that integrates data from multiple biological replicates of a
ChIP-seq experiment to identify reproducible binding sites (Chapter 4).
b) Develop and evaluate a model that captures patterns of sequence, chromatin accessibility
and protein binding events to predict transcription factor binding sites across cell types
(Chapter 5).
c) Develop knowledge extraction techniques to identify patterns captured by our predictive
model and define the genetic and epigenetic features of a transcription factor binding event
(Chapter 5).
3. Genetic and epigenetic patterns of enhancer-promoter pairs can be used to predict long distance
interactions between a transcription factor binding site and a target gene (Chapter 6).
a) Develop and evaluate a programmatic tool to model available chromatin conformation
capture data sets to identify enhancer-promoter pairs and determine whether they share
patterns of epigenetic modification and transcription factor binding.
The following publication has been incorporated as Chapter 2.
1. Alexandra Essebier et al. “Bioinformatics approaches to predict target genes from transcription
factor binding data”. In: Methods 131 (2017), pp. 111–119
Contributor Statement of contribution %
Alex Essebier writing of text 80
proof-reading 80
supervision, guidance 40
theoretical derivations 80
preparation of figures 90
initial concept 80
The work in this Chapter was published and my contribution was conducting the review of available
approaches to predict target genes over large distances identifying strengths, limitations and weaknesses
in the current body of literature. I also wrote the initial document and constructed the included figures.
I developed and performed the required analysis for the case study portion of the text to demonstrate
the application of multiple approaches to determine a high quality set of target genes. The co-authors
assisted by editing the text and contributing to descriptions of the reviewed approaches.
Chapter 2
Bioinformatics approaches to predict target
genes from transcription factor binding data
In Chapter 1 it was noted that annotating a transcription factor binding event to a target gene was
fraught with challenges due to the complexity of long distance interactions mediated by DNA loops.
This Chapter reviews available predictive approaches to perform the required target gene annotation
and provides clear examples of how existing approaches can be integrated to ensure a biologically
relevant outcome. The integration steps described in this Chapter can be applied more broadly to cases
where multiple approaches are available to perform the same task, a common occurrence in the field
of bioinformatics. Specifically, they provide a baseline approach for annotating transcription factor
binding events to target genes in our workflow.
2.1 Abstract
Transcription factors regulate gene expression and play an essential role in development by maintaining
proliferative states, driving cellular differentiation and determining cell fate. Transcription factors are
capable of regulating multiple genes over potentially long distances making target gene identification
challenging.
Currently available experimental approaches to detect distal interactions have multiple weaknesses
that have motivated the development of computational approaches. Although an improvement over
experimental approaches, existing computational approaches are still limited in their application, with
different weaknesses depending on the approach. Here, we review computational approaches with a
focus on data dependency, cell type specificity and usability.
With the aim of identifying transcription factor target genes, we apply available approaches to
typical transcription factor experimental datasets. We show that approaches are not always capable
of annotating all transcription factor binding sites; binding sites should be treated disparately; and
a combination of approaches can increase the biological relevance of the set of genes identified as
targets.
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2.2 Introduction
Transcription factors are a set of DNA binding proteins that play a key role in regulation by providing
delicate control over the expression of genes [76]. Transcription factors can also act as oncogenes or
tumour suppressors, leading to uncontrolled growth and avoidance of apoptosis; they are therefore key
targets for the diagnosis and treatment of cancer [14, 139]. Understanding the role of a transcription
factor in gene regulation requires knowledge of the transcription factor’s binding sites and most
importantly, its target genes.
Annotating a binding event to a target gene presents three key challenges:
• a single binding event can control multiple genes;
• a single gene can be coordinately controlled by multiple binding events; and
• binding sites can be involved in distal interactions facilitated by the formation of DNA loops.
Numerous approaches exist to annotate transcription factor binding sites to their target genes, with
different approaches aiming to address neither, some or all of the key challenges. Here, we explore the
factors that influence the identification of an accurate set of target genes, review annotation approaches
that have previously been shown to reproduce linkages captured by chromatin conformation assays, and
finally, present two case studies to demonstrate that treating binding events disparately and applying a
variety of annotation approaches can increase the number of identified, biologically relevant target
genes.
2.2.1 Binding context
Transcription factors do not act independently, instead relying on numerous genetic and epigenetic
features to bind DNA and regulate gene expression. Therefore, when attempting to identify the genes
targeted by a transcription factor, it is essential to use multiple data sources to determine not only
where binding occurs but the binding context.
Chromatin immunoprecipitation followed by sequencing (ChIP-seq) is regularly used to identify
binding sites of transcription factors [63, 108, 6, 98]. ChIP-seq shows the hundreds to tens of
thousands of specific locations at which a transcription factor binds including distal, proximal, intronic
and intergenic regions. Binding preference across these regions depends on the transcription factor,
cell type and condition, and genetic and epigenetic features [148].
Key epigenetic features include histone modifications and chromatin accessibility. ChIP-seq is
again used to detect different post-translational modifications to the histones around which the DNA is
wrapped; a collection of ChIP-seq experiments can provide significant insights into regulation beyond
a single transcription factor. Both DNase I hypersensitivity (DHS) and assay for transposase accessible
chromatin (ATAC) sequencing identify regions of accessible chromatin: a feature generally required
for transcription factor binding to occur. (So-called pioneer factors are a notable exception to this [149,
159].)
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Together, these assays have been used to identify and classify cis regulatory modules (CRMs):
locations on the genome characterised by clustered transcription factor binding sites, distinct patterns
of histone modifications and chromatin accessibility, specific sequence features, and evolutionary
conservation [63]. Enhancers and promoters are both types of CRMs and have historically been
viewed as distinct elements with unique roles in regulation [2, 150]. Epigenetic patterns associated
with enhancers and promoters are visualised in Fig. 2.1. They both drive target gene expression;
promoters are recognised by general transcription factors and recruit RNA Pol II at sites proximal to
known genes; enhancers are bound to by transcription factors at sites potentially (but not necessarily)
distal to their target genes, where they can substantially modulate the transcriptional efficiency.
A transcription factor binding site outside a region with relevant binding context (see Fig. 2.1 is
likely to be a false positive event, which are common in ChIP-seq analyses. Therefore, CRMs can be
used to filter transcription factor binding sites. This presents two alternate ways to link a transcription
factor binding site to a target gene: using the binding site alone or using the CRM that the transcription
factor is bound to. A number of approaches exist for each of these concepts.
2.2.2 DNA loops
As shown in Fig. 2.1, DNA loops allow interaction between CRMs over distances of up to 1Mb to
facilitate the formation of regulatory clusters [31, 142]. This secondary structure is dynamic, with
a many:many relationship between genes and gene-distal CRMs. Enhancers and promoters can be
brought into close proximity creating regulatory clusters that allow different CRMs to coordinately
influence the transcriptional output of multiple genes [2, 104]. Through this mechanism, a CRM is
able to regulate multiple genes, and a gene can be regulated by multiple CRMs. These are two of the
key challenges when annotating CRMs and transcription factors to target genes.
Linking CRMs to their targets over long distances is the third major challenge when annotating
binding events. In the past, researchers have approached the problem by assigning a CRM to the
nearest gene. Studies have shown that as few as 7% of DNA loops link a CRM to the nearest gene;
it is common to observe a number of genes in the DNA loops whose expression is not influenced
[145]. By proxy, transcription factors bound to CRMs involved in long distance interactions are often
incorrectly annotated to target genes [94]. The interaction between two CRMs through DNA loops is
referred to in the literature by a variety of names including enhancer-promoter pairs, enhancer-gene
pairs, enhancer-target gene pairs and more. To move away from the enhancer/promoter dichotomy, we
refer to such interactions as regulatory partners.
2.2.3 Experimental annotation approaches
Chromosome conformation capture techniques provide significant clues for identifying regulatory
partners. There are a number of protocols, including 3C [171], 5C [145], Hi-C [105, 135, 81], Capture
Hi-C (CHiC) [114] and ChIA-PET [101]. These approaches detect DNA contact points or secondary
structure; however, since not all interactions are regulatory and due to inherent, technical challenges,
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they have high false negative rates and low resolution [101]. Hi-C and CHiC cannot reliably detect
interacting regions shorter than 1Mb and 40Kb, respectively [105, 135, 81, 114]. ChIA-PET detects
interactions based on a single transcription factor or histone modification at a satisfactory resolution;
however, the use of a single marker means it does not detect any other interactions [54]. Most of the
above experiments are non-trivial, which means that computational approaches are an attractive option
to the scientist.
2.2.4 Computational annotation approaches
A number of tools exist that detect regulatory partners computationally. In this review we focus on
approaches which link CRMs (and by proxy transcription factors) to target genes, validated using
linkages detected by chromatin conformation assays. Most tools that predict long distance interactions
fall into one of two broad categories: tools that infer linkages based on statistical relationships between
specified genomic or epigenetic markers, or tools that predict linkages using machine learning models
trained from examples. Available experimental datasets can be used to train models and to validate
predicted interactions.
Each category has the capacity to detect different types of interactions. Methods that use statistical
analyses to establish regulatory partners are not restricted to types of physical interactions that are
detected by current experimental technologies. On the other hand, machine learning based methods
are typically trained with chromosome conformation capture data, essentially limiting their scope to
physical interactions. Using a combination of other features, such predictions can be restricted to the
subset that specifically pair CRMs and genes.
Each individual approach also detects a variety of interactions. Several approaches aim specifically
to link gene-distal CRMs to genes or their promoters over long distances, rather than promoter-promoter
or enhancer-enhancer interactions. They generally do not aim to make predictions for gene-proximal
CRMs, under the assumption that transcription factors bound to proximal sites are not influencing
the expression of other, distal genes. For this reason, the application of multiple, complementary
approaches can elicit a set of target genes with increased accuracy.
All the available tools utilise a variety of high-throughput sequencing data representing chromatin
accessibility, histone modifications, gene expression, conservation, DNA methylation and transcription
factor patterns. Assuming that regulatory partners can be extracted without the use of physical
interaction data simplifies the approach: in several of the available tools only one or a couple of
features are required to make predictions. Usually, statistical relations are based on data widely
available across a large number of cell types. The tools based on machine learning tend to make
predictions based on multiple input datasets. While this has the potential to make the tools more
sensitive to differences between types of interactions; it restricts their application to studies that have
access to all of the datasets; this can be a prohibitive requirement for the scientist.
Other differences between existing tools include how they define positive and negative data, their
criteria for identifying gene-distal CRMs and the algorithms used to predict regulatory partners. Each
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Figure 2.1: Graphical and linear representations of a hypothetical long distance interaction. Through
formation of a DNA loop, enhancer and promoter regions can be brought into contact over long
distances. This interaction allows CRMs to coordinately regulate transcription. A DNA loop can
contain genes whose expression are not altered by the paired CRMs. Active enhancers and promoters
are historically characterised by H3K27ac and DNase I hypersensitivity (accessible chromatin) with
enrichment of transcription factor binding. Promoters are generally marked with H3K4me3, while
enhancers are marked with H3K4me1. Published in [43].
tool has its own limitations and disadvantages. No current tool is able to consistently and accurately
identify all regulatory partners across multiple conditions and cell types. The tools identify only cell
type specific or cell type non-specific regulatory partners and generally make significant assumptions
about the data that are required to develop and use their models. This paper aims to establish guidelines
for their application in terms that would apply to scenarios faced by scientists; we refer to other,
detailed accuracy comparisons on controlled datasets in the literature [195, 65, 142].
2.2.5 Verifying targets with gene expression
We expect that knowing the status of binding in a CRM is predictive of changes in its targets’ level
of expression. RNA sequencing (RNA-seq) and cap analysis gene expression (CAGE) are used to
measure expression levels of genes and transcripts [169, 173, 162, 3]; as a bonus, CAGE is also able to
detect precise (alternative) transcription start sites (TSSs) and transcriptionally active enhancers. Both
RNA-seq and CAGE are applicable to develop (and train) methods; they are also able to validate them.
Expression level assays on a sample where the target transcription factor has been knocked out
or knocked down can be used to determine which genes show significant changes in expression
compared to a wild type sample. Genes showing significant changes in expression and evidence of
transcription factor binding can be annotated as direct target genes with some confidence. Indirect
targets are identified by this approach as genes showing expression changes with no indication of
target transcription factor binding.
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2.3 Predicting regulatory partners
Transcription factor binding at promoters proximal to a known gene has long been recognised as
influencing the expression of that gene [154]. Researchers have historically adopted an approach of
assigning binding events to the nearest gene as measured in basepairs, even when binding occurs
outside what would form the promoter. We henceforth refer to this annotation approach as nearest
gene (NG). While universally applicable, NG cannot ever assign the same CRM to different genes;
NG is blind to the many:many relationship between CRMs and it fails to consider distal interactions in
a cell type or condition specific manner.
Other distance based approaches exist which build on NG by scoring transcription factor peak-to-
gene assignments using additional parameters and a variety of statistical procedures [128, 110, 154].
These approaches were evaluated using expression perturbation data by Sikora-Wohlfeld et al. [154]
and the best performance was achieved by ClosestGene; an approach which generates transcription
factor target genes identical to NG with the addition of a probability score. Parameters in addition to
distance did not improve performance in the approaches explored by Sikora-Wohlfeld et al. [154] and
no validation of approaches using chromatin conformation assays are available. NG therefore remains
representative of distance based annotation approaches.
Here, we review computational tools currently available to predict target genes of distal CRMs,
beyond using a distance. We highlight specific technical approaches, data dependencies, application to
new data and any notable limitations. We pay particular attention to the different definitions of CRMs
and the ability to link cell type specific regulatory partners.
2.3.1 Unsupervised, statistical approaches
Initial attempts to identify distal regulatory regions were based on extracting more general relationships
between histone modification marks, chromatin accessibility and gene expression patterns across
multiple cell types [40, 168, 147]. Without providing any functional or structural information, the
studies showed that (unsupervised) models are able to discover and label states corresponding to
circumstances in which different chromatin and genome features co-occur. Indeed, it was shown that a
subset of the automatically labelled states corresponds to promoters and enhancers, which become
accessible and inaccessible, active and inactive, or poised in different cell types.
These initial studies explored a variety of datasets. Ernst et al. [40] used histone modification
intensity and gene expression; Thurman et al. [168] scanned chromatin accessibility (DNase I hypersen-
sitivity signals); and Sheffield et al. [147] explored chromatin accessibility and gene expression. Using
their models, Thurman et al. [168] and Sheffield et al. [147] successfully recovered enhancer/promoter
pairs in 5C and ChIA-PET data, and 3C data respectively; however, the enhancer/promoter pairs they
compared were limited to a distance of 100Kb up to 500Kb.
While these approaches were ground-breaking in terms of utilising chromatin markers and epi-
genetic features to label genomic regions by their potential role in different cell types, they were not
specifically designed and made available for predicting regulatory partners. The tools discussed in this
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section predict regulatory partners by exploiting statistical relationships between genomic states at
CRMs and at potential targets not unlike the aforementioned studies, and in many cases separated by a
distance.
CISMAPPER links target genes and transcription factor binding sites identified by ChIP-seq [127],
rather than CRMs. CISMAPPER calculates a correlation score between a histone modification signal
at the transcription factor binding site, and the level of expression at all TSSs within 500Kb, across
multiple cell types. The strength of correlation indicates the most likely target TSS. The success of this
strategy varies with the choice of histone modification and expression datatype; correlations between
histone 3 lysine 27 acetylation (H3K27ac) and CAGE expression levels at TSSs provide the highest
enrichment in experimental interactions determined by CHiC [127]. CISMAPPER excludes genes and
locations with low expression, low binding signal or those with weak variation across cell types.
ELMER (Enhancer Linking by Methylation/Expression Relationships) predicts enhancer/promoter
pairs by correlating DNA methylation patterns with expression data, for the closest N genes upstream
and N genes downstream of an enhancer [186]. Limiting the set of potential target genes to a given
number proximal to an enhancer, rather than those within a fixed distance of the enhancer, is a point
of difference for this approach. ELMER was developed on data specific to a number of cancer
methylomes. Although not experimentally validated, Yao et al. [186] provided evidence that DNA
methylation can identify enhancer regions and consequently be incorporated into enhancer/promoter
pair prediction.
PreSTIGE (Predicting Specific Tissue Interactions of Genes and Enhancers) predicts CRM-gene
pairs using a cell type specificity score (based on information theory) for histone 3 lysine 4 mono-
methylation sites (H3K4me1; commonly regarded as an “enhancer mark”) and gene expression using
data collected from twelve cell types [31]. PreSTIGE only considers genes and H3K4me1 sites that are
specifically expressed in each cell type. PreSTIGE defines sequence domains of 100Kb or by the first
occurrence of a CTCF site. (CTCF is commonly regarded as defining transcriptional insulators.) All
cell type specific H3K4me1 sites within the sequence domain of a cell type specific gene are annotated
as interacting or paired. Predictions of pairs based on these principles were shown to be enriched in
3C, 5C, ChIA-PET and eQTL datasets.
The FANTOM5 consortium have developed an atlas of enhancers for the human genome [3] that
can be incorporated into an analysis to link transcription factor binding sites with their target promoters.
Enhancers in this atlas can be linked to gene-proximal sites with transcriptional output by pairwise
expression correlation across a large number of cell types [3]. Enhancers are defined as gene-distal sites
with transcriptional output presenting in sense and anti-sense directions (on opposite strands) at most
400b apart, with the intervening sequence potentially bound to by transcription factors. Andersson et al.
[3] demonstrated that using these enhancer maps for predicting links recovered ChIA-PET supported
interactions. While the level of recovery was low (15%) at moderate correlation, similar tests with
alternative markers such as DNase I hypersensitivity assays demonstrated an even lower recovery rate.
Notionally, the FANTOM5 enhancer maps are not specific to cell type however; transcribed
enhancers and promoters in specific cell types can still be used to manually filter out links in the map
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where one or both partners are not expressed. The same principle applies to other cell type non-specific
tools such as CISMAPPER, e.g. remove any predicted links in which a partner (CRM or gene TSS) is
not active or expressed in a specific cell type, respectively.
2.3.2 Supervised, machine learning-based approaches
Unsupervised, statistical approaches offer a simple solution for identifying regulatory partners; however,
their predictive accuracy may be limited because they typically only consider one or a couple of
datatypes when evaluating regulatory links. The tools in this section consider a wider range of datasets
and their relationships, and apply machine learning techniques to predict distal interactions. This
guidance comes in the form of known physical interactions (and non-interactions), improving the
chance of finding discriminative combinations of features.
IM-PET (Integrated Method for Predicting Enhancer Targets) predicts cell type specific en-
hancer/promoter pairs using features that summarise relationships between enhancers, target promoters
and transcription factors [65]. Enhancers are scored and correlated with expression data of potential
target genes. Each enhancer is assigned a score based on transcription factor motif scanning and a
score for transcription factor concentration. These scores are correlated with gene expression. The
distance between an enhancer and a target gene, sequence conservation, and synteny across fifteen
mammalian species are included as additional features, which are used to train a classification model.
He et al. [65] demonstrated that IM-PET performs well on cross-validated training data. In their own
tests, IM-PET was more accurate than PreSTIGE and NG approaches.
RIPPLE (Regulatory Interaction Prediction for Promoters and Long-range Enhancers) predicts
cell type specific regulatory partners using features from many data sources that indicate relevant
relationships: architectural proteins, transcription activation, gene body activation and elongation,
transcription repression, chromatin accessibility and gene expression [142]. Promoter regions are
defined as genomic regions within 2.5Kb of a TSS. Enhancer regions are defined as genomic regions
at least 2.5Kb from a TSS. Enhancer/promoter pairs are represented by a vector representing the
statistical significance of signal enrichment for each feature. Regulatory links are tested for non-zero
enhancer/promoter pairs that are within 1Mb. RIPPLE provides accurate predictions across different
cell types; however, it cannot accurately predict enhancer/promoter pairs over shorter distances, which
is likely due to the poor resolution of the initial 5C training data. Roy et al. [142] showed that, in their
hands, RIPPLE predicts regulatory partners more accurately than IM-PET and PreSTIGE.
PETModule (Predicting Enhancer Target by Modules) predicts enhancer/promoter pairs by in-
corporating sequence conservation across five species, enhancer and promoter separation distance,
and correlation between enhancer and promoter chromatin accessibility with a functional similarity
score [195]. The functional similarity score between enhancers and putative target genes is measured
using GO terms of the target gene and predicted GO terms for the enhancer. Enhancer GO terms
are predicted from groups of binding motifs that co-occur in a significant number of the enhancer
regions [34, 35]. Putative target genes are considered if they appear within 2Mb of the enhancer
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regions. Although enhancers should theoretically have similar functional outcomes to their target
genes, it is not strictly the case in practice. Predicting target genes based on functional similarity is
consequently a coarse method for detecting regulatory relationships. Zhao, Li, and Hu [195] found
that the most informative feature for predicting regulatory pairs was distance, followed by sequence
conservation, gene function, and chromatin accessibility correlation. PETModule compared favourably
with IM-PET and PreSTIGE; however, it was unclear how Zhao, Li, and Hu [195] derived the compar-
ative performance metrics for each tool. This was further confounded by widely different numbers of
predicted partners, with PETModule much less conservative.
2.4 Application of NG, CISMAPPER and PreSTIGE
Exploring the role of a transcription factor typically involves a ChIP-seq analysis of the transcription
factor itself, combined with additional experimental datasets, which can include: ChIP-seq of one or
more histone modifications; ChIP-seq of transcription factors with a genome organisation role (e.g.
CTCF, cohesin, p300, Med1 or RNA Pol II); chromatin accessibility; and gene expression in a wild
type sample and a knockout sample (a sample where the target transcription factor is ablated).
Several studies have demonstrated that supervised machine learning-based approaches more
accurately annotate regulatory partners when compared to unsupervised statistical approaches [196,
142, 65]; however, most researchers are restricted to techniques that require a smaller number of
datasets due to lack of data availability.
This section demonstrates approaches that are applicable to datasets typical of a standard study.
We explore the role of two transcription factors; ATOH1 in a paediatric cancer of the cerebellum
(medulloblastoma) and OCT4 in mouse embryonic stem cells (mESCs). For ATOH1, we have access
to ChIP-seq [89], DNase-seq [48] and RNA-seq for wild type and ATOH1 knockout conditions [89].
For OCT4, we have access to ChIP-seq [28] and microarray data for wild type and OCT4 knockdown
conditions [107].
We compare the ability of NG, PreSTIGE and CISMAPPER to predict biologically relevant target
genes of transcription factors and highlight practical considerations of each approach. CISMAPPER
was run on transcription factor binding sites using the available web tool to generate annotations.
Pre-computed annotations for H3K4me1 sites in mouse cerebellum and mESCs were downloaded
from the PreSTIGE website with annotations overlapping ATOH1 and OCT4 binding sites extracted
respectively.
ATOH1 is a basic helix-loop-helix transcription factor that plays a role in the development of numer-
ous cell types, including key neuronal subtypes such as cerebellar granule and brainstem neurons [89].
Within the cerebellum, ATOH1 promotes proliferation of cerebellar granule neuron progenitor cells
and overexpression of this transcription factor is evident in some subtypes of medulloblastoma [47,
16, 5]. OCT4 is a transcription factor containing a POU domain with a key role in early mammalian
development [107]. It is essential for somatic cell reprogramming and its overexpression is associated
with multiple cancers [190, 28]. Identifying the target genes of ATOH1 and OCT4 will enhance our
Table 2.1: Description of available tools for computationally detecting regulatory partners
Tool Prediction Techniquea Feature/s and training datab Enhancer definition Cell
typec
Unsupervised, statistical approaches
CISMAPPER Correlation Variety of histone modifications (ChIP-seq) and transcriptional start sites
(CAGE tags) across multiple cell types
Binding site not enhancer NS
ELMER Correlation DNA methylation and gene expression (RNA-seq) across multiple cell
types
DNA methylation NS
PreSTIGE Cell-type specificity H3K4me1 and gene expression (RNA-seq) across multiple cell types H3K4me1 S
FANTOM5 Correlation Transcriptional start sites (CAGE tags) across multiple cell types Bi-directional transcription NS
Supervised, machine learning-based approaches
IM-PET Random Forest 4: Correlation between enhancer and target gene expression (RNA-seq),
transcription factor binding (ChIP-seq), distance between enhancer and
gene, sequence conservation and ChIA-PET
Predicted by CSI-ANN (based on histone
modification)
S
RIPPLE Random Forest 11: CTCF, RAD21, H3K4me2, H3K27ac, H3K9ac, H3K36me3,
H4K20me1, H3K27me3, chromatin accessibility (DNase-seq), TBP and
gene expression (RNA-seq) and 5C
Elements at least 2.5Kb away from a TSS S
PETModule Random Forest 4: Distance between enhancer and gene, sequence conservation,
correlation between enhancer and promoter chromatin accessibility
(DNase-seq) and GO term functional similarity score and ChIA-PET, 3C,
and 5C
Log ratio of H3K4me1 and H3K4me3;
H3K4me1 and H3K4me3; H3K27ac,
H3K4me1 and H3K4me3
S
aRandom Forest classifier takes the mode prediction output of many trained decision trees
b3C and 5C are chromosome conformation capture techniques that represent chromatin organization; ChIA-PET
combines chromosome capture with ChIP-seq to represent chromatin organization and protein binding sites
cNS indicates non-specific cell types; S indicates specific cell types
Table 2.2: Interface and limitations of available tools for computationally detecting regulatory partners
Tool Input Output Limitations Implementation Details
Unsupervised, statistical approaches
CISMAPPER ChIP-seq peaks Target genes, chromosomal
positions and confidence scores
Limited to the human (hg19) and mouse (mm9)
genomes and cannot introduce new data
Web interface
(http://bioinf.scmb.uq.edu.au/cismapper)
ELMER Custom R object containing
minimum of four data sources:
DNA methylation, RNA-seq,
probe information and gene
information
Nearby genes, expression levels,
significant partners, and motif
enrichment
Relatively complicated interface R-package
PreSTIGE ChIP-seq, H3K4me1 peaks and
RNA-seq gene expression
Target genes, chromosomal
positions, enhancer region, gene
expression and confidence score
Provides pre-computed annotations for human (hg18,
hg19) and mouse (mm9) genomes; limited to datasets
for which H3K4me1, ChIP-seq and RNA-seq are
available; 3-6 hours run-time; stringent input file
structure requirements
Galaxy and web interface
(http://genetics.case.edu/prestige/)
FANTOM5 Query chromosomal location or
gene expression
Enriched enhancer regions and
cell-type details
Limited to the human genome (hg19) Files available from SlideBase
(http://slidebase.binf.ku.dk/)
Supervised, machine learning-based approaches
IM-PET CSI-ANN output (enhancer
positions and enhancer signals,
ChIA-PET) and RNA-seq gene
expression
Target genes and prediction
score
Relies on ChIA-PET data, which is limited to
interactions involving the target protein and is
susceptible to false negatives [140, 32]; installation is
non-trivial and limited documentation
Galaxy and command-line software
package
RIPPLE Enhancer region, ChIP-seq
peaks, DNase-seq accessibility
and RNA-seq gene expression
(optional)
Feature values,
enhancer/promoter locations and
scores
Limited to human genome (hg19); inaccurate for
predictions over short distances; limited documentation
and application to new data is not obvious
Web interface
(http://pages.discovery.wisc.edu/ sroy/rip-
ple/index.html) and open source
software package
PETModule Enhancer locations Target genes and prediction
score
Only supports human (hg19) and mouse (mm10)
genomes and limited documentation
Command-line software package
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understanding of the transcriptional program driving cerebellar formation and embryonic development
respectively. Likewise, an understanding of ATOH1 target genes in medulloblastoma could lead to the
identification of factors that can be targeted for therapeutic intervention.
Both transcription factors have a wide range of functions, and likely regulate a diverse cohort of
genes, both during development and in pathological states such as cancer [89, 107, 190]. Klisch et al.
[89] provided 4,859 genes with significant changes in expression when comparing RNA-seq data
from ATOH1-null cerebellar tissue to wild type tissue. We analysed ChIP-seq data from cerebellar
granule neuron precursors [89], to identify potential ATOH1 binding sites. After rejecting sites not
overlapping with DNase-seq sites, we found 8,042 sites with high confidence. Since more than 92% of
these binding sites occur at locations further than 2Kb from TSSs, we consider ATOH1 primarily a
distal regulator and therefore a good candidate for comparing NG, CISMAPPER and PreSTIGE.
Microarray analysis of an OCT4 knockdown compared to wild type cells identified 4,712 genes
with significant changes in expression [107]. Processed ChIP-seq data of OCT4 in mESCs was
retrieved from GSE90893 and identified 36,477 binding sites [28]. Although DNase-seq is available in
mESCs, we chose not to use it to filter OCT4 binding sites as OCT4 is a pioneer factor and capable of
binding to inaccessible DNA [189, 159, 78]. We consider OCT4 a good candidate for exploring long
distance regulation as 90% of binding sites occur at locations further than 2Kb from TSSs and, in
mESCs, it has been shown to bind preferentially to enhancers [26, 28].
Expression data represents the biological outcome of gene regulation and is often available in
transcription factor studies. For this reason, we measure the performance of NG, CISMAPPER and
PreSTIGE using RNA-seq and microarray data. The best configuration of NG, CISMAPPER and
PreSTIGE will predict direct targets of a transcription factor with the greatest statistical enrichment of
differential expression (wild type vs perturbation).
2.4.1 Annotation of regulatory partners
Annotating regulatory partners presents three key challenges: identifying multiple target genes of each
promoter or enhancer region occupied by the transcription factor(s) of interest; identifying multiple
transcription factor binding sites that regulate each gene; and identifying distal regulatory relationships.
Although NG cannot identify multiple target genes, NG addresses the second challenge by annotating
multiple binding sites to single genes and is also capable of identifying limited distal interactions.
PreSTIGE and CISMAPPER address all three challenges by linking individual binding sites to multiple
genes, multiple binding sites to single genes, and linking CRMs to genes over long distances. NG is
the only technique able to annotate all transcription factor binding sites. CISMAPPER and PreSTIGE
are more conservative annotating 25.8% and 8.2% of ATOH1 sites respectively; and 74.1% and 7.8%
of OCT4 sites respectively. CISMAPPER and PreSTIGE both annotate gene-proximal binding sites to
targets other than the proximal gene for ATOH1 and OCT4. No approach has the capacity to detect
interactions between pairs or groups of gene-distal CRMs.
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2.4.2 Prediction of transcription factor target genes: individual methods
NG annotates all binding sites to target genes, resulting in a set significantly enriched with differentially
expressed genes for both transcription factors, i.e. NG was able to identify genes whose expression
changed with loss of transcription factor, with a number that cannot be explained by chance alone.
The size and enrichment of the target gene sets are reported in Fig. 2.2c&g (NG). PreSTIGE is
conservative when annotating binding sites for each transcription factor, resulting in a smaller set of
target genes, still with a significant enrichment for differential expression (see Fig. 2.2a&e (P)). For
ATOH1, CISMAPPER annotated a moderate number of binding sites, but was unable to predict a large
enough number of differentially expressed genes to be statistically significant (see Fig. 2.2b (CIS)).
For OCT4, CISMAPPER annotated a larger number of binding sites while maintaining statistical
significance (see Fig. 2.2f (CIS)).
2.4.3 Prediction of transcription factor target genes: combined methods
Strikingly, both PreSTIGE and CISMAPPER leave a substantial number of ChIP-seq peaks un-assigned
for both ATOH1 and OCT4. We are led to hypothesise that both methods are unlikely to have captured
the full diversity of either transcription factor’s role. Since each method uses different strategies, we
expect that they complement each other. Next, we combine both PreSTIGE and CISMAPPER with
NG, in two different ways.
First, NG can be consulted for all sites the original method fails to assign to a target gene. Com-
bining NG annotations with CISMAPPER annotations this way results in a larger set of target genes
significantly enriched for differentially expressed genes in both ATOH1 and OCT4 (see Fig. 2.2b&f
(CIS+NGR)). Similarly, applying NG annotations for all sites not identified by PreSTIGE with
PreSTIGE’s own annotations increases the number of identified genes. However, in contrast with
CISMAPPER, this results in an ATOH1 target gene set that is not significantly enriched in differentially
expressed genes while OCT4 maintains significant enrichment (see Fig. 2.2a&e (P+NGR)).
Second, NG can annotate only the binding sites that are not annotated by the original method,
and appear proximal to genes (±2Kb of TSS); even in the absence of corroborating evidence in the
form of epigenetic markers that the original method considers, the proximity to a gene is a strong
determinant. Based on this assumption, NG annotations for the remaining proximal binding sites are
combined with the PreSTIGE annotations. For both transcription factors there is an increase in the
number of identified genes while retaining enrichment of significantly differentially expressed genes
(see Fig. 2.2a&e (P+NGP)). The same application of NG, for not-yet annotated proximal binding sites
combined with the original CISMAPPER annotations, fails to result in a gene set statistically enriched
for differential expression in ATOH1 while significance is maintained for OCT4 (see Fig. 2.2b&f
(CIS+NGP)).
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2.5 Comparison of approaches
The target gene sets that maximise gene count and maintain enrichment from PreSTIGE and CISMAP-
PER are compared to NG target genes in Fig. 2.2c&g. Each approach detects unique target genes
however; the OCT4 comparison shows increased overlap of approaches compared to ATOH1. The
union of the three approaches results in the largest target gene sets showing significant enrichment of
biologically relevant genes for ATOH1 and OCT4.
NG and CISMAPPER are able to annotate the small subset of binding sites annotated by PreSTIGE.
We use this subset to directly compare the ability of NG, CISMAPPER and PreSTIGE to predict
transcription factor target genes. As illustrated by the Venn diagram in Fig. 2.2d&h, the sets of
predicted target genes do not entirely overlap. For this subset of ATOH1 sites, PreSTIGE predicts
the most significant enrichment of biologically relevant genes and CISMAPPER does not reach the
statistical threshold of relevant target genes. For the OCT4 subset of sites, a similar separation of
identified targets is observed however, statistically significant enrichment is maintained across all
approaches.
2.6 Implications of predicted ATOH1 target genes
OCT4’s role in mESCs is diverse; as evidenced by the large number of genes identified as targets
(3,737 target genes in the union of all approaches), and consequently DAVID functional annotation of
any target gene set detects numerous enriched terms and pathways which are highly generalised. A
number of target genes previously identified for OCT4 are present in the union of target genes across all
three approaches including; SOX2, NANOG and KLF4 belonging to the OSKM group of transcription
factors involved in cellular reprogramming [20, 163]. Also, SALL4, FGF4, LIN28a and ESRRB
which contribute broadly to proliferation, differentiation, developmental timing and maintenance of
ESCs [188, 91, 151, 194].
DAVID functional annotation of the ATOH1 union of target genes across all three approaches
(Fig. 2.2c) includes GO terms for nervous system development, brain development, cell differentiation
and transcription regulation. These terms indicate the predicted target genes agree with the known role
of ATOH1 as a transcription factor that plays a role in neurogenesis in the cerebellum reinforcing the
biological relevance of the set [89].
One-third of medulloblastomas are characterised by somatic mutations in genes from the Sonic
hedgehog (Shh) pathway or genes which interact with the pathway [125, 126]. ATOH1-predicted
target genes KIF3a [9] and GLI2 [47] are members of the Shh pathway; CXCR4 [174] is co-operative
with the Shh pathway and E2F1 [15] expression is triggered by the Shh pathway. KIF3a and E2F1 are
identified as target genes by all three annotation approaches, while GLI2 and CXCR4 are not identified
by PreSTIGE.
CISMAPPER identifies a set of unique target genes including four ZIC genes (1, 2, 3 and 5) as
targets of ATOH1, with ZIC2 previously linked to medulloblastoma [130]. Where CISMAPPER fails
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to identify target genes, no correlation has been detected or the gene expression levels or histone
modification signal representing the binding site may not have changed significantly enough to allow a
correlation to be calculated.
PreSTIGE identifies a small set of unique target genes with none that have previously been linked
to medulloblastoma. Why PreSTIGE fails to identify certain target genes could be due to lack of a
H3K4me1 mark at an ATOH1 site of interest, a H3K4me1 mark present at an ATOH1 site but not
deemed cell type specific, or that the ATOH1 cell type is not directly comparable to the original
PreSTIGE data source. The PreSTIGE annotations are from whole cerebellum and may not include
H3K4me1 marks specific to the cell population used to generate ATOH1 binding sites (cerebellar
granule neuron precursors).
The identification of multiple potential target genes of ATOH1 that have been previously implicated
in medulloblastoma highlights the utility of this approach. Through a combination of approaches, a
more diverse subset of target genes is identified than by any individual approach.
2.7 Conclusion
A number of approaches exist to annotate CRMs and transcription factor binding sites to their target
genes. We categorised them into two groups: unsupervised, statistical approaches and supervised,
machine learning approaches, to recognise on what basis they determine regulatory linkages between
regions on the genome. On the one hand, it is possible to detect coordinated activities just by measuring
statistical enrichment. CISMAPPER, PreSTIGE and ELMER fall into this category; FANTOM5 makes
available a simple enhancer/promoter map. All make use of large and commonly available datasets to
later support predictions based on limited user input. On the other hand, experiments can determine
physical interactions which can be learned from examples, and supporting datatypes. IM-PET, RIPPLE
and PETModule fall into this category. Since the user will need to provide the same input datatypes for
a prediction to occur, this latter category of tools put greater requirements on data availability beyond
a typical study.
When selecting an approach, it is important to consider the available data, the accessibility of
the tool and any limitations or weaknesses the approach has. Supervised approaches generally
have increased accuracy from published reports. We note that the specific tools available in this
category currently require more input data, have long run times and are less accessible to users without
programming experience. Unsupervised approaches typically require less input data at the time the user
applies them. These approaches tend to run efficiently and have implementations that are accessible to
all users.
We have provided a case study demonstrating the application of unsupervised methods and
highlighting their limitations and weaknesses. We have shown that a combination of unsupervised
methods can be applied to predict a more diverse set of biologically relevant target genes. These
predictions are based only on ChIP-seq data of the transcription factor of interest; while we also filtered
binding sites with chromatin accessibility data, and relied on a standard cell type being available for
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Figure 2.2: Predicted target gene set counts, comparisons and enrichment levels. P represents
predictions of PreSTIGE; CIS represents predictions of CISMAPPER; NGR represents NG run on all
binding sites not annotated by original approach; NGP represents NG run on proximal binding sites
not annotated by original approach; and PA represents the set of ATOH1 binding sites annotated by
PreSTIGE.
(a&e) Target gene sets were generated by applying PreSTIGE as an individual approach [P], in
combination with NG on all un-annotated binding sites [P+NGR] or in combination with NG on
proximal un-annotated binding sites [P+NGP]. [P+NGP] gave the largest gene set while maintaining
enrichment for biologically relevant genes in ATOH1 while [P+NGR] achieved this for OCT4. (b&f)
CISMAPPER was used to generate target gene sets as an individual approach [CIS], in combination
with NG on all un-annotated binding sites [CIS+NGR] or in combination with NG on proximal
un-annotated binding sites [CIS+NGP]. [CIS+NGR] gave the only set of genes showing enrichment
for biologically relevant targets in ATOH1 while all sets showed enrichment for OCT4. (c&g) NG
was used to annotate all binding sites and compared with [P+NGP] and [CIS+NGR] to observe the
consistency of annotations. PreSTIGE and CISMAPPER share target genes not detected by NG and
each approach identifies unique target genes for both transcription factors. Each target gene set was
enriched for biologically relevant genes and the union of all target genes from these approaches
resulted in a large set highly enriched for biologically relevant genes in ATOH1 and OCT4. (d&h)
To explore the target gene sets from each approach using the same original set of binding sites;
CISMAPPER and NG were used to annotate the subset of binding sites annotated by PreSTIGE [P].
When applied to the same set of binding sites, the three models are less consistent in their target
gene predictions and more likely to predict unique target genes. For ATOH1, the target gene set
from CISMAPPER is not enriched for biologically relevant genes while the other two approaches
identify biologically relevant targets. For OCT4, enrichment is maintained across all three approaches.
Published in [43]. *p < 0.05, **p < 1e−5, ***p < 1e−12
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PreSTIGE, these approaches can be applied with minimal data.
Ultimately, selecting the approach by which transcription factor binding sites are annotated
depends on the biological question and the transcription factor itself. If there is limited evidence of
a transcription factor operating over long distances, there is no incentive to select an approach that
makes such predictions. Different binding sites and types of interactions will be of more or less interest
and different approaches are better suited to annotating subsets of binding sites.
After selecting the approaches that can be used with the available data, the user must be aware of
the binding sites that each approach is capable of annotating. Exploring a combination of approaches
can strengthen the analysis and ensure that all three key challenges of annotation are addressed. We
have demonstrated that not all binding sites are equal with a variety of genetic and epigenetic features
leading to different approaches predicting different target genes given the same original binding sites.
When annotating transcription factor binding sites or CRMs, the required input data, the combination
of approaches, the biological question and handling of unannotated binding sites affect the number
and biological relevance of identified target genes.
2.8 Overall contribution
The conclusions stated above are valuable to the specific application of our workflow but are also
more broadly relevant to a number of other biological problems addressed by bioinformatics. As the
field of bioinformatics has developed, numerous computational approaches to align sequencing data,
process HTS assays or predict biological outcomes have been made available. In each case, there is an
argument that one should not limit their analysis to a single approach that has specific strengths and
weaknesses but rather explore the outcomes of multiple approaches and combine them in an informed
manner. By combining approaches, it is possible to mitigate the weaknesses or limitations of a single
approach and provide a more robust outcome. While the work described here specifically refers to
transcription factor gene targets, the logic and techniques employed to combine outcomes can be
adapted to a number of different scenarios.
The following publications include work outlined in Chapter 3.
1. James Fraser et al. “Cell-type-specific expression of NFIX in the developing and adult cerebel-
lum”. In: Brain Structure and Function 222.5 (2017), pp. 2251–2270
2. James Fraser et al. “Granule neuron precursor cell proliferation is regulated by NFIX and
intersectin 1 during postnatal cerebellar development”. In: Brain Structure and Function 224.2
(2019), pp. 811–827
3. James Fraser et al. “Nfia and Nfix shared target gene analysis”. In: TBC 0 (2019), pp. 0–1
Contributor Statement of contribution Reference 1 % Reference 2 % Reference 3 %
Alex Essebier writing of text 5 10 10
proof-reading 5 10 10
theoretical derivations 10 30 30
numerical calculations 10 30 30
preparation of figures 0 30 30
initial concept 5 50 50
I contributed an RNA-seq analysis to the first publication including writing a method section,
outlining the results of the speicific analysis and providing input into the interpretation of the results.
The second and third publications include work taken directly from this chapter and I contributed to
data processing and idea development as well as writing methods, constructing figures and writing and
interpreting results based on my contributions.
Chapter 3
Identifying key transcription factor binding
sites and their target genes through
integration of expression data and epigenetic
data
3.1 Introduction
Transcription factors control gene expression patterns through DNA binding and interaction with co-
factors ultimately leading to recruitment of RNA polymerase to up regulate expression or alternatively
creating an environment that prevents transcription thereby repressing gene expression [97]. With the
advent of high throughput sequencing assays generating numerous data sets that provide information
about transcription factor binding, epigenetics and regulatory outcomes; a challenging new field has
developed to determine how to extract high quality peaks from ChIP-seq data, identify target genes of
the transcription factor and determine the factor’s functional role given these targets. Well conceived
data processing and integration approaches in the form of a bioinformatic workflow are required to
extract this information however, no single approach or workflow currently exists to understand the
regulatory role a transcription factor plays in a specific cellular context. This chapter addresses Aim
1b to build a bioinformatic workflow that characterises the functional role of a transcription factor by
integrating high throughput sequencing data.
Here, we identify, evaluate and implement the required steps to create a workflow that characterises
the functional role and specific targets of a transcription factor by integrating available data from
multiple sources. Identification of a small set of specific targets allows further experiments to be
conducted in an hypothesis driven manner without the need to exhaustively test large numbers of
genes reported by broad brush approaches. As part of this chapter we identify key biological questions
required to characterise a transcription factor, report on currently available tools to perform different
stages of the workflow, identify gaps or weaknesses in the process where new approaches are required
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and ultimately address these gaps across the remainder of the thesis to improve the workflow itself but
also improve our general ability to extract new knowledge from available high throughput sequencing
data sets.
3.1.1 Approaches to identify transcription factor binding sites
ChIP-seq identifies protein binding sites in vivo and the use of ChIP-seq to investigate transcription
factor binding in specific cell types during development and disease is frequently used by molecular
biologists, driving the need for accessible and accurate tools to process data in an hypothesis driven
manner. Given an antibody specific to a transcription factor and the ability to extract the cells or
tissue of interest, ChIP-seq can detect transcription factor binding sites genome wide with reasonable
accuracy.
The data produced by ChIP-seq experiments is processed using statistical tools known as ‘peak
callers’ which identify regions of increased read depth and report the significant regions as ‘peaks’ or
transcription factor binding sites. Dozens of ChIP-seq peak calling tools are available each reporting
sets of peaks that can vary by number and location as a result of the statistical approach employed.
Peak calling approaches and associated challenges and weaknesses have previously been reviewed
and are not the focus of this work [166, 120]. However, we identified that tools to combine data from
multiple biological replicates were lacking leading to development of a new replicate merging approach
described in Chapter 4. ChIP-seq reveals up to tens of thousands of binding sites depending on the role
of the transcription factor with a known high false positive rate however, ChIP-seq data alone will only
reveal where the transcription factor is binding and not explicitly the genes it is regulating or the role it
is playing [56, 6]. Further, the presence of a transcription factor binding event identified by ChIP-seq
at a gene does not confirm that the transcription factor is regulating the gene at that point in time.
MACS2 was selected as a peak caller in this chapter to provide transcription factor binding sites that
are further resolved using our workflow by integrating supporting data sets such as RNA-sequencing
(RNA-seq) and DNase I Hypersensitivity (DHS) assays. Transcription factors are known to bind
preferentially in regions of accessible chromatin [60, 76] and DHS was therefore used to extract only
ChIP-seq peaks occurring in accessible regions.
ChIP-seq experimental data is not always available for all transcription factors and cell types
however a sufficient amount of data now exists to apply machine learning and statistical approaches to
predict cell type specific transcription factor binding sites across the genome. A workflow with the
ability to characterise transcription factor binding without the need for experimental data would be
widely applicable assuming the predictions are accurate. While this chapter focuses on ChIP-seq data
to identify transcription factor binding events, currently available predictive approaches are reviewed
in Chapter 5 along with a description of our own approach to predict transcription factor binding in
vivo.
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3.1.2 Annotating transcription factor binding sites to target genes
The most challenging aspect of discovering functional roles of transcription factors is annotating
binding sites to target genes. When a binding site is distal to a transcription start site (TSS) (>2,00bps
away), it is unlikely to target the nearest gene with studies of DNA looping showing as few as 7% of
distal sites linked to the nearest gene [145]. Multiple approaches have been reported to annotate distal
events to target genes with increased accuracy as reviewed in Chapter 1 where they were found to
face numerous challenges and limitations. No approach will accurately annotate all binding events
and at the time the work in this Chapter was conducted, CISMAPPER [127] was identified as current
best practice for annotating distal binding events to target genes based on CISMAPPER’s improved
performance over other tools. A combination of the nearest gene approach and CISMAPPER were
incorporated into our workflow to annotate binding events to target genes. The way that this workflow
is defined would allow for additional or completely different annotation approaches to be applied to a
users’ specific problem, a key conclusion of our published literature review.
3.1.3 The mechanism of action and functional role of a transcription factor
Using chromatin state to define and filter transcription factor binding events
Previous studies have shown that transcription factor binding sites exhibit distinct patterns of histone
modifications and DHS sequencing [42, 40, 63, 98]. Where available, these data sets can be overlapped
with ChIP-seq transcription factor peaks in order to better understand a transcription factor’s binding
mode and functional role. Specifically, they can be used to filter binding sites to extract high confidence
peaks or peaks with a specific role (e.g. repressive), determine the epigenetic environment preferentially
bound by a transcription factor and define regulatory regions such as promoters and enhancers. No
approach currently exists to annotate binding events with associated epigenetic data, a novel feature
that is integrated into our bioinformatic workflow that sheds light on the mode of operation of the
target transcription factor.
Assigning function to a transcription factor
RNA-seq can be performed under wild type (WT) conditions and compared to a knock out (KO)
condition where the target transcription factor is removed to identify genes showing significant changes
in expression that are likely to be directly or indirectly regulated by said transcription factor [169,
173]. Transcription factors are known to regulate expression of other transcription factors orchestrating
multiple, successive and coordinated changes in expression across the regulatory system [176, 164].
This is an added challenge when attempting to use expression data from perturbation experiments
to determine the genes regulated by a transcription factor. Many genes will be detected as changing
between conditions but only a handful will be directly regulated by the target transcription factor itself.
It is also possible that, through redundancy in the system or functional overlap, target genes will not
show a change in expression between the two conditions [85]. Combining genes showing differential
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expression patterns with known binding events from ChIP-seq data provides a more complete set of
true target genes (a targetome) from which function can be inferred. Our workflow implements steps
to combine this information reporting a refined targetome for the transcription factor of interest, a
novel approach that has not previously been reported.
The resulting sets of genes that show differential expression patterns and are bound by the target
transcription factor can be characterised using functional annotation tools such as DAVID. While
effective guides, the different functional annotation approaches that are available can be temperamental
and are highly dependent on their incomplete knowledgebases and should therefore be used cautiously
[75, 73, 37, 175]. One advantage of using functional annotation is to prioritise genes that are related to
each other and perform a function of interest within the cell. Improvements to functional annotation of
target genes are outside the scope of this work.
Another method for exploring the functional role of a transcription factor, particularly in the context
of development, is through the use of temporal data. Binding events at key developmental time points
that are absent in later stages identify a reduced set of genes with a major role in development. As
part of constructing our workflow, we implemented a novel approach that characterises binding events
based on changes to accessible regions over time identifying events that are specific to the time point
of interest refining the target genes of interest even further.
3.1.4 Identification of interacting factors
Transcription factors rarely, if ever, act alone to regulate expression and can work with other factors
in a variety of ways including protein-protein interactions (homo- or hetero-dimers and oligomers),
cofactor interactions, cooperatively, competitively and additively [80, 55, 152, 90, 115, 165, 138].
Two transcription factors that interact will likely share a set of binding events and have a common
set of target genes and the degree at which the targetomes overlap is indicative of similarities in the
functional roles of each individual transcription factor. Our workflow reports high confidence binding
events and a well defined targetome for a transcription factor; information that can be compared
between different factors to determine whether they bind similar locations or regulate a similar set
of target genes. There exist tools to compare ChIP-seq experiments [7, 66] and simple approaches
to overlapping and comparing RNA-seq outcomes are also available but no approach uses all of this
information to characterise potential interactions between two transcription factors. Our workflow is
capable of considering all of the available information across two factors to generate a ‘pair targetome’
consisting of genes bound by both factors with significantly differential expression in both KO lines
and a log fold change (LFC) in the same direction. A small set of coordinately regulated target genes
between transcription factors would indicate that the two factors have distinct functional roles while a
high number of coordinately regulated genes can indicate a shared interaction between the two factors.
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3.1.5 NFIs and Atoh1
To determine the effectiveness of the presented processing workflow, three transcription factors were
identified that had all the relevant high throughput sequencing data including ChIP-seq, accessibility
and RNA-seq data in the same cell line. Advantageously, these factors play a similar role in driving
development of the cerebellum with key changes occurring between postnatal day five and seven (P5
and P7 respectively) in granule neuron progenitor cells (GNPs) [89, 88]. This provides additional
opportunity to explore whether Nfia, Nfix and Atoh1 coordinately regulate gene expression changes.
ChIP-seq data (transcription factor and histone modification) of Nfia and Nfix in P7 GNPs and Atoh1
in P5 GNPs was explored alongside DHS data from whole cerebellum at P7, histone modification
data in GNPs at P7 and RNA-seq perturbation studies where each of the transcription factors had been
knocked out with expression compared to wild type samples. Additionally the Atoh1 motif was found
to be enriched in Nfix binding peaks providing evidence that the two factors are interacting in their
respective roles at driving neural development in the cerebellum [50]. These data were used in two
published case studies to illustrate the effectiveness of our bioinformatic workflow at characterising
the functional role and specific target genes of a transcription factor.
It is worth noting that it was challenging to find studies that included RNA-seq performed under
conditions where the transcription factor had been knocked out. This is somewhat surprising as this
information is invaluable when determining the functional role of a transcription factor.
3.1.6 Workflow presentation
A standalone workflow tool is currently not a practical outcome of this work. Bioinformatics as a
field suffers from a high diversity of tools presented to solve the same task making a workflow that is
applicable to a wide variety of data and biological questions challenging. For example, the alignment
tool of choice when handling ChIP-seq, RNA-seq or DHS data can vary depending on species,
sequencing type, data quality and personal preference. Building a standalone packaged workflow that
can be distributed but is limited to a strict set of tools will restrict its use and reduce its application to
novel hypotheses. In this chapter we include a detailed methodology that captures the key processes
and functionality of our workflow from which others can construct a replica workflow specific to their
data and choice in bioinformatic tools. While presenting the workflow as a methodology requires more
work on behalf of the user, it ensures that the workflow will be applicable to a wide variety of use
cases and compatible with any combination of tools as selected by the user.
3.1.7 Summary
This chapter forms a preliminary review of tools, techniques and protocols available to answer each of
the key aspects of transcription factor biology addressed here combined into a functional bioinformatic
workflow. It also identifies the steps that lack available tools or approaches that could be improved
forming the basis of subsequent chapters in the thesis.
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The workflow, presented as a detailed methodology, characterises the functional role of a tran-
scription factor by identifying high confidence and specific target genes based on ChIP-seq, DHS and
RNA-seq data. In addition to this core functionality to define transcription factor regulatory activity,
our workflow provides novel epigenetic profiles that can aid in defining the mechanism of action
of a transcription factor. It can also integrate data across two factors to identify a ‘pair targetome’
and define the regulatory relationship between two transcription factors. Finally, where temporal
accessibility data is available, a novel approach within our workflow can characterise binding events
relative to changes in chromatin state and identify which events are playing a key regulatory role at
specific points in time.
3.2 Methods and materials
3.2.1 Bioinformatic workflow
Figure 3.1 illustrates the key steps of our workflow and the specific details of each step as applied to a
set of mouse cerebellar data are described below. Our workflow can be easily repeated on new data
through application of the methods described here. The specific data described here in the workflow
methodology form the output data on which our workflow is evaluated in the rest of this chapter.
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Figure 3.1: Summary of bioinformatic workflow and associated references in chapter body.
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3.2.2 Data
Raw ChIP-seq data from Nfia and Nfix in granule neuron progrenitor (GNP) cells at postnatal day seven
(P7) was available from a collaborator [50, 51] as well as raw ChIP-seq data for histone modifications
histone-3 lysine-4 mono- and tri-methylation (H3K4me1 and H3K4me3), and histone-3 lysine-27
acetylation (H3K27ac) in P7 GNP cells. Raw ChIP-seq data for Atoh1 in GNP cells at postnatal
day 5 (P5) was sourced from Klisch et al. [89] along with H3K4me1 and H3K4me3 data. DNase I
hypersensitivity sequencing called peaks from whole cerebellum at P7 and P14 were retrieved from
Frank et al. [48].
RNA-seq data from P7 GNP cells of wild type (WT), Nfix-/- (Nfix KO) and Nfia-/- (Nfia KO) mice
was processed to identify genes differentially expressed (DE) after loss of each transcription factor
(see Methods in [49]). For Atoh1, processed RNA-seq data was obtained comparing expression of
embryonic day 18.5 (E18.5) WT and Atoh1- (Atoh1 KO) cerebellar tissue [89].
DNase I hypersensitivity (DHS) called peaks from whole cerebellum at P7 across three replicates
were retrieved from Frank et al. [48] (GEO: GSE60731). UCSC liftover was used to convert the
processed mm9 bed files to mm10.
3.2.3 Data processing
Alignment
All raw ChIP-seq data was aligned to the mm10 reference genome using bowtie2 [99]. Unaligned
reads and reads which aligned to multiple locations were removed to ensure each aligned bam file
contained only uniquely mapped reads. The bam files were sorted and indexed to allow efficient access
and visualisation where required. RNA-seq data was processed according to the Methods in [49].
Peak calling
Peaks were called for transcription factors and histone modifications using MACS2 [46]. For Atoh1,
Nfix and Nfia, narrowpeaks were called using the callpeaks command. For histone modifications
(H3K4me1, H3K4me3 and H3K27ac), broadpeaks were called using the callpeaks command with the
‘- -broad’ flag.
Merging replicates
Where biological replicates were available, peaks were called for each individual replicate then
merged using a set theoretic approach (an approach discussed and improved on in Chapter 4) in which
overlapping peaks were merged if they met a depth threshold set by the user. The Atoh1, H3K4me1
and H3K4me3 data sets from Klisch et al. [89], and the Nfix and Nfia data sets from Fraser et al. [50,
51] each had two replicates and the final set of peaks represents locations where a peak was observed
in both replicates. The DHS and H3K27ac data each had three replicates and a peak was recorded
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Group DHS H3K27ac H3K4me1 H3K4me3
Specific States
Active promoter
Active enhancer
Poised promoter
Poised enhancer
Broad States
Active regulatory
Poised regulatory
Active accessible
Accessible
Inaccessible
Table 3.1: A description of the epigenetic state labels applied to different transcription factor binding
sites and descriptions of the marks (grey) which define each state. The states are adapted from
descriptions in Ernst et al. [40] with a specific state linked to a key role while a broad state carries
non-specific marks with decreased biological significance.
when it was observed in at least two replicates. A peak which passes the depth criteria was recorded
using the maximum boundaries of the supporting peaks.
3.2.4 Annotating transcription factor binding sites
Epigenetic environment
To explore the epigenetic environment of transcription factor binding sites, each set of peaks was
overlapped with H3K27ac, H3K4me1, H3K4me3 and DHS sites. Depending on the observed overlaps,
each peak was annotated with an epigenetic state as described in Table 3.1 and supported by observa-
tions made by Ernst et al. [40]. DHS was used as the primary filter of ChIP-seq transcription factor
peaks as binding in inaccessible regions is uncommon and linked to false positive peaks.
Binding location and gene targets
A promoter region is defined as ±2,000bps around a TSS. Binding sites located in a promoter are
annotated as proximal, while sites outside the promoter region but overlapping a gene are labeled as
genic. All remaining binding sites are labeled as distal. All binding sites were assigned two target
genes. First, the nearest gene and then, to a predicted gene target from CISMAPPER. CISMAPPER
provides target gene identification for distal binding sites but can also detect secondary targets for
genic and proximal binding sites. Binding sites were converted to mm9 coordinates and CISMAPPER
was run using the mm9 H3K27ac track with links filtered to a threshold of 0.05 [127]. All genes
3.3. RESULTS 35
identified as targets of a binding site by CISMAPPER were recorded (potentially multiple) and all
binding sites were also annotated to the nearest gene for comparison.
ChIP-seq data alone identifies large numbers of putative target genes that cannot be accurately
characterised by functional annotation. Additional filters are required to reduce target genes to
those that are most biologically relevant. Therefore, the associated q-value from relevant RNA-seq
differential expression analyses was recorded for each gene target of a transcription factor binding site.
Target genes with a q-value < 0.05 are considered significantly differentially expressed (DE) and form
the targetome for each transcription factor.
Pairs of transcription factors were explored to identify a pair targetome, specifically Nfix/Atoh1
and Nfix/Nfia. Genes in a pair targetome are targeted by both transcription factors, have a q-value <
0.05 in both experiments and show coordinated positive or negative log fold change values (i.e. both
positive or both negative).
3.2.5 Functional annotation of gene targets
All functional annotation analyses were performed using DAVID (6.8) including the targetome of each
transcription factor and pair targetomes of Nfix/Nfia and Nfix/Atoh1 [72, 74].
Known transcription factors from the Mus musculus genome were sourced from multiple databases
including DBD: transcription factor prediction database, Animal Transcription Factor database (Ani-
malTFDB3.0) and Uniprot (search term: ‘transcription factor AND reviewed:yes AND organism:”Mus
musculus (Mouse) [10090]”’) [179, 192, 30, 71].
3.2.6 Identifying changes in chromatin landscape over time
DHS data across P7 and P14 provided an opportunity to explore the changing chromatin landscape
of the developing cerebellum. Comparing pairs of the two key time points, DHS sites unique to P7
compared to P14 are ‘closing’ and sites unique to P14 compared to P7 are ‘opening’.
3.3 Results
3.3.1 The bioinformatic workflow delivers validated observations about the
role of transcription factors in regulation
The new workflow allowed the integration of data that had previously only been considered indepen-
dently resulting in improved understanding of transcription factor binding, gene targets, epigenetic
patterns and ultimately the role of one or more transcription factors in the target cell (in this case
Atoh1, Nfia and Nfix in GNPs). The workflow refined available data to identify new and targeted
hypotheses that could be experimentally validated as shown here and in [50] and [51]. The specific
outcomes of the workflow are demonstrated through the case studies in Section 3.3.10 where we gain
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a unique understanding of Atoh1, Nfia and Nfix biology due to the integrative nature of the workflow
that allows multiple data sets to be considered when defining transcription factor biology.
3.3.2 Filtering steps in the workflow generate a set of binding sites with in-
creased confidence for each transcription factor
Extracting sites present in both biological replicates and further filtering sites based on accessibility
provides a set of binding sites from ChIP-seq data with higher confidence than independent repli-
cates or ChIP-seq alone. No complete true positive set of peaks is available for any ChIP-seq data
making confidence or accuracy impossible to quantify and instead requiring biological significance
to demonstrate performance. Figure 3.2 provides a summary of the binding events observed for
each transcription factor before and after the accessibility filter was applied with 95%, 85% and 89%
of binding sites retained for Atoh1, Nfix and Nfia respectively. The proportion of binding sites at
inaccessible regions given the genomic location relative to a gene is also shown in Figure 3.3.
Binding sites at inaccessible regions of the genome are linked to a similar set of target genes as
those occurring at accessible regions. Atoh1, Nfix and Nfia inaccessible binding events target 115,
116 and 221 genes respectively that have significant differential expression. 30%, 32% and 18% of
Atoh1, Nfix and Nfia genes respectively targeted by binding events in inaccessible regions were also
targeted by binding events at accessible regions for the same factor. Genes that were targeted by only
an inaccessible binding event showed no significant enrichment of functional terms. This supports the
exclusion of inaccessible binding sites from consideration.
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Figure 3.2: Summary of binding events, target genes, RNA-seq identified genes and final targetome of
each TF. This figure illustrates how ChIP-seq data is filtered based on DHS overlap then combined
with RNA-seq analysis to refine target genes to a high confidence targetome.
3.3.3 Data integration generates epigenetic profiles that reveal primary mech-
anism of each transcription factor
The new bioinformatic workflow combines all available epigenetic data to create epigenetic profiles
that describe the the epigenetic state across all binding locations. The epigenetic profiles displayed
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in Figure 3.3 (based on Table 3.1) subsequently reveal the binding preferences of each transcription
factor indicating that Nfia and Nfix operate similarly while Atoh1 has a distinct profile.
Atoh1 has the highest proportion of binding sites located at promoters followed by Nfia and then
Nfix however the majority of binding sites across the three factors occur at genic or distal locations.
The promoter epigenetic profile of Atoh1 is distinct to the Nfi profiles with over half the sites marked
by broad chromatin states while the remainder are a mix of active and poised promoter states. A higher
proportion of binding events overlapping active promoter epigenetic states indicates an increased
regulatory potential. The promoter profiles of both Nfi factors tend to indicate a higher proportion of
specific states including active and poised promoter, with an increase in active and poised enhancer
activity compared to Atoh1. Enhancer activity at a promoter region could indicate that these binding
events are under distal regulatory control.
In regard to distal and genic binding events, Atoh1 stands out as having distinct profiles where
only 3.4% (distal) and 4.0% (genic) of binding events overlap specific chromatin states (see Table
3.1). In contrast, the Nfi factors show a higher proportion of binding events that overlap specific
chromatin states, in particular active and poised enhancer states. A small subset of binding sites overlap
active promoter states possibly marked as such by long distance DNA looping interactions with active
promoter regions.
No histone marks associated with repressive activity were available for these transcription factors
and we cannot, therefore, make comment on whether binding events are repressing target genes and
how that could influence the epigenetic profiles of these factors.
Overall, the Nfi factors appear to be operating distally with a large proportion of their binding
sites overlapping enhancer linked chromatin states. Many of the binding sites overlap poised states
indicating that they are not actively regulating their target genes at this stage in development. Generally,
Atoh1 operates over long distances and, at this stage in development, is actively regulating only a small
fraction of its target genes and is poised to act on the majority or is perhaps repressing targets and we
cannot capture this pattern.
3.3.4 A combination of approaches identifies transcription factor target genes
Combining annotation approaches for transcription factor binding sites identifies novel target genes
for all explored transcription factors. Table 3.2 shows that the nearest gene approach identifies a set of
unique target genes (not identified by CISMAPPER) with a proportion showing differential expression
in the respective KO RNA-seq analyses. CISMAPPER identifies smaller sets of unique target genes
but similar proportions of differential expression as the nearest gene approach. Genes identified as
targets by both approaches show the highest proportion of differential expression. These target genes
have support from both approaches and are more likely to have multiple binding events increasing the
likelihood they are regulated by the target factor.
Functional annotations of the three sets of differentially expressed target genes (Nearest Gene
unique, CISMAPPER unique and common) (Appendix C) show that all are linked to terms relevant to
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Figure 3.3: A breakdown of the epigenetic environment in which each binding site occurs across three
transcription factors. All binding sites of each transcription factor are represented in this figure and
broken down by location (x-axis) and then by the observed proportion of each epigenetic state (y-axis).
Raw counts and proportions of peaks belonging to each location are recorded at the top of each plot.
For example, 271 (3.92%) of Nfix binding events occur at a promoter and roughly 13% of those events
have an ‘Active Promoter’ state. Table 3.1 describes the histone modification and accessibility patterns
that define each state represented in this figure.
Table 3.2: Summary of unique and common gene targets identified by each annotation approach across
three transcription factors. The Nearest Gene and CISMAPPER annotation approaches each identify
a set of unique target genes represented as a count with the number of genes showing differential
expression (DE) represented as a percentage. The two approaches also have a subset of common target
genes which have the highest percentage of differentially expressed genes.
NearestGene % DE CISMAPPER % DE Common % DE
Atoh1 2,977 24 1,869 24 1,043 36
Nfix 2,575 12 1,313 9 733 21
Nfia 3,724 15 2,541 10 1,606 26
neural development but the common targets show increased significance and GO terms that are more
specific to cerebellar development. This indicates that combining target gene annotation approaches
returns the most relevant gene set.
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3.3.5 Transcription factor target genes are refined by expression data
A small proportion of genes bound by a transcription factor, referred to as target genes, show significant
changes in expression when the target transcription factor is knocked out; indicating that not all binding
events are functional in terms of directly affecting expression. 26%, 13% and 16% of Atoh1, Nfix and
Nfia bound genes show significant changes in expression. A number of genes identified as differentially
expressed show no evidence of being targeted by the transcription factor of interest with only 32%, 41%
and 54% of Atoh1, Nfix and Nfia DE genes bound by their respective target transcription factor. This
is visually represented in Figure 3.2. This indicates that, although each transcription factor appears
to be binding a number of target genes, their expression levels are not being altered at this stage in
development. This is further supported by the lack of active epigenetic states observed across all the
factors in Figure 3.3. The addition of repressive marks to the analysis would indicate what proportion
of binding events are influencing expression changes by repressing target genes.
Across all three transcription factors, this is a demonstration of direct and indirect targets within the
genome as many genes have been disrupted, but not all by the target transcription factor. Transcription
factors themselves regulate other transcription factors which would, in turn, regulate expression of
their own target genes: known as indirect targets. These patterns are also indicative of redundancy and
functional overlap as many genes which appear to be targets of a transcription factor based on ChIP-seq
data alone are not supported by the RNA-seq analysis; their expression hypothetically regulated by
other factors in an attempt to maintain homeostasis.
Considering all differentially expressed genes in the Atoh1 RNA-seq data, only a small proportion
are bound by a ChIP-seq peak while 59% of all Atoh1 peaks are annotated to a differentially expressed
gene; i.e. binding of Atoh1 indicates a higher probability that the target gene will be misregulated but
differential expression does not indicate that Atoh1 is bound. For Nfia and Nfix; 43% and 26% of
peaks are annotated to a differentially expressed gene.
3.3.6 Targetomes generated by the new bioinformatic workflow reveal novel
gene targets and the functional role of a transcription factor
Our bioinformatic workflow was applied to two different sets of transcription factors (Atoh1 and
Nfix, Nfia and Nfix) to generate and experimentally validate hypotheses to improve our understanding
of each transcription factor’s role in cerebellar development. I am listed as co-first author on two
analyses reported in detail in Fraser et al. [50] and Fraser et al. [51] and summarised below that include
specific details about the workflow and a full set of results acting as published case studies for our
bioinformatic workflow. Briefly, all targetomes identified by the workflow contained specific genes
that had previously been linked to each transcription factor and were also enriched for functional terms
consistent with the role each factor is known to play in cerebellar development validating that the
workflow generates results consistent with known biology. Each analysis goes on to then validate
specific novel targets of the transcription factors under consideration illustrating how new knowledge
can be extracted from the output of our bioinformatic workflow.
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3.3.7 Targetome genes annotated as known transcription factors by the work-
flow reveal broader functional role of target factor
Our workflow further characterises targetome genes by extracting genes that are known transcription
factors offering insight into the broader regulatory role of the target factor. In total, 3,084 transcription
factors were identified in the mouse genome across three explored databases. The Atoh1 targetome
had the highest number of transcription factors at 319, followed by Nfia at 198 and Nfix at 103. A
high number of transcription factors as targets will lead to an increase of indirect target genes showing
changes in expression and offers an explanation as to why Atoh1 has more differentially expressed
genes compared to Nfix and Nfia. For each pair of transcription factors, the transcription factors
appearing in both targetomes were also counted with Nfix and Nfia sharing more factors than Nfix
and Atoh1 (60 compared to 37). Nfix and Nfia belong to the same transcription factor family and
have a coordinated regulatory role increasing the likelihood they would bind to similar targets. This
information can be used to begin construction of gene regulatory networks however that is outside the
scope of this study.
3.3.8 Temporal accessibility data identifies development specific binding events
Comparing accessibility data at P7 and P14, we can identify the sites in P7 that have become inaccessi-
ble or ‘closed’ by P14 at which time key developmental stages of cerebellar development have been
completed. Nfia and Nfix binding events at these P7 unique accessibility sites are more likely to be
involved with driving cerebellar development. 22,121 sites unique to P7 exist covering 2,441 Nfia and
983 Nfix binding events. These Nfia and Nfix events accessible only in P7 are bound to 460 and 232
significantly differentially expressed genes respectively in their specific RNA-seq analyses. DAVID
functional annotations showed that each reduced set of genes was enriched for a subset of terms from
the original analyses that are more closely linked to neural development (Appendix C).
Each gene set also had unique enriched terms compared to the original analysis that reinforced
the efficacy of using temporal data to identify genes closely linked with development at P7. For Nfia
P7 specific target genes; a new pair of terms was detected as enriched which did not appear in any
other functional enrichment tests: semaphorin-plexin signaling pathway and semaphorin receptor
binding. Semaphorins regulate where cells navigate to, branch and terminate and have previously been
shown to play a role in cerebellar development [116, 93]. For Nfix P7 specific target genes; neuron
migration, neuron development and neuron projection morphogenesis were included in the unique
terms indicating the genes are directly involved in driving development. While no new genes were
identified, reducing the number of genes allows generation of more specific hypotheses regarding the
role of Nfia and Nfix in cerebellar development and would not have been possible without the use of
our new workflow’s ability to integrate temporal data.
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3.3.9 Transcription factor pair targetomes as defined by the bioinformatic
workflow reveal levels of interactions between factors
Considering all RNA-seq DE genes for each of the three transcription factors; Nfix and Atoh1
misregulate 459 common genes of which 198 (43%) show coordinated LFC (e.g. both up regulated or
both down regulated) compared to Nfix and Nfia that misregulate 643 common genes of which 590
(92%) show coordinated LFC. The higher proportion of genes with coordinated LFC between Nfix and
Nfia indicates that the functional role of the two factors is more similar than that of Nfix and Atoh1.
This is unsurprising as Nfia and Nfix belong to the same family of transcription factors.
Considering both ChIP-seq and RNA-seq data to generate pair targetomes, Nfia and Nfix share
304 target genes of which 283 (93%) show coordinated LFC while Nfix and Atoh1 have a smaller
pair targetome of 177 target genes with only 90 (51%) showing coordinated LFC. While Atoh1 and
Nfix share functional roles, Nfix itself is regulated by Atoh1 and the overlap in target genes may be
a result of the two factors working in the same regulatory network or pathway rather than cofactor
binding. Nfix and Nfia are known to operate as dimers and the similarity in target genes and activating
or repressive tendencies represented by LFC supports the hypothesis that they function in a highly
coordinated manner.
3.3.10 Published case studies implementing bioinformatic workflow
In both studies outlined below, our bioinformatic workflow made it possible to integrate the disparate
pieces of information available regarding transcription factors and extract new information about their
functional role to specifically identify novel targets for factors under consideration.
Atoh1 and Nfix coordinately regulate a set of genes during cerebellar development
This result is reported in full in Fraser et al. [50] or Appendix A. The analyses I was responsible for
are represented in Figures 5 and 6 that I constructed based on the results generated by our workflow.
In summary, de novo motif discovery of Nfix ChIP-seq peaks identified both the Nfix and Atoh1
motifs. This provided evidence that both transcription factors bind together and regulate transcription
in a coordinate manner. Our bioinformatic workflow was applied separately to Nfix and Atoh1 to
generate individual targetomes and a pair targetome was also generated as there were indications the
factors interacted with one another. We successfully generated targetomes that were linked to the
expected functional role of each transcription factor using our pipline. Nfix was identified as a target
gene of Atoh1 further supporting a relationship between the two transcription factors.
Multiple genes of interest exist in the pair targetome which consists of 90 genes from the Nfix
targetome that overlap the Atoh1 targetome where fold change is coordinately misregulated (i.e. up
in both data sets or down in both data sets). This set included the oncogenes KIT and OTX2 as well
as a number of genes previously identified as playing key functional roles in development in the
Cerebellum. All the genes identified are prime candidates for further experimental exploration and
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validation. Specifically, Itsn1 was explored as a target of Nfix and Atoh1, its expression was validated
using q-PCR and a KO line was shown to have a highly similar phenotype to Nfix KO mice.
Common roles of Nfix and Nfia
This result is reported in full in Fraser et al. [51] or Appendix B. The analyses I was responsible for
are represented in Figures 5 and 6 that I constructed based on the results generated by our workflow.
In this study, our bioinformatic workflow was applied to analyse common regulatory targets of
the NFI family of transcription factors to reveal that Nfia and Nfix share a significant proportion of
target genes and common functional roles in the developing cerebellum. This analysis also included a
third ChIP-seq data set capturing Nfib binding events but lacked RNA-seq data to identify direct target
genes. Our workflow was able to integrate the Nfib ChIP-seq data and found that 282 of 283 genes
that belonged to the Nfia and Nfix pair targetome were additionally bound by Nfib confirming the
hypothesised coordinated role of the NFI family of transcription factors in cerebellar development.
3.4 Discussion
This chapter describes a bioinformatic processing workflow that provides new insight into transcription
factor biology that had previously not been possible. This is achieved through the workflow’s ability
to integrate accessibility, histone modification and RNA-seq data to accurately identify transcription
factor binding sites, target genes, functional role and interacting factors to characterise the role of the
target transcription factor in vivo. We successfully applied this workflow to three transcription factors;
Atoh1, Nfia and Nfix, and identified new target genes and further characterised their role in regulating
GNP biology within the postnatal cerebellum. We also identified interactions between Atoh1 and Nfix
specifically but the NFI family more broadly and confirmed the highly coordinated regulatory roles of
Nfia and Nfix. Ultimately, we developed a new workflow that can generate valuable biological insights
by strategically integrating and summarising available data.
3.4.1 Identification of transcription factor binding sites
ChIP-seq data is known for a high false positive rate and variation between biological replicates as
a result of heterogeneity in samples. To address this, the workflow used both available replicates
for all transcription factors tested, and required a peak be present in both replicates to identify high
confidence binding sites. This is a naive approach that ignores cases where a true peak is present in
one replicate but not the other limiting the number of true peaks identified and increasing the false
negative rate. Conversely, a strong signal across replicates is not always a true binding event and can
represent bias from the sample increasing false positive rates. Therefore, the naive approach described
in this first iteration of our workflow is not sufficient for combining replicates as it is prone to reporting
both false positive and false negative peaks. Without a complete true positive set of peaks, this effect
cannot be demonstrated as a result. While a naive technique for combining replicates was capable of
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identifying relevant target genes, an approach that combines replicates based on statistical significance
or reproducibility would provide a more complete and accurate set of binding sites and subsequently
gene targets. Chapter 4 describes a new tool to better combine available biological replicates and
improve identification of transcription factor binding sites and target genes. It is supported by a
number of validation techniques that focus on captured biology. Chapter 5 further expands this stage
of the workflow to characterise the features of a transcription factor binding site and ultimately predict
binding events rather than extract binding events from existing data making our workflow applicable
to a broader range of analyses.
Binding of transcription factors to inaccessible regions and the associated outcomes is poorly
understood making accessibility data, in this case DHS, a reasonable filter to reduce the initial set of
binding events. We showed that genes targeted by binding events at inaccessible regions of the DNA
were not linked to cerebellar development across the three factors tested justifying their exclusion
from subsequent analyses. While a small proportion of events were inaccessible for the tested factors,
other factors may have a higher proportion of inaccessible sites. In this case, much of the information
captured in ChIP-seq experiments would be lost if an accessibility filter is applied indicating the need
for additional steps to determine whether or not accessibility should be used as a filter to ChIP-seq
binding events. Accessibility patterns have previously been used to predict transcription factor binding
events and Chapter 5 of this thesis explores their influence on transcription factor binding more
broadly in the context of a predictive model to gain a better understanding of the relationship between
accessibility, transcription factor binding and regulation.
3.4.2 Generating a transcription factor targetome
RNA-seq data was shown to be an effective filter to reduce the genes bound by each transcription
factor to a set of target genes that are directly controlled by the transcription factor of interest and
functionally active. The Atoh1, Nfia and Nfix targetomes generated across the two case studies
revealed more broadly the role of each factor through functional annotation and identification and
validation of specific target genes. The individual genes that were identified using this workflow
included genes previously linked to the transcription factors of interest as well as new genes which
were experimentally shown to be targeted by the transcription factors of interest further demonstrating
the effectiveness of the new bioinformatic workflow.
A combination of annotation approaches accurately linked distal binding events to target genes
that were relevant to neural development. Without access to experimental conformation capture data,
target genes of distal binding events can only be predicted and currently available tools have multiple
limitations as described in Chapter 6. While CISMAPPER provided evidence based predictions that
were experimentally validated in this analysis, many distal sites were still only annotated to the nearest
gene and many misregulated genes were not linked to a binding event indicating that performance can
be improved with a more robust approach. While CISMAPPER’s predictions are biologically relevant
to an extent, they are based on a limited number of datasets and in mouse, there is no cerebellar data
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included in training limiting CISMAPPER’s application to this specific problem. Despite its limitations
it was, at the time this work was completed, the best choice to identify gene targets of distal binding
events. Chapter 6 describes how a lack of biological evidence to describe true positive transcription
factor target genes makes accurate target gene prediction unreliable, especially when applied across
cell types.
3.4.3 Characterising the functional role of a transcription factor
When epigenetic data is available, categorising binding sites into broad chromatin states reveals the
regulatory potential of a transcription factor. For the transcription factors included in this study, we
observed Nfia and Nfix to bind distally with a majority of events in enhancer like regions with ‘poised’
chromatin states indicating they are not currently influencing the expression of their target gene. Atoh1
also had a high proportion of distal binding events but was not as strongly associated with enhancer
activity. One major flaw in the epigenetic profiles included here is the absence of any repressive marks
limiting our ability to define the role of a number of binding events. While this workflow explores
epigenetic state as a means of breaking down and categorising binding events, further exploration of
the relationship between binding events and histone modifications is outside the scope of this thesis
and not further explored.
Based on functional annotation of gene sets by DAVID, we determined that a number of genes
relevant to neural development and previously linked to the transcription factors of interest were
identified in each targetome. Beyond identifying new targets of each factor, we also gained a better
understanding of the role of each individual factor. Atoh1 regulates a large number of transcription
factors compared to the NFIs indicating that it has greater regulatory potential in regard to indirect
targets. Functional terms enriched in the Atoh1 targetome support and extend existing knowledge
of Atoh1’s role in cerebellar development. Nfia and Nfix regulate fewer transcription factors and
therefore have less regulatory potential compared to Atoh1. The NFI factors share a number of enriched
functional terms and appear to play a similar role in neural development that is further described in
[51]. Functional annotation can be used to broadly assign a role to transcription factors however there
are limitations to the approach including incomplete knowledgebases and while it is an important
guide to biologists, a great deal more research is required to improve its performance. Such work is
outside the scope of this thesis.
3.4.4 Characterising transcription factor interactions
This workflow does not identify potential transcription factor interactions on a global scale but does
allow known interactions to be further characterised given the similarity of each factor’s targetomes.
We showed that Nfia and Nfix share a larger proportion of genes that were coordinately regulated
compared to Nfix and Atoh1. This indicates that the regulatory role of Nfia and Nfix has great similarity
confirmed by brains of Nfi knock out mouse being phenocopies of one another while Atoh1 show a
similar but distinct phenotype. The similarities between Nfia and Nfix’s binding profiles are further
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explored in Chapter 4 using a statistical tool to combine all available binding data and identify the sites
that are reproducible across both factors. This is another small scale approach to probing potential
interactions between transcription factors.
3.5 Conclusion
Bioinformatic workflows such as the one described here are vital tools when it comes to learning
from independent assays that describe dependent relationships in vivo. Without robust and informative
approaches for integrating available data, we will not effectively improve our understanding of the
biological system under consideration. This is especially important now when so many informative
assays have been generated to describe various factors, cells, tissues and conditions. This workflow
outlines a number of techniques that are broadly applicable to related, but distinct, biological problems
increasing the value of it’s contribution to the field and reinforcing the decision to describe it through
descriptive methods as opposed to a highly restricted programmatic tool.
During the development of our workflow a number of strengths and weaknesses in the currently
available approaches for merging ChIP-seq biological replicates, understanding the conditions required
for transcription factor binding to occur and annotating binding events that occur distally were
identified: aspects that are addressed in more detail in Chapters 4, 5 and 6 in the remainder of this
thesis.
The following publication has been incorporated as Chapter 4.
1. Rhys Newell et al. “ChIP-R: Assembling a reproducible set of ChIP-seq peaks from multiple
replicates”. In: TBC 0 (2019), pp. 0–1
Contributor Statement of contribution %
Alex Essebier writing of text 60
proof-reading 50
supervision, guidance 50
theoretical derivations 40
preparation of figures 70
initial concept 50
I was involved throughout ChIP-R’s development in a supervisory capacity providing support, ideas
and guidance to Rhys through his honours project. I tested ChIP-R extensively through its development
identifying multiple flaws in the methodology and contributing the idea to fragment the peaks, a key
feature of ChIP-R. Once the tool was performing well on all tested data sets, I conceived validation
approaches as there are limited known transcription factor binding sites to compare to. Specifically, I
performed de novo motif discovery and differential motif enrichment on output data, sourced genome
browser tracks to visualise the performance of different tools and developed the motif read depth
approach to compare the biological and experimental support for peaks produced by different tools.
Specifically, I performed the analyses behind and constructed Figures 4.1, 4.2, and 4.3b, Supp.
Figures D.2 & D.3 and Supplementary Tables D.1, D.2 & D.3 as key contributions to the results section
of [123]. I also wrote and edited significant portions of the text.
Chapter 4
Exploring reproducibility of ChIP-seq
biological replicates using a rank sum based
approach
4.1 Introduction
Chromatin immunoprecipitation followed by sequencing (ChIP-seq) is an approach commonly used
to identify protein binding sites across the genome; specifically transcription factor binding sites.
Variation and noise in ChIP-seq experimental data is common and occurs as a result of a protocol
that is susceptible to low antibody specificity and lack of cellular homogeneity in samples. The peak
calling tools available to process ChIP-seq experiments attempt to account for these weaknesses but
noise and experimental artifacts are often introduced into the processed data. Biological replicates are
therefore a requirement when performing ChIP-seq analyses as, when properly utilised, biological
replicates can reduce the variation seen in ChIP-seq data and aid in identifying binding sites with
improved performance and accuracy.
In Chapter 3 it was reported that when handling replicates, a naive approach of merging peaks
present in both replicates was capable of defining a set of peaks with higher confidence than either
replicate independently but was likely to report both false positive and false negative output peaks
based on our understanding of ChIP-seq experimental data. Other approaches for combining replicates
include irreproducible discovery rate or IDR as recommended by ENCODE guidelines and MSPC
[102, 79]. Both approaches have weaknesses and limitations with IDR limited to pairwise analyses (i.e.
a maximum of two replicates) and MSPC tested only on a single transcription factor with a tendency
to report large numbers of peaks. Other existing approaches also have significant limitations and weak
performance as reviewed in Newell et al. [123]. Here we present an approach called ChIP-R that
statistically combines multiple biological replicates to identify high confidence transcription factor
binding events that better represent the biological role of the target transcription factor. We show
that ChIP-R identifies reproducible peaks between replicates that are more biologically relevant to
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the target transcription factor. This is evidenced by increased motif enrichment, higher read depth
at binding sites and the ability to identify true positive transcription factor binding sites. ChIP-R
also outperforms other available approaches and is capable of combining data from more than two
replicates.
Here, the ChIP-R paper is presented in full as the methodology was constructed to address Aim 2a
and concerns raised in Chapter 3 over merging biological replicates by building a robust statistical
method to refine ChIP-seq data with multiple replicates to only the most relevant binding sites.
Given the success of ChIP-R, an additional case study using the data presented in Chapter 3
was conducted to further illustrate ChIP-R’s biologically significant results and demonstrate it’s
effectiveness when included in the workflow that forms the basis of this thesis. The case study is
presented as part of this chapter following on from the paper and highlights additional applications of
ChIP-R beyond merging replicates.
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4.2 ChIP-R: Assembling a reproducible set of ChIP-seq peaks
from multiple replicates
4.3 Abstract
Motivation: Chromatin immunoprecipitation followed by sequencing (ChIP-seq) is the primary proto-
col for detecting genome-wide DNA-protein interactions, and therefore a key tool for understanding
transcriptional regulation. A number of factors, including low specificity of antibody and cellular het-
erogeneity of sample, may cause “peak” callers to output noise and experimental artefacts. Statistically
combining multiple experimental replicates from the same condition could significantly enhance our
ability to distinguish actual transcription factor binding events, even when peak caller accuracy and
consistency of detection are affected.
Results: We developed and used the principles of the rank-product test to statistically evaluate the
reproducibility from any number of ChIP-seq experimental replicates. We demonstrate over a number
of benchmarks that our adaptation “ChIP-R” (pronounced ‘chipper’) performs as well as or (more
often) significantly better than comparable approaches on recovering transcription factor binding sites
in ChIP-seq peak data, including the practice recommended by ENCODE. ChIP-R decomposes peaks
across replicates into “fragments” which either form part of a peak in a replicate, or not. We show
that by re-analysing existing data sets, ChIP-R reconstructs reproducible peaks from fragments with
enhanced biological enrichment.
Availability: ChIP-R is implemented in Python3 and available freely at https://github.com/
rhysnewell/ChIP-R/.
4.4 Introduction
Chromatin immunoprecipitation followed by sequencing (ChIP-seq) provides an in vivo snapshot
of genomic sites occupied by a target protein in a biological sample [82]; the target is typically a
transcription factor (TF) or a histone with a specific modification. ChIP-seq protocols are susceptible
to produce false positive signals as DNA regions not bound by the target protein can be pulled down
indiscriminately during immunoprecipitation. The protocol requires a large cell population, increasing
the risk of sample impurities that in turn compromise both sensitivity and specificity, with targeted
binding events only present in a fraction of the cell population [56, 6].
A reproducible experiment is one performed over multiple, independent replicates with consistent
results [172, 77]. Measuring reproducibility of a whole experiment indicates the overall quality of the
resulting data set and is thus vital to the scientific process [102]. This is particularly pertinent in the
case of ChIP-seq where variability between individual data points, both within and across replicates is
commonplace; an understandable and reportable metric enables filtering of binding sites with the aim
of reducing noise and prioritising binding sites for further study.
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Peak calling methods identify “peaks” or regions where the target protein is bound based on the
aggregation of sequenced reads. A large number of peak calling tools exist; the most popular include
MACS2, SPP, SISSRs and GEM [46, 87, 84, 62, 167]. Peak calling tools often have stringent cutoffs
to combat false positives which, if used carelessly, result in false negatives. Taking this, and the
variance in ChIP-seq data into account, it is advisable to use relaxed cutoffs for peak calling and,
through the application of proper reproducibility testing, filter by statistics instead [102]. Many peak
calling methods are only capable of assessing biological replicates individually and few report on the
reproducibility of the experiment or individual peaks present across replicates.
ENCODE guidelines for ChIP-seq experiments stipulate the use of at least two biological replicates
[98] and public data sets predominantly follow the minimal requirement. Until now, methods for
analysis have not been required to, or tested for, an ability to extract information from more than two
replicates. The cost of sequencing has been steadily decreasing [118] and recently it was shown that
more than two replicates can improve the accuracy with which ChIP-seq experiments determine real
biological events [192].
Highly variable yet reproducible peaks will often be missed during a pairwise analysis, especially
if a peak signal is strong in one replicate but weak in another [184]. Using a third or fourth replicate
can validate signals by providing a broader context for the observed variability. A less considered
aspect is that reproducibility of a peak is usually evaluated after its genomic boundaries are predicted.
Optimising specificity of peak boundaries through the use of additional replicates ensures the inclusion
of sequence content relevant to the biology of the cell being studied, and exclusion of neighbouring
regions that do not capture actual binding events.
The assessment of reproducible peaks representing thousands of TF binding events is non-trivial;
independently verified data sets are limited to a small number of TFs and conditions, and they typically
include few negative data points. Therefore, this paper outlines several complementary analyses to
measure performance of reproducibility metrics, with a focus on identifying genomic regions enriched
with biologically relevant information and highlighting the ability to recover reproducible portions of
TF binding sites without loss of information.
Current implementations that provide metrics for ChIP-seq assay reproducibility are tailored
for pairwise comparison, including irreproducible discovery rate (IDR; [102]); others use empirical
methods that are computationally prohibitive in the presence of multiple replicates [46, 124, 194].
Peak callers that themselves process biological replicates include MACS2 [46], PePr [192], Sierra
Platinum [119] and BinQuasi [57]. MACS2 can analyse multiple replicates by pooling reads into a
combined super sample. Reads from separate replicates occurring at the same location are filtered
out as a result from over-amplification of DNA, which causes loss of information and resolution.
PePr, Sierra Platinum and BinQuasi also combine reads across multiple replicates to improve peak
calling; while quality statistics are produced, none report specifically on peak reproducibility and all
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require alignments as input, which are not always available. While we include MACS2 as a baseline
comparison, our focus is on the category of tools that are run subsequent to peak calling, treating each
sample as originating from an independent experiment.
The current most widely used approach for assessing reproducibility from replicates is IDR. IDR is
suggested by the ENCODE guidelines and quantifies reproducible peaks by evaluating the consistency
in the assignment of ranks between replicates [102]. The standard implementation of IDR is limited
to evaluate two replicates at a time, requires that a peak occurs in both, and assigns a reproducibility
metric to the interval represented by the (single, unadjusted) peak favoured by the peak caller. If
the goal is to merge more than two replicates, a naive approach is to take the union of peaks across
replicates. MSPC [79] corroborates statistical evidence in individual replicates using Fisher’s method
to rescue weaker peak calls; it extends naturally to greater than two replicates but was only tested on a
single transcription factor (TF), and reports a large number of peaks compared to IDR.
The rank-product test is inherently suited to look at multiple replicates in tandem, avoiding the need
for pairing replicates arbitrarily for analysis [17, 18]. The test is non-parametric and has previously
been used to evaluate reproducibility of other data types including microarrays [38]. We hypothesised
that this statistical approach can effectively evaluate reproducibility of peaks as well as ascertain the
most reliable boundaries of such, by decomposing individual peaks across replicates. Ultimately,
reproducible and appropriately specific ChIP-seq peaks should display greater enrichment of biological
content. This paper outlines our approach, implemented as a tool called ChIP-R; we demonstrate that
an adaptation of the rank-product test enhances the quality of biological information extracted from
ChIP-seq data, while outperforming other approaches that statistically combine multiple replicates.
4.5 Methods
4.5.1 Data sets and peak calling
We obtained BAM files containing ChIP-seq data for six transcription factors including REST and
MAX in K562, SRF in GM12878, CTCF in MCF-7, CEBPB in A549 and FOXA1 in HepG2 (D.4).
Each TF was assayed using two biological replicates in two separate, but consistent experiments,
resulting in four biological replicates per TF. The REST, SRF and MAX data sets are uniquely suited to
evaluate differences in reproducibility performance across multiple replicates as independent validation
was available [144] (subsection 4.5.5). Additionally, three replicate BAM files from CTCF ChIP-seq
assays in A549 were retrieved.
For peak calling across reproducibility tests, we first consistently used MACS2 to ensure results are
not confounded by choice of peak caller; MACS2 provides a p-value, q-value (statistical estimators)
and signal value (overall read depth at peak location) for each reported peak [46, 167]. Most peak
calling tools output a p-value, so we used this (when applicable) as the score by which peaks are
ranked. We called peaks for each individual TF replicate using both replicates of the cell type specific
input files (D.4).
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To verify that the evaluation herein is not specific to tool used, we also called peaks using SPP
on the REST, MAX and SRF data sets. To understand the influence of peak caller on reproducibility
statistics, we explored a handful of them on CTFC in A549.
4.5.2 Analysis of replicates
Alternative method 1: m-union
Each peak identifies a genomic interval, allowing peaks from multiple replicates to be merged by set
theoretic operators. For instance, BEDTools is commonly used to identify a set of peaks with support
from a collection of BED files [132].
We define an m-union to be the union of intersecting intervals defined by peaks from a minimum
of m replicates, where m≤ k (where k is the total number of replicates). While lacking in terms of
statistical evaluation, set operators offer a baseline approach to combining peaks from k replicates into
a single set. The union of a pair of two genomic intervals (which must intersect) is a single interval
defined by the widest combination of the two start and end points. For example, with k = 3 and m set
to 2 (styled m2), peaks from at least two replicates must have intervals that intersect for a union to be
performed and an output peak to be reported. An output peak is considered reproducible and assigned
the same p-value as the most significant intersecting input peak.
Alternative method 2: IDR
IDR analysis was run using default parameters on all combinations of pairs from each set of replicates,
for each TF. Results are based on the “global IDR value” assigned to each peak; reproducible peaks are
those with a value ≤ 0.05. IDR implicitly selects sites where a peak is represented in both replicates,
equivalent to m2 which is the maximum number of replicates IDR processes. For comparison, we
include results for peaks sourced directly from ENCODE, which use SPP as peak caller and IDR to
evaluate reproducibility, with settings determined independently by the ENCODE consortium. In lieu
of an implementation for more than two replicates, we include results from pooling peaks from two
runs with IDR, each on two replicates, to emulate a four-replicate version of IDR [184].
Alternative method 3: MSPC
MSPC was run using using the recommended parameters of a stringent threshold of 1E-8 and a
permissive threshold of 1E-4 on all replicates as joint inputs. MSPC produces consensus peaks
that were used to evaluate its performance. Each output peak is assigned a p-value, determined by
Fisher’s method from the p-values of each overlapping input peak, and corrected for multiple testing.
Reproducible peaks are defined as having a corrected p≤ 0.05.
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Alternative method 4: MACS2
MACS2 analysis was run using default parameters on all replicates as “multiple treatment files”,
essentially combining all reads into a single sample. All results are based on the q-value determined
by MACS2. While reproducibility is not defined by MACS2, we used q≤ 0.05 to separate positives
from negatives.
4.5.3 Rank-product analysis of replicates
ChIP-R initially inspects peaks in all k replicates to extract n canonical “fragments” (details in the next
subsection). Each fragment is defined in terms of the genomic interval it occupies; each fragment is
linked separately to each replicate by the value that the peak caller assigned to the peak it originates
from. With a total of exactly n canonical fragments, each linked to k replicates, a fragment i - replicate
j tuple is assigned a rank ri j, based on the relative level of confidence or signal it has within the
replicate j; the rank ranges between 1 and n, for the highest to the lowest confidence (or signal),
respectively. Tied fragments receive a rank that is the average of the positions they occupy, e.g. if three
fragments are tied at positions 13 to 15, all three receive a rank of 14.
From the above, each canonical fragment i is associated with a rank tuple {ri1,ri2, ...,rik}. The
rank-product statistic is then calculated as the product of these ranks for the ith fragment across k
replicates.
rpi =
k
∏
j=1
ri j (4.1)
Peak fragments and composite peak boundary
While peaks often occupy similar, intersecting genomic locations between replicates, the base pairs of
start and end points of such intervals are not always identical (shown schematically in Figure 4.1a).
Minor differences in location reflect the nature of data and are not a sign of low reproducibility. The
availability of multiple replicates exacerbates the fragmentation but provides us with a basis to identify
the specific genomic interval that makes up the most reproducible peak.
To determine the rank-product statistic, a consistent set of entries is required to compare and rank
across replicates; we developed a scanning approach to define the start, end and support for peak
fragments across the genome (Figure 4.1b).
In our approach, fragments are formed from (a) inspecting all intervals that make up peaks in a
genomic region across the replicates, and (b) decomposing the intervals into the largest sub-intervals
from which all the original peaks can be reconstructed by concatenation. The fragments are defined
by the sub-intervals and are consistent across and shared between all replicates; each fragment when
linked to a replicate is assigned the same level of confidence or signal as the peak it originates from.
Each fragment can then be ranked within each replicate and labeled with a rank tuple (Figure 4.1d).
There is one important exception to this. Some peak fragments do not intersect with any peak
interval in a specific replicate; subject to a user-specified minimum number of intersecting peak
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Figure 4.1: An illustration of evaluating and composing a set of reproducible peak intervals from three
replicates. a) Peak intervals for three replicates with ranks based on the rank of composite fragments
within each replicate. b) Fragments identified based on the intersubsection of peak intervals. c) Pseudo
fragments introduced to account for absence of an intersecting peak interval in one or more replicates.
d) Rank tuples for each peak fragment (of n possible, here n = 50). e) Rank-product scores for each
peak fragment alongside the scored fragments themselves which are then filtered and combined into
reproducible peaks.
intervals (m, by default 1), we assign to this “pseudo” fragment the lowest rank in the corresponding
replicate (Figure 4.1c).
When assessing a fragment across all replicates, with one or more being pseudo fragments, the
rank-product will be penalised, decreasing the likelihood of the fragment being called reproducible.
Pseudo fragments allow detection of actual binding sites within peak regions of high variability (e.g.
supporting reads occurring in a small fraction of the input cell population).
Thresholding reproducible peak fragment
Designating a specific fragment as reproducible involves two steps. First, a rank-product p is calculated
from the null sampling distribution described in [67]; this efficiently reproduces the original rank-
product statistic [92, 38] that involves large numbers of permutations of k ranked lists of n fragments.
Preliminary tests showed that using rank-product p < 0.05 results in a comparatively small number
of peaks being called reproducible, relative to IDR p < 0.05 used by [102]. To address this, as a
second step, we use the cumulative distribution function of the binomial distribution to determine a
cut-off for fragments to be reported; this avoids the arbitrary scaling of p, in favour of adapting it to
the data at hand. For each fragment l ∈ {1,2, ...,n} enumerated in ascending order of rank-product p,
we determine the probability of seeing l or more successes from n attempts
F(l;n, p) =
n
∑
i=l
(
n
i
)
pi(1− p)n−i. (4.2)
F is close to 1 almost regardless of rank-product p for small l, and gradually decreases to 0 as l
approaches n; in words, designating at least one fragment as a “success” is very probable, for every
single one to be a success is highly improbable. Again by reference to l ∈ {1,2, ...,n}, the point of
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intersubsection between the binomial cumulative function and p recovers a sweet spot, where p is
sufficiently permissive to include exactly l fragments and no more; this p (referred to a ChIP-R’s
threshold θ ) identifies the point l after which we will no longer be recovering a reproducible fragment.
To give the user ultimate control of what cut-off to use, ChIP-R produces three output files: “T1”
for peaks with rank-product p≤ 0.05, “T2” for peaks p≤ θ and “ALL” containing all peaks regardless
of p.
Assembly of reproducible peaks
ChIP-R first assembles output peak intervals from adjacent peak fragments, requiring that they meet
the statistical test of reproducibility (as above; failed fragments are removed from consideration).
Second, we apply a criterion to ensure retained fragments form sound peaks (explained below), which
filters fragments further. ChIP-R annotates each output peak with the p-value of the most significant
of the composite fragments. A complete workflow is illustrated in Supp. Figure D.1.
In more detail, ChIP-R determines the median peak interval width for each fragment, based on
the width of the peak in each replicate to which it belongs, or if a pseudo fragment, the closest peak
in that replicate. We remove fragments whose size is less than half the median width, if it has no
capacity by adjacency to other supported fragments to form a composite interval longer than that width;
adjacent fragments need to have similar or stronger statistical support (for statistical significance to be
“similar” they need to be within one order of magnitude). To keep it simple, we adjusted these rules
from inspecting sites in data sets separate from those on which we evaluated the approach; we thus
leave scope to optimise and benchmark them systematically.
4.5.4 Evaluating ChIP-R p-value distributions between peak callers
We called peaks from high quality CTCF ChIP-seq experiment with three replicates by MACS2, SPP,
SISSRs and GEM. We also retrieved peaks as processed and archived by the ENCODE pipeline. We
ran ChIP-R on the output of each peak caller using m set to 1, 2, and 3 to evaluate how the probability
distributions changed alongside increased peak fragmentation. We calculated rank-product p-values
and truncated positives at p≤ θ , as described in 4.5.3.
4.5.5 Evaluating the recall of experimentally validated true and false binding
sites
[144] provides an independently validated but incomplete set of positive and negative peak labels for
three transcription factors in their respective cells lines. With an arbitrarily set threshold the method
divides tens of thousands of potential peaks into two groups (positive and negative predictions) with
validated labels available only for a fraction (ranging from 156 to 289 depending on TF; see Supp.
Table D.1); an overwhelming number of samples can therefore not be labelled, even though they
are predicted to belong to exactly one class. Standard metrics such as auROC, auPRC and F1 that
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rely on the grouping of data into true and false positives, and true and false negatives are therefore
compromised. Moreover, the number of peaks that are evaluated varies from method to method,
arbitrarily truncating predictions and distorting metrics.
We devised a test based on the recovery of positives while minimising the inclusion of negatives,
allowing for (a large number of) undesignated predictions. Output peaks were first sorted by method
specific p-value and labeled as overlapping a true positive peak, true negative peak or no peak. The
sum of positive and negative peaks identified was plotted against the number of peaks reported by
each method with all peak counts normalised to their respective totals (total positive, total negative
or total peaks). The area between the positive and negative curves (ABC value) indicates improved
performance as it approaches 1 and was calculated by finding the difference of the area under the
positive and negative curves using the trapezoidal method. Negative ABC values indicate a greater
accumulation rate of true negative peaks compared to positive peaks. ABC values are influenced by
the number of predictions that a method produces, as the number of known positives and negatives
are usually not exhausted. If two ABC values are equal, the method with better performance is the
one that called fewer peaks. Some methods do not quantify all possible peaks, so to find a universal
metric to compare, we also calculated an ABC value for the Top-N peaks, where N equals the smallest
number of peaks produced by any method for a TF.
4.5.6 Evaluating discovery and presence of sequence motifs
To improve the comprehensiveness and biological meaning of evaluation, we devised two tests to
evaluate the biological specificity of reproducible peaks as offered by different methods and by varying
numbers of replicates; both tests are based on the expectation that TFs bind to specific sequence motifs.
Sequences that affect binding of a TF are easier to recover if peaks are centered and confined around
all actual binding events, and exclude regions that are not supporting binding. Both tests use evidence
for binding as is offered through the presence or absence of sequence motifs, or the extent of sequence
reads from the ChIP-seq experiment.
Testing for known motif in confined, reproducible peaks
We used FIMO from MEME suite to identify sites with significant motif matches across the union of
TF specific replicates, supplying independent evidence of potential binding [7, 58]. We represented
each TF by a position weight matrix (PWM), sourced from JASPAR [113]. FIMO returned a set of
motif occurrences that were then be scored by the number of sequence reads (in the merged BAM files
for the TF) that overlapped precisely with the motif match site. “Motif positive peaks” are peaks that
are reported reproducible by the method and also overlap at least one motif match. Appropriately set
peak boundaries ensures the inclusion of motif matches with greater sequence read support relevant to
the binding of the TF, and exclusion of sequence that is not supported by reads from binding events.
In our assessment, a better method identifies a higher proportion of peaks with motif matches,
while still allowing for binding events not represented by a motif match. More importantly, amongst
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motif positive peaks only, a better method produces more peaks with increased read depth, and fewer
peaks with low read depth at the motif match site.
Testing if sequence motif is discoverable in reproducible peaks
De novo motif discovery should benefit from including precisely the peaks with bound sequences, and
excluding everything else. We used MEME-ChIP version 5.0.2 [7, 109] to perform motif discovery
and tested for differential enrichment of sequence motif comparing a foreground set of peaks p < θ
against all remaining peaks (p > θ ). To avoid conflating the inclusion of positives with the effects of
refining the boundaries of them (as in the motif matching test), we generated uniform 500 base pair
peaks using a ± 250 base pair window around peak centres deemed reproducible by all methods.
In our assessment, the better method (or setting of method) allows for (a) the discovery of enriched
sequence motif (reported by MEME-ChIP as motif E-value), (b) significant differential enrichment
of sequence motif in foreground compared to background sets (reported by MEME-ChIP as Fisher
E-value) and (c) optimised centering of peak around the potential site of binding.
4.6 Results
4.6.1 ChIP-R recovers known positives with fewer predictions
The adaptation of the rank-product test identifies reproducible peaks from multiple ChIP-seq samples
and recovers known positives ahead of known negatives, as illustrated by high ABC values, while
providing the user with a biologically relevant number of potential TF binding sites; Figure 4.2b shows
representative outcomes for the TF REST. Supp. Table D.1 contains both ABC and Top-N ABC values
for all tested TFs.
It is essential to interpret ABC values alongside peak counts and peak width to represent perfor-
mance, as a method calling a greater number or overly broad reproducible peaks is more likely to
identify a peak validated to be true by chance (see Supp. Table D.1). In several instances, MSPC, m-
union and MACS2 also achieve high ABC values at default settings; these methods are permissive and
report a contestably large number of peaks. IDR is conservative in its peak calls and has consistently
low ABC values; IDR identifies no true peaks in SRF.
Each method shows key differences in the quality of returned peaks as exemplified in Figure 4.2a.
First, MSPC and m-union both provide the union of overlapping peaks for each genomic location
resulting in a broader range of peak sizes including large peaks and, at less stringent settings, a number
of smaller peaks less likely to represent actual binding events. In contrast, ChIP-R and IDR do not
rely on a union approach and report peaks that are more concentrated around the highest scoring
motif matches. IDR selects a single, original peak to represent the genomic region. ChIP-R alters the
reproducible peak boundary based on all available information; resulting widths tend to be uniform,
rather than influenced by the number of replicates and in line with the size expected for a TF.
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4.6.2 ChIP-R recovers peaks that are biologically meaningful
We evaluated the ability of methods to recover peaks that are implicated by the occurrence of a
TF-specific sequence motif, where that motif match is also supported by a large number of sequence
reads. Here, ChIP-R selectively identifies motif matches with greater read depth that are more likely
true binding sites compared to other approaches (Figure 4.2b and Supp. Figures D.2 & D.3). Most
methods recover the motif matches with greater read depth (the green line represents the mean score
of motif matches overlapping known positives); IDR is the exception that discards a set of genomic
regions containing highly supported motif matches. This is also supported by the Top-N ABC values
in Supp. Tables D.1 & D.2 which show all tools have comparable performance when identifying the
most reproducible peaks. Increasing the number of output peaks from IDR (by relaxing its threshold)
includes motif matches with lower read counts.
Across all TFs, MSPC, m-union and MACS2 recover large numbers of peaks with scores compara-
ble to motif matches overlapping true negative peaks, while ChIP-R and IDR tend to recover peaks
with highly supported motif matches (Figure 4.2b and Supp. Figures D.2 & D.3). IDR’s performance
varied across TFs with mean scores for CTCF, CEBPB and FOXA1 dropping in line with or below
MSPC, m-union and MACS2 while ChIP-R consistently maintained high scores. For REST, IDR has
the highest proportion of motif positive peaks followed by ChIP-R while the other methods drop to
low proportions. ChIP-R generally has equal or higher proportions of motif positive peaks across all
tested TFs. It is unlikely that all biologically relevant peaks contain a motif match and this is reflected
by only 78% of the (independently verified) true positive peaks containing one (Figure 4.2c).
Multiple replicates influence and improve biological enrichment
To further understand what settings maximise the biological content in reproducible peaks, we used
motif discovery followed by enrichment tests. ChIP-R identifies sets of reproducible peaks centrally
enriched for a target sequence motif, from the replicates available for each tested TF. m indicates the
minimum number of intersecting peak intervals across k replicates, and thus controls the degree with
which pseudo-fragments fill in for missing replicates. Figure 4.3b shows that for REST, a full or partial
sequence motif is discovered in peak sets deemed reproducible at any value of m, while in SRF, a full
or partial sequence motif is discovered in all except the most stringent setting (m = 4). For REST and
SRF, reproducible peaks are enriched for the target sequence motif for m≤ 3; for CTCF, CEBPB and
FOXA1 the same is true for m≤ 2 (not shown). MAX is the exception; here, the target sequence motif
is only found when m≥ 3.
Figure 4.3a shows an example for each TF of the proportion of positive and negative peaks detected
as more peaks are considered, as well as the difference between the curves captured as the ABC value,
with an optimal score of 1. We observed a decrease in the ABC value with m increasing across REST
and SRF. For MAX, which has a highly variable set of replicates, we observed an increase (Supp.
Table D.1).
The ideal setting of m varies with TF and data quality. As the set of known peaks is limited,
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ABC values with motif information (read depth and enrichment), peak count and peak size provide a
guide to setting m. Using SRF as an example, setting m to 2 returned the expected number of peaks
(representative of SRF’s activity in K562) with a high ABC score, high Top-N ABC score, high mean
motif score and strong presence of the motif combined with enrichment of the motif in the foreground
set indicating a biologically relevant result (Figure 4.3 and Supp. Tables D.1, D.2 & D.3). 4-union had
a comparable ABC and Top-N ABC score but called a large number of peaks with increased breadth
and lower mean motif scores.
Pseudo-fragments identify variable but reproducible peaks
Pseudo-fragments permit peaks represented non-exhaustively across replicates to still be included
in the rank-product test, thereby alleviating consequences of peak callers failing to recognise under-
represented events. Technically, this effect is increased at lower values of m, and the permissibility of
pseudo-fragments appears to influence our ability to extract biologically meaningful events from the
resulting peaks. Weakly- or non-reproducible, but biologically relevant peaks are ever-present; for
example where a binding event occurs in a sub-population of cells present in only one replicate. All
tested TFs (bar MAX) show a general decrease in ABC values, motif enrichment and peak count as m
increases (Figure 4.3 and Supp. Tables D.1 & D.2). This suggests requiring that all replicates carry a
peak inhibits the capturing of biological information; to make matters worse, this restrictive setting is
required by MSPC and m-union to achieve higher performance. Through the use of pseudo-fragments,
the rank-product test evaluates peaks across all replicates (at m≥ 1) and by re-composing them into
reproducible peaks, our adaptation achieves consistent performance above or on par with comparable
methods (Supp. Tables D.1 & D.2).
4.6.3 The binomial test accurately removes non-reproducible peaks
The binomial test provides a dynamic and informative threshold p < θ for separating reproducible
from non-reproducible peaks. Of note is that θ is consistently placed at the ‘elbow’ of the positive
curve where a large proportion of positives have been identified without introducing negatives for all
tested TFs (Figure 4.3a). Secondly, when used to as a default threshold to distinguish positive from
negative peaks, the outcomes are encouraging relative to alternative methods (Supp. Tables D.1 &
D.2); sequences at the recovered positive sites often contain the expected motifs (Figures 4.2 and 4.3,
Supp. Figure D.2), an ability which seems unaffected by choice of peak caller as discussed below.
4.6.4 ChIP-R evaluates reproducible peaks from a variety of peak callers
We evaluated ChIP-R when applied to peaks called by MACS2, SPP, SISSRs and GEM. Supp. Figure
D.4 shows that the distributions of rank-product p-values are consistent across peak callers, while
the number of peaks varies as m increases. Variation in the number of reproducible peaks may be
manifested in differences inherent to each peak caller; specifically, SISSRs was previously shown to
produce inconsistent results compared to other peak callers in [102].
60
CHAPTER 4. EXPLORING REPRODUCIBILITY OF CHIP-SEQ BIOLOGICAL REPLICATES USING A
RANK SUM BASED APPROACH
Supp. Figure D.3 shows motif matches and read depth distributions when SPP is used to call
peaks for the REST, SRF and MAX data with reproducible peaks identified using ChIP-R or IDR; the
patterns are broadly consistent with observations for MACS2 inputs, shown in Figure 4.2b and Supp.
Figure D.2. ChIP-R has equal or slightly higher proportions of motif positive peaks when SPP is used
instead of MACS2. IDR is optimised for use with SPP but ChIP-R was still able to identify higher
proportions of motif positive peaks, with increased read depth. Finally, we emulated the use of IDR
with four replicates [184] but doing so did not improve the proportions seen when compared to the
paired runs (Supp. Figure D.3).
4.7 Discussion
The rank-product test is a non-parametric statistical test based on differences from independently
conducted and ranked experimental measurements; it extends naturally and efficiently to more than
two replicates. This study shows when adapted to transcription factor ChIP-seq data this test provides
a robust reproducibility metric across peaks originating from separate biological samples.
A unique feature of ChIP-R is that peaks are first decomposed into fragments that are statistically
evaluated. This peak decomposition allows all replicates to be considered when identifying the genomic
region most likely to contain a binding site; it is used in deciding whether to retain or discard individual
fragments rather than complete peaks. The flexibility of the approach is extended by pseudo-fragments
which can identify a variety of fragment combinations as reproducible across replicates rather than
strictly ignoring regions where a fraction of replicates lack a peak. The flip-side of this flexibility is
that ChIP-R is not suited to fragment (and de-fragment) truncated peaks that do not present the full
region associated with the target TF, as produced by some peak callers, including GEM and SISSRs.
4.7.1 Biological relevance of reproducible peaks
We demonstrate that ChIP-R enhances our ability to extract biologically meaningful events from the
output of existing peak calling methods, for two or more replicates (Section 4.6.2). ChIP-R identifies
and restricts the boundaries of peaks by first decomposing them to recover TF motifs robustly supported
by ChIP-seq read depth; it aptly discards low read depth regions of the genome and overall provides a
biologically relevant peak set, all without requiring direct access to raw reads.
The ChIP-R work-flow contains a number of parameters that can be varied to enable the user to
expand their search to low reproducibility peaks or select for regions with stronger statistical support.
Ultimately, this results in peak boundaries that are specific to the target TF binding event. Strikingly,
using a strict m value (i.e. minimal number of peaks required to overlap for evaluation to occur) does
not guarantee optimal performance; we show that lower m values often provide more biologically
relevant sets of reproducible peaks. We hypothesise that a larger m captures either bias in the initial
ChIP-seq data or a different class of binding event, either of which could compromise the signal in the
peak. TF binding is rarely independent; highly reproducible peaks across all replicates could represent
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specific co-occurring events that implicate genome regions not relevant to the binding of the TF itself
(e.g. co-factors or associations with transcriptional processes).
4.7.2 Improvements compared to existing methods
The rank-product reproducibility p-value prioritises known independently validated positive peaks
ahead of negatives and the binomial test identifies a moderate threshold that accurately distinguishes a
realistic number of supported sites allowing ChIP-R to perform as well as or better than alternative
methods (Section 4.6.1 and Supp. Tables D.1 & D.2).
m-union and MSPC outputs are constructed by set theoretic mergers of individual replicate peaks
around putative binding sites; they share highly similar outcomes despite MSPC being informed
by additional statistics. Both identify large numbers of peaks with low read depth and broad peak
boundaries more likely associated with noise than true binding events. IDR peaks are generally broader
than ChIP-R peaks and in our tests, IDR cautiously reports fewer peaks than other methods; working
with only two replicates, motif matches are sometimes missed even if supported by greater read
depths. ChIP-R’s advantages over MACS2 to call peaks when using a set of pooled reads are also
clear (Figure 4.2, Supp. Figure D.2 and Supp. Tables D.1 & D.2). Pooling the reads from all replicates
results in MACS2 calling broader peak regions with lower scoring motif matches when compared to
both ChIP-R and IDR; instead we suggest the practice of treating peak calling as a first step before
evaluating reproducibility of peak fragments with ChIP-R, which in turn helps to detect boundaries of
relevant sequence content.
4.8 Supplementary material
Supplementary material for this Chapter can be found in Appendix D.1.
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4.9 ChIP-R case study: NFI family
With two biological replicates for both Nfix and Nfia, we can determine whether ChIP-R can be applied
to refine each targetome to gene sets with higher confidence as identified by a reproducible set of peaks.
A reduced set of target genes allows researchers to focus experimental validation on only the most
relevant targets saving both time and money. The new targetomes can be compared in regard to their
functional outcome and relevance to the role NFIs play in development of the cerebellum.
While ChIP-R was created to merge biological replicates, it has wider applications when it comes
to exploring interacting transcription factors such as Nfix and Nfia. Working under the assumption that
two interacting transcription factors will co-bind a subset of genomic locations, we applied ChIP-R
to identify the sites supported by replicates from both factors and generated a new pair targetome to
determine whether ChIP-R can be used to better define the common roles of two factors based on
ChIP-seq and RNA-seq data compared to the approach used previously in Chapter 3.
Comparing approaches that return variable gene sets as outputs is challenging as there is no accurate
measure of performance. Functional annotation can be used to broadly characterise each gene set into
functional terms with associated enrichment scores however tools such as DAVID have incomplete
knowledgebases and the statistical tests applied are heavily influenced by gene set size [75, 73, 37,
175]. For example, a unique functional term can be identified as significant only in gene set A with size
100 that is a subset of gene set B with size 250 despite both sets containing the same genes linked to
that term. While statistically correct, these tests do not capture the true functional capacity of gene sets
and rather prioritise targets based on functional role. This still remains a useful feature for generating
hypotheses from gene sets.
Another measure of performance is to test output gene sets for a subset of genes known to be
regulated by the target transcription factor. Where this information is available the subset is often small
and incomplete. For lack of a better option, performance is compared using functional annotation and
measuring similarity of output gene sets dependent on initial peak processing by a naive union approach
(as described in Chapter 3) or through our new tool ChIP-R. Specific genes that have previously been
linked to the Nfi family of transcription factors are also highlighted within output gene sets as a
measure of performance [50, 51].
Overall, we report the influence ChIP-R had on identifying binding events and subsequently
changes in each individual transcription factor targetome as well as the pair targetome compared
to the analysis performed in Chapter 3. The original analysis has already been shown to be valid
and informative and this case studies aims to illustrate ChIP-R’s ability to improve on this result
by producing a statistically robust high confidence set of binding events from multiple biological
replicates.
4.9.1 Applying ChIP-R to NFI data
Nfia and Nfix each had two biological replicates on which peaks were called using MACS2 with
default parameters and a q-value threshold -q 0.1 (slightly relaxed) as ChIP-R tends to perform better
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when there are more peaks in the input data. ChIP-R was applied to the biological replicates of Nfia
and Nfix using default parameters and m = 2. The results from Chapter 3 linking binding sites of
Nfia and Nfix to their target genes were updated to represent whether each binding site was identified
as reproducible by ChIP-R. To ensure consistency between the methods (ChIP-R and the original
2-union/naive approach), ChIP-R peaks were also filtered by removing any peaks not overlapping an
accessible region as captured by DNase I hypersensitivity (DHS).
To explore the applications of ChIP-R and working under the assumption that Nfia and Nfix have
similar roles and therefore similar binding sites across the genome, ChIP-R was applied to all four
replicates with default parameters and m = 1 to identify sites where there is support of a binding event
coming from all four sample data sets. Binding sites from the ChIP-R analyses were then annotated to
genes using the same protocol as Chapter 3.
4.9.2 ChIP-R reports smaller sets of NFI binding sites and subsequently smaller
targetomes
Using ChIP-R to merge biological replicates from Nfia and Nfix independently results in fewer
high confidence binding sites and a reduced set of target genes. Table 4.1 contains a summary of
the differences observed in peaks between original (2-union) and ChIP-R approaches and how this
influences the pairwise analysis of the two factors and identification of common genes. The ChIP-R
reproducible peaks are almost a complete subset of the original peaks (2-union approach) with the
two additional peaks called by ChIP-R for Nfix a result of the relaxed q-value threshold. This is in
line with observations made in Newell et al. [123] of ChIP-R producing a smaller set of output peaks
compared to the original replicates.
The Nfia ChIP-R peaks contained a higher proportion of sites that overlap a DHS region compared
to 2-union (95% and 89% respectively). The Nfix ChIP-R peaks had a comparable proportion of
accessible sites to the 2-union approach (86% and 85% respectively). As DHS is used as a filter for
high confidence peaks, seeing an increase or no change in the proportion of output peaks overlapping
DHS indicates high quality peaks are being retained.
When comparing Nfia to Nfix peaks, the proportion of sites unique to each factor, a measure of
how similar their binding profiles are, is consistent across both the original and ChIP-R approaches at
54-56% for Nfia and 5-6% for Nfix (unique counts are shown in Table 4.1). Therefore, across both
approaches, the majority of Nfix sites are also bound by Nfia while a large proportion of Nfia sites
are unique. It’s also worth noting that the genomic locations that are unique change when comparing
ChIP-R reproducible peaks for each factor as shown by the low count of common regions for each
unique set in Table 4.1. This indicates that while the ChIP-R peaks for each factor are a subset of the
original peaks, there are a number of locations where Nfia and Nfix sites previously overlapped that
are now unique to one factor. In simple terms; if a Nfia site is reproducible as defined by ChIP-R, it
does not guarantee Nfix data at the same location is also reproducible.
Despite a reduction in the number of peaks identified for each factor, a large proportion of the
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Table 4.1: Summary values after reanalysing biological replicates of Nfia and Nfix using ChIP-R and
filtering by DHS
Source Original ChIP-R peaks Common
peaks (% of original)
Nfia 12,539 3,337 (27%) 3,337
Nfix 5,843 1,636 (28%) 1,634
Nfia unique 6,975 1,811 (26%) 348
Nfix unique 267 106 (40%) 1
AX union 12,795 3,443
Source Original ChIP-R genes
genes (% of original)
Nfia 1,232 622 (50%)
Nfix 578 232 (40%)
AX union 283 123 (44%)
genes from the original targetomes are still detected as shown in Table 4.1. While 16% and 13% of
bound genes for Nfia and Nfix respectively showed differential expression in the original analysis,
20% and 14% do so in the ChIP-R set of bound genes. This indicates that ChIP-R identifies binding
events with increased biological relevance as they are linked to a higher number of genes that show
significant differential expression in their respective RNA-seq analyses.
The Nfia ChIP-R targetome is enriched for a reduced set of GO terms that are equally relevant in
regard to cerebellar development but exclude broad and unrelated terms like heart development or
kidney development compared to the original targetome (full list of terms reported in Appendix D). A
similar pattern is observed when comparing the functional annotations of the original Nfix targetome
to the ChIP-R targetome. Specific genes relevant to Nfi biology include Otx2, Robo1, Dab1, Wnt5a,
Etv5, Kalrn and Gas6 as described in Chapter 3, Fraser et al. [50] and Fraser et al. [51]. All of these
genes were identified in the original targetomes of each factor and the ChIP-R targetomes of each
factor except Dab1 in Nfix. This is evidence that ChIP-R identifies a reduced set of peaks that remain
biologically relevant in regard to their target genes. The advantage of a reduced set of peaks is that
subsequent regulatory studies where disruption to binding events and the impact on expression are
studied can be conducted with more confidence that the correct or most relevant site is being modified.
4.9.3 The pair targetome is strongly influenced by loss of Nfix binding events
after ChIP-R analysis
A new pair targetome for Nfia and Nfix was constructed based on the ChIP-R reproducible peaks
from each factor identifying 123 target genes. DAVID analysis of the target genes identified using
ChIP-R are significantly enriched for many (41/57) of the same terms as the original analysis despite
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fewer genes under consideration (full list of terms reported in Appendix D). This indicates that the
genes are equally relevant with the advantage of having a smaller set from which hypotheses can be
drawn. There are also seven terms enriched only in the ChIP-R targetome including axonogenesis,
neuromuscular junction and asymmetric synapse that are relevant to development of the cerebellum.
Comparing the new gene set to the original targetome, 160 genes that were originally annotated as
coordinated were absent from the ChIP-R analysis. Of these, 88 (55%) are no longer valid due to loss
of Nfix binding, 1 (0.6%) due to loss of Nfia binding and 71 (44%) due to loss of both. Figure 4.4
contains examples of how binding events change when using ChIP-R. This indicates that Nfix binding
events were a limiting factor in the ChIP-R pair targetome.
Genes no longer considered targets due to exclusion of both Nfia and Nfix binding events are
not functionally relevant resulting in only five significantly enriched terms after DAVID analysis;
none of which are linked closely with development of the cerebellum. In contrast, genes linked
to the loss of Nfix binding are biologically relevant with significant enrichment of relevant terms
including neuronal cell body, neuron projection and axon (full list of terms reported in Appendix D).
This indicates that despite only weak peak signals at non-reproducible Nfix locations, binding and
subsequent regulation of target genes still occurs. This raises the question of whether the peaks deemed
non-reproducible should truly be excluded from the analysis as they appear to target relevant genes
leading us to investigate the use of all four replicates simultaneously in the next section.
4.9.4 Family replicates
Analysing both transcription factors and their replicates simultaneously allows identification of repro-
ducible peaks across all available data, specifically sites bound by both factors with high confidence.
Nfia and Nfix are family members that have a highly coordinated role in the cerebellum and from the
original peaks called by MACS2 we can observe that binding of Nfix is indicative of Nfia binding as
5,576/5,843 Nfix sites are bound by Nfia. ChIP-R identified 5,588 reproducible peaks across all four
data sets compared to 5,559 sites bound by both Nfix and Nfia in the original analysis.
Nfia and Nfix ChIP-R reproducible peaks are linked to 275 coordinated target genes of which 261
are common to the original coordinated targetome, 14 are unique to the ChIP-R derived targetome
and 22 are unique to the original targetome. High similarity to the original coordinated targetome
that was shown as biologically relevant in Chapter 3 and Fraser et al. [51] indicates that ChIP-R can
be used to accurately identify biologically relevant genomic regions bound by both factors with high
confidence. The limiting factor in both analyses is lack of evidence of Nfix binding as the Nfix data
set has a lower read depth and coverage reducing the number of true peaks that can be identified. All
the genes previously identified as targets of Nfix and Nfia are detected in the ChIP-R coordinated
targetome including Dab1 which was excluded from the ChIP-R Nfix targetome.
Unique genes identified by ChIP-R but not the original analysis, recorded in Table 4.2, generally
do not have evidence of a peak across all replicates but are identified as reproducible and related to
development of the cerebellum. One example of a newly identified gene is Slc1a3 that has previously
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Table 4.2: Genes unique to the original analysis pair targetome and ChIP-R analysis pair targetome
when compared to one another. The ChIP-R unique genes include genes previously linked to cerebellar
development and Nfi biology including Slc1a3. The genes unique to the original analysis are not as
strongly linked to cerebellar development based on GeneCard’s annotations of each gene’s known
function but they are also not completely irrelevant.
Unique to original analysis Unique to ChIP-R analysis
Acot7 Mn1 Txlnb Cd44 Lama5 Plekho2 Myh8
Gpr153 Adcyap1 Spats2l Lifr Mybpc3 Csf1 Gm5087
Icmt Col4a2 Loxl1 Fam20c Unc13c Slc1a3 Sparc
Aldoc Col4a1 Ildr2 Dpysl4 Fam69c Col4a6 Pgpep1
Calcrl Cdh11 Gpr26 Ano1 Celf5 Lin7a
Nhlrc4 Pdgfc
been shown as co expressed with and directly influenced by Nfia and Nfib [33]. The Slc1a3 gene was
annotated with five Nfia binding events in the original analysis but only one of the two Nfix replicates
carried any evidence of binding at the same locations ruling Slc1a3 out of consideration as a target
gene despite its significant differential expression in both RNA-seq experiments. Using ChIP-R on all
four replicates, one site has enough support across replicates to call a reproducible peak despite not all
replicates reporting a peak at that genomic location. This is evidence of a clear advantage to using
ChIP-R in that a peak can be reproducible without occurring across all replicates and in this case, it
identified at least one new target gene of interest. Additionally, this illustrates ChIP-R’s application
to exploring pairs of transcription factors with common roles to identify with high confidence sites
occupied by both factors.
4.10 Discussion
Overall, ChIP-R is a tool that can take multiple replicates and identify reproducible ChIP-seq binding
events with high performance addressing Aim 2a. It has multiple advantages over other available tools
including its ability to dynamically assign peak boundaries, use two or more replicates, identify peaks
that are not present in all replicates but are still reproducible based on the rank product test and report
peaks with increased biological relevance.
Using ChIP-R to identify reproducible peaks of Nfia and Nfix independently reduces the size of
each targetome while maintaining enrichment of functionally relevant terms and retaining previously
identified target genes. One weakness of using ChIP-R on each factor independently became evident
when observing the resulting pair targetome. While relevant genes are still included, a number of
genes functionally linked to development of the cerebellum are excluded due to absence of a Nfix peak
indicating a need to identify co-bound sites with more statistical support than a simple overlap.
ChIP-R run on all available data sets and biological replicates accurately identified a coordinated
set of gene targets for Nfia and Nfix that was highly similar to the original pair targetome but included
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additional gene targets, such as Slc1a3, that have been previously shown as regulated by the Nfi family.
Across all analyses conducted in this case study, ChIP-R identified a smaller set of high confidence
binding events that were consistently linked to relevant target genes. ChIP-R’s ability to identify
similar, if not more accurate, targetomes or pair targetomes with a reduced number of binding events is
advantageous as it clarifies the specific events that are most likely to be regulating gene expression.
Specifically, ChIP-R generally reduced the number of binding events linked to a target gene limiting
the number of sites to be investigated for their influence on gene expression. The ability to target a
specific regulatory element or binding event is valuable when validating distal regulatory elements or
enhancers and in identifying regulatory elements that can be modified to control a specific gene.
4.11 Conclusion
The need for an approach to effectively evaluate biological replicates of ChIP-seq data was identified in
Chapter 3 and resolved in this chapter as a new tool: ChIP-R. The full analysis of ChIP-R describes a
robust approach to identifying reproducible peaks from multiple biological replicates. This chapter also
adds additional support to the advantages of using ChIP-R as well as ChIP-R’s broader applications to
characterising interacting transcription factors that share binding events across the genome through an
additional case study. In future, the ChIP-R tool could be expanded to investigate common binding
sites of different transcription factors using a more robust statistical approach as opposed to simple
overlapping of independently identified binding sites. It could also be expanded to integrate different
HTS assays for example accessibility data and transcription factor binding events to identify common
sites that are statistically significant.
For researchers implementing the workflow described in this thesis, cases where multiple replicates
of ChIP-seq transcription factor binding data exist should be merged through the application of ChIP-R
because it provides a more accurate and biologically relevant set of binding events.
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Figure 4.2: ChIP-R (CR) recovers reproducible sites with greater read depth in motif positive peaks,
here exemplified for REST. (a) Genome viewer tracks show the raw read accumulation, called peaks,
scored motif matches and reproducible peaks identified by alternative methods, using a variety of
settings at a 14 kilobase region around CACNA1b (not shown). Darker or brighter colours represent
peaks with higher scores (specific to each method). (b) Motif matches are annotated with the absolute
read depth at their genomic location. Greater read depth indicates increased likelihood of a true binding
event. The read depths at motif matches that overlapped peaks (from each method) are plotted as
linearly scaled beans. Each configuration is annotated with 1) area between the positive and negative
peak accumulation curves (ABC value), 2) output peak count, 3) the mean width ±SD of output peaks
and 4) percent of output peaks that overlapped a motif match and are represented in the bean. The
green horizontal line represents the mean motif score for the true positive peaks and the red horizontal
line the true negative peaks as recorded in the inset Table (c). MSPC c and CR m represent parameter
settings while ‘p3’ identifies the specific pair being tested. The second plot represents the beans from
the box in greater detail. (c) Summary table of the true positive and true negative peak sets. Mean
motif score is the mean read depth at motif matches overlapped by each set of true peaks. IDR (global
<0.05), IDR rlxd (global <0.4) and ChIP-R were run on the same pair of replicates (noted as p3)
while ChIP-R and all other methods were run on all four replicates for REST with increasing m or c
settings.
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Figure 4.3: ChIP-R recovers known binding sites and regions with sequence motifs for a given TF. (a)
The sum of positive and negative peaks was plotted against the number of peaks reported by ChIP-R
(sorted by p-value) with all peak counts normalised to their respective totals (total positive, total
negative or total peaks). The area between the positive and negative curves (ABC value) approaches 1
by including known positives and excluding known negatives. The threshold from the binomial test θ
is marked by a dashed line. (b) MEME suite analysis of ChIP-R outputs from analysing REST and
SRF. ChIP-R was run on all four replicates from REST and SRF with m set from 1 to 4. Outputs
were separated into a foreground of peaks at p < θ and a background of all remaining peaks. MEME
suite was used to perform motif discovery and differential enrichment. Each plot shows the central
enrichment of the foreground set (solid line) and background set (dashed line) for the discovered target
sequence motif represented as a logo with associated E-value (from MEME). A small value means
greater enrichment of the sequence motif. A small Fisher E-value (from MEME-ChIP) implies a
difference of motif occurrence between the foreground and background peaks, which in turn indicates
that the background have less biologically relevant sequence content. Motif E-values and Fisher
E-values for all factors and m settings are available in Supp. Table D.3.
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Figure 4.4: Nfia and Nfix binding events after ChIP-R was used to merge the available biological
replicates. a) Examples of weak peaks called by MACS2 that do not overlap and are not reproducible.
b) An example of a genomic region where both approaches in Nfia and Nfix have identified binding
events indicating with high confidence that this is a true binding site. c) An example where a Nfia
peak was identified in the original analysis but not deemed reproducible by ChIP-R. d) An example
where a Nfix peak was identified reproducible in the original analysis but not deemed reproducible
by ChIP-R. In addition, this location carries a high confidence Nfia site and stands as an example of
where analysing all four replicates simultaneously adds support to binding of either Nfi factor.
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Figure 4.5: Slc1a3 binding track. A series of browser tracks including the original peaks called by
MACS2 for each replicate of Nfia and Nfix (rep*), peaks that met the original filtering criteria in
Chapter 3 and peaks identified after running ChIP-R on all four Nfia and Nfix data sets. The tracks
are focused on the region around gene Slc1a3 and show a number of Nfia binding sites that indicate
Slc1a3 is a target gene but a lack of Nfix binding sites which prevented the gene from inclusion in
the original pair targetome. Using ChIP-R across all data, Slc1a3 is detected as having a reproducible
binding site correctly including it in the ChIP-R coordinated targetome. CR = ChIP-R
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Chapter 5
A Bayesian network approach to predicting
transcription factor binding sites in vivo
The following chapter was initially conducted as part of a DREAM Challenge and extended signifi-
cantly after the challenge was completed. There is not currently a final report on all teams and their
performance however, my overall performance placed me in the top half of the field. Importantly,
no team was able to produce a model with satisfactory performance across all factors and cell types
illustrating the difficulty of this task and further supporting observations made in the following chapter
about the need for additional data. The challenge organisers are still in the process of preparing a
manuscript that describes this work. The work will eventually be submitted to Cell with myself as a
co-author. Many conclusions that I reach in this chapter are supported by this publication but I cannot
share specific details as the text and a number of supporting data sets remain under embargo.
5.1 Introduction
The aim of this chapter was to develop and apply a computational method that can predict in vivo
binding of transcription factors in a variety of cell lines (Aim 2b). A predictive approach with high
accuracy would be a valuable asset to our bioinformatic workflow allowing characterisation of the
functional role of a transcription factor without the need for experimental data to identify binding
events. As part of training and testing our predictive model we identified limitations in the process of
knowledge extraction and developed new knowledge extraction techniques that are applicable across
numerous machine learning approaches to discover relevant patterns in the system under consideration.
In this case, to identify the genetic and epigenetic features linked to transcription factor binding.
Identifying locations of transcription factor binding sites in vivo is essential to understanding
regulation in the genome. Chromatin immunoprecipitation followed by high throughput sequencing
(ChIP-seq) has allowed detailed exploration of a number of transcription factors across multiple cell
types, tissues and conditions. However, for many transcription factors a specific antibody does not
exist and it is not feasible to assay binding across all cell types limiting the application of ChIP-seq.
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ChIP-seq also requires large numbers of cells to be successful and cases exist where isolating pure
cell cultures at such high levels is not possible. Finally, it is not feasible to test the large number
of transcription factor and cell type combinations. To explore transcription factor binding more
broadly, a computational approach to predict in vivo binding sites is required. With a large number of
high throughput sequencing data sets now available to describe transcription factor binding and the
associated genetic and epigenetic features, such an approach should be possible.
5.1.1 Existing approaches to predict transcription factor binding in vivo
A full and critical review of the tools available to predict transcription factor binding at the time this
work was conducted in late 2016 is summarised here and included in full in Appendix E.
Previous tools and approaches to predict transcription factor binding in vivo have explored a wide
variety of features that can assist in identifying binding sites. These include evolutionary conservation,
DNA shape, chromatin accessibility data, DNase I hypersensitivity (DHS) footprints (defined in the
‘Feature space’ section below), and detailed sequence features [68, 42, 181, 27, 131, 122, 4, 187, 141,
149, 133, 129, 106]. The available tools can be broken into three subgroups based on the features they
use to predict binding: sequence specific, sequence with local epigenetic environment and sequence
combined with DHS footprints. The majority of tools used sequence specific binding motifs as a
feature to predict binding with the sequence specific subset relying on motif scanning alone. The
second subset of tools explore features relating to sequence, histone modifications and regions of
accessible chromatin. The tools using sequence combined with DHS footprints focus more explicitly
on the advantages provided by footprinting while still considering sequence. Only one tool did not take
into account sequence motifs as they focused on patterns of co-occupancy which cannot be explicitly
captured by sequence [106].
A number of the available tools apply statistical approaches to generate predictions including
Poisson distributions, Bayesian mixture models, or linear discriminative analysis (LDA) [149, 141,
106]. A second theme across the existing approaches is the use of machine learning in the form of
classifiers to generate predictions for in vivo binding. This includes logistic regression, support vector
machines (SVMs) and hidden Markov models (HMMs) [42, 4, 111]. Although these statistic and
machine learning approaches have provided significant improvements to binding site prediction, their
main limitation is the inability to explore the contributing features and their influence on binding
outcomes. For example, a SVM is able to classify a site as bound or unbound but cannot provide any
information on why it has made that decision. By exploring the feature space around transcription
factor binding sites in vivo using a Bayesian network approach, not only will predictions be made
about binding, but the features that determine the environment for a binding event to occur can be
queried and defined. A Bayesian network is able to capture relationships and patterns stored in the
feature space making it a powerful tool for better understanding transcription factor binding in vivo.
This is particularly important when dealing with a complex system like the human regulome.
The tools available to predict transcription factor binding events in vivo share one major limitation
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in that they are only able to consider single transcription factor binding events and not additional
interactions (e.g. co-factors, cooperation or protein-protein interactions). Many tools were also
dependent on a sequence motif preventing their application to transcription factors that do not bind
directly to DNA or have noisy/weak motifs. On top of this, the minority of tools performed validation
of their approaches across cell types limiting their application to identifying binding events in a cell
type where ChIP-seq data is not available.
Xu et al. [183] includes a thorough and up to date review of predictive approaches with the majority
of new tools building on the current body of work described here with the only new advances relating
to the use of neural networks as a method to predict binding. Newer tools are still limited in the same
areas outlined above. Overall, very little advancement has been made over the last three years to
improve transcription factor binding site prediction in vivo providing the first indications that this
problem may not be solvable with the information we currently have available to us and further
illustrating the importance of knowledge extraction to understand the drivers of transcription factor
binding and to identify situations where predictions cannot be accurately made and why.
We hypothesise that a Bayesian network approach to combine multiple features, represented with
greater detail, across a large number of cell types will improve prediction of transcription factor binding
sites. Using an optimised set of features, a Bayesian network will allow exploration of relationships
and patterns in the data and their influence on binding. By including features that capture binding of
not only our target transcription factor but also additional factors (as described below) and testing our
model across cell types we will address the limitations of approaches currently available to predict
transcription factor binding in vivo.
5.1.2 Bayesian networks to predict binding
Bayesian networks are probabilistic, graphical and generative models. The network structure is
represented by a directed acyclic graph where relationships are represented by directed edges from a
parent to child node capturing conditional dependence of a child node given parent/s [52, 13]. While
Bayesian networks may not achieve the same performance of discriminative models, they have the
advantage of being generally interpretable using inference making them advantageous when it comes
to extracting knowledge or learning patterns from the data. The significant advantages of using an
interpretable model are discussed in Rudin [143]. We trained our Bayesian networks in a supervised
manner using expectation maximisation; an iterative method to find model parameters that best fit the
data.
Features included in a Bayesian network can be discrete or continuous. Discrete features are easier
to model and are represented by condition probability tables (CPTs) as demonstrated in Figure 5.1.
CPTs of child nodes grow as the number of parents increases and also as the number of possible states
increases. CPTs are fully accessible but can quickly become large depending on the complexity of
the network. Continuous features can be represented as tables of Gaussian distributions given state of
parent/s and are more difficult to interpret but remain accessible.
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Another advantage of Bayesian networks is the ability to query an outcome given evidence using
an inference algorithm called variable elimination. Unlike other models that only provide information
about an initially selected output feature, any feature included in a Bayesian network can be queried
to extract the probability of each feature state given the provided evidence. For example, given the
network in Figure 5.1 we could query the probability the grass is wet given that it’s raining and the
sprinkler is off but we could also query the probability that it is raining given that the sprinkler is off
and the grass is wet. Further, Bayesian networks can handle missing data reducing information loss in
training data as a result of missing data and allowing more complex queries to be made to capture the
influence features have on overall outcomes. For example, we can query the probability that the grass
is wet given the sprinkler is off and compare that to the probability the grass is wet given the sprinkler
is off and it’s raining to determine how important knowledge about whether or not it is raining is to
predict if the grass is wet.
As Bayesian networks can handle missing data, it’s also possible to create more complex rela-
tionships in the network by including ‘latent’ or unspecified nodes which have no real world data by
which they are defined. Latent nodes still have a predefined number of states and are represented by
CPTs that capture the probabilities of each state given the state of the parent node/s. Latent nodes
are advantageous as they influence the flow of information across the network and can allow more
complex relationships to be captured [121, 11].
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T F
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0.20 0.80
T F
Sprinkler
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T
T
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F
F
F
0.75 0.25
0.00 0.20
D
0.01
0.05
0.05
0.80
Figure 5.1: This schematic represents a simple Bayesian network with three features or nodes and their
associated conditional probability tables. Rain and Sprinkler have two possible states True or False.
Grass wet has three possible states (Wet, Moist and Dry).
By exploring the feature space around transcription factor binding sites using an interpretable
model such as a Bayesian network, not only will predictions be made about binding, but the features
that indicate a binding event can be queried and explored.
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5.1.3 Knowledge extraction challenges
To the best of our knowledge, no approaches exist to extract, summarise and quantify the patterns
and relationships discovered by a trained Bayesian network. While the probability tables that define
nodes and dependencies in the network are accessible and a Bayesian network can be dynamically
queried to probe not only the output variable but all other features in the network, formalised and
defined approaches to quantify observations on a large scale are required. In this work we conceive and
implement new techniques to address these limitations and extract new knowledge from our Bayesian
network to better define transcription factor binding patterns.
Interpreting Bayesian network probability tables
Early in this work we discovered that, despite our efforts to build a network with relatively simple
structure, the number of states required to accurately represent features and the need to relate features
to one another with the addition of more edges led to conditional probability tables that were large
and convoluted. We could not conceive an approach to summarise and compare the information
captured in these tables. The inclusion of latent nodes, while beneficial to model performance, further
disrupted our ability to compare trained models as the states captured by latent nodes are not directly
comparable. For example, a latent node may have three states (0, 1, 2) and in one trained model an
outcome may be captured by state 1 while in another model the same outcome is captured by state 2 as
the states themselves are not constrained. These challenges prevented us from successfully extracting
meaningful information from the probability tables generated by our networks.
Extensive querying of network with varied inputs was uninformative
Querying probability distributions of different nodes given a wide array of simulated evidence covering
all combinations of feature states and including evidence where various inputs are ignored should
allow investigation of how features impact the probability of a binding event. This turned out to be
uninformative because nodes would default to reporting the highest probability outcome based on
the observed data and querying the state of latent nodes had no biological meaning as they represent
multiple inputs that varied between models. Likewise, querying the probability of binding given
different evidence provided to the network did not inform us as to which variables had the greatest
influence on outcome, as we failed in our attempts to resolve and quantify the output of thousands
of queries and interpret the influence of different variables in a Bayesian network. Additionally, we
noted that ignoring data greatly reduced model performance indicating that more features are required
to achieve reasonable predictions and no feature can independently identify binding events with any
accuracy.
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Relating input data to predictive performance to reveal patterns associated with transcription
factor binding
With our initial aim of extracting knowledge from networks using probability tables and dynamic
querying of the network unsuccessful in the early stages of this analysis, new concepts were explored
that would make knowledge extraction a possibility. We opted to probe feature importance and identify
new patterns by relating testing data to the probability of binding. In this way, we could work with true
positive data and determine where the model was successful in its predictions and where it struggled
to assign the correct probability of binding. Our approach effectively identified patterns on a small
scale and is applicable to a variety of machine learning methods to extract knowledge.
5.1.4 Feature space
A number of different features have been used in various approaches to predict transcription factor
binding in vivo. Here we describe the features that will contribute to our Bayesian network approach
including sequence scanning using motifs, accessibility data and footprint analysis. We also justify the
decision to exclude gene expression data, a feature previously used by other approaches, and identify
features that could inform transcription factor binding but are not currently available.
Motif
Transcription factors are known to bind to sequence specific DNA motifs with each of the transcription
factors explored in this analysis and their associated motif reported in Table F. Only transcription
factors with known motifs are included in this analysis. Motifs are represented as position weight
matrices (PWMs) which can be used to scan query sequences to identify and score motif matches. A
genomic region that contains a high scoring match to the motif would have an increased probability
of a binding event. If a transcription factor is operating through interactions with other transcription
factors and not DNA directly, it will not have an associated sequence motif making it impossible to
predict all true binding events based on sequence alone.
Accessibility and footprints
DHS peaks represent accessible regions of chromatin and, in most cases, a transcription factor requires
the DNA to be accessible to allow binding. Where a protein is bound to DNA, e.g. a transcription
factor binding event, the activity of the DNase I enzyme can be blocked leaving evidence of binding in
the form of a DHS footprint making them a valuable feature to predict binding events [68, 122, 149].
Knowing that there is a footprint at a location, even if it is not linked to the target transcription factor,
is informative as it represents situations where a transcription factor does not bind directly to the DNA,
instead binding as a co-factor [122].
To better define the environment around a binding site, the number of footprints occurring in a
±250bp window is also recorded. A high number of DHS footprints at a location indicates increased
binding activity as transcription factors are enriched at promoter and enhancer regions [122]. This
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feature addresses in part the limitation of existing tools failing to take into account binding of other
events that could be interacting with the target transcription factor.
Transcription factor interactions
While the inclusion of DHS footprints allows our model to learn from the broader regulatory potential
of a genomic region and the potential influence of other binding events; it does not specifically capture
transcription factor interactions. Attempts were made as part of this research project to quantify
transcription factor interactions using the information available in the ReMap data base and incorporate
this into our model, but were unsuccessful. This remains an area that requires additional research to be
fully resolved and falls outside the scope of this thesis.
Target gene annotation and gene expression
Gene expression data is available for all the cell types included in this analysis and represents the
outcome of regulation in the genome. It was not incorporated into the model due to the lack of
available approaches to accurately annotate binding events to target genes with reasonable accuracy.
Without an accurate annotation approach, gene information introduced noise as binding events were
linked to expression values that were unrelated and added little to overall performance. An analysis of
approaches available to predict target genes given transcription factor binding events are reviewed in
Chapter 6.
5.1.5 Summary
In this chapter we describe our Bayesian network and the approaches we took to train, test, query and
learn from our models with the aim of not only predicting transcription factor binding events in novel
cell types but generally improving our understanding of the conditions required for transcription factor
binding through the application of novel techniques for knowledge extraction. While our model did
not achieve the performance required to be incorporated into our workflow, we gained valuable insight
into the features that define transcription factor binding sites in vivo.
5.2 Methods
5.2.1 Data selection
Binding data for 98 ChIP-seq data sets across 29 transcription factors and 10 cell types was retrieved
from ‘The Dream Challenge’ competition website in partnership with the ENCODE consortium
as recorded in Appendix F. Each ChIP-seq data set was broken into conserved and relaxed peaks.
Conserved peaks were present across multiple replicates and had an irreproducible discovery rate
(IDR) score of < 5% [103], while relaxed peaks were present in multiple replicates but had an IDR
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score > 5%. The data was part of a competition and therefore conformed to their data standards
restricting the application of our own tool ChIP-R to merge replicates.
Each ChIP-seq data set was represented as 200bp windows at intervals of 50bp across the Human
genome using three labels (see Figure 5.2a). A 200bp window was allocated a label ’U’ (unbound) if
there was no evidence of any ChIP-seq peak at that location. A label of ’A’ (ambiguous) was given to
200bp windows overlapping a relaxed peak or the edges of conserved peaks. ’B’ (bound) was assigned
to windows overlapping conserved peaks. A set of blacklisted regions which have been shown to
contain artificially high signal were excluded from the set of locations across the genome [39]. In total,
each ChIP-seq data set consisted of 60,519,747 labels.
It was not feasible to explore all available locations due to size, time and computational complexity.
A maximum of 0.5% of locations across all ChIP-seq label files were annotated as ’B’ indicating
many of the windows did not contain sites of interest and would therefore not be informative in
identifying patterns associated with transcription factor binding. To reduce the size of the data sets,
only locations which fell under the union of all conservative ChIP-seq peaks and DHS accessible
regions were explored with the addition of 1,000,000 additional random 200bp windows. This reduced
the number of labels to 9,483,900 and raised the maximum occurrence of ’B’ to 6%. Using the union
of all ChIP-seq peaks and accessible regions plus an additional set of random windows ensures that
individual transcription factor/cell type combinations contain examples of no binding.
We know that transcription factor binding events occur at DNA sequence specific locations in the
genome and a transcription factor motif, a key feature in identifying transcription factor binding, is
generally <30bps. Therefore, 200bp windows are a coarse measure and we chose to instead represent
each location in the genome using a window of 50bps with the conversion described below.
5.2.2 ChIP-seq labels
A new ChIP-state was assigned to each 50bp window that captures the binding state from the original
200bp windows. The ChIP-state ranges from 0-14 depending on the count of each label (U, A and B),
as shown in Table 5.1. Where a binary representation is required to separate ‘Bound’ from ‘Unbound’
states; ‘Bound’ includes states 0 - 9 where at least one overlapping window is labeled ‘Bound’ and
‘Unbound’ includes states 10 - 14.
5.2.3 Feature selection
As binding events are dependent on the cell type specific epigenetic environment as well as sequence
features and transcription factor specific motif, a feature data set was generated for each transcription
factor and cell type combination. A number of biological features are continuous by nature (most
captured by distance to feature or expression levels) however for the purposes of this analysis a number
were discretised to be easily represented by a conditional probability table, reduce complexity of the
model and improve training outcomes (continuous nodes can fail to train if appropriate distributions
are not identified within the data). Discretising data leads to information loss but would otherwise
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Figure 5.2: a) Data was labeled U, A or B for every 200bp window at 50bp intervals across the Human
genome for each ChIP-seq data set as shown here. U for unbound regions which did not overlap
a ChIP-seq peak. A for ambiguous regions which overlapped relaxed peaks (present in multiple
replicates but had an IDR score > 5%) or to represent low confidence edges of a ChIP-seq peak. B for
bound regions which overlap conservative ChIP-seq peaks (IDR score of < 5%). b) A 50bp window
was deemed more acceptable for exploring transcription factor binding sites requiring transformation
of the data. Given the count of each label above a 50bp window, a state was assigned to represent the
binding event (see Table 5.1).
U 0 0 0 1 1 2 0 1 2 3 0 1 2 3 4
A 0 1 2 0 1 0 3 2 1 0 4 3 2 1 0
B 4 3 2 3 2 2 1 1 1 1 0 0 0 0 0
State 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Binary state Bound Unbound
Table 5.1: Given the count of each label above a 50bp window (see Figure 5.2b), a new chIP-state
was assigned to represent the binding event resulting in 15 possible states. The states capture genomic
regions with high confidence binding (state 0) and high confidence lack of binding (state 14) as
well as ambiguous binding events. Capturing different types of binding events in detail provides the
opportunity to explore associated genomic features and improve our understanding of transcription
factor binding.
make training and interpretation near impossible. The discretisation approach for each feature was
decided by plotting raw data to visualise each distribution and identify representative bins combined
with testing the performance of the network given different bins.
Motif matches
Each 50bp window ±motif length is scanned to identify the maximum motif match score for the
transcription factor motif of interest. Scanning beyond the window ensures that motifs on the boundary
are not excluded from the analysis.
PWMs vary in size and distribution between transcription factors and as such, two motifs may
not have the same maximum score. To make scores comparable between transcription factors, each
score was normalised to between 0 and 1 based on the possible maximum and minimum scores.
The maximum motif score (MaxMS) is the score assigned to a sequence where each position in the
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sequence contains the best match (i.e. the score of a perfect match). The minimum motif score
(MinMS) is the score assigned to a sequence where each position in the sequence contains the worst
match that does not have a probability of 0.0. The invalid motif score (InvMS) is the score assigned to
a sequence where one or more positions in the sequence contain a match that has a probability of 0.0.
(moti f score−MinMS)/(MaxMS−MinMS)
It is possible that a transcription factor motif cannot contain a certain base pair/position combina-
tions in the PWM resulting in a probability of 0.0. The PWM scoring method used to explore query
sequences operates in log space and cannot handle values of 0.0 but instead applies a pseudo count
of 0.000001. In the case where a query sequence contains the base pair/position combination with a
value of 0.0, the resulting score is an extreme negative value and a very poor match for the motif. In
this case scores were normalised to between 0 and -1.
−(1− (moti f score− InvMS)/(MinMS− InvMS))
5.2.4 Accessibility data
Conserved DHS peaks were defined as having an IDR threshold of < 10% while relaxed peaks were
identified in pseudo-replicates but had no IDR threshold applied [103]. Originally, each peak was
labeled as overlapping a DHS peak or not but this did not capture enough information and had a
negative impact on model performance. Instead, the minimum distance was calculated between the
edge of each 50bp window and the nearest DHS peak, with overlaps having a distance of zero, to
describe the general chromatin environment around a binding event. This distance was then converted
to a discrete value ranging from 0-7 as noted in Table 5.2.
Footprints were identified by running PIQ on each of the 512 motifs in the JASPAR core 2016
database in every available cell type to identify as many transcription factor binding sites as possible
[113]. First, motif scanning is used to identify putative transcription factor binding sites then, the
read distributions from the DHS bam file are modeled to identify patterns marking DHS footprints.
Footprints in each cell type were identified across replicates by merging all available replicate bam
files. Each 50bp window can then be assigned a distance to the nearest general or non-specific footprint
as well as the distance to the nearest specific footprint that overlaps the target motif. This distance was
then converted to a discrete value ranging from 0-7 as noted in Table 5.2.
The number of footprints occurring in a ±250bp range around each window is also recorded and
converted to a discrete value between 0-5 as noted in Table 5.2.
5.2.5 Location
Transcription factors can bind in promoter regions, within genes (exonic and intronic) or at enhancer
regions which can be up to 1mbps from the gene they are regulating [31, 142]. A promoter region is
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defined as ±2,000bps around a TSS. Locations outside the promoter region but overlapping a gene are
labeled as genic while all remaining locations are labeled as distal. Promoters and enhancers (i.e. distal
locations) contain variations in their epigenetic environment and are likely to demonstrate different
binding patterns. Enhancers are known to operate over limited distances therefore, distance can act as
a filter for true binding sites. The distance to the nearest TSS was recorded for each 50bp window and
discretised as noted in Table 5.2.
5.2.6 Model construction and training
The Bayesian network used in this analysis and represented in Figure 5.3 was manually constructed
using expert knowledge and running performance testing across multiple configurations to identify the
best structure. Once an ideal network structure was identified, condition specific training data was
used to train the same network structure multiple times resulting in a set of condition specific models.
Training data consisted of the same 100,000 randomly selected window locations from the full set of
9,483,900 labeled data points specific to each transcription factor and cell type. Networks were trained
using expectation maximization as described below.
When measuring model performance, auROC values are generally uninformative due to a small
number of true positive events and consistently high across all tested conditions with auPRC values
offering a better representation of performance. Therefore, auPRC values were used to measure
performance of all models.
A Bayesian network is composed of a number of vertices associated with variables (1:1). The
variables represent a range of features that are either observed or latent, in relation to a 50bp window.
These variables can be discrete, meaning that they take on one of a finite number of values, or
continuous, meaning that they take on a real value. For each location in our training data set, we assign
observed values to these variables, or leave them unspecified when not known.
Generally, the joint probability of all variables, X1, . . . ,XN , in the Bayesian network is given by
P(X1 = x1, . . . ,XN = xN) =
N
∏
i=1
P(Xi = xi | pa(Xi))
where pa(Xi) is the set of parents of the ith variable, as indicated by the acyclic graph formed from
directed edges between vertices (parent-to-child).
The parameters of the network define the conditional probabilities associated with each vertex,
i.e. the probability of the variable associated with it, conditioned on the variable’s parents. In this
study they are learned from observations in the data sets using standard Expectation-Maximization to
cope with the absence of explicit evidence for variables. The structure is fixed to accommodate causal
relationships that are evident from the literature.
Some child variables are continuous and are here represented by a Gaussian density, meaning that
EM finds a mean and a variance for each possible combination of parent variable assignments. In
several cases, the value is first log-transformed to suit a Gaussian density.
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Node Feature Type State(s)
DHS.Peak Distance to nearest DHS peak Discrete 0-7: 0, ≤ 50, ≤ 200, ≤ 500,
≤ 1,000, ≤ 20,000,
≤ 100,000, > 100,000
Gen.FP Distance to nearest DHS footprint Discrete
Spec.FP Distance to motif matched DHS footprint Discrete
Dist.Gene Distance to nearest TSS Discrete 0-5: ≤ 2,000, ≤ 5,000,
≤ 10,0000, ≤ 50,000,
≤ 100,000, > 100,000
GF.Count Count of DHS footprints in ±225bp window Discrete 0-5: < 2, < 4, < 6, < 8, < 10,
> 10
Motif.Score Normalised PWM score Real Normalised between -1 and 1
Table 5.2: A record of the nodes in the Bayesian network, the features they represent and their data
type.
Inference of P(X | E = e) where X is the (uninstantiated) query variable(s), and E = e is the
assigned evidence, is based on the full joint probability. In order to obtain this value, we marginalise
over the set of unobserved variables Y , which take values y,
P(X | E = e) = η∑
y
P(X ,E = e,Y = y)
where η is a normalising constant that ensures that conditional probabilities of X’s possible values sum
to 1. Any variable can be inferred in the Bayesian network. When estimating the ability of the model
to predict transcription factor binding, we infer the posterior probability of the variable representing
this variability given evidence available for that locus, for instance sequence composition, and number
of repeat copies.
Binding.State
LatentDist.Gene
Latent
GF.Count
Motif.Score
DHS.Peak Gen.FP Spec.FP
Latent
Figure 5.3: The network structure of the model that will be used to capture patterns and relationships
from the data. Nodes are coloured by their input with green being discrete, blue being continuous or
real, black as latent (no input) and red representing the node which will capture binding probabilities
(also discrete). Nodes are described in detail in Table 5.2 and in ’Feature selection’ above. Arrows
represent the node edges and conditional dependency between a child node given its parent.
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5.2.7 Knowledge extraction techniques
To determine the effectiveness of our Bayesian network approach, each condition specific model was
tested on a distinct test set of 100,000 locations with features specific to each transcription factor and
cell type (condition specific data). The performance of each condition specific model at predicting
binding events for each set of condition specific data was then tested and recorded as an auPRC value.
To determine the pattern of binding most strongly associated with a true positive prediction, a
balanced set of 235,000 positive data points and 235,000 negative data points across all transcription
factor and cell type combinations were extracted and for each data point a binding probability was
calculated by each available model. Data points were then grouped by all combinations of the five
discrete features in the model ranging from single features to five features. Based on these groupings,
a distribution of probabilities across all data points and models in the group was generated along
with a mean probability of binding. For example, all data points that had a DHS.Peak state of 0
and a GF.Count state of 5 were grouped and all available probabilities were plotted then averaged to
determine whether this combination of features was predicted well across all models.
To determine the relationship between feature prevalence and performance, the frequency at which
each feature combination was observed in both the positive and negative data sets was recorded to
calculate the correlation between the proportion of each feature state in positive data and model
performance in this case measured by mean predicted probability of binding.
5.3 Results
5.3.1 A simple network structure allowed knowledge to be extracted from the
system
We constructed a Bayesian network structure from expert knowledge using a set of features known
to influence transcription factor binding. To keep the model simple, we separated features by latent
or unspecified nodes taking advantage of information flow between serial, convergent and divergent
nodes to capture conditional dependencies without a direct edge. This keeps conditional probability
tables small, reduces training time and increasing the overall interpretability of the model. Figure 5.3
shows the structure of the Bayesian network with conditional dependence indicated by directed edges
and Table 5.2 describes the features in detail.
5.3.2 Data preprocessing and formatting influenced model performance
Initially, boolean discretisation was employed to capture whether a window did or did not overlap
any of the three features describing DHS peaks and footprint data but significant improvement in
performance was gained when more states were introduced to capture a wider range of distances (see
Table 5.2). This indicates that the wider environment around a window is more informative than the
environment immediately over a genomic site to predict whether a binding event has occurred.
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Further, GF.Count was initially represented as a continuous variable but the distributions given
each parent state overlapped significantly and did not distinguish binding from non-binding events
well. The final network has GF.Count represented as a discrete node with six states (Table 5.2) that is
later shown to have a strong influence on the ability of the network to predict binding events indicating
that representing data in it’s raw state does not always provide the optimal training outcome.
5.3.3 Performance of model varied depending on transcription factor and cell
type tested
Figure 5.4 shows that models trained and tested on a withheld set of the same cell type specific
transcription factor data have a wide range of performance. The best performance came from the
models trained on transcription factor MAX in cell line HCT116 and CTCF in H1-hESC with auPRC
scores of 0.54 and 0.53 respectively indicating that a number of binding events were still incorrectly
predicted. In contrast, factor SRF in cell line H1-hESC and MAFK in GM12878 have auPRC scores of
only 0.03 and 0.01 respectively indicating near complete failure of these models as they were unable
to identify true binding sites in the data. This variation in performance was the first indicator that the
patterns of transcription factor binding are far more complex and diverse than previously expected
given the generality of features included in the model. This level of performance indicates that, at
best, our model is not an optimal predictor but can offer insights into the features that are linked to
transcription factor binding events.
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Figure 5.4: Model performance on withheld set of the same cell type specific transcription factor data.
Performance was measured by both auPRC and auROC with the models sorted based on auPRC values
as auROC values do not truly capture performance due to the limited number of true positives. At best
the MAX HCT116 model achieves an auPRC value of 0.54 while MAFK GM12878 has the worst
performance at 0.01.
5.3.4 Individual features are inadequate to predict binding events
In each cell type specific transcription factor data set, while the distributions of all features are
significantly different (Zolmogorov-Smirnov test p− value < 0.05) there is no clear separation of
features when comparing bound windows to unbound windows (i.e. comparing states 0-9 to states
10-14) (Figure 5.5). This is evidence that no single feature is capable of distinguishing between
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transcription factor specific binding events and general binding events. Therefore, a combination of
features is required to separate bound from unbound windows and accurately identify true binding
sites in vivo. Specific combinations of features are captured by the Bayesian network model to make
predictions about binding and we go on to explore how these combinations can be extracted and
characterised.
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Figure 5.5: Distributions of model features across a sample of transcription factors. A sample of
100,000 data points from CTCF, MAX and MAFK transcription factors in cell type H1-hESC were
extracted and the distribution of states for each model feature were plotted given whether the data point
represented a Bound (B) or Unbound (U) window. There lacks a clear distinction of states between
bound and unbound windows. For example the motif scores of MAFK bound and unbound windows
are highly similar.
5.3.5 Model features were unable to distinguish transcription factor specific
binding events from general binding events
Both true binding events and true unbound events were observed as having high PWM scores (Figure
5.5) confounding the model and preventing accurate prediction of transcription factor specific binding
events. The same genomic window can be labeled as bound for one transcription factor and unbound
for another resulting in identical data for four of the six features in the model with Motif.Score and
Spec.FP present to separate a specific from general binding event. However, PWM scanning only
weakly captures sequence specificity and binding affinity limiting its ability to distinguish between
a general binding event and a transcription factor specific binding event. A number of transcription
factors share very similar motifs disguising the specific transcription factor that is bound and resulting
in unbound windows carrying unexpectedly high motif scores and close distances to specific footprints
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as seen in Figure 5.5. This indicates that the currently available features are inadequate when it comes
to distinguishing transcription factor specific from general binding events
5.3.6 A generic set of features associated with a non-specific binding event
does not exist
After determining that the features included in the model have weaknesses in separating general
binding from specific events, we instead began looking for patterns associated broadly with binding to
allow prediction of general binding locations in a novel cell type. If such a pattern exists, one would
expect that a top performing model would have reasonable performance when tested on a novel cell
type and transcription factor data set.
We tested each cell type specific transcription factor model on all withheld cell type and transcrip-
tion factor combination test sets and found that top performing models generally cannot predict binding
events in novel cell type and/or transcription factor data with great accuracy. Rather, a subset of cell
type specific transcription factor data can be predicted by all models as shown in Figure 5.6. This
indicates that all data sets have a pattern that is strongly associated with transcription factor binding
and learned by all models but this pattern is more prevalent in some data sets including MAX and
CTCF combinations allowing all models to perform well on this data.
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Figure 5.6: Performance of cell type specific transcription factor models across all available data.
Each cell type and transcription factor specific model was tested on all available data sets with auPRC
recorded to measure performance. The results were stored as a matrix and clustered based on similarity
of each model’s performance on a data set. A group of data sets including all the MAX and CTCF
factor data can be predicted with reasonable performance by all models (left side of plot). Other data
sets cannot have their binding events accurately predicted by any of the available models.
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Figure 5.7 shows that models trained on the same cell type but different transcription factors do
not have consistent performance ruling out a cell type specific pattern. Similarly, models trained on
the same transcription factor but different cell types also lack the ability to predict transcription factor
binding events across cell types excluding the existence of a transcription factor specific set of features.
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Figure 5.7: Performance of cell type specific transcription factor models across all available data.
Each cell type and transcription factor specific model was tested on all available data sets with auPRC
recorded to measure performance. The results were stored as a matrix and clustered based on cell type
or transcription factor. These matrices represent the same data as Figure 5.6 with data sets ordered
differently to illustrate a lack of consistency in performance within cell type or transcription factor.
Variation in predictive ability given training data shows that not all transcription factor binding
events can be described accurately by the same set of features. In other words, there does not exist
a pattern across all condition specific data that is indicative of transcription factor binding. As we
considered broad or non-specific biological features, and as transcription factors generally share
similar mechanisms, we expected a strong pattern of binding to emerge and such a pattern could not
be observed.
5.3.7 Merging data to reinforce strongest binding patterns leads to poorer per-
formance overall
A non-condition specific model trained on a merged set of condition specific data resulted in poorer
performance when tested across condition specific data. This indicates that increasing the diversity of
data weakens patterns previously associated with a stronger probability of binding and suggests that
the model is not complex enough to account for more subtle patterns in the data.
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5.3.8 Extracting probability of a binding event across test data and multiple
models revealed feature combinations that led to true positive predic-
tions
Comparing probabilities generated across all models on a balanced set of 235,000 true binding events
to 235,000 non-binding events allows the characterisation of feature combinations that are associated
with high or low probabilities of binding to extract new knowledge about the relationships captured by
our model.
Individual features can be linked to performance outcomes and transcription factor biology
Considering only single features and plotting the distribution of all predicted probabilities, Figure 5.8
shows that the probability of binding increases when a window matches expectations of transcription
factor binding e.g. accessible, near a footprint, with other binding events in the window and near
a TSS. GF.Count and Spec.FP features have the states associated with highest mean probability of
binding. While better performance is linked to certain features and states, all features and states can
still be associated with a high probability of binding reinforcing that single features are not adequate
to define binding events.
MAX data has the highest proportion of binding events with high GF.Count states while CTCF
has the highest proportion of binding events with low Spec.FP events (i.e. overlapping). This could
explain why these data sets are predicted well by all models across the board and also suggests that the
MAX transcription factor binds in regions of high regulatory activity while CTCF is more likely to
bind directly to DNA resulting in a specific footprint.
Feature combinations strongly associated with true positive predictions fit the known pattern
of transcription factor binding
Quantifying probability distributions across all feature combinations can identify patterns linked to true
positive or true negative outcomes. Figure 5.8 showed that DHS.Peak, Spec.FP and GF.Count are each
individually influence model performance. Figure 5.9 shows that by combining DHS.Peak, Spec.FP
and GF.Count the pattern of higher probability of binding where features match expected transcription
factor binding is reinforced. Separating by more features also increases the mean probability of binding
across different feature combinations represented in Figure 5.9.
The combination of features that results in the highest average probability of binding includes all
five discrete features and describes a window within 2,000bps of a TSS that overlaps an accessible
region and general footprint, is within 50bps of a specific footprint and has 10 or more other footprints
within a 500bp window: a set of features that matches expectations of what a binding event would
look like. The highest average probability of binding when only considering three features includes
DHS.Peak, GF.Count and Spec.FP with the same observations and sits at 0.345 compared to the top
average of 0.355.
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Figure 5.8: Probability distributions over each feature’s states indicate relationships between each
feature and overall performance. A probability was calculated by every model for each data point in a
test set of 235,000 bound windows. A random set of 5,000 data points was extracted and separated
based on the observed state of each feature to determine whether single features states were associated
with a higher probability of binding. All 5,000 data points are represented in each set of axes but sorted
based on state of single, specified feature. All single features show a relationship to performance for
example a greater distance to the nearest DHS.Peak results in lower probabilities of binding and a
higher count of general footprints within a 500bp window results in higher probabilities of binding.
The large spread of data across all distributions indicates again that no single feature is strongly
associated with binding.
Conversely, the data points accurately predicted as unbound (i.e. binding probability of 0.00) had
features not typically associated with transcription factor binding e.g. more than 100,000bps from
nearest accessible peak, general footprint and specific footprint, more than 500,000bps from the nearest
TSS and no other binding footprints in a 500bp window. However, a number of true binding events
carried patterns very similar to this indicating a large proportion of binding events occur in non-typical
regions of the genome that hold unusual epigenetic patterns. For example 650/235,000 true binding
events are > 100,000bps from the nearest DHS peak or specific footprint with no other footprints in a
500bp window.
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Figure 5.9: Probability distributions over a subset of feature combinations of Spec.FP and GF.Count
where DHS.Peak = 0 indicate relationships between feature combinations and overall performance. A
probability was calculated by every model for each data point in a test set of 235,000 bound windows.
A random set of 5,000 data points was extracted and separated based on the observed state of each
feature to determine whether feature combinations were associated with a higher probability of binding.
In Figure 5.8 we observed that individually DHS.Peak, Spec.FP or GF.Count have a strong influence
on performance and combining the three reinforces that observation as observed in this plot where,
for example, a combination of 0,1,5 has a higher average probability of binding compared to any
individual feature.
Feature combinations strongly associated with true positive predictions are more prevalent in
training data
We determined that the feature combinations that resulted in the highest average probability of binding
had a higher proportion of true binding events that carry the combination of features compared to
non-binding events. As shown in Table 5.3, the previously identified pattern of DHS.Peak = 0, Gen.FP
= 0, Spec.FP = 1, GF.Count = 5 and Dist.Gene = 0 strongly associated with transcription factor binding
had the highest average probability of binding across all models and of the 631 data points that carried
this combination, 621 were true binding events while only 10 were non-binding events. The Pearson
correlation between the average predicted probability and proportion of true binding events for every
observed combination of five discrete features including combinations with only two features up to
all five features is 0.80. This supports the hypothesis that the prevalence of a feature combination in
true positive data is an indicator of how accurately data containing the feature combination will be
predicted as bound.
The ‘Low’ group in Table 5.3 represent false negatives that have features highly similar to unbound
5.3. RESULTS 93
High Moderate Low
Feature
combination
Mean Proportion Feature
combination
Mean Proportion Feature
combination
Mean Proportion
0,0,5,1,0 0.355 0.984 0,1,2,4,5 0.112 0.825 7,4*,*,* 0.005 0.087
0,*,5,1,0 0.354 0.983 *,*,3,7,* 0.112 0.767 *,*,5,5,* 0.005 0.105
0,1,5,1,0 0.346 0.978 *,1,*,4,* 0.111 0.601 6,4,0,6,3 0.005 0.106
0,*,5,2,0 0.346 0.978 2,*,4,*,4 0.109 0.572 7,4,0,7,0 0.005 0.055
0,1,5,2,0 0.346 0.99 *,*,3,6,2 0.108 0.693 5,3,*,7,* 0.005 0.105
0,*,5,1,0 0.346 0.981 1,1,*,3,3 0.107 0.667 7,*,0,7,1 0.004 0.065
0,*,5,0,* 0.345 0.98 3,*,5,*,4 0.106 0.652 7,3,0,6,4 0.004 0.159
0,0,5,1,* 0.345 0.984 2,1,4,7,1 0.106 0.833 *,4,*,5,1 0.004 0.144
*,*,5,1,* 0.330 0.978 4,1,1,1,5 0.105 0.917 7,2,0,6,0 0.003 0.098
*,*,5,2,* 0.323 0.966 6,*,*,1,* 0.105 0.899 6,5,0,6,2 0.003 0.103
Table 5.3: The mean performance of all models on 235,000 true binding events grouped by combi-
nations of five discrete features with the associated proportion of true positive events in each group
compared to unbound events in group. Each feature combination is ordered DHS.Peak, Gen.FP,
GF.Count, Spec.FP, Distance with a * representing allowance of any state in that feature. E.g. *,*,5,1,*
includes all data points with GF.Count= 5 and Spec.FP = 1.
windows and cannot be accurately predicted as bound. The proportion of true positive events carrying
these features is low indicating not enough knowledge is available to accurately distinguish them from
unbound windows.
5.3.9 Detailed analysis of model performance on specific feature combinations
provides knowledge about how transcription factors operate
A robust approach that can interpret the influence of features as shown below on a larger scale would
improve our understanding of transcription factor binding. At this time, such an approach is still not
available. Here, we identified two examples or case studies of how specific feature combinations are
interpreted differently across condition specific models and the information this provides on how a
transcription factor can operate across different cell types and compared to other factors.
Comparing a subset of feature combinations reveals models that show varied performance high-
lighting differences in transcription factor binding
Figure 5.10 shows the performance of each model tested on the same set of true binding data points
with three different feature combinations of DHS.Peak, Spec.FP and GF.Count. The 0,0,5 (red)
combination represents windows that overlap an accessible region, a specific footprint and have 10 or
more general footprints in a 500bp window. The 1,2,5 (green) combination represents windows that
are 50bps from an accessible region, 200bps from a footprint but still in a 500bp region with 10 or
more other footprints. The final combination of 7,6,0 (blue) represents windows where the nearest
94 CHAPTER 5. TRANSCRIPTION FACTOR BINDING SITE PREDICTION
accessible peak is >100,000bps away, the nearest specific footprint is between 20,000 and 100,000bps
away and there are no footprints in a 500bp window.
The red and green feature combinations are more closely aligned with our expectations of transcrip-
tion factor binding and are more prevalent in the true positive data set. The blue feature combination
seems unlikely to harbour a binding site based on our knowledge of transcription factor biology and a
low proportion of data with this combination are labeled as bound. Most models perform comparably
on the green and red feature combinations with some transcription factor models, including those based
on Atf3, MAFK, REST and TEAD4 data, demonstrating lower probability distributions compared
to others such as CTCF or MAX based models. The spread of distributions also indicates that other
features in the data influence performance of some models including models based on CTCF, Gabpa
and Myc data while models based on MAX, JUND and CEBPB data return consistent probabilities.
This begins to describe the biology of different factors suggesting, for example, that JUND binding is
generalised; dependent on accessibility, specific footprint and general footprint count but not motif
score, distance to gene or general footprint, while models with greater spread in their distributions are
affected by additional features and their binding patterns are more specific.
The blue feature combination cannot be predicted with great accuracy by any of the models despite
this combination of features being associated with true positive data. All TEAD4 models and the
MAFK HepG2, JUND HepG2 and Arid3a HepG2 models show some ability to predict this type
of event as bound. These models also have generally low predictive ability across other condition
specific data. Together, this indicates that these transcription factors bind at locations that are distinct
in their features to other transcription factor binding patterns. Alternatively, as many of the models
that generate higher probabilities for this feature combination were trained on HepG2 specific data, the
HepG2 cell line may employ a different mechanism of transcription factor binding or the accessibility
data for this cell line was not accurate leading to distorted patterns of binding.
Motif score influences the probability of binding differently across condition specific models
Probability distributions for different feature combinations were widely spread, particularly around
feature combinations with a higher average probability of binding as shown in Figures 5.8 and 5.9.
This indicates that different condition specific models can generate diverse probability predictions for
the same combination of features. Therefore, the features not represented in the feature combination
being tested must have a significant influence on model performance.
Figure 5.11a shows distributions of binding probabilities predicted by each model on 65 data points
where DHS.Peak = 0, Gen.FP = 0, Spec.FP = 1, GF.Count = 5 and Dist.Gene = 0, i.e. a window
strongly associated with transcription factor binding due to accessibility, promoter state and multiple
footprints and the features most likely to result in a prediction of ’Bound’. Even with five of the six
variables in the network being equal, some models show a spread in their distributions indicating
that Motif.Score influences the final probability while other models show no spread indicating all
data points have the same probability despite a change in Motif.Score. Figure 5.11b shows a sample
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Figure 5.10: Probability distributions specific to each model given across three feature combinations
of Spec.FP and GF.Count where DHS.Peak reveal transcription factor and cell type combinations
that behave uniquely. A probability was calculated by every model for each data point in a test set of
235,000 bound windows. A random set of 5,000 data points was extracted and separated based on
the observed state of each feature to determine whether feature combinations were associated with a
higher probability of binding. Data points carrying each of the three represented feature combinations
were extracted and their probability distributions given each model were plotted to reveal how models
perform given different input data. The red and green feature combinations can be predicted with some
accuracy across all models while the blue feature combination is rarely assigned a binding probability
above 0.
of model outputs illustrating that the distribution of probabilities depends on Motif.Score and that
Motif.Score influences predicted binding probability differently across condition specific models.
Arid3a HepG2, JUND HeLa-S3, MAFK GM12878 and MAX A549 show low probability at
low Motif.Score and higher probability at higher Motif.Score indicating that Motif.Score forms two
groups that receive highly similar probabilities. The jump from low to high in MAX A549 indicates
that the Motif.Score has a bigger impact on model performance. CTCF MCF.7 shows no change in
probability given Motif.Score which is similarly reflected in Figure 5.11a where there is no spread
in the distribution of probabilities. CEBPB IMR-90, REST H1-hESC and TEAD4 A549 predict
the same probabilities for Motif.Scores in the lower band but as Motif.Scores increase they have
a bigger impact on probability with CEBPB IMR-90 showing an expected increase in probability,
TEAD4 A549 an unusual dip followed by an increase and REST H1-hESC showing an unusual drop in
probability given a high motif score. Overall, this approach demonstrates the influence of Motif.Score
on different transcription factor and cell type combinations identifying conditions where Motif.Score
is more strongly linked to binding and conditions where Motif.Score does not effect binding. This
could indicate how specifically a transcription factor binds to it’s associated DNA motif.
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Figure 5.11: Identifying the influence of motif score on predicted probabilities given a specific feature
state. a) Distribution of binding probabilities predicted by each model on 65 data points where
DHS.Peak = 0, Gen.FP = 0, Spec.FP = 1, GF.Count = 5 and Dist.Gene = 0, i.e. a window strongly
associated with transcription factor binding due to accessibility, promoter state and multiple footprints.
This illustrates that even when five of six model features are specified, probability is still influenced
by Motif.Score for some, but not all models (e.g. those with no spread in their distributions). b)
Motif.Score is plotted against probability from a selection of models in a) that bear the same colours
showing how probability changes depending on the recorded Motif.Score. The CTCF based model
illustrates a scenario where Motif.Score has no impact on probability of binding. The Arid3a, JUND,
MAFK and MAX models demonstrate a scenario where a high motif score improves the probability of
binding. CEBPB, REST and TEAD4 based models include scenarios where the relationship between
Motif.Score and binding probability are more complex.
5.4 Discussion
This chapter describes a Bayesian network approach to predict transcription factor binding sites in
vivo. The model achieved variable and generally low performance across available transcription
factor and cell type specific data however we successfully extracted new knowledge about the genetic
and epigenetic data that defines transcription factor binding sites. While our approach did not work
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effectively enough to be incorporated into our bioinformatic workflow and remove the need for ChIP-
seq binding data to characterise the functional role of a transcription factor, we identified areas of
improvement and further study that would lead to a more successful approach in the future.
5.4.1 Knowledge extraction approach and limitations
Machine learning and statistical models are more accessible now than ever, but they are not the answer
to every problem and the tools to extract new knowledge are lacking. This combined with lack of user
experience is cause for concern as published results are increasingly irreproducible or uninformative.
Ultimately, we need approaches that ensure models are not just achieving high accuracy but also
capturing relevant information from the system.
Using a model that did not achieve the best performance, but was more transparent than some
‘black-box’ approaches, we could still learn about the features of transcription factor binding in vivo.
We also outlined approaches to extracting knowledge that could be applied more broadly to other
models.
Overall, we extracted new knowledge about how different transcription factors bind while also
informing how future models could be built to more accurately predict transcription factor binding
in vivo. Our hope is that predictive models will be treated with more scrutiny in the future and new
techniques for extracting knowledge will be developed beyond what we have described here. Until
we can unlock the patterns driving predictive or classification models, we cannot truly understand the
system we are studying.
5.4.2 New knowledge gained
We demonstrated that a general pattern associated with transcription factor binding does not exist, that
models trained on one set of data cannot accurately make predictions in a novel set of conditions and
that a model trained on data from multiple conditions had low performance leading to the conclusion
that binding patterns of different transcription factors across different cell types are diverse and more
complex than previously anticipated. As the performance of this model was tested against a number
of other models based on the same set of features and no approach could predict transcription factor
binding with high accuracy (results under embargo); we conclude that the biology captured by currently
available features is lacking enough detail to predict transcription factor binding within, and especially
across, cell types.
The biggest weakness in regard to available features is that currently no known feature exists that
is unique to each transcription factor and able to accurately identify a transcription factor specific
binding event from a general binding event. Further, transcription factors rarely bind independently
so attempting to discover a feature specific to a transcription factor could be impossible as there will
be differences depending on other factors that are present at each genomic location. While some
methods provide more accurate identification of binding given sequence, the fact that transcription
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factor binding events are rarely independent and often rely on similar sequence motifs will remain a
hurdle to specific predictions.
Given our model and the features that were available, we showed that features traditionally
associated with transcription factor binding resulted in the highest predicted probabilities of binding
while data labeled as false negatives had features more strongly associated with a lack of binding.
Interestingly, the number of footprints in a 500bp window had a stronger impact on the probability
of binding than previously thought. This shows that information about the regulatory potential of
a genomic location is itself an indicator of binding and further reinforces the need to characterise
transcription factor interactions in a broader sense to accurately predict binding in the future.
A larger than expected number of binding events shared features that were more commonly
associated with an absence of binding and do not conform to traditional ideas of how transcription
factors interact with DNA as they were inaccessible, had no DHS footprints nearby and were far away
from any gene. ChIP-seq and accessibility assays each have their own limitations, weaknesses and
bias and this raises concerns over whether these binding events are accurate or represent false positive
data from the ChIP-seq experiments. On top of this, false negative data from DHS assays may lead
to inaccurate annotation of distances to the nearest accessible region further confounding the model
and linking true positive binding events to inaccurate data features. Refined experimental protocols,
increased biological replication, improved peak calling approaches and processing with a robust tool
like ChIP-R to identify reproducible peaks could be used in future to ensure training data itself is more
accurate leading to clearer identification of patterns truly associated with transcription factor binding.
While we were unable to develop a large scale approach to define and quantify key feature combi-
nations associated with binding; we successfully demonstrated on a small scale how the relationship
between feature combinations and model performance could be interpreted to determine how different
transcription factors operate. We showed that features such as Motif.Score have a larger impact
on the probability of binding in factors such as REST and TEAD4 while factors including MAX
and JUND are more dependent on regulatory activity and CTCF binding is strongly linked to the
presence of a specific footprint. We also showed that a subset of models including MAFK, TEAD4 and
Arid3a generally in HepG2 cell lines are more effective at predicting binding given data not typically
associated with binding indicating that these factor’s interaction with DNA is distinct to that of other
factors.
Overall, we have clearly demonstrated that taking the time to extract knowledge from a model rather
than just accepting the provided predictions can elicit invaluable information about the system under
consideration and inform future experiments and models to improve performance when predicting
transcription factor binding sites in vivo.
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5.4.3 Increase diversity and size of training data sets to improve model perfor-
mance
The main limitation of a Bayesian network approach is its generative nature. Bayesian networks
can struggle to make predictions when presented evidence in the form of feature combinations not
previously observed. When dealing with multiple features each with a high number of states there exist
a large number of possible combinations that exist in the data with varying frequency and a number
of combinations that are not observed at all. Additionally, the scale of data presented in this work
prevented all available data from being explored further reducing the feature combinations observed
by each model. Due to resource limitations in regard to time and computational power, single models
trained only on 100,000 data points were explored increasing the likelihood that distinct sets of patterns
were observed by all models. This would have contributed to the poor performance we saw across
condition specific data as Bayesian networks struggle to accurately predict probabilities based on
evidence that has not previously been observed.
Models trained on larger data sets should be employed in future analyses to support the observations
made in this work. Alternatively, rather than one model for each transcription factor and cell type
combination, multiple models trained on multiple data sets and combined using an Ensemble approach
would also improve general performance of our approach but make interpretation and knowledge
extraction even more challenging.
Improve motif scanning or identify new biological features linked to specific binding
PWM scans to identify specific binding events were shown to report scores that did not accurately
represent sequence matches and produced numerous false positive results. Features such as accessibility
were introduced to reduce the incidence of false positives however, motif scores were still found to
lack the ability to separate transcription factor specific binding events from general binding events.
The application of other available methods designed to identify sequence based binding events that
outperform PWM scans when detecting specific transcription factor binding sites could be applied to
improve performance.
Tools and approaches that are reliant on a motif to predict binding are not applicable to factors
that do not directly bind to DNA or factors that have motifs with large variation within and/or across
different cell types. We showed that a pattern of general binding did not exist and that we have
insufficient features to identify specific binding. In future, to construct a model that can accurately
predict binding without the need for a sequence motif, we need new biological data that captures
information that must exist in the system to control binding but is currently not detected.
Exploring transcription factor interactions is essential to predicting binding
While attempts were made to take into account co-factor binding, co-occupancy or cooperative
interactions between transcription factors, further improvements would be valuable. Our approach
used general DHS footprints to detect whether nearby binding events of different transcription factors
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influenced the likelihood of a specific transcription factor binding however, motif databases are limited
and footprinting approaches are still being developed and improved therefore, not all potential events
would have been explored.
There is opportunity to build transcription factor relationships into future predictive approaches
with a particular focus on classifying known transcription factor interactions to better define types of
binding events (e.g. co-factor vs cooperative). This characterisation of interactions does not currently
exist and while preliminary attempts were made to develop an approach to define transcription factor
interactions globally, it was unsuccessful. A resource that reports transcription factor interactions
would also be advantageous when attempting to predict binding events of transcription factors that do
not themselves bind to DNA but rather bind to another factor and interact with DNA in this way.
A lack of accurate target gene annotation prevents use of gene expression as model feature
Although gene expression data was available, binding events occurring distally could not be correctly
annotated to a target gene and therefore gene expression could not be accurately built into the model.
This is a major limitation of our approach as gene expression could provide valuable information in
regard to transcription factor binding and approaches to predict target genes are further explored in
Chapter 6.
5.5 Conclusion
Our aim for this work was to improve our bioinformatic workflow by using a predictive approach
to define transcription factor binding sites alleviating the need for experimental data. By employing
Bayesian networks to model the data we aimed not only to generate accurate predictions but also to
extract new knowledge about patterns of transcription factor binding across multiple factors and cell
types. The knowledge extraction techniques utilised in this Chapter are applicable to any machine
learning methodologies and should, in future, be improved to ensure that predictive models are not only
evaluated on key performance metrics like auROC and auPRC but also whether the learned patterns
truly reflect the system under investigation.
Our model did not achieve the accuracy required to become an effective part of our bioinformatic
workflow but we were able to learn extensively about the different conditions that elicit transcription
factor binding. In fact, we reached the conclusion that currently there is insufficient biological data
available to accurately predict transcription factor binding events in novel cell lines. Ultimately, this
new knowledge can be used to conceive a more effective modeling approach and develop techniques
to identify the missing biological data.
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Chapter 6
The challenges of target gene identification
6.1 Introduction
In the previous chapters, it was noted that linking a transcription factor binding event to the gene(s)
it regulates (i.e. target gene(s)) is challenging and lacks a fully resolved solution. This information
is, however, crucial to our understanding of the functional role of a transcription factor. This Chapter
addresses Aim 3a by conducting a secondary review of existing approaches for predicting transcription
factor binding sites, describing a programmatic tool to model chromosome conformation capture data
and finally demonstrating that we currently lack sufficient experimental data to allow any approach to
be successful at predicting target genes, especially in novel conditions (i.e. a new cell type).
6.1.1 Published work
In 2017 we published Essebier et al. [43], a review and associated case study of approaches available to
predict target genes. This work presents all background information and a full review of tools available
prior to publication and was presented as Chapter 2.
In the original workflow described in Chapter 3, target genes were identified using a combination of
nearest gene annotation and annotation by CISMAPPER. This allowed identification of a biologically
relevant targetome for all tested transcription factors. In Chapter 2 we identified CISMAPPER
and PreSTIGE as the only tools capable of making predictions in mouse cerebellum and combined
the approaches to identify a new targetome for Atoh1 showing that the union of target genes from
CISMAPPER, PreSTIGE and the nearest gene approach was highly enriched for biologically relevant
genes as measured by differentially expressed genes from RNA-seq data. This indicates that PreSTIGE
would be a suitable addition to our workflow however, like most approaches explored, PreSTIGE is
only effective in a handful of cell lines and does not allow inclusion of additional supporting data.
Including an approach into our workflow that limits its application to a small number of cell lines is
not ideal therefore CISMAPPER is maintained as the approach of choice to predict target genes.
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6.1.2 A programmatic tool to model chromosome conformation capture data
As part of this initial review, we identified that there are currently no tools available for post-processing
analysis of chromosome conformation capture data, i.e. a tool able to read in and perform actions on the
final product of chromosome conformation capture analyses: paired data. We built a Java framework
which allows us to load, search, filter, and extract paired data to identify patterns, remove irrelevant
data and gain an improved understanding of what is represented by the observed interactions. A tool
which can be used across the board will ensure that analyses are consistent and comparable. It will also
make the approaches used transparent when currently methodologies are unique to each publication
and rarely reported in detail and reproducible. Additional it enables more complex analyses to be
conducted on such data to better define the functional role and drivers of long distance interactions
between regulatory regions.
My tool enables multiple analyses to be undertaken including:
1. Constructing a higher order graph structure from paired interactions
2. Calculation of degree (hubs), betweenness centrality and clustering coefficient for each regulatory
region or ‘node’
3. Annotation of nodes, edges and interactions using supporting data including SNPs, DHS, ChIP-
seq of histone modifications, RNA-seq and any other data that can be represented in a bed
file
4. Classification of interactions based on their annotations including enrichment analyses of gene
expression patterns
5. Extraction of specific interactions based on presence or absence of selected data (e.g. exclude
interactions that do not overlap a DHS peak or only report interactions where a SNP occurs in at
least one contact point)
6. Generation of output formats that allow for visualisation of graph structures and additional
functional annotations
The baseline functionality of this new programmatic tool has been tested and shown to be the-
oretically correct however, its biological impact could not be validated satisfactorily. While it has
great merit as a tool to aid researchers and it could be experimentally validated by a group with more
resources, it is not described in detail here on the advice that it would not add value to this thesis. The
author feels it is worth noting that this body of work exists, including an example of its application
below, despite her inability to complete the project in full.
6.1.3 Additional approaches to predict target genes
Since the publication of Essebier et al. [43], a number of new approaches have surfaced that aim to
improve our ability to predict interactions between enhancers and promoters or distal binding events
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and their target genes. The new approaches can be split into those that consider functional genomics
(e.g. epigenetic state and transcription factor binding), those based on sequence features and those
based on CTCF motif orientation and represented in Table 6.2.2. The focus of this Chapter is a review
of new tools which ultimately identified significant flaws in the body of predictive work relating to
long distance interactions. These flaws are described in detail including how they limit the predictive
power of approaches trained on existing chromosome conformation capture data sets to the point that
they cannot be considered accurate.
6.2 Review of new approaches available to predict target genes
6.2.1 Summary of methodologies employed by emerging predictive tools
It is important to note that the validation data used by all approaches is very limited (see Table 6.2.2),
does not completely and accurately represent the true biological events that are occurring and is not
balanced. Balanced training and testing data should have an equal number of cases for all outcomes, in
this case interacting or non-interacting enhancer-promoter pairs. While unbalanced data can be used
for training and testing, it can affect model performance and certain performance metrics are not suited
to measure outcomes; specifically auROC. These concepts are explored in more detail below but must
be considered when reviewing available tools.
Functional genomics based tools
TargetFinder, EpiTensor, JEME and 3DEpiLoop use functional genomics to predict target genes over
long distances [178, 197, 22, 1]. Each tool trains their models on potentially hundreds of functional
features including transcription factor binding events, histone modifications, accessibility data and
gene expression patterns. This generally limits their application to cell lines or primary tissues that
have been annotated with a large number of supporting experimental data sets.
EpiTensor applies tensor modeling to perform high order generalisation of a matrix containing
available functional data and identifies all pairs of interactions between promoters, enhancers, exons,
introns and intergenic regions [197]. EpiTensor’s performance was only measured using auROC values
rather than more robust performance metrics and it was only compared to one of the early predictive
approaches described byErnst et al. [40]. 3DEpiLoop first filters potential interactions based on
presence or absence of functional features then applies a random forest approach to classify remaining
interactions [1]. 3DEpiLoop also lacks sufficient performance metrics only reporting auROC values
and while it compares its performance to EpiTensor, RIPPLE and IM-PET; it claims to have improved
performance based on its ability to report higher counts of true positive interactions identified with no
further performance metrics reported.
TargetFinder uses a boosted decision tree approach and a large number of functional features
to make predictions but fails to compare its performance to any other approaches and does not test
performance across cell types [178]. Despite this, many consider TargetFinder to be the ‘gold standard’
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approach against which other approaches should be measured despite lacking a robust analysis of
performance. JEME uses a LASSO regression model combined with a random forest classifier to
predict interactions between enhancers and promoters [22]. The authors comment that validation
data in the form of chromosome conformation data are likely to miss active pairs and therefore used
a variety of methods to generate negative data against which performance was measured that are
discussed in detail below. JEME was compared to Ernst et al. [40], IM-PET, RIPPLE, Prestige and
TargetFinder and was outperformed by TargetFinder when comparing predictions made within the
same cell type but showed the best performance when predicting interacting pairs across cell types.
Sequence based tools
PEP, SPEID and EP2VEC use sequence alone to predict interactions over long distances [185, 155,
191]. The advantage of only using sequence as a feature is that it can be applied to any cell type
and does not require additional supporting data. PEP encodes enhancer and promoter sequences as
features on which to train a gradient tree boosting model to predict enhancer-promoter interactions
demonstrating improved performance compared to RIPPLE and TargetFinder but showing weaker
performance across cell types [185]. SPEID uses a deep learning approach to encode and then classify
sequence features with improved performance over TargetFinder and PEP [155]. EP2VEC uses
sequence encoded similarly to PEP as training data for a gradient boosted regression tree classifier and
reports improved performance compared to TargetFinder and SPEID [191].
CTCF motif orientation based tools
Finally, Lollipop and CTCF-MP use a combination of sequence and functional genomics to predict
interactions between genomic elements based on the presence of a CTCF motif and a CTCF ChIP-seq
binding event [86, 193]. CTCF motif orientation has been identified as a strong indicator of loop
formation making it an ideal feature from which to identify genomic regions that could be participating
in loops [135, 180]. Lollipop uses a number of functional genomics features on top of CTCF motif
features to train a random forest classifier with performance limited to auROC and no additional
metrics [86]. CTCF-MP builds on the approach taken by PEP by including encoded sequence and
functional genomics features when training their boosted tree classifier [193]. Neither compare their
performance to any approaches discussed here but do test performance across cell types reporting that
while enhancer-promoter interactions common to multiple cell types could be predicted well in a novel
cell type, performance was lower when classifying cell type specific enhancer-promoter interactions; a
pattern observed in all other approaches that tested performance across cell types.
6.2.2 Limitations and weaknesses of existing approaches
All of the new approaches (bar EpiTensor) apply supervised machine learning techniques to predict
interactions between genomic regions; in most cases between enhancers and promoters. Table 6.2.2
shows that gradient boosted decision trees or random forests were the model of choice likely due to
Table 6.1: New approaches to predict enhancer-promoter interactions
Approach Validation data Enhancer definition Negative set Model Validation Available Important features
TargetFinder Six Hi-C data sets
[135]
ENCODE Segway,
ChromHMM and Roadmap
Epigenomics ChromHMM
Non-interacting enhancer-
promoter pairs were binned
by size and pairs were subsam-
pled within each bin
Gradient
boosted de-
cision tree
ensemble
10-fold cross validation of ran-
domly separated interactions
within cell types
Code available “DNA methylation, activation- and
elongation-associated histone marks,
binding of structural proteins, open
chromatin, binding of proteins re-
lated to repression (MXI1, MAZ, and
MAFK), and cap analysis of gene ex-
pression (CAGE) data”
EpiTensor Six Hi-C data
sets [135], single
Hi-C data set [81]
and merged set of
ChIA-PET data
GSE59395
Enhancers were predicted us-
ing Rajagopal et al. [134] and
filtered by H3K27ac peaks
Non-interacting random pairs
between ‘peaks’ identified by
EpiTensor
Tensor model EpiTensor was not trained on val-
idation data removing need for
cross validation
Not available Not possible
JEME Single Hi-C
data set [81],
ChIA-PET from
GSE33664 and
GSE32677
Enhancers were defined based
on ChromHMM, FANTOM5
active enhancers and CSI-ANN
Non-interacting enhancer-
promoter pairs from four methods
including assigning enhancers to
random promoters, promoters to
random enhancers and randomly
pairing enhancers and promoters
Lasso regres-
sion combined
with random
forest classifier
Five times five-fold cross valida-
tion and across sample tests
Code available Not reported
3DEpiLoop Six Hi-C data sets
[135] and CTCF
and RNAPII
ChIA-PET data
from GSE39495
and GSE72816
Enhancers and promoters were
defined by transcription factor
and histone modification pat-
terns mined by 3DEpiLoop
All non-interacting combinations
of defined enhancer and promoter
regions within TADs
Random forest
classifier
Trained on one chromosome and
tested on another. Trained and
tested on whole genome. Trained
on one cell type and tested on an-
other cell type.
Code available,
unclear if cus-
tom analysis
possible
For CTCF ChIA-PET data transcrip-
tion factors were most important. For
RNAPII ChIA-PET data histone mod-
ifications were most important. For
Hi-C data RAD21, SMC3, H2AZ,
H3K4me1, H3K4me2, H3K27ac and
H3K36me3 were most important.
PEP Six Hi-C data sets
[135]
Same as TargetFinder Same as TargetFinder Gradient tree
boosting
10-fold cross validation of ran-
domly separated interactions
within cell types
Code available CTCF and ZNF143 motifs had high
importance but additional motifs ex-
tracted from sequence were not inter-
pretable
SPEID Six Hi-C data sets
[135]
Same as TargetFinder Same as TargetFinder Deep learning 10-fold cross validation Code available Not possible
EP2VEC Six Hi-C data sets
[135]
Same as TargetFinder Same as TargetFinder Gradient
boosted re-
gression tree
classifier
10-fold cross validation of ran-
domly separated interactions
within cell types
Code available Linked identified motifs to known
factors in HUVEC cells including
MYB, SOX15, GFI1 and IKZF1
CTCF-MP ChIA-PET data
GSE72816, EN-
CLB559JAA and
ENCSR000CAD
CTCF motif bound by CTCF Non-interacting enhancer-
promoter pairs with convergent
CTCF motifs
Boosted tree
classifier
Negative samples are not shared
between training and testing data
Code available Motifs extracted from sequence were
not interpretable
Lollipop Six Hi-C data
sets [135],
ChIA-PET data
GSE72816 and
ENCLB559JAA
CTCF motif bound by CTCF Random pairing of CTCF binding
sites that lack a paired end tag
in ChIA-PET data and are absent
from the Hi-C experiments
Random forest
classifier
10-fold cross validation run five
times
Code available RAD21 and CTCF binding, length of
loop and CTCF motif orientation and
strength.
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their availability, high performance and the ability to extract feature importance to gain new knowledge
about the system. All approaches are also generally trained and tested on similar sets of chromosome
conformation capture data (‘Validation data’ in Table 6.2.2). This includes high resolution Hi-C data in
seven cell lines generated by Rao et al. [135] and Jin et al. [81] and ChIA-PET data generally sourced
from ENCODE [39] in half a dozen cell lines.
Code repositories are available for all approaches except EpiTensor however, they can only be
run via the command line and often require large amounts of memory and long periods of compute
time. While it appears that most of the approaches can be run on new cell lines or data, the process
is labour intensive as significant data preparation is required. The functional genomics approaches
can also require a prohibitive number of experimental data sets to train successfully. In general, these
approaches are not accessible to most users limiting their application. This is highly similar to the
challenges and limitations identified in the original literature review included in Chapter 1.
It is important to note that all reported approaches link an enhancer region to a promoter region and
that the definition of these regions changes across approaches (Table 6.2.2). To apply this knowledge
and identify transcription factor target genes, interactions must be filtered using ChIP-seq data from
the transcription factor of interest or, though less effective, motif scanning to identify binding sites. It
is also possible that transcription factor binding events will fall outside the genomic regions of interest
as defined by each approach making annotation of all binding events impossible.
The functional genomics approaches perform ‘best’ when more features are included but can still
make predictions given a reduced feature set; JEME with as few as four features and TargetFinder as
few as eight. Not requiring additional features is the main advantage of using a sequence based ap-
proach providing broad applicability and comparable performance to functional genomics approaches.
However, the output of sequence based approaches is difficult to interpret as enhancer and promoter
sequences are encoded into a feature space that can be used to train a model but is not interpretable.
Therefore, while predictions made by functional genomics approaches are linked to biology by extract-
ing features with high importance from decision trees, the sequence features driving enhancer-promoter
predictions cannot be easily explained. This makes knowledge extraction challenging limiting our
ability to verify that the model is making predictions based on biological features and not inherent bias
or contamination of the training data.
Similar to the transcription factor binding site predictive literature (Appendix E and Chapter 5),
many approaches fail to test performance across cell types and those that do tend to report poorer
performance in a novel cell type. This indicates that the regions used in cell type specific interactions
have unique features and that the features representing cell type specific interactions vary across cell
types. Alternatively, this indicates that the approaches are overfitting the data resulting in inaccurate
classification of enhancer-promoter pairs in novel cell types; a theory explored in more detail below.
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6.3 Flaws in model validation
6.3.1 Approaches aim to reproduce incomplete validation data
EpiTensor and 3DEpiLoop only report auROC masking the true ability of each predictive approach
but generally, multiple metrics are used to measure and compare performance of approaches. As
an example, an auPRC value close to 1 indicates that the model is performing optimally and able
to classify test data with 100% accuracy. All the reported approaches strive to build a model that
can achieve this claiming that an auPRC value of 0.92 in their approach compared to 0.90 in another
approach makes their model the ‘best’. Validation is generally performed on Hi-C and ChIA-PET
data however, these assays are known for their low resolution and high false negative rate and are
expected to miss true enhancer-promoter interactions [101, 22]. Therefore, aiming to build a model that
perfectly classifies interactions according to this validation data is inherently flawed and an example of
overfitting.
No approach reports on what level of performance is required for downstream analyses to be
conducted with high confidence. Alleged improvements in performance are also not tested to deter-
mine statistical significance or even biological significance. Outside of recreating validation data,
a successful approach would, among other tasks, generate predictions that can be used to annotate
transcription factor binding events to target genes and begin construction of a gene regulatory network
or predict gene expression levels based on all the enhancers linked to a promoter.
Only two approaches prove their tools are predicting biologically relevant enhancer-promoter
interactions outside the validation data. EpiTensor and Lollipop both undertook additional experimental
validation using 3C and found that novel predicted enhancer-promoter pairs exist in vivo (i.e. pairs that
were not detected in Hi-C or ChIA-PET training/testing data). This further illustrates that building a
model with the aim of achieving high performance on flawed validation data is the wrong approach.
6.3.2 Test set contamination
Another challenge addressed with varying degrees of success among approaches is generation of
true positive and true negative sets of peaks. All approaches shuffled enhancer-promoter pairs across
defined promoter and enhancer regions while maintaining the same distribution of distances between
pairs. No approaches consider whether their background maintains a similar degree distribution,
however, Figure 6.1 shows that all data sets from Rao et al. [135] have a degree distribution consistent
with complex networks. If this degree distribution is altered in the negative set, any comparisons made
could be a result of comparing unmatched positive and negative data.
All approaches classify enhancer-promoter pairs as true positive if they overlap validation data
from a specific cell type but fail to consider whether the enhancer and promoter interact in any other
context. This is particularly relevant to sequence based models or models relying on CTCF motif
orientation as an event classified as a true negative in one cell type could be a true positive in another
cell type; both carrying identical sequence features. This is likely a contributing factor to poor cross
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Figure 6.1: The degree distributions of Hi-C data generated by Rao et al. [135]. The distributions were
generated by identifying all pairs in each Hi-C data set and constructing a higher order graph structure
where genomic locations participated in multiple pairs. E.g. considering pair A-B and pair B-C, a
small network of three nodes exist where B has degree = 2 while A and C have degree = 1. Once
degree was calculated for all genomic locations that participate in at least one pair, the frequency of
each degree was plotted to reveal a power distribution indicating that the graph structure that exists in
Hi-C data is complex. Complex graphs have specific features that must be considered when shuffling
interactions to build a negative set.
cell type performance.
On top of this, Xi and Beer [182] and Belokopytova et al. [10] have identified JEME and Tar-
getFinder (and implicitly PEP, SPEID and EP2VEC) as approaches whose performance is artificially
high due to test set contamination. Xi and Beer [182] reports, among other concerns, two forms of
contamination: promoters bound by multiple enhancers and therefore over represented, and window
regions that overlap between different enhancer-promoter pairs. Correcting for contamination by
ensuring all enhancer-promoter pairs involving the same promoter were in one training or test set
or using separate chromosomes for training and testing resulted in TargetFinder’s approach having
performance that was barely better than random. Cao et al. [21] reports a new tool that addresses the
concerns of test set contamination and reports auPRC values ranging from 0.17 to 0.78 at best. This
result could be perceived as negative due to low performance metrics but is likely a more accurate
representation of the biology because it is not overfitting inherently flaw validation data.
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6.4 Limitations in available data prevent robust approaches be-
ing developed
TargetFinder notes that signal is rarely unique to interacting pair vs non-interacting pair indicating
that we are missing features that define interacting pairs. We have also already indicated in Chapter
5 that our current suite of experimental assays do not completely capture the biology in regard to
transcription factor binding and this could easily extend to predicting enhancer-promoter pairs. On top
of this, there is strong evidence that the handful of validation sets currently available to test predictive
approaches is incomplete and any approach that aims to use standard performance metrics against this
validation data results in an overfitted model.
Ultimately, without additional supporting data, pursuing this type of predictive model will not
greatly enhance our knowledge and understanding of enhancer-promoter interactions on a global scale.
EpiTensor and JEME were able to validate specific examples of novel enhancer-promoter interactions
indicating that these approaches can be used to find biologically relevant interactions on a small scale
despite lacking optimal performance.
6.5 CTCF based annotation of enhancer-promoter pairs
Inspired by the approaches discussed above that model enhancer-promoter pairs based on CTCF motif
patterns and ChIP-seq binding data we built our own approach to annotate enhancer-promoter pairs
across the genome.
CTCF and cohesin have a coordinated role in mediating formation of DNA loops. Cohesin is
know to stabilise long range interactions via an unknown mechanism and CTCF is a known insulator
that can block the action of an enhancer but also promotes long range interactions [180, 70, 161, 61].
When considering the output of Hi-C analyses, 86% of interacting regions contain a CTCF binding
event, 86% contain RAD21 and 87% contain SMC3 (components of the cohesin complex) [135]. This
significant overlap indicates the role of CTCF and cohesin in mediating DNA loops and is further
supported by evidence that loss of cohesin eliminates loop formation in vivo [136]. Further, when
considering sequence patterns of interacting regions, a majority of DNA loops are associated with
pairs of CTCF motifs in a convergent orientation [180, 135]. The literature describes convergent CTCF
motifs as prevalent at interacting regions to the point where identification of this pattern can be used to
predict interactions [86, 193].
We compared annotations across different cell types to identify not only cell type specific enhancer-
promoter pairs but also anchor points and edges that were specific to different cell types. Our
preliminary analysis showed that a truly cell type specific enhancer-promoter interaction in which
both the enhancer and promoter region are observed as forming interactions in a single cell type
are almost non-existent, even when only considering four cell lines. On top of this, integration of
functional genomics data (e.g. histone modifications) identified patterns that were common across
enhancer-promoter pairs both within and across cell types but were also significantly shared with
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enhancer-promoter pairs that had no evidence of an interaction. If interacting and non-interacting
enhancer-promoter pairs share common functional genomics patterns then a model that can accurately
classify interactions will not be possible. This is additional strong evidence that with the currently
available data, it is not possible to build a model that will accurately predict enhancer-promoter
interactions both within and across cell types.
To make these preliminary discoveries, I applied my new Java framework with a unique data
structure to capture the intricacies of chromosome conformation capture data. My framework can
identify and report the higher order graph structures described by the input pairwise data including
any circuits or cliques that are present. My data structure also allows pairs or graphs to be annotated
with additional data stored in bed files including ChIP-seq, accessibility data, SNP locations or gene
location and expression patterns. There also exists additional functionality that was identified as
valuable based on analyses run on similar data in other experimental reports. This framework requires
biological validation that is not currently possible however it’s theoretical value is high.
It is the author’s great regret that these two related bodies of work could not be completed within
the time frame of a PhD and under challenging personal circumstances. While they represent promising
early stages of discovery, they were not near enough to completion to be satisfactorily written up as
independent chapters in this thesis despite best efforts. However, they would be valuable contributions
to the field if they are pursued and should be considered evidence of the author’s in depth knowledge
and understanding of the field despite their incomplete nature.
6.6 Conclusion
Determining enhancer-promoter pairs with high accuracy across cell lines is of great importance as
it will allow us to identify new disease pathways, predict gene expression patterns and build gene
regulatory networks with greatly improved efficacy. In this Chapter we provided overwhelming
evidence that the current suite of predictive approaches are mishandling available validation data
and attempting to build models with performance that recreates validation data exactly; a flawed
aim. We also described more specifically features of the data that are preventing accurate models
being constructed including similarity in functional genomics patterns between interacting and non-
interacting enhancer-promoter pairs.
It is the author’s opinion that there are additional elements of the biology that we are not yet
aware of preventing us from creating predictive approaches that function across cell types and until
that information is available, such models will not be completely successful. Current approaches can
provide insight and identify specific new interactions but they have not achieved the performance
required to be applicable on a larger scale. They are also limited in regard to their validation data that
exists in only a handful of immortalised cell lines that may not truly reflect human biology and are
further known to be flawed and incomplete. At the very least, a new ‘gold standard’ set of validation
data is required to prevent future models reporting high performance when, in reality, they are training
models that are overfitting a spurious data set.
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In regard to our workflow for determining the functional role of a transcription factor, using a
combination of predictive approaches to provide a wide array of putative long distance interactions
is the recommended best practice. Multiple predictions can then be refined using RNA-seq data or
overlapped to identify high confidence interactions or predictions made consistently across tested
approaches. When combining tools, it is important to understand their limitations, strengths and
weaknesses so an informed decision can be made regarding how best to combine results. While
we have shown that the current approaches face numerous challenges, there is still value in their
predictions and they should not be completely ignored. Advances in our experimental techniques to
improve the accuracy of existing assays or to develop new assays that capture previously unknown
aspects of the regulatory system will, in future, allow annotation of transcription factor binding events
to target genes be made with improved accuracy.

Chapter 7
Conclusion
Transcription factors are a set of regulatory proteins that bind to DNA and, along with other elements
of the regulatory system (see Figure 7.1), provide fine scale control over expression of target genes.
Disruption of transcription factors has been identified as the cause of a number of developmental
diseases and as a contributing factor to multiple human cancers. This makes understanding the role
a transcription factor plays within the regulatory system invaluable information not only to describe
the specifics of regulation within the genome but also to define disease pathology in greater detail.
The overall aim of this thesis was to characterise transcription factor biology by integrating multiple
sources of genetic and epigenetic data to determine the regulatory role of a transcription factor.
This thesis outlines a bioinformatic workflow that integrates genetic and epigenetic data to define
various aspects of transcription factor biology including binding sites, epigenetic patterns, interactions
and target genes. This workflow is outlined in Figure 7.2 with references to relevant chapters and
specific outcomes described in detail below. The workflow defines improved data processing steps
along with novel data integration techniques and knowledge extraction approaches to identify high
confidence binding sites, determine binding mode and report a refined set of target genes.
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Figure 7.1: A simplified representation of the key features in the human regulatory system that
influence one another to control the dynamic and sequential gene expression changes required for
normal development and a healthy life.
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The field of bioinformatics is expanding at a rapid pace with a high diversity of tools available
to solve highly similar problems or process the same types of data. We took this into consideration
when defining our workflow concluding that a packaged workflow that is limited to a strict set of
bioinformatic tools would severely limit its applicability. Instead we provided a detailed methodology
of the processes included in our workflow to allow others to construct a replica workflow specific to
their data and favoured bioinformatic tools. This makes our workflow applicable to a wide variety of
use cases across species, sequencing type, data quality and personal preference.
Ultimately, our workflow provides other researchers with methodological guidelines on how
multiple sources of data can be integrated and predictive models can be applied to take advantage of
all available data and provide the clearest understanding of the question at hand. In addition, single
components or a combination of components from the workflow can be adapted to address a number
of related biological problems broadening the application of the workflow. These adaptations are
explored in more detail below.
A series of case studies were presented to demonstrate the performance of our workflow and
more generally the valuable outcomes of specific components of the workflow with application to
characterising transcription factor biology. Applying our workflow to these case studies we identified
new, specific knowledge around each tested transcription factor and it’s regulatory role.
Finally, this thesis demonstrated the impact of considering multiple aspects of the regulatory system
when defining transcription factor activity and observed that, while valuable information is gained by
including more data, currently available assays to define epigenetic features are not adequate to predict
transcription factor binding sites or long distance interactions between a transcription factor and target
gene.
7.1 Outcomes
The main focus of this thesis was to identify, implement and evaluate the required steps to create
a workflow that characterises the functional role and specific targets of a transcription factor by
integrating available data from multiple sources. Such an approach is required as identification of a
small set of specific targets allows further experiments to be conducted in an hypothesis driven manner
without the need to exhaustively test large numbers of genes reported by broad brush approaches.
Additionally, there is a limit to how much knowledge can be gained from transcription factor ChIP-seq
data alone and a workflow that provides instruction on integrating additional data sources to understand
a transcription factor in the broader context of the regulatory system would be a valuable resource to
many researchers.
Chapter 1 provides an initial review of available approaches to address the different aspects of
transcription factor biology. This review allowed us to identify strengths, weaknesses and limitations
of currently available approaches and also confirm that no other cohesive workflow exists to integrate
multiple sources of data for characterisation of transcription factor biology. Chapter 3 builds on this
review and provides proof of concept regarding the validity of a cohesive data integration workflow
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Figure 7.2: Summary of bioinformatic workflow and associated references in Thesis body.
by conducting a number of analyses focused on different aspects of transcription factor biology. This
baseline work showed that accessibility can be used to extract biologically relevant binding events
from ChIP-seq data and that epigenetic data can be built into a profile across binding events to reveal
the primary mechanism of a transcription factor. We showed that combining approaches for predicting
target genes of transcription factors identifies the most biologically relevant gene targets and that these
gene targets can be accurately refined by integrating RNA-seq gene expression data. The combination
of filtering ChIP-seq events and accurate gene annotation reduced by gene expression data produced a
high confidence set of gene targets for a transcription factor that was smaller and more biologically
relevant than target genes identified by ChIP-seq or RNA-seq data alone.
The outcomes of the proof of concept workflow were demonstrated successfully across three case
studies. These case studies illustrate how data integration applied over ChIP-seq transcription factor
experimental data improves our ability to identify binding sites that are biologically relevant to the
transcription factor under investigation. The outcome of the workflow is a targetome or set of genes
regulated by a transcription factor. For each case study, the targetomes had a broad functional role in
line with the expected regulatory impact of the transcription factor under consideration. Each targetome
also contained novel gene targets that were experimentally validated. This provided clear evidence
that our workflow could characterise transcription factor biology with more detail and refinement than
any other combination of approaches.
Chapter 3 proved that our workflow is a valuable contribution to the field capable of providing
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detailed insights into transcription factor biology but it also identified areas where improvements
could be made. This included the need for a new approach to merge replicate data sets, a requirement
to predict binding events when experimental data was unavailable and the ability to accurately link
transcription factor binding events to target genes particularly over long distances.
Chapter 4 developed a new, statistically robust approach to integrate data from multiple biological
ChIP-seq replicates to identify binding sites with increased biological relevance and filter out sites
representing bias or false positives and negatives. The new tool, ChIP-R, can merge any number of
replicates and identify reproducible peaks that are statistically significant but also biologically relevant
where other available tools were limited to two replicates and reported high numbers of peaks that
lacked biological relevance. The reproducible peaks identified by ChIP-R are biologically relevant due
to increased read depth, increased motif activity and links to genes that are shown to be regulated by
the target transcription factor using RNA-seq data. This high confidence set of binding sites are an
excellent resource for generating new hypotheses and limiting unnecessary experimental validation of
binding events that are ‘poised’ or static and not actively impacting regulation.
The case studies included in Chapter 4 illustrate how ChIP-R detected reproducible peaks result in
a highly similar targetome to the case studies in Chapter 3 given a smaller set of statistically significant
binding events. This provides evidence that ChIP-R can refine our workflow by reducing the number
of binding events under investigation while still identifying target genes that are biologically relevant
to the transcription factor being studied. In addition, new target genes were identified with ChIP-R
incorporated into our workflow that were not previously detected in Chapter 3 including genes that
have previously been linked to the Nfi family’s role in regulation of development in the cerebellum.
Chapter 4 provides ample support that ChIP-R can merge replicates to identify those that play a key
role in regulation and is a valuable addition to our workflow.
Chapter 5 describes a Bayesian network based predictive approach to identify binding events in vivo
by integrating genetic and epigenetic data. A successful predictive model would allow our workflow
to be applied to transcription factors for which ChIP-seq data was not available making it applicable
to a wider array of transcription factor analyses. A secondary aim for this Chapter was extraction of
knowledge to define the genetic and epigenetic environment of a transcription factor binding event
providing new insights into the regulatory system. Our predictive model was not accurate enough
to be incorporated into our workflow but provided valuable insights into the relationship between
transcription factor binding and epigenetics that could be used in future to conceive a more effective
modeling approach. We showed that we currently lack enough data to allow predictions across
transcription factors or cell types and that a generic set of features associated with non-specific binding
does not exist. Through extensive querying of our model we identified links between data features and
true positive predictions showing that an accessible region with a high number of DHS footprints and
a DHS footprint specific to the target factor is the strongest indicator of a transcription factor binding
event across all models. In contrast, a number of binding events occurred at inaccessible regions with
no other features that support a binding event raising questions about the accuracy of the provided
data and potentially missing information that would allow us to accurately predict these unusual
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transcription factor binding events. While not included in our workflow due to poor performance and
a number of new questions raised about the genetic and epigenetic features of a transcription factor
binding event, this Chapter presents an informative model and a description of techniques that can be
used to perform knowledge extraction and explain the predictions made by this, or any other model.
Chapter 6 addresses our ability to accurately link a transcription factor binding event to a target
gene or gene on which it is having a regulatory effect. We reviewed a large body of literature around
experimental and predictive approaches to achieve the most accurate annotation and found that there is
still a large amount of research to be done to ensure annotations are made correctly. Our workflow
recommends the use of multiple predictive approaches where available combined with nearest gene
annotation and any supporting experimental data to annotate transcription factor binding events to target
genes. In Chapter 1 we illustrated how annotations from CISMAPPER, PresTIGE and annotations
to the nearest gene can be combined to identify a set of target genes that are significantly more
relevant to the known regulatory role of a target transcription factor. While the resulting annotation
was biologically significant we also provided evidence that it was incomplete with PresTIGE and
CISMAPPER unable to annotate a number of distal transcription factor binding events.
In addition, Chapter 6 reviews a new set of predictive approaches and new literature that raises
questions about how existing predictive approaches are trained and tested highlighting that available
‘gold standard’ data is incomplete and not 100% accurate. Building on discoveries made in Chapter
5 that indicate we lack enough data to accurately capture regulation in the genome, Chapter 6
demonstrates that this holds true for target gene prediction with all approaches showing decreased
performance when attempting to predict across cell types and making observations that patterns
associated with a long distance interaction overlap with genetic and epigenetic patterns where no
interaction is observed. The main outcome of our work on transcription factor target gene identification
addressed in Chapter 6 is the realisation that there is insufficient knowledge and experimental data
to accurately predict interactions between regulatory regions over long distances. This indicates that
our workflow will not truly capture the full extent of a transcription factor’s regulatory role as it lacks
a complete and accurate annotation of binding event to target gene however, it provides methods
to integrate annotations across existing predictive approaches that are the current best practice to
annotating binding events to target genes despite their reported flaws.
7.1.1 Additional workflow features to inform transcription factor biology
Transcription factor mechanisms
A supporting outcome of our workflow was the ability to gain an insight into the mode of operation for
a transcription factor based on epigenetic profiles, temporal data and gene expression patterns. We
describe a number of data integration techniques in Chapter 3 that allow construction of epigenetic
profiles that help define whether a binding event is located in a region likely to be involved in active,
repressive or poised regulation. We also showed how this knowledge combined with RNA-seq data
indicating an increase or decrease in gene expression further clarifies the specific impact a binding
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event is having on regulation. Finally, we showed that temporal accessibility data can aid in identify
binding events that are more likely to play a key role in regulating gene expression during development.
Together, this information can assist in generating new and targeted hypotheses while improving our
understanding of how the transcription factor binds to DNA and how it controls associated target
genes.
Transcription factor interactions
Our workflow has the unique ability to consider partner transcription factors and provide insights
as to whether or not there is overlap in both binding events and regulatory impact. Identification of
interactions between transcription factors is an important step in building gene regulatory networks
that indicate how a transcription factor functions relative to other factors in the system. The approach
described in Chapter 3 to define a pair targetome for two transcription factors quantifies the similarity
between the regulatory roles of two transcription factors but could be greatly improved by implementing
more robust statistical techniques and expanding the approach to consider more factors. Currently,
our workflow provides targeted information about two factors that will aid researchers in better
understanding the regulatory role of their target transcription factor in the context of others.
7.2 Future directions
Our workflow as it currently stands addresses all aspects of transcription factor biology that are
relevant to characterise it’s functional role given our current understanding of the regulatory system.
The limitations of our workflow lie within the approaches to perform specific analyses including
identification of interacting transcription factors, predicting binding sites and annotating transcription
factor target genes. In future, construction of a dynamic workflow tool that maintains the flexibility to
integrate with multiple other tools for alignment and processing but handles the data integration aspects
independently would be advantageous. This would reduce the amount of implementation required
by those who wish to use the workflow in its current, descriptive state. Having such a dynamic tool
that can withstand the inconsistencies of various bioinformatic approaches would be challenging to
develop but would set a standard in the field of bioinformatics for approaches that can easily be applied
across multiple cases.
New technologies are constantly emerging that improve our understanding of the regulatory system,
for example the advent of single cell sequencing. Our workflow is not limited to a strict set of
experimental inputs and requires bed formatted files, the output of most HTS assays, as inputs to
various integration steps. Therefore, little change would be required to expand the functionality of
our workflow beyond the currently available data; primarily, additional research would be required
to understand the strengths and weaknesses of new experimental techniques and how they relate to
and support existing assays. One consideration in developing this work going forward would be using
an approach other than DAVID, such as Enrichr [25], to perform gene set enrichment analysis with
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improved confidence in the results and therefore a better understanding of the functional role of a
transcription factor.
Our workflow is limited in its capacity to only consider a single transcription factor. While a second
factor can be investigated against the regulatory impact of the target transcription factor, we know that
there is not a one-to-one relationship between a binding event and a gene expression change. Rather,
multiple factors work coordinately to alter gene expression and currently this is not well represented.
In future, once more is known about transcription factor interactions, incorporating information about
additional factors would be a valuable improvement to our workflow. This new knowledge may
be a result of new experimental techniques or new bioinformatic techniques that integrate currently
available transcription factor databases to mine transcription factor interactions. It would not only add
more detail to the different types of binding modes for a transcription factor but it would also allow
us to improve predictive models of binding events and even work toward predicting changes in gene
expression patterns given a set of transcription factor binding events.
ChIP-R could be expanded to a more robust statistical approach for merging data other than
biological replicates in future. In Chapter 4 we explored ChIP-R’s application to merging ChIP-seq
assays from multiple transcription factors and found support that ChIP-R could accurately identify
binding events consistent across transcription factor data from different factors belonging to the same
family. This provides support for further testing ChIP-R’s application to identifying relationships
between transcription factors by extracting reproducible binding sites with high confidence. In addition,
ChIP-R could be used to distinguish sites that are bound by any combination of factors with statistical
support as opposed to simple overlap of information. For example, testing the use of ChIP-R to
integrate accessibility data with transcription factor binding events. A more robust approach to
overlapping different assays could be advantageous in numerous scenarios relating to the regulatory
system but also more broadly to research where combining data can improve our understanding of a
system.
One major limitation that was highlighted in both Chapters 5 and 6 was the apparent missing
knowledge around the driving factors of transcription factor binding but also long distance interactions.
Both binding site prediction and prediction of long distance interactions are driven by similar sets
of functional genomics assays and sequence content. In both cases, predictive approaches show
adequate performance within cell types but drops in performance when attempting to predict binding
or interactions in a novel or unseen cell type. This strongly indicates that the information we currently
have to describe the genetic and epigenetic environments does not completely capture the factors
that influence regulation in the genome. It is possible that this missing information relates to binding
of other transcription factors, an aspect not currently included in any of the predictive approaches
considered. In future, a new set of assays that provide new knowledge of the regulatory process
will improve these predictive approaches to obtain more accurate results and new information about
regulation across different cell types and conditions. In addition to new assays, improvement of existing
assays or processing techniques to generate validation data that is more complete and representative of
the true biological system would allow predictive methods to perform at a higher standard.
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The application of the knowledge extraction techniques presented in Chapter 5 are of benefit to
all researchers who are incorporating machine learning techniques into their research. As the field of
machine learning becomes increasingly popular and more accessible to users who lack a background
in programming or an in depth understanding of the complex algorithms that make machine learning
possible, it is important that knowledge discovery is employed to ensure that detected patterns and
relationships are related to the hypothesis and not a result of bias, training and test set contamination
or model overfitting. Essentially, we need new approaches to validate model performance beyond
the standard metrics of auROC, auPRC and F1 scores which can present a model as accurate even
though the model is not making meaningful predictions. In this thesis, the core example of machine
learning or predictive approaches that would benefit from knowledge extraction are in Chapter 6
where we showed that multiple flaws in the training data prevent models from capturing true driving
factors of long distance interactions. Had researchers employed knowledge extraction to understand
why their models were making certain classifications, these flaws may have been identified earlier
preventing further research being conducted that focused on making ineffective improvements. This
thesis presents basic knowledge extraction techniques and identified a need for improvements in this
field to ensure machine learning models are not providing misleading results. In future, researchers
employing machine learning into their projects should incorporate knowledge extraction techniques as
additional validation that their models are performing to the highest possible standard.
The applications of this workflow are not limited to the characterisation of transcription factor
biology. Many aspects of the regulatory system as represented in Figure 7.1 could be clarified or refined
through integration of multiple experimental data sets. For example, different epigenetic markers
detected by ChIP-seq could be linked to gene expression patterns to classify their functional role (e.g.
active or repressive, promoter or enhancer activity) or sequence features could be defined given the
chromatin state observed across multiple cell types. Outside of the key factors of the regulatory system,
you could investigate SNPs and use available data to better understand the effect different SNPs have
on gene expression and disease pathology. An accurate approach to link distal regulatory regions that
harbour disease associated SNPs to target genes could help determine the true genetic impact that is
captured by the SNP providing new therapeutic targets and pathways to treatment.
This work has the possibility to make a significant difference to the study of the regulatory system
but also to the study of any system in which multiple types of data capture different aspects of the
system itself. The techniques presented here can be improved and adapted moving forward to integrate
more data relating to different aspects of the system and also to grow through the addition of predictive
approaches to fill the gaps where experimental data is lacking. This thesis has also provided researchers
with valuable insights into the challenging field of machine learning or predictive models highlighting
the precautions that must be taken to ensure models truly represent the data that they were trained to
capture.
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7.3 Summary
Our biological workflow will guide researchers on approaches to integrate data from multiple sources
to characterise the functional role of a transcription factor. The workflow benefits from an improved
approach for merging biological replicates, robust data integration techniques and applicability to a
number of different data sets and hypotheses. This thesis has demonstrated the impact that such a
workflow can have when characterising transcription factor biology through a number of examples
providing evidence of new knowledge gained. While our predictive approaches were not successful,
they provided valuable information regarding the relationships between different factors of the regula-
tory system (Figure 7.1) and highlighted numerous improvements that could be made to advance the
field. This workflow is a worthy addition to the body of work around the regulatory system and will
provide researchers not only with new approaches but also new ideas around the possibilities of data
integration going forward and how they can improve our understanding of biology. Overall, this thesis
has added valuable insights into the regulatory system, demonstrated a number of data integration
techniques, explored predictive approaches to replace experimental data and highlighted the pitfalls of
machine learning in general.
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Abstract 
 
 
Cerebellar granule neurons are the most numerous neuronal subtype in the central 
nervous system. Within the developing cerebellum, these neurons are derived from a 
population of progenitor cells found within the external granule layer of the cerebellar 
anlage, namely the cerebellar granule neuron precursors (GNPs). The timely 
proliferation and differentiation of these precursor cells, which, in rodents occurs 
predominantly in the postnatal period, is tightly controlled to ensure the normal 
morphogenesis of the cerebellum. Despite this, our understanding of the factors 
mediating how GNP differentiation is controlled remains limited. Here, we reveal that 
the transcription factor nuclear factor I X (NFIX) plays an important role in this process. 
Mice lacking Nfix exhibit reduced numbers of GNPs during early postnatal 
development, but elevated numbers of these cells at postnatal day 15. Moreover, Nfix-/- 
GNPs exhibit increased proliferation when cultured in vitro, suggestive of a role for 
NFIX in promoting GNP differentiation. At a mechanistic level, profiling analyses 
using both ChIP-seq and RNA-seq identified the actin-associated factor intersectin 1 as 
a downstream target of NFIX during cerebellar development. In support of this, mice 
lacking intersectin 1 also displayed delayed GNP differentiation. Collectively, these 
findings highlight a key role for NFIX and intersectin 1 in the regulation of cerebellar 
development. 
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Introduction 
During nervous system development, transcription factors play a variety of key roles, 
including the regulation of the genes that control proliferation and self-renewal, 
differentiation, migration and maturation. The cerebellum provides a salient example 
of how different transcription factors mediate the development of neural stem cells and 
their progeny (Heng et al. 2012; Kilpatrick et al. 2012; Piper et al. 2011). The 
cerebellum coordinates the timing and execution of motor commands in response to 
sensory feedback from the peripheral nervous system (Leto et al. 2015; Martinez et al. 
2013). In the developing rodent brain, the cerebellum is ultimately derived at 
approximately embryonic day (E) 12 from precursor cells in the rhombic lip, a rapidly 
dividing group of neuroepithelial cells located within the emerging hindbrain 
(Chizhikov and Millen 2003). The specification and proliferation of these cells is driven 
in large part by transcription factors including OTX2, PAX6 and ATOH1 (Landsberg 
et al. 2005; Machold and Fishell 2005; Vernay et al. 2005). These progenitor cells then 
migrate to populate the outer surface of the cerebellar anlage (Miale and Sidman 1961), 
forming a secondary, transient proliferative zone known as the external granule cell 
layer (EGL) (Chizhikov and Millen 2003). The proliferation of these cells continues 
well into the postnatal period, a process regulated by transcription factors including 
PAX6, ZIC1 and ZIC3 (Aruga 2004; Engelkamp et al. 1999). During the first 2 weeks 
postnatally, progenitor cells within the EGL differentiate into immature granule 
neurons, which subsequently migrate radially into the emerging cerebellum to the inner 
granule layer (IGL), where they fully mature. Again, transcription factors such as 
NEUROD1, MBH1, MBH2, ZIC1 and ZIC2 contribute to these processes (Aruga et al. 
2002; Kawauchi and Saito 2008; Pan et al. 2009). 
 
Another suite of transcription factors that have been shown to regulate development of 
the hindbrain and cerebellum are the nuclear factor I (NFI) family (Heng et al. 2012; 
Kilpatrick et al. 2012). These transcription factors are expressed in a variety of 
progenitor cell populations within the developing (Chaudhry et al. 1997; Piper et al. 
2014; Piper et al. 2010) and adult nervous system (Chen et al. 2017; Heng et al. 2015), 
as well as by progenitor cells in other regions of the body (Chang et al. 2013; Messina 
et al. 2010; Harris et al. 2015). NFIs have been implicated in a variety of facets of 
brainstem development (Kilpatrick et al. 2012). NFIB, for example, has been shown to 
mediate basilar pontine development, as precerebellar neurons and pontine neurons 
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exhibit delayed differentiation in the absence of this gene (Kumbasar et al. 2009). NFIA 
and NFIB are also expressed by granule neuron progenitors (GNPs) within the postnatal 
EGL, and by the progeny of these cells as they migrate to, and differentiate within, the 
postnatal IGL (Wang et al. 2007). Importantly, many aspects of granule neuron 
migration and maturation are abnormal in Nfia-/- mice, including migration, axonal 
formation and arborisation of dendritic processes (Wang et al. 2007; Wang et al. 2004). 
NFIs have further been shown to control these processes via the regulation of genes 
that mediate granule neuron maturation, including Tag1, Wnt7a and Gabra6 (Wang et 
al. 2010; Wang et al. 2007; Wang et al. 2004). These findings highlight the critical role 
played by NFI transcription factors in cerebellar development. 
 
We have recently shown that another NFI family member, NFIX, is highly expressed 
by GNPs within the postnatal EGL (Fraser et al. 2017). Moreover, Nfix-deficient mice 
exhibit delayed cerebellar development (Piper et al. 2011). These findings are 
suggestive of NFIX mediating progenitor cell differentiation within the postnatal 
cerebellum. Our previous work within the forebrain supports this concept, as we have 
shown NFIX to be a pivotal factor in promoting neural stem cell differentiation within 
the neocortex (Campbell et al. 2008; Heng et al. 2015) and hippocampus (Harris et al. 
2016; Heng et al. 2014), via the transcriptional regulation of genes such as Sox9, Gfap, 
Insc and Bbx (Dixon et al. 2013; Harris et al. 2016; Heng et al. 2014). Here we sought 
to define the mechanism by which NFIX regulates GNP biology. We reveal that Nfix-/- 
mice exhibit delayed GNP differentiation in vivo, and that Nfix-deficient GNPs 
proliferate more extensively than control GNPs in vitro. Moreover, we used both 
chromatin immunoprecipitation and sequencing (ChIP-seq) and RNA sequencing 
(RNA-seq) to identify potential NFI targets within postnatal GNPs, and identified 
intersectin 1 as a target for NFIX-mediated transcriptional activation. Crucially, 
analysis of intersectin 1 mutant mice revealed phenotypically similar cerebellar defects. 
These findings thus provide novel insights into the transcriptional regulation of GNP 
differentiation, revealing that NFIX-mediated regulation of intersectin 1 plays a central 
role in ensuring the timely differentiation of this postnatal neural progenitor cell pool. 
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Methods 
Animals and ethics approvals 
This research involved the use of animals. Nfix+/+ and Nfix-/- mice were used in this 
study with approval from the University of Queensland Animal Ethics Committee 
(AEC approval numbers: QBI/143/16/NHMRC/ARC and QBI/149/16/ARC). Itsn1- 
deficient animals were also used in accordance with the recommendations of the 
Canadian Council on Animal Care and animal care regulations and policies of the 
Hospital for Sick Children, Toronto. Animals were genotyped as previously described 
(Campbell et al. 2008; Sengar et al. 2013). Primer sequences are available on request. 
All experiments were performed according to the Australian Code of Practice for the 
Care and Use of Animals for Scientific Purposes. Pregnant females were produced by 
placing male and female mice together overnight. The next day, females were inspected 
for the presence of a vaginal plug and, if present, this day was designated as E0. The 
day of birth was designated as postnatal day (P) 0. Mice were housed in Optimice IVC 
caging, with double HEPA filters and built in ventilation. Food and water was available 
ad libitum. 
 
 
Immunohistochemistry 
Chromogenic immunohistochemistry and immunofluorescence labelling was 
performed as described previously (Fraser et al. 2017). Briefly, mice were anesthetised 
and perfused transcardially with phosphate-buffered saline (PBS), followed by 4% 
paraformaldehyde (PFA), then post-fixed for 48-72 hours before long term storage in 
PBS at 4°C. Cerebella were isolated and embedded in 3% Noble agar and sectioned in 
a sagittal plane at 50 µm intervals using a vibratome. Sections were placed sequentially 
across the wells of a 6-well plate to ensure appropriate sampling from different medio- 
lateral regions of the cerebellum. There were between 6-8 cerebellar sections per well. 
Thus, for all analyses we had >6 sections per animal to image and analyse. Sections 
were mounted on slides before heat-mediated antigen retrieval was performed in 10 
mM sodium-citrate solution at 95°C for 15 min. For chromogenic 
immunohistochemistry, sections were incubated overnight in primary antibodies at 
room temperature. A list of antibodies used in this study is given in Table 1. The 
following day, sections were rinsed in PBS, then incubated in a solution containing a 
biotinylated secondary antibody (Vector Laboratories) for 1 hour at room temperature, 
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followed by processing with a VECTASTAIN ABC kit for 1 hour at room temperature 
(A used at 1/500, B used at 1/500, Vector Laboratories). Sections were rinsed again in 
PBS, then were processed for colour reaction using a nickel- 3,3'-diaminobenzidine 
(DAB, Sigma) solution (2.5% nickel sulfate and 0.02% DAB in 0.175 M sodium 
acetate) activated with 0.01% (v/ v) hydrogen peroxide. The colour reaction was 
stopped by rinsing multiple times with PBS, and sections were then coverslipped with 
DPX mounting medium (Thermo Fisher Scientific). For IF labeling, sections were 
incubated at 4C overnight with primary antibodies against the target proteins (see 
Table 1). The following day sections were rinsed in PBS, then incubated with the 
relevant secondary antibodies (Table 1) for 1 hour in the dark at room temperature. 
Sections were rinsed in PBS, then were counterstained with 4’,6-diamidino-2- 
phenylindole (DAPI), and mounted in fluorescent mounting media (DAKO). For all 
experiments, at least three animals at each age were analysed. 
 
 
Cerebellar imaging 
All brightfield images were captured using a Aperio XT Slide scanner and visualized 
using Aperio ImageScope (Leica Biosystems). For fluorescence images a Diskovery 
inverted spinning disk confocal microscope using a 20 X objective and a 70 μm pinhole 
(Nikon TiE; Nikon) was used. We took 10 consecutive 1 μm-thick optical sections to 
generate a 10 μm-thick z-stack. In all cases the 10 μm z-stack was taken from the middle 
of the section to minimize potential artefacts arising from the sectioning process such 
as damage to the tissue. Image acquisition was performed using NIS-elements 
Advanced Research software (Nikon). For comparative analysis of Nfix-/- and Nfix+/+ 
mice, high magnification images were taken of the same lobe of the cerebellum, using 
at least five biological replicates at each of the ages assessed. For Itsn1-/- and Itsn1+/+ 
mice, at least three biological replicates were used. For quantification of granule neuron 
and proliferative markers (PAX6 and Ki67, respectively), three 200 m regions of the 
EGL were quantified for each section. This ensured more representative count of the 
EGL thickness. 1 m-thick optical sections were viewed in Fiji, and the ‘cell counter’ 
plugin used to mark and quantify cells expressing respective markers in each 
fluorescent channel. Cells co-expressing markers (for example PAX6 and Ki67) were 
also quantified this way, and DAPI was used to visualize the cell nucleus, to ensure 
accuracy, especially in areas of high cell density. 
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Granule cell isolation 
GNPs from P7 Nfix+/+ and Nfix-/- mice were isolated using the method outlined by Lee 
and colleagues (Lee et al. 2009) and a papain dissociation kit (Worthington 
Biochemical Corporation). Briefly, the cerebellum was dissected from three wild-type 
and three knockout mice and the tissue was dissociated using a 20 units/mL papain 
solution at 37°C for 15 mins. A single cell suspension was obtained by trituration with 
a serum-coated P1000 pipette tip and nuclear membranes were removed using an 
albumin-ovomucoid inhibitor gradient. GNPs were separated from other cells using a 
30%-60% percoll gradient. Purified GNP cells were then lysed in Trizol (Ambion) and 
RNA isolated using an RNeasy miniprep kit (Qiagen). RNA-sequencing was then 
performed on the samples using the Illumina NextSeq High Output system (Illumina; 
150 base pair read length, paired-end reads). 
 
RNA-seq analysis 
Three RNA-seq replicates each from P7 wild type GNPs and Nfix-/- mice were aligned 
by TopHat2 (v2.0.9) (Trapnell et al. 2012) to the Mus musculus, UCSC, mm10 
reference transcriptome and FASTA annotation downloaded from the TopHat index 
and annotations page (https://ccb.jhu.edu/software/tophat/igenomes.shtml). Cufflinks 
(v2.1.1) (Trapnell et al. 2012) was used to assemble each replicate’s transcripts from 
the alignment file generated by TopHat. Cuffmerge was used to create a single 
assembly containing transcripts across all samples and replicates. Cuffdiff was run 
using the merged set of transcripts and the three replicate TopHat2 bam files from each 
sample. Atoh1 differential expression data was obtained from Klisch and colleagues 
(Klisch et al. 2011), comparing RNA-seq expression of E18.5 wild-type and Atoh1-/- 
cerebellar tissue. 
 
NFIX ChIP-seq 
For chromatin immunoprecipitation, litters of P7 pups were pooled for GNP isolation. 
Isolated GNPs were crosslinked with 1% formaldehyde for 10 minutes, then were 
quenched with glycine. Cells were lysed in RIPA buffer supplemented with protease 
and phosphatase inhibitors (Roche) and sonicated with a Bioruptor (Diagenonde) for 
six 15 minute intervals of 30 seconds on, 30 seconds rest. Chromatin 
immunoprecipitation was performed as described previously (Blythe et al. 2009), using 
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a mouse anti-NFIX antibody (Sigma Aldrich). We have previously shown the 
specificity of this antibody using tissue from Nfix-/- mice (Chen et al. 2017). Briefly, 
immunocomplexes were isolated with protein G-agarose beads (Roche), washed once 
for 5 minutes with buffers 1 through 4. Crosslinking was reversed by incubation with 
proteinase K (Roche) at 60 degrees overnight. DNA was isolated by phenol-chloroform 
extraction then incubated with RNAse A (Roche) for 30 minutes before final cleanup 
with PCR columns (Qiagen). Sequencing libraries were constructed using the standard 
protocol for the NEBNext Ultra II DNA Library Prep Kit for Illumina (New England 
BioLabs). Pooled libraries were sequenced on an Illumina HiSeq2000 (Illumina; 30 
base pair single end read). 
 
 
ChIP-seq analysis 
Alignment was performed on both the NFIX ChIP-seq data and ATOH1 ChIP-seq data 
set (GSE22111) by bowtie2 (Langmead and Salzberg 2012) to mm10. Unaligned reads 
and reads which aligned to multiple locations were removed leaving only uniquely 
mapped reads. MACS2 (Feng et al. 2012) was used to call narrow peaks with default 
parameters for both datasets. Both experiments contained two biological replicates and 
if both biological replicates shared a peak, it was recorded using the maximum 
boundaries of the supporting peaks to generate a merged set of peaks for each 
experiment. Uniform 500 base pair peaks from the NFIX ChIP-seq data were created 
using a ± 250 base pair window around peak centres. This uniform set of peaks was 
input to MEME Suite to perform de novo motif discovery using MEME-ChIP version 
5.0.1 (Bailey et al. 2009; Machanick and Bailey 2011). 
 
 
Annotation of ChIP-seq peaks 
A set of target genes was identified for both NFIX and ATOH1 by the following 
method. A promoter region was defined as ± 2000 base pairs around a transcription 
start site. ChIP-seq binding sites located in a promoter region were annotated as 
proximal, while sites outside the promoter region but overlapping gene boundaries 
(transcription start to stop) were labelled as genic. All remaining binding sites were 
labelled as distal. A binding site annotated as proximal was assigned the nearest gene 
as a target while genic binding sites were assigned the overlapping gene as a target. 
Distal binding sites are difficult to assign target genes to, as they are not necessarily 
135
  
regulating the nearest gene (by genomic distance). CisMapper was used to annotate 
distal binding sites and provide a secondary annotation to proximal and genic sites, with 
resulting links filtered to a threshold of 0.05 (O'Connor et al. 2017). 
 
After identifying a gene target for each NFIX binding site; the associated p-value from 
both the Nfix and Atoh1 RNA-seq differential expression analyses was recorded. Genes 
targeted by both Nfix and Atoh1 with a significant (p < 0.05) change in expression in 
both experiments were extracted. Genes showing coordinated positive or negative log 
fold change values across both experiments were selected to generate a putative set of 
genes under the control of Nfix and Atoh1. Functional annotation was performed using 
DAVID (6.8) on target genes identified for Nfix (Huang da et al. 2009a, b). 
 
DNase I hypersensitivity analysis 
DNase I hypersensitivity (DHS) called peaks from whole cerebellum at P7 across three 
replicates were retrieved from Frank et al. 2015 (GEO: GSE60731). UCSC liftover was 
used to convert the mm9 files to mm10. If at least two replicates shared a peak, it was 
recorded using the maximum boundaries of the supporting peaks to generate a merged 
DHS peak file. Transcription factors are known to bind preferentially in regions of 
accessible chromatin (Guertin and Lis 2013; Hughes 2011) and DHS was therefore 
used to extract NFIX ChIP-seq peaks occurring in accessible regions. 
 
Neurosphere assays 
GNPs were isolated from P7 wild-type and Nfix-/- mice and were seeded into a T25 
flask in neurobasal stem cell medium containing 20 ng/mL of epidermal growth factor 
(EGF), 10 ng/mL of basic fibroblast growth factor (bFGF) and 3.5 μg/mL of heparin. 
After 7 days, neurospheres were dissociated using trypsin to form a single cell 
suspension. Cells were counted and seeded at a density of 2.5 x 105 cells per T25 flask. 
Cells were passaged until passage three. Neurospheres were counted and sphere 
diameter was measured at each passage. 
 
Medulloblastoma cell lines 
The medulloblastoma cell lines DAOY, D283, and UW228 were maintained in RPMI 
medium containing 10% foetal bovine serum. The MB4 primary cell line was 
maintained in StemPro NSC SFM media (Thermo Fisher). 2.5 x 105 cells were seeded 
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into a 6 well plate and cells were lysed in Trizol (Ambion) after 48 hours. RNA was 
extracted using the RNAeasy miniprep kit (Qiagen). cDNA was prepared from RNA 
isolated from the medulloblastoma cell lines using a Superscript III Reverse 
Transcription kit (Invitrogen). cDNA was transcribed from human cerebellum RNA 
(Clontech) and used as a control for comparison of gene expression levels. qPCR was 
performed with the Quantifast SYBR kit (Qiagen). Gene expression was calculated 
using 2−ΔΔCt method relative to the housekeeping gene glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH). 
 
qPCR analysis of target genes 
RNA isolated from GNPs of wild-type and Nfix-/- mice at P7 was used to prepare cDNA 
as described previously (Piper et al. 2014). qPCR was performed with Quantifast SYBR 
Green (Qiagen) to detect gene expression levels of the genes identified in the RNA-seq 
analysis. The primers for these genes are listed in Table 2. Gene expression was 
calculated using 2−ΔΔCt method relative to the housekeeping gene glyceraldehyde 3- 
phosphate dehydrogenase (Gapdh). All the samples were tested in triplicate within each 
experiment, and each experiment was repeated three times. 
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Results 
 
 
Delayed EGL differentiation in the cerebellum of postnatal Nfix-/- mice. 
In our preliminary description of the cerebellar phenotype of Nfix-/- mice, we 
demonstrated that these mice have reduced numbers of PAX6-positive GNPs in the 
EGL at P5 in comparison to wild-type controls (Piper et al. 2011). Within the 
embryonic forebrain of these mutant mice, radial glial progenitor cells exhibit delayed 
differentiation (Dixon et al. 2013; Harris et al. 2016). We hypothesised that GNPs 
within the EGL would exhibit a similar delay in differentiation within Nfix-/- mice. To 
test this hypothesis, we used PAX6-immunocytochemistry to visualise GNPs within 
the EGL of P5, P10 and P15 wild-type and Nfix-/- mice. At P5, there were fewer GNPs 
in the EGL of mutant mice in comparison to controls, whereas at P10, the number of 
these cells in both genotypes was comparable (Fig. 1A-D). Interestingly, at P15 there 
were more PAX6-positive cells in the EGL of the mutant in comparison to the control 
(Fig. 1E, F), indicative of delayed GNP differentiation. 
 
To quantify this phenotype, we performed co-immunofluorescence labelling against 
PAX6 and the proliferation marker, Ki67, followed by confocal microscopy. We 
performed cell counts within the EGL on confocal optical sections of the emerging 
cerebellum. At P5, there were significantly more cells expressing PAX6 and Ki67 in 
the wild-type EGL compared to the mutant (Fig. 2A-J). At P10, however, the numbers 
of PAX6-positive cells and proliferating cells within the EGL was not significantly 
different between genotypes (Fig. 2 K-T). In contrast, there were significantly more 
GNPs within the EGL of P15 Nfix-/- mice compared to the control, as the majority of 
these cells had differentiated in wild-type mice by this age (Fig. 2U-DD). A similar 
trajectory of GNP differentiation was observed when we used a second marker for 
proliferation, the mitotic marker phosphohistone H3 (PHH3; Fig. 3). 
 
Nfix-/- GNPs exhibit increased proliferation in vitro. 
These findings led us to posit that NFIX mediates GNP differentiation, and that the 
absence of this gene could lead to elevated GNP proliferation, as has been previously 
reported in the embryonic hippocampus of Nfix-/- mice (Harris et al. 2016). To test this 
hypothesis, we isolated GNPs from the EGL of P7 wild-type and Nfix-/- mice using 
papain dissociation and a percoll gradient (Lee et al. 2009; Fraser et al. 2017). We 
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performed qPCR on cDNA generated from this tissue, and revealed that the expression 
of the stem cell markers Hes1 and Notch 3 was significantly elevated in GNPs isolated 
from P7 Nfix-/- mice in comparison to controls (Hes1: control 0.0051  0.0001, Nfix-/- 
0.0079  0.0003; Notch 3: control 0.0023  0.0001, Nfix-/- 0.0038  0.0002; p < 0.01, 
t-test). Moreover, the analysis of two markers for neuronal differentiation, Neurod1 and 
NeuN (Rbfox3) revealed significantly reduced expression of these factors in GNPs 
isolated from P7 Nfix-/- mice in comparison to controls (Neurod1: control 0.53  0.01, 
Nfix-/- 0.37  0.002; Rbfox3: control 0.13  0.003, Nfix-/- 0.005  0.004; p < 0.01, t-test). 
Next, we used the percoll gradient protocol to again isolate GNPs from the EGL of P7 
wild-type and Nfix-/- mice and cultured these cells in a neurosphere assay. We cultured 
cells for three passages, and quantified both the number of spheres, as well as sphere 
diameter. At each passage, there were significantly more spheres in cultures derived 
from Nfix-/- EGL progenitors in comparison to controls (Fig. 4A-C). Furthermore, 
whereas the majority of wild-type spheres were less than 50 μm in diameter, in the 
mutant, the majority of spheres were over 70 μm in diameter (Fig. 4D). Interestingly, 
the expression of GFAP by developing Bergmann glia was also delayed in the absence 
of Nfix [Supp. Fig. 1; (Piper et al. 2011)], suggesting that a delay in glial differentiation 
could also potentially underlie the accumulation of PAX6-positive cells within the EGL 
of Nfix-/- mice. However, our neurosphere data clearly indicate elevated levels of 
proliferation in GNPs isolated from Nfix-/- cerebella, indicating that NFIX plays a 
central role in mediating the differentiation of cerebellar GNPs. 
 
Mutations in another NFI family member, Nfia, have previously been implicated in 
medulloblastoma, a paediatric cancer of the cerebellum (Genovesi et al. 2013). Using 
a Sleeping Beauty transposon screen, Genovesi and colleagues revealed that mutations 
to Nfia led to reduced latency of medulloblastoma formation in a Ptch1+/- background. 
Transposon insertions were also identified within the Nfix locus in this screen 
(Genovesi et al. 2013), but the role of NFIX in medulloblastoma is poorly defined. In 
light of our data in the developing cerebellum, we analysed NFIX expression in three 
medulloblastoma cell lines (DAOY, UW228 and D238), and a primary 
medulloblastoma cell line (MB4). NFIX mRNA was significantly reduced in 
comparison to control mRNA isolated from the adult cerebellum (Fig. 4E). A similar 
reduction in expression was also obtained when we analysed the expression of the other 
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NFI family members, NFIA, NFIB and NFIC (data not shown). Collectively, these data 
are consistent with the in vivo cerebellar phenotype of Nfix-/- mice, and suggest that 
NFIX acts to drive the differentiation of cerebellar GNPs. 
 
Transcriptomic profiling reveals a broad suite of potential targets of NFIX within 
GNPs. 
To define transcriptional targets for NFIX during GNP differentiation, we undertook a 
range of bioinformatic approaches using both published, and newly generated, 
transcriptomic data, aimed at defining a small list of high-confidence targets that we 
could experimentally validate. To determine the transcriptomic landscape in GNPs 
lacking Nfix, we first isolated GNPs from both wild-type and Nfix-/- cerebella at P7, and 
performed transcriptomic profiling (RNA-seq) on the RNA isolated from these cells. 
Analysis revealed 1,402 genes as being significantly misregulated in Nfix-/- GNPs in 
comparison to controls (Fig. 5A, Supp. Table 1). Gene Ontology and Pathway analyses 
of these genes using DAVID (Huang da et al. 2009a, b) identified a diverse range of 
processes potentially controlled by NFIX within GNPs, including cell adhesion, 
extracellular matrix organisation and axon guidance (Fig. 5B). 
 
To determine direct targets of NFIX in GNP differentiation, we next performed ChIP- 
seq on DNA derived from isolated P7 GNP preparations using an anti-NFIX antibody 
whose specificity has been previously demonstrated (Chen et al. 2017; Vidovic et al. 
2018). This experiment identified 6,910 specific NFIX binding peaks (Fig. 5C, Supp. 
Table 2). Interestingly, a recent publication used DNase 1 hypersensitivity analysis on 
whole cerebellar tissue to investigate chromatin accessibility within these cells at 
different stages in development (Frank et al. 2015). We posited that NFIX ChIP-seq 
peaks identified within regions of open chromatin would be more likely to regulate 
gene transcription directly. As such, we filtered our NFIX ChIP-seq data using the 
DNase 1 hypersensitivity data from P7 (Frank et al. 2015), an analysis that revealed 
that 5,843 of the NFIX ChIP-seq peaks were found in regions of accessible chromatin 
at this age (Fig. 5C, Supp. Table 2). Finally, the intersection of the differentially 
expressed genes identified via RNA-seq (Fig. 5A) with those genes identified as having 
an NFIX ChIP-seq peak in an accessible region of chromatin (Fig. 5C) identified 578 
genes as being potential targets for direct NFIX-mediated regulation within P7 GNPs 
(Fig. 5D, Supp. Table 3). This analysis revealed a number of genes previously 
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implicated in cerebellar development, such as Otx2 and Dab1, as well as a range of 
genes whose role in cerebellar development has not been previously studied (e.g. Heg1, 
Tiam2). Interestingly, Nfix was also identified via this filtering analysis, suggesting that 
NFIX autoregulates its own expression within the context of GNP development. 
 
To search for further ways in which we could refine our list of potential NFIX target 
genes, we performed motif discovery and enrichment analyses (Bailey et al. 2009, 
Machanick et al. 2011) on the NFIX binding peaks isolated in our ChIP-seq experiment. 
As expected, the conserved motif bound by NFI transcription factors (Heng et al. 2012) 
was identified as being enriched in our ChIP-seq peaks. Interestingly, we also observed 
enrichment of the ATOH1 binding motif within NFIX ChIP-seq peaks (Fig. 6A). 
ATOH1 is strongly and specifically expressed by GNPs, and has previously been 
shown to regulate the proliferation of these cells, as well as concomitantly priming them 
for differentiation (Klisch et al. 2011). This finding indicates that NFIX and ATOH1 
could potentially regulate a common suite of genes developmentally. Given this, we 
postulated that we could use the analysis of ATOH1 target genes to further refine our 
list of potential NFIX targets. To do this, we used a recent analysis of the ATOH1 
targetome in cerebellar tissue (Klisch et al. 2011). This study mapped differential gene 
expression in E18.5 cerebellar tissue isolated from Atoh1-deficient mice, as well as 
identifying potential direct targets of ATOH1 by performing ChIP-seq on P5 cerebellar 
tissue (Klisch et al. 2011). Analysis of these two sequencing datasets identified 1551 
genes as potential ATOH1 targets (i.e. the target gene containted at least one ATOH1 
ChIP-seq peak, and was significantly differentially expressed in E18.5 Atoh1-/- 
cerebellar tissue; Fig. 6B) (Klisch et al. 2011). The comparison of these potential 
ATOH1 target genes with those 578 NFIX target genes identified in our RNA-seq and 
ChIP-seq analyses (Fig. 5D; Supp. Table 3) revealed 177 genes as potential targets of 
both ATOH1 and NFIX in cerebellar development. Critically, 90 of these genes were 
coordinately misregulated in both Nfix-/- GNPs and Atoh1-/- cerebellar tissue (Fig. 6B, 
C). This list of putative NFIX targets included Nfix itself, as well as other factors 
previously implicated in cerebellar development, including Otx2, Robo1 and Dab1 
(Vernay et al. 2005; Gallagher et al. 1998; Tamada et al. 2008). Interestingly, this 
analysis also revealed a range of genes that have not previously been implicated in 
cerebellar development, including Coro2b, and intersectin 1 (Itsn1; Fig. 6D). 
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Intersectin 1 is a target for transcriptional activation by NFIX during GNP 
differentiation. 
Of those novel factors identified in our transcriptomic screens, Itsn1 was of particular 
interest to us. This gene encodes a multi-domain scaffold protein that has been 
implicated in regulating numerous cellular signalling pathways (Herrero-Garcia and 
O'Bryan 2017). With relation to neuronal development, Itsn1 has been implicated in 
connectivity at the cortical midline of the dorsal telencephalon, with deficiencies to this 
gene correlated with aberrant higher order cognition (Sengar et al. 2013). 
Mechanistically, Itsn1 has recently been implicated in neuronal migration within the 
hippocampus as part of the reelin signalling pathway, via its interaction with the reelin 
receptor VLDLR, and with Dab1, a signalling molecule downstream of VLDLR (Jakob 
et al. 2017). Given the importance of reelin signalling for cerebellar development 
(Vaswani and Blaess 2016), and the identification of Dab1 in our transcriptomic screen, 
we focussed on Itsn1 as a target for NFIX in GNP differentiation. We first validated 
our RNA-seq dataset by performing qPCR on GNPs isolated from independent P7 Nfix- 
/- and control cerebella (Fig. 7A). In line with our sequencing results, Itsn1 mRNA was 
significantly reduced in Nfix-/- samples in comparison to controls, whereas the mRNA 
levels of Kit, serpine 2 and Dab1 were significantly increased in the mutant. These data 
suggest that NFIX acts to promote the expression of Itsn1 during GNP differentiation. 
If this were the case, we would hypothesise that mice lacking Itsn1 would potentially 
phenocopy those lacking Nfix with regards to cerebellar development. To test this 
hypothesis, we analysed the cerebellum of Itsn1-/- mice at P15. Hematoxylin staining 
revealed that foliation of the cerebellum was grossly normal in these mice in 
comparison to controls (Fig. 7B, C). However, closer analysis of the EGL of mutant 
mice revealed that the EGL of Itsn1-/- mice at P15 was markedly thicker when compared 
to control mice (7B’, C’). Indeed, immunofluorescence labelling with PAX6, followed 
by confocal microscopy, revealed significantly more GNPs within the EGL of Itsn1-/- 
mice at this age than controls (Fig. 7D-J). Similarly, there were significantly more 
Ki67-expressing cells in the EGL of mutant mice at this age in comparison to wild-type 
controls (Fig. 7K). The expression of GFAP by Bergmann glia was comparable 
between wild-type and Itsn1-/- mice at this age (Supp. Fig. 2), although it is possible 
that GFAP expression was reduced at earlier time points akin to what we observed with 
the Nfix mutant, and that this may also have contributed to the enlarged EGL at P15 in 
the absence of Itsn1. Finally, like NFIX, the expression of ITSN1 was also significantly 
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reduced in medulloblastoma cell lines (Fig. 7L). Collectively, these data, in association 
with our RNA-seq and ChIP-seq analyses, suggest that NFIX-mediated regulation of 
Itsn1 plays an important role in GNP differentiation during cerebellar development. 
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Discussion 
 
 
Studies into the role of the NFI family in cerebellar development have highlighted a 
key role for these transcription factors in mediating neuronal migration and synaptic 
maturation (Kilpatrick et al. 2012). Here, we extend these findings, revealing that NFIX 
regulates GNP biology within the postnatal cerebellum. Indeed, the delayed 
differentiation of GNPs in vivo in Nfix-deficient mice, coupled with the elevated 
proliferation of Nfix-/- GNPs in vitro, are supportive of a role for NFIX in promoting 
timely GNP differentiation within the postnatal cerebellum. This is in accordance with 
studies into the role of the NFI family during nervous system development (Fane et al. 
2017; Harris et al. 2015), with impairments in neural stem cell differentiation observed 
in the absence of NFIs from diverse regions of the brain, including the neocortex (Piper 
et al. 2009), hippocampus (Heng et al. 2014; Piper et al. 2014) and spinal cord 
(Matuzelski et al. 2017). Collectively, these data implicate the NFI family, including 
NFIX, as key drivers of neural development via the promotion of neural stem cell 
differentiation. 
 
How do NFIs drive this process at a mechanistic level? A number of studies have 
investigated the roles these factors play during nervous system development. Early 
studies using Nfi-deficient mice revealed severe delays in astrocyte differentiation, 
suggesting a central role for this family in gliogenesis within the cerebral cortex and 
spinal cord (Deneen et al. 2006; Shu et al. 2003). More recently, transcriptional 
profiling experiments such as microarrays, coupled with molecular analyses and 
bioinformatics, have identified a range of target genes in the developing and adult 
nervous system that act to either repress stem cell identity or to promote cellular 
differentiation (Harris et al. 2018; Harris et al. 2016). These include Apcdd1, Mmd2 
and Zcchc24 (spinal cord) (Kang et al. 2012), Insc, Sox9 and Ezh2 and (hippocampus) 
(Harris et al. 2016; Heng et al. 2014; Piper et al. 2014), as well as Bbx and Hes1 
(cerebral cortex) (Dixon et al. 2013; Piper et al. 2010). The advent of genome-wide 
profiling using techniques such as RNA-seq and ChIP-seq now means that the direct 
targets of transcription factors like NFIX can be investigated globally in a more 
rigorous manner. To the best of our knowledge, this is the first study that has 
investigated downstream targets of a specific NFI family member within the nervous 
system by using these techniques co-operatively. Moreover, when coupled with 
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available data relating to chromatin accessibility (Frank et al. 2015) and the ATOH1 
targetome (Klisch et al. 2011), this study provides a significant conceptual advance in 
our understanding of the transcriptional landscape regulated by NFIX within the 
postnatal cerebellum. 
 
One of the novel targets identified as a potential regulator of GNP biology downstream 
of NFIX using these techniques was the scaffold protein intersectin 1. The gene coding 
for this factor contained NFIX ChIP-seq peaks near its 3’ UTR, and was significantly 
downregulated in the absence of Nfix. Moreover, mice lacking Itsn1 phenocopied Nfix- 
/- mice with regards to delayed differentiation of GNPs within the postnatal EGL. These 
data suggest that ITSN1 contributes to the differentiation of GNPs. At this stage, it is 
unclear precisely how ITSN1 regulates the differentiation of GNPs. However, given 
the nature of this protein as a scaffold capable of binding and influencing many 
signalling pathways (Herrero-Garcia and O'Bryan 2017), there are many potential 
means by which ITSN1 could mediate GNP differentiation. For example, ITSN1 has 
been shown to regulate Ras family GTPases, including Ras, with ITSN1 postulated to 
promote Ras activation (Adams et al. 2000). As RAS signalling has previously been 
shown to be required for the proliferation of GNPs postnatally (Sanchez-Ortiz et al. 
2014), abnormal activation of this factor, and the downstream ERK-MAPK pathway, 
may potentially contribute to the phenotype evident in these mice. ITSN1 has also been 
shown to mediate caveolin-mediated endocytosis (Gubar et al. 2013). This may be 
particularly pertinent for GNP biology, as the continued proliferation of these cells is 
controlled, at least in part, by sonic hedgehog (Shh) released by Purkinje cells (Roussel 
and Hatten 2011). Endocytosis of the Shh receptor, Ptch1, to the lysosome plays a key 
role in continued GNP proliferation (Yue et al. 2014). It is feasible that ITSN1 may 
contribute to this process. Looking forwards, proteomic studies performed on postnatal 
GNPs will provide a framework in which to understand the molecular partners of 
ITSN1, and so the processes this scaffold protein may regulate in vivo. 
 
Our findings also suggest a potential role for NFIX in medulloblastoma, a malignant 
childhood cancer of the cerebellum. Another NFI family member, NFIA, was recently 
linked to the formation of medulloblastoma using a Sleeping Beauty transposon screen 
to identify genetic modifiers of tumour formation in Ptch1 heterozygous mice 
(Genovesi et al. 2013). This study also identified Nfix as being significantly enriched 
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as a tumour-suppressor. In humans, recent gene expression analyses of patient 
medulloblastoma samples revealed that NFIX expression is significantly lower in type 
3α and type 3γ medulloblastomas, subtypes with poor prognosis and increased 
frequency of metastasis (Cavalli et al. 2017). Although both of these studies identified 
NFIX, Shh and type 3 medulloblastoma subgroups are characterised by different 
oncogenic drivers. However, preliminary data suggest that Hedgehog-dependent 
tumours, including medulloblastomas and basal cell carcinomas, are capable of 
switching oncogenic pathways, and hence becoming more metastatic (Ransohoff et al. 
2015; Zhao et al. 2015). It remains to be tested whether NFI family members play a 
role in this transition, or appear as tumour suppressors solely due to their pro- 
differentiation roles. Furthermore, haploinsufficiency to NFIX in human patients 
culminates in Malan Syndrome, a disorder characterised by overgrowth of many organ 
systems, including the brain (Klaassens et al. 2015; Malan et al. 2010). This implies a 
pro-differentiation role for NFIX during development, and is consistent with our work 
on NFIX in the cerebellum. 
 
A key advance we have made in this work is to use RNA-seq, ChIP-seq (this study) 
and chromatin accessibility (Frank et al. 2015) to define the potential targets of NFIX 
during development. This approach enabled us to identify 5,843 high-confidence NFIX 
ChIP-seq peaks. Through the combination of our RNA-seq analysis, these high- 
confidence peaks were subsequently linked to 578 target genes. Motif discovery further 
led us to identify ATOH1 as a factor that may bind to similar genes as NFIX during 
GNP development. Published data pertaining to the loss of Atoh1 expression (Klisch et 
al. 2011) revealed that Nfix is downregulated in Atoh1-/- cerebellar tissue, suggesting 
that ATOH1 potentially regulates Nfix expression. Indeed, a number of genes were 
commonly misregulated in both RNA-seq perturbation data sets (Fig. 6B). Therefore, 
genes bound by NFIX and showing expression changes in both data sets where NFIX 
was perturbed, albeit using different approaches, were considered to be high-confidence 
target genes of NFIX. 
 
Ultimately, this focussed, multifaceted approach led us to identify 90 potential NFIX 
target genes. While we focussed here on Itsn1, the role of NFIX in mediating other 
genes identified via this screen offers a number of interesting avenues of future 
research. For example, the factors mediating the transcriptional activation of the Nfis 
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themselves is very poorly defined. Our findings suggest that NFIX may autoregulate 
itself, a finding consistent with a recent report identifying NFIB as a regulator of Nfix 
expression in the developing spinal cord (Matuzelski et al. 2017). Moreover, 
investigating the expression and role of other novel factors highlighted in this screen 
will enhance our understanding of GNP biology. Another point to consider is the fact 
that we filtered our target gene list (RNA-seq and ChIP-seq; Fig. 5D) following our use 
of motif enrichment, which identified the ATOH1 consensus binding site within our 
NFIX ChIP-seq peaks (Fig. 6A, B). We filtered our gene list based on those genes that 
were also potential targets of ATOH1 [i.e. contained an ATOH1 ChIP-seq peak, and 
were differentially regulated in Atoh1-deficient cerebellar tissue (Klisch et al. 2011)] 
Many potential NFIX target genes (401 in total) were not identified in the ATOH1 
datasets, and as such, many more avenues remain to study novel targets of NFIX in 
GNP differentiation (e.g. Tiam2, Lingo3, Adamts1). Finally, we also filtered our NFIX 
ChIP-seq peaks by only considering those peaks located within open chromatin (Frank 
et al. 2015). An interesting finding of our ChIP-seq data was that many of the peaks 
were located in regions of closed chromatin. This suggests that NFIX may play roles in 
addition to regulating direct gene transcription. Indeed, NFIs have previously been 
shown to bind to histone H3, and to regulate nucleosomal architecture (Fane et al. 2017; 
Esnault et al. 2009; Muller and Mermod 2000). NFIB was also shown recently to 
regulate chromatin accessibility in small cell lung cancer in a manner that promoted 
tumour metastasis (Denny et al. 2016). Looking forward, defining the functional 
significance of NFIX binding to closed regions of chromatin may provide new insights 
into how these factors regulate neural stem cell biology. 
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Figure legends 
 
 
Figure 1: Delayed differentiation of GNPs in the cerebellum of Nfix-deficient mice. 
Mid-sagittal sections of P5 (A-B’), P10 (C-D’) and P15 (E-F’) wild-type (A, C, E) and 
Nfix-/- (B, D, F) mice stained with antibodies against PAX6. The boxed regions in A-F 
are shown at higher magnification in A’-F’ respectively. The morphology of the 
cerebellum appeared grossly normal in mice lacking Nfix. However, higher 
magnification views of the external granule layer (EGL) revealed that this germinal 
zone was thinner at P5 in mutant mice. At P10 the EGL of the mutant was comparable 
to the control. At P15, whereas the EGL was almost completely depleted in the wild- 
type, there were still numerous PAX6-positive cells in this cellular layer of Nfix-/- mice. 
Scale bar (in A) A-F =250 m, A’-F’ = 25 m. 
 
Figure 2: Retention of GNPs in late postnatal Nfix-/- mice. 
Expression of the nuclear marker DAPI (blue), the proliferative marker Ki67 (green), 
and PAX6 (red), a marker of GNPs and their progeny, in P5 (A-H), P10 (K-R) and P15 
(U-BB) mice. The EGL in delineated by brackets in panels C, G, M, Q, W and AA. At 
P5 there were significantly more PAX6-positive cells (I) and PAX6/Ki67 double- 
positive cells (J) in the wild-type EGL in comparison to the mutant. At P10, there were 
no significant differences in either PAX6- (S) or PAX6/Ki67-expressing (T) cells 
between groups. At P15, however, there were significantly more PAX6-positive cells 
(CC) and PAX6/Ki67 double-positive cells (DD) in the EGL of Nfix-/- mice in 
comparison to the control. * p < 0.05, t-test. Scale bar (in A) = 25 m. 
 
Figure 3: Delayed proliferation profile of GNPs in the absence of Nfix. 
Transverse sections of P5 (A-D), P10 (F-I) and P15 (K-N) wild-type and mutant 
cerebella labelled with DAPI (blue) and antibodies against the proliferative marker 
phosphohistone H3 (PHH3). At P5, there were significantly more proliferating cells in 
the EGL of the wild-type (arrows in A, B) in comparison the control (arrowheads in C, 
D; quantified in E). At P10, however, the rate of proliferation within the EGL was 
comparable between sample wild-types and mutants (arrows in F-I; quantified in J). At 
P15, the situation was reversed, with there being significantly fewer proliferating cells 
within the EGL of wild-type mice (double arrowheads in K, L) in comparison to mutant 
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mice (arrows in M, N; quantified in O). * p < 0.05, *** p < 0.001 t-test. Scale bar (in 
A) = 25 m. 
 
Figure 4: Nfix-/- GNPs exhibit elevated proliferation in vitro. 
GNPs were isolated from P7 wild-type and Nfix-/- cerebella and were cultured in a 
neurosphere assay for multiple passages. At passage 3, wild-type spheres (A) were 
smaller and fewer in number than those derived from Nfix-/- GNPs (B). Indeed, there 
were significantly more spheres derived from Nfix-/- GNPs at each passage in 
comparison to the control (C). Moreover, at passage 3, spheres derived from Nfix-/- 
GNPs were on average larger than controls (D). (E) qPCR revealed that different 
medulloblastoma cell lines had significantly lower NFIX expression in comparison to 
normal cerebellar tissue. * p < 0.05, *** p < 0.001 ANOVA. Scale bar (in A) = 30 m. 
 
Figure 5: Transcriptomic profiling of Nfix-/- GNPs. 
(A) Volcano plot representing the transcriptional profile of P7 Nfix-/- GNPs in 
comparison to controls. Red dots represent the 1,402 significantly misregulated genes 
in P7 Nfix-/- GNPs as identified by RNA-seq. (B) Gene Ontology (DAVID 6.8) analysis, 
showing those biological processes, cellular components and molecular functions 
misregulated in P7 Nfix-/- GNPs, as well as KEGG pathways identified as being 
abnormal in these cells. (C) To narrow the list of potential NFIX target genes, we 
performed ChIP-seq on wild-type P7 GNPs with an anti-NFIX antibody. This revealed 
6,910 NFIX binding peaks. We compared this with a published DNase I 
hypersensitivity analysis of P7 cerebellar tissue (Frank et al. 2015). Of the 6,910 ChIP 
peaks, 5,843 were in regions of accessible chromatin. We then compared the 4,621 
genes associated with these 5,843 NFIX peaks with our RNA-seq data (A). This 
analysis identified 578 potential NFIX target genes (D). 
 
Figure 6: Combined analysis of Nfix-/- GNPs and Atoh1-/- cerebellar tissue 
(A) MEME-suite de novo motif discovery run on NFIX ChIP-seq peaks revealed both 
the NFI motif, and the ATOH1 motif, suggesting the two transcription factors 
potentially regulate a common suite of target genes. (B) Comparison of 1,551 genes 
bound by ATOH1 and misregulated in Atoh1-/- cerebellar tissue (Klisch et al. 2011) and 
578 genes bound by NFIX and misregulated in Nfix-/- GNPs identified 177 shared target 
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genes. Of the 177 shared target genes, 90 were coordinately misregulated (i.e. up in 
both datasets, or down in both datasets) in both Atoh1-/- cerebellar tissue (Klisch et al. 
2011) and Nfix-/- GNPs. These 90 genes are listed in panel C, with those genes in red 
being downregulated in Nfix-/- GNPs, and those genes in green being upregulated in 
Nfix-/- GNPs. The remaining 87 genes were not coordinately misregulated in the two 
datasets (i.e. expression was up in one dataset and down in the other, or vice versa). (D) 
Panel D shows genome browser tracks for the regions around the Itsn1 and Dab1 genes. 
The tracks reveal NFIX binding sites from our ChIP-seq dataset (NFIX_full, dark 
green), NFIX binding sites that appear in regions of accessible chromatin 
(NFIX_filtered, light green) and regions of open chromatin from published DNase 1 
hypersensitivity analysis (DHS, red). Itsn1 has binding events occurring intronically 
and Dab1 has binding events occurring distally and intronically. 
 
Figure 7: Intersectin 1 is a downstream target for NFIX in GNP development. 
(A) qPCR performed on P7 GNPs from wild-type and Nfix-/- mice revealed significantly 
reduced levels of Itsn1. Levels of Kit, serpine 2 and Dab1 were, conversely, 
significantly elevated in the mutant in comparison to the controls. (B, C) Mid-sagittal 
sections of P15 wild-type (B) and Itsn1-/- (C) mice stained with hematoxylin. Gross 
morphology of the cerebellum was not altered in the absence of Itsn1. The boxed 
regions in B and C are shown in B’ and C’ respectively. These reveal that the EGL is 
markedly larger in Itsn1-/- mice on comparison to the controls. (D-I) 
Immunofluorescence staining with PAX6 revealed that, whereas few PAX6-expressing 
cells remained in the EGL of wild-type mice (D-F) at this age, there were numerous 
PAX6-expressing GNPs in in the EGL of Itsn1-/- mice (G-I). Quantitation of the EGL 
of P15 mice revealed significantly more PAX6-expressing (J) and PAX6/Ki67- 
expressing (K) cells in the EGL of the mutant in comparison to the control at P15. (L) 
qPCR revealed that different medulloblastoma cell lines had significantly lower ITSN1 
expression in comparison to normal cerebellar tissue. * p < 0.05, ** p < 0.01, *** p < 
0.001 t-test. 
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Antibody Source 
species 
Company Catalogue 
number 
Dilution 
used 
Purpose 
NFIX Mouse SIGMA SAB1401263 1/200;1/1000 IF/IHC 
PAX6 Rabbit Millipore AB2237 1/400 IF 
NEUN Rabbit Millipore MAB377 1/200 IF 
GFAP Rabbit DAKO Z0334 1/1000 IF 
PHH3 Rabbit Millipore 06-570 1/400 IF 
Ki67 Mouse BD 
Pharmigen 
550609 1/400 IF 
 
Table 1: Antibodies used in this study. 
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Gene Forward Rev 
Itsn1 TCAGTTTCCCACACCTTTCG TCAGGCTAAGGAACTGCTGG 
Kit CACATACACGTGCAGCAACA GAAGGCCAACCAGGAAAAGT 
Serpine2 ACGGCAAGACAAAGAAGCAG AGCCTTGTTGATCTTCTTCAGC 
Dab1 AACCAGCGCCAAGAAAGAC ATCAGCTTGGCTTTGTACCG 
Hes1 TCTGAGCACAGAAAGTCATCA AGCTATCTTTCTTAAGTGCATC 
Dll1 TTCTCTGGCTTCAACTGTGAG CATTGTCCTCGCAGTACCTC 
Notch3 AGTGCCGATCTGGTACAACTT CACTACGGGGTTCTCACACA 
Neurod1 ATGACCAAATCATACAGCGAGAG TCTGCCTCGTGTTCCTCGT 
Rbfox3 GGCAAATGTTCGGGCAATTCG TCAATTTTCCGTCCCTCTACGAT 
Gapdh GCACAGTCAAGGCCGAGAAT GCCTTCTCCATGGTGGTGAA 
NFIX AGGACTGTTTTGTGACTTCCG GGTTGATGTTGTAGTAGCTGGG 
GAPDH CCCTTCATTGACCTCAACTACAT TCCTGGAAGATGGTGATGG 
ITSN1 GGGCCATAACTGTAGAGGAAAGA ACAGGTTGAGGTAACCCAGAT 
 
Table 2: qPCR primers used in this study. 
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 Abstract  
 
Transcriptional regulation plays a central role in controlling neural stem and progenitor 
cell proliferation and differentiation during neurogenesis. For instance, transcription 
factors from the nuclear factor I (NFI) family have been shown to co-ordinate neural 
stem and progenitor cell differentiation within multiple regions of the embryonic 
nervous system, including the neocortex, hippocampus, spinal cord and cerebellum. 
Knockout of individual Nfi genes culminates in similar phenotypes, suggestive of 
common target genes for these transcription factors. However, whether or not the NFI 
family regulate common suites of genes remains poorly defined. Here, we use granule 
neuron precursor cells (GNPs) of the postnatal murine cerebellum as a model system 
to analyse regulatory targets of three members of the NFI family; NFIA, NFIB and 
NFIX. By integrating transcriptomic profiling (RNA-seq) of Nfia- and Nfix-deficient 
GNPs with epigenomic profiling (ChIP-seq  against NFIA, NFIB and NFIX, and DNase 
I hypersensitivity assays), we reveal that these transcription factors share a large set of 
potential transcriptional targets, suggestive of complementary roles for these NFI 
family members in promoting neural development.  
 
 
 
 
Key words 
NFIX, NFIA, NFIB, cerebellum, external granular layer, granule neuron. 
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 Introduction 
 
Transcription factors are integral to nervous system development, orchestrating a broad 
range of processes including cell proliferation, migration, differentiation, and 
maturation. The nuclear factor I (NFI) family of transcription factors (NFIA, NFIB, 
NFIC and NFIX) mediate several of these processes in the developing rodent nervous 
system [1-3]. For example, during embryogenesis, NFIs regulate cellular proliferation 
and differentiation in the neocortex, hippocampus, spinal cord and cerebellum [4-12]. 
Given these key roles of NFIs in the developing nervous system, it is perhaps 
unsurprising that their expression is highly overlapping. Indeed, NFIs are expressed by 
a broad range of cell types in the developing central nervous system, including radial 
glia, intermediate progenitors and neurons [3,13-16]. In the developing cerebellum, 
NFIA, NFIB and NFIX are expressed by GNPs at postnatal day (P) 6 [3]. Thus, the 
expression of NFIs across key cellular populations, and within multiple brain regions, 
enables these transcription factors to coordinate nervous system development. 
 
The role of the NFIs in nervous system development is also evident through the analysis 
of knockout mouse models. The phenotypes of Nfi knockout mice are markedly similar. 
For example, neuroanatomical defects are evident in Nfia, Nfib and Nfix knockout mice, 
including aberrant development of the corpus callosum and hippocampus 
[8,10,13,17,18]. Midline glial populations also fail to develop correctly in Nfia, Nfib 
and Nfix knockout mice [13,17,18], reflecting altered astrocytic development. Indeed, 
with regards to the development of the neocortex and hippocampus, mice lacking Nfia, 
Nfib and Nfix show delayed differentiation of radial glial stem cells into mature neurons 
and glia [8-10,19], in part due to delayed generation of intermediate progenitor cells 
[7]. In the cerebellum, NFIX was recently shown to promote GNP differentiation [20], 
and, while the role of other NFI family members in GNP biology is unclear, the 
expression of NFIA and NFIB by GNPs at P6 [3] is indicative of a role in regulating 
GNP differentiation. Moreover, NFIs have been shown to bind to the same DNA 
recognition motif [21]. Collectively, these data suggest that these transcription factors 
regulate the expression of similar cohorts of genes. 
 
Despite much work outlining the expression and proposed function of NFIs in brain 
development, whether NFI family members actually regulate similar gene targets is 
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 poorly defined. To date, there has been one published report highlighting overlapping 
NFIA and NFIB gene targets in the developing forebrain [22]. This analysis, whilst 
insightful, did not include epigenomic data to refine potential gene targets and was 
performed on a heterogeneous population of cells. We therefore sought to overcome 
these limitations, and examined if NFIs regulate similar gene targets using the 
developing cerebellum as a model system. In the rodent brain, cerebellar development 
begins at approximately embryonic day (E) 12, when ATOH1-expressing granule 
neuron precursors (GNPs) are generated in the rhombic lip [23]. These GNPs then 
proliferate and migrate tangentially, forming a transient germinal zone called the 
external granule layer (EGL) [23-25]. Cerebellar development continues postnatally, 
with GNPs proliferating and differentiating into immature neurons, which ultimately 
migrate radially through the molecular layer, becoming mature granule cells within the 
internal granule layer (IGL) of the cerebellum [26]. Whilst NFIA, NFIB and NFIX are 
expressed in GNPs [3] it remains an open question whether or not the NFIs are co-
expressed in these cells. Moreover, it is unclear whether these transcription factors 
share any common gene targets during cerebellar development. Here, we reveal co-
expression of the NFI transcription factor family within GNPs of the EGL. Moreover, 
using a combination of transcriptomic and epigenomic profiling, we reveal that a 
significant proportion of potential target genes are common between the NFI family 
members, highlighting the functional complementarity within this group of 
transcription factors. 
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 Materials and methods 
 
Animals  
All the mice used in this study were maintained on a C57Bl/6 background. Nfia null 
mice on this genetic background are embryonic lethal. As such, we used a conditional 
Nfia allele (Nfiafl/fl)  crossed to a Atoh1 cre line [27]. This line enabled the ablation of 
Nfia from ATOH1-expressing cells from embryonic day (9) [25] including the cells of 
the rhombic lip, that will ultimately give rise to GNPs within the EGL of the postnatal 
cerebellum.  Knockout animals were Nfiafl/fl; Atoh1-cre+; controls were Nfiafl/fl; Atoh1-
cre-. Animals were used with approval from the University of Queensland Animal 
Ethics Committee (AEC approval numbers: QBI/143/16/NHMRC/ARC and 
QBI/149/16/ARC). Animals were genotyped by PCR; primer sequences are available 
on request. All experiments were performed according to the Australian Code of 
Practice for the Care and Use of Animals for Scientific Purposes. Pregnant females 
were acquired by placing male and female mice together overnight. The next day, 
females were inspected for the presence of a vaginal plug and, if present, this day was 
designated as E0. The day of birth was designated as postnatal day (P) 0. Mice were 
housed in Optimice IVC caging, with double HEPA filters and built in ventilation.  
Food and water was available ad libitum, and materials were provided for nesting and 
enrichment.  
 
Immunohistochemistry 
To analyze the cell-type specific expression of NFIA, NFIB and NFIX, we performed 
co-immunofluorescence labelling, as described previously [14]. Briefly, postnatal mice 
at P3, P7 or P15 were anesthetized with pentobarbital and perfused transcardially with 
phosphate-buffered saline (PBS), followed by 4% paraformaldehyde, then post-fixed 
for 48-72 hours before long term storage in PBS at 4°C. Cerebella were isolated and 
embedded in Noble agar (3%) and sectioned (50 µm) in a sagittal plane using a 
vibratome. Sections were placed sequentially across the wells of a 6-well plate to ensure 
appropriate sampling from different medio-lateral regions of the cerebellum. Sections 
were mounted on SuperFrost Plus (Thermo Scientific) slides, before heat-mediated 
antigen retrieval was performed in 10 mM sodium-citrate solution (pH 6.0) at 95°C for 
15 min. Sections were blocked for 2 hours in a solution containing 2% serum and 0.2% 
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 Triton-X-100 in PBS. Sections were then incubated overnight at 4C with primary 
antibodies against the target proteins (Table 1). Subsequently, sections were rinsed in 
PBS, then incubated with the relevant secondary antibodies (Table 1) for 2 hours in the 
dark at room temperature. Sections were rinsed in PBS, then were counterstained with 
4’,6-diamidino-2-phenylindole (DAPI), and mounted in fluorescent mounting media 
(DAKO). For all experiments, at least three animals at each age were analyzed. 
 
Cerebellar imaging 
Fluorescent immunolabelling was visualized using a Nikon 20x Air objective  on a 
spinning disk confocal microscope (Diskovery; Andor Technology, UK) on a Nikon 
Ti-E body (Nikon Corporation, Japan), equipped with a Zyla 4.2 10-tap sCMOS camera 
(Andor Technologies). For comparative sections identical imaging parameters were 
used including pinhole size (70 m), laser power and exposure time. We took 10 
consecutive 1 μm-thick optical sections to generate a 10 μm-thick z-stack. In all cases 
the 10 μm z-stack was taken from the middle of the section to minimize potential 
artefacts arising from the sectioning process such as damage to the tissue. Image 
acquisition, tiling and stitching was performed using NIS-elements Advanced Research 
Imaging Software (Nikon Corporation, Japan). All brightfield images were captured 
using a Aperio ScanScope XT Slide scanner (Leica Biosystems, Germany) with a 
doubled 20x objective (40x magnification overall, Nikon Corporation, Japan) and 
visualized using Aperio ImageScope software. 
 
For analysis of wildtype, Nfiafl/fl; Atoh1 Cre+ and Nfiafl/fl; Atoh1 Cre- mice, high 
magnification images were taken of the same lobule of the cerebellum, using at least 
three biological replicates at each of the ages assessed. For quantification of granule 
neuron and proliferative markers (PAX6 and Ki67, respectively), three 200 m regions 
of the EGL were quantified for each section. This ensured more representative count of 
the EGL thickness across the whole lobule. 1 m-thick optical sections were viewed in 
Fiji, and the ‘cell counter’ plugin used to mark and quantify cells expressing respective 
markers in each fluorescent channel. Cells co-expressing markers (for example PAX6 
and Ki67) were also quantified this way, and DAPI was used to visualize the cell 
nucleus, to ensure accuracy, especially in areas of high cell density. 
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 Granule cell isolation 
To isolate GNPs from the cerebellum of P7 Nfix+/+ and Nfix-/- mice, and of P7 Nfiafl/fl; 
Atoh cre+ and Nfiafl/fl; Atoh cre- mice, we used a technique originally described by Lee 
and colleagues [28]. To do this, we isolated the cerebellum from wild-type and 
knockout mice, carefully removing the choroid plexus and meningeal tissue. Cerebellar 
tissue was dissociated using a 20 units/mL papain solution at 37°C for 15 mins. A single 
cell suspension was obtained by trituration with a serum-coated P1000 pipette tip and 
nuclear membranes were removed using an albumin-ovomucoid inhibitor gradient.  
GNPs were separated from other cells using a 30%-60% percoll gradient. GNPs were 
lysed using Trizol (Ambion). We next used an RNeasy miniprep kit (Qiagen) to isolate 
RNA from lyzed GNPs. 
 
RNA-seq analysis 
RNA-sequencing was performed on the samples using the Illumina NextSeq High 
Output system (Illumina; 150 base pair read length, paired-end reads). We isolated cells 
from three P7 Nfiafl/fl; Atoh cre- mice and three P7 Nfiafl/fl; Atoh cre+ mice. RNA-seq 
analysis was performed on RNA isolated from P7 cerebella as described previously. 
Briefly, the three replicates for each cohort were aligned by TopHat2 (v2.0.9) [29] to 
the Mus musculus, UCSC, mm10 reference transcriptome and FASTA annotation 
downloaded from the TopHat index and annotations page 
(https://ccb.jhu.edu/software/tophat/igenomes.shtml). Cufflinks (v2.1.1) [29] was used 
to assemble each replicate’s transcripts from the alignment file generated by TopHat. 
Cuffmerge was used to create a single assembly containing transcripts across all 
samples and replicates. Cuffdiff was run using the merged set of transcripts and the 
three replicate TopHat2 bam files from each sample. 
 
ChIP-seq 
ChIP-seq was performed on chromatin isolated from P7 wild-type C57Bl/6 GNPs as 
described [20]. We used antibodies against NFIA, NFIB or NFIX, for which specificity 
has previously been demonstrated [30]. For chromatin immunoprecipitation, litters of 
P7 pups were pooled for GNP isolation. Isolated GNPs were crosslinked with 1% 
formaldehyde for 10 minutes, then were quenched with glycine. Cells were lyzed in 
RIPA buffer supplemented with protease and phosphatase inhibitors (Roche) and 
sonicated with a Bioruptor (Diagenode) for six 15 minute intervals of 30 seconds on, 
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 30 seconds rest. Chromatin immunocomplexes were isolated with protein G-agarose 
beads (Roche), washed once for 5 minutes with buffers 1 through 4. Crosslinking was 
reversed by incubation with proteinase K (Roche) at 60 degrees overnight. DNA was 
isolated by phenol-chloroform extraction then incubated with RNAse A (Roche) for 30 
minutes before final cleanup with PCR columns (Qiagen). Sequencing libraries were 
constructed using the standard protocol for the NEB Next Ultra II DNA Library Prep 
Kit (New England BioLabs). Pooled libraries were sequenced on an Illumina 
HiSeq2000 (Illumina; 30 base pair single end read). 
 
ChIP-seq analysis 
Alignment was performed on the NFIA, NFIB and NFIX ChIP-seq data sets by bowtie2 
[31] to mm10. Unaligned reads and reads which aligned to multiple locations were 
removed leaving only uniquely mapped reads. MACS2 [32] was used to call narrow 
peaks with default parameters for both datasets. Each experiment contained two 
biological replicates and if both biological replicates shared a peak, it was recorded 
using the maximum boundaries of the supporting peaks to generate a merged set of 
peaks for each experiment. 
 
Annotation of ChIP-seq peaks 
A set of target genes was identified for NFIA, NFIB and NFIX by the following 
method. A promoter region was defined as 2,000 base pairs either side of a transcription 
start site. ChIP-seq binding sites located in a promoter region were annotated as 
proximal, while sites outside the promoter region but overlapping gene boundaries 
(transcription start to stop site) were labelled as genic. All remaining binding sites were 
labelled as distal. A binding site annotated as proximal was assigned to the nearest gene 
as a target while genic binding sites were assigned to the overlapping gene as a target. 
Distal binding sites are difficult to assign target genes to, as they are not necessarily 
regulating the nearest gene (by genomic distance) and proximal and genic sites are also 
capable of regulating a gene other than the nearest. While distal binding sites were also 
annotated to the nearest gene, where available, CisMapper was used to provide a 
secondary annotation to all sites, with resulting links filtered to a threshold of 0.05 [33]. 
Both the CisMapper annotation and nearest gene annotation were used where available. 
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 After identifying a gene target for each NFI binding site; the associated p-value from 
both the Nfix and Nfia RNA-seq differential expression analyses was recorded. Genes 
targeted by both NFIX and NFIA with a significant (p < 0.05) change in expression in 
both experiments were extracted. Genes showing coordinated positive or negative log 
fold change values across both experiments were selected to generate a putative set of 
genes under the control of NFIX and NFIA. Functional annotation was performed using 
DAVID (6.8) on target genes identified for NFIX, target genes identified for NFIA and 
target genes under the control of both NFIX and NFIA [34,35]. 
 
DNase I hypersensitivity analysis 
The DNase I hypersensitivity (DHS) data from Frank et al. 2015 (GEO: GSE60731) 
[36] was accessed for comparison to our transcriptomic and epigenomic profiling. 
These data contain called peaks from whole cerebellar tissue at P7 across three 
replicates. UCSC liftover was used to convert the mm9 files to mm10. Maximum 
boundaries of the supporting peaks were used to generate a merged DHS peak file, with 
the stipulation that peaks need to be shared by at least two replicates. Given that 
transcription factors preferentially bind to regions of accessible chromatin [37,38], 
DHS was used to extract NFI ChIP-seq peaks occurring in accessible regions. 
 
qPCR analysis of target genes 
RNA isolated from P7 GNPs from the cerebella of Nfix+/+, Nfix-/-, Nfiafl/fl; Atoh cre- or 
Nfiafl/fl; Atoh cre+  mice was used to prepare cDNA as described previously [9]. qPCR 
was performed with Quantifast SYBR Green (Qiagen) to detect gene expression levels 
of the genes identified in the RNA-seq analysis.  The primers for these genes are listed 
in Table 2. Gene expression was calculated using the 2−ΔΔCt method relative to the 
housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (Gapdh). All the 
samples were tested in triplicate within each experiment, and each experiment was 
repeated three times. qPCR was run using the QuantStudio 7 Flex Real-Time PCR 
system (Applied Biosystems, USA). 
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 Results 
 
NFIA and NFIX are co-expressed in the developing cerebellum 
NFI transcription factors are expressed across the developing and adult central nervous 
system. This includes the cerebellum, where NFIX is broadly expressed in the 
embryonic, postnatal and adult cerebellum [11,14], and where it regulates postnatal 
GNP differentiation [20]. NFIA is also critical for cerebellar development, and is 
expressed by GNPs [3,39,40]. Given the broad roles of NFI transcription factors in 
progenitor cell differentiation and that their protein expression overlaps in other brain 
regions [22,41], we first examined whether NFIA and NFIX were co-expressed in 
GNPs. We used co-immunofluorescence to analyse NFIX and NFIA expression across 
postnatal cerebellar development (P3, P7 and P15). We found that not only do GNPs in 
the EGL express NFIX, in agreement with our previous data [14], but we also found 
that these cells co-express NFIA (Fig. 1). Expression of Nfi family members is also 
seen within the embryonic rhombic lip (Supp. Fig. 1). 
 
NFIX expression is also detected within astrocytes within the emerging cerebellum 
[14]. We also labelled sections with an antibody against the astrocytic marker s100, 
and revealed that astrocytes within the IGL were immunoreactive for both NFIX and 
NFIA (Figs. 1 and 2). Moreover, we also found co-expression of NFIX and NFIA in 
Bergmann glia across these ages (Fig. 2). These analyses also revealed that granule 
neurons within the IGL also co-express NFIA and NFIX (Fig. 2). Finally, to verify the 
expression of NFIA in GNPs in the EGL, we performed co-immunofluorescence 
labelling with the progenitor cell marker, PAX6, and the proliferation marker Ki67. We 
found co-expression of NFIA and PAX6 within the EGL (Fig. 3A-D). Consistent with 
this, those proliferating cells in the EGL were also immunopositive for NFIA (Fig. 3E-
H). These data suggest that NFIA, in addition to driving the development of mature 
cerebellar neurons [3] may also contribute to GNP proliferation and differentiation. 
Collectively, these data demonstrate that NFIX and NFIA expression is overlapping in 
the developing cerebellum, with both transcription factors expressed by GNPs within 
the postnatal EGL. This led us to hypothesize that these transcription factors drive GNP 
differentiation in the postnatal cerebellum through regulation of common target genes. 
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 We sought to address this hypothesis via co-ordinate analysis of transcriptomic and 
epigenomic profiling datasets.   
 
Nfia cKO mice exhibit cerebellar abnormalities 
To determine the extent of overlap in function between NFI family members in 
cerebellar GNPs, we first sought to define the cohort of genes potentially under direct 
control of NFIA. To do this, we used a number of transcriptomic and epigenomic 
sequencing approaches, as well as utilising published DNase I hypersensitivity analyses 
detailing chromatin accessibility within the whole cerebellum at P7 [36]. As Nfia null 
mice on a C57Bl/6 are embryonic lethal [17], we employed a conditional Nfia allele 
(Nfiafl/fl) crossed to a Atoh1 cre line [27]. ATOH1 is expressed by progenitor cells 
within the nascent rhombic lip from E9 [25], and thus enables the removal of Nfia from 
these cells, as well as their progeny, including GNPs. We crossed the Nfiafl/fl line to the 
Atoh1 cre, and analyzed NFIA expression in GNPs within the postnatal cerebellum (P7) 
to validate ablation of Nfia. Immunolabelling with NFIA, and PAX6, revealed that 
NFIA expression was still present within cells at the border of the IGL (likely 
Bergmann glia) and within the IGL (Fig. 4). However, expression of NFIA was 
dramatically reduced within the EGL of Nfiafl/fl; Atoh1 cre+ mice (hereafter referred to 
as Nfia cKO mice). Interestingly, the ablation of Nfia was not fully penetrant within all 
of the lobes of the cerebellum, with GNPs within lobe X retaining a higher percentage 
of NFIA expression in comparison to lobes IV-V and VIII (Fig. 4 E-G). Incomplete 
ablation of a conditional Nfib allele was recently reported [7], suggesting that some 
cells may escape Cre-mediated depletion when this strategy is used to ablate Nfi family 
members. Despite this caveat, these data suggest that this is a valid model in which to 
study the role of NFIA in GNP biology.  
 
The role of NFIA in cerebellar development has been studied almost exclusively 
through the prism of the migration and maturation of postmitotic granule neurons 
[39,40,42]. In other regions of the nervous system, such as the developing 
hippocampus, Nfia-/- mice exhibit very similar phenotypes to Nfix-/- mice [8,10]. Given 
that a delay in the differentiation of GNPs is evident in the cerebellum of P15 Nfix-/- 
mice, we posited that a similar delay would be evident in Nfia cKO mice. We firstly 
analysed the gross morphology of the cerebellum in Nfia control and Nfia cKO mice. 
In contrast to Nfix-/- mice [20], haematoxylin staining at the level of the vermis revealed 
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 increased foliation in Nfia cKO mice in comparison to the controls, with lobe VI 
showing the clearest phenotype (Fig. 4H, I). Critically, however, PAX6 and Ki67 
labelling revealed there were more PAX6-positive cells within the EGL of the mutant 
at this age in comparison to controls (Fig. 4J-M), although the width of the EGL was 
comparable between mutant and control animals at this age (Fig. 4N). These data reveal 
that the retention of PAX6-expressing GNPs within the EGL is a shared phenotype 
between mice lacking either Nfia or Nfix.  
 
Transcriptomic profiling in GNPs reveals common gene targets of the NFI 
transcription factor family 
The co-expression of NFIA and NFIX (Fig. 1), coupled with the retention of GNPs 
within the EGL at P15 in both strains (Fig. 4; [20]) led us to posit that these transcription 
factors may regulate a common set of genes during GNP development. We have 
recently detailed transcriptomic profiling (RNA-seq) of Nfix-/- P7 GNPs, coupled with 
genome-wide analysis of NFIX binding (ChIP-seq; [20]). To determine the extent of 
shared targets between NFIA and NFIX, we repeated these analyses with NFIA. Firstly, 
we isolated P7 control and Nfia cKO GNPs, and performed RNA-seq. Analysis of these 
datasets revealed 2,267 genes as being significantly misregulated in the absence of Nfia 
(Fig. 5A; Supp. Table 1). Profiling of these data using the Gene Ontology and Pathway 
tool in DAVID [34,35] revealed a suite of different biological processes (e.g. cell 
adhesion; nervous system development), cellular components (e.g. membrane; 
proteinaceous extracelluar matrix) and molecular functions (e.g. calcium ion binding; 
integrin binding) (Fig. 5B; Supp. Table 2). 
 
To begin to refine this potential list of NFIA target genes, we performed ChIP-seq with 
an NFIA-specific antibody [30], using GNPs isolated from wildtype P7 cerebella. This 
profiling identified 14,025 NFIA binding peaks (Supp. Table 3). Cross correlation of 
these data with published chromatin accessibility data (DNase I hypersensitivity 
analysis) from P7 cerebellum [36] revealed that 12,539 of these NFIA binding peaks 
were in accessible regions of chromatin, whereas 1,486 were in closed regions of 
chromatin (Fig. 5C). Interestingly, the 12,539 NFIA ChIP-seq peaks in regions of 
accessible chromatin correlated to 7,870 NFIA-bound genes. When we took this cohort 
of 7,870 genes and compared it to the list of differentially regulated genes within Nfia 
cKO GNPs (Fig. 5A), we determined that 1,232 of the 2,267 genes that were 
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 significantly misregulated also contained a NFIA ChIP binding peak (Fig. 5D, Supp. 
Table 4), highlighting them as strong candidates for direct regulation by NFIA. 
Critically, DAVID analysis on this NFIA targetome of 1,232 genes identified many 
processes and functions previously identified in our analysis of Nfix-deficient GNPs 
[20], including many associated with neural function (e.g. axon guidance; neuronal cell 
body; cell adhesion; Fig. 5D; Supp. Table 2), indicative of potential shared functions 
of these transcription factors.  
 
Finally, to define whether or not NFA and NFIX regulate a common cohort of genes, 
we compared our refined NFIA targetome (1,232 targets; Fig. 5) with an analysis 
performed the same way but targeting NFIX (578 targets; [20]). This analysis revealed 
that 304 genes were high-confidence targets for both NFIA and NFIX in P7 GNPs, and, 
moreover, that more than 93% of these (283 out of 304) were co-ordinately regulated 
by both NFIA and NFIX (i.e. gene was downregulated in both Nfia cKO and Nfix-/- 
datasets, or upregulated in both; Fig. 6, Supp. Table 5).  
 
NFIB is also expressed by NFIX-expressing GNPs within the postnatal cerebellum 
(Supp. Fig. 1; [3]). Although we did not have access to the conditional strain crossed to 
a cerebellum-specific driver, we were able to gain insight into potential NFIB targets 
by performing ChIP-seq on isolated P7 GNPs using a specific NFIB antibody [30]. This 
analysis identified 24,950 NFIB ChIP-seq peaks (Supp. Table 3), of which 21,712 were 
in regions of accessible chromatin. Comparison of the accessible binding sites in each 
of the three NFI ChIP-seq datasets revealed that, of the 22,129 sites where at least one 
of NFIA, NFIB of NFIX had a binding event associated with it, 25% were bound by 
all three of these transcription factors (Supp. Fig. 3). Importantly, when we overlaid our 
NFIB ChIP-seq results onto our combined NFIA/NFIX targetome (Fig. 6A), the 
analysis that revealed that 282 of the 283 co-ordinately regulated NFIA/NFIX targets 
genes also possessed an associated NFIB ChIP-seq peak. DAVID analysis revealed that 
categories enriched in this dataset included axon, neuron projection, neuronal cell body 
and nervous system development (Fig. 6B). This cohort of genes potentially targeted 
by NFIA, NFIB and NFIX included a number of genes known to mediate cerebellar 
development, including Otx2, Epha4 and Nfix itself, as well as a number of factors 
whose role in cerebellar genesis is novel (Fig. 6C). Analysis of the proportion of NFI 
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 ChIP-seq peaks in proximal, genic or distal locations revealed that the majority of 
binding sites were in distal or genic locations (Fig. 6D). Finally, we validated six of 
these misregulated genes using qPCR, focussing on a mix of genes with known (Wnt5a) 
and novel (Kalrn, FoxO6, Id3, Gas6 and Etv5) roles in cerebellar development. We 
confirmed that the levels of Kalrn, Wnt5a, FoxO6, Id3, Gas6 and Etv5 mRNAs were 
significantly higher in both Nfia-/- and Nfix-/- GNPs at P7 (Fig. 6E-J). 
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 Discussion 
The NFI proteins are transcription factors that exhibit conserved N-terminal DNA-
binding domains, as well as a common DNA recognition motif [43]. Within the nascent 
mouse nervous system, neural stem and progenitor populations have been shown to co-
express individual NFI family members [1], and, moreover, individual Nfi knockout 
mice exhibit broadly similar cortical phenotypes [4,8,10,12]. However, the extent to 
which these factors share common regulatory targets has not been investigated 
thoroughly, apart from a recent study that used RNA-seq in developing cortical tissue 
from both Nfia-/- and Nfib-/- mice to investigate potential overlap in gene regulation [30]. 
Here, we use a range of transcriptomic approaches to more clearly demarcate common 
targets of the broader NFI family, demonstrating that NFIA, NFIB and NFIX likely 
regulate a common suite of genes to promote the differentiation of GNPs within the 
postnatal cerebellum.  
 
A coherent theme emerging from many of the studies on NFI function is their role in 
promoting differentiation and maturation. Within the cerebellum, NFIX is required for 
the timely differentiation of GNPs within the postnatal EGL [20], and NFIA has been 
reported to regulate a program of gene expression required for the migration and 
maturation of granule neurons [3,39,42]. Within the broader central nervous system, 
NFIB has also been shown to regulate neural stem cell differentiation within the 
cerebral cortex [5], a function also reported for NFIA and NFIX [44]. Outside the 
nervous system, NFIs have also been shown to regulate differentiation; for instance, 
NFIX has been shown to contribute to skeletal myogenesis by promoting a switch from 
embryonic to fetal-specific gene programs [45,46]. In line with this, our transcriptomic 
analyses suggest that the NFI family are key mediators of GNP differentiation within 
the postnatal cerebellum. Indeed, our DAVID analysis of the 282 genes we identified 
as potential NFI targets included a high proportion of terms associated with the nervous 
system (Supp. Table 2). For instance, of the 20 most enriched terms for Cellular 
Component in the DAVID analysis, 10 were directly associated with the nervous 
system (e.g. Neuron projection, Axon, Dendrite, Neuronal cell body), with a further 
seven associated with the plasma membrane and extracellular matrix, both of which are 
central to mature neural biology. These data reinforce the role for NFIs in promoting 
neural differentiation within the cerebellum. 
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 The targetome identified for the NFI family within postnatal GNPs includes a number 
of specific factors that highlights their role in promoting differentiation. For example, 
Wnt5a, a factor known to regulate neural progenitor proliferation within the cerebellum 
[47], is upregulated in the absence of either Nfia or Nfix, consistent with the phenotype 
for delayed GNP differentiation in these strains. Conversely, factors known to promote 
neural differentiation, such as Neurod1, Neurod4 and Nfix were reduced, as was the 
neuronal marker Rbfox3. In addition to these individual factors identified as likely 
targets of co-regulation by the NFI family, a novel theme to arise from this multi-
faceted analysis was that NFIs may regulate cohorts of genes related to similar 
processes. For example, within the NFI targetome we identified 6 collagen genes, 13 
genes encoding potassium channel or glutamate receptor subunits, and a range of 
factors related to axon guidance (e.g. Slit1, Robo1, Epha4, Epha5, Epha8). These 
findings may point to previously unrecognised roles for the NFI family. For example, 
NFIs are widely expressed in neurons [30], but their role in these cells is unknown. The 
identification of potassium channel and glutamate receptor subunit genes in our target 
list suggests that NFIs may contribute to the process of neurotransmission. Looking 
forwards, more sophisticated approaches using multiple conditional Nfi alleles crossed 
to cell-type specific drivers (e.g. CamK2a CreERT2) may enable the role of the NFI 
family in specific functions such as neurotransmission to be investigated.  
 
Our approach to determine shared NFI target genes also highlighted a number of other 
interesting elements of NFI biology whose significance has not been previously 
appreciated. For example, partitioning of reported ChIP-seq peaks for each of NFIA, 
NFIB and NFIX into defined regions (proximal, genic or distal) revealed that only 3-
6% of binding peaks were in proximal regions (defined as  2000 base pairs from a 
transcriptional start site), whereas approximately 44% were found in genic regions 
(sites outside the promoter regions but overlapping gene boundaries), with the 
remaining 50% of ChIP-seq peaks within distal regions. This implicates a large 
portion of NFI binding may be related to interactions with distal enhancers. The role of 
NFIs in distal binding is at this stage unclear, but a recent report of NFIB mediating 
chromatin accessibility in small cell lung cancer [48] may point to this family playing 
a much broader role in transcriptional architecture than regulating promoter activity. In 
future, the role of NFIs in mediating enhancer activity could be investigated using 
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 techniques including luciferase assays, whereas chromatin interaction analysis by 
paired-end tag sequencing (ChIA-PET) could be used to interrogate the role of NFIs in 
mediating long-range chromatin interactions in vivo. Our findings also suggest that 
numerous NFI binding sites can be found in regions of closed chromatin. Exactly what 
this means is, at this stage, unclear, but the possibility of the NFIs acting to promote 
chromatin accessibility in a developmental context, in addition to that seen in small cell 
lung cancer [48], is a tantalising possibility. One way in which could be analysed would 
be to combine ChIP-seq on GNPs at different developmental stages with DNase I 
hypersensitivity analyses at the same age. From this, the capacity of NFIs to bind to, 
and potentially open, regions of previously compressed chromatin, could be 
ascertained.  
 
Our analyses also raise a number of questions. For instance, our analysis revealed a 
high proportion of ChIP-seq peaks that were common between NFIA, NFIB and NFIX. 
One interpretation of this could be that the NFI proteins promiscuously form 
heterodimers to bind DNA. Although heterodimerization of the NFIs has long been 
known to occur in vitro [49], its prevalence in vivo is less clear. NFIA and NFIB were 
recently reported to co-immunoprecipitate in lysates from embryonic day 13 mouse 
cerebral cortical tissue [22]; our data suggest that heterodimerization between NFIA, 
NFIB and NFIX may be a common theme in the way this family regulates development, 
a theory supported by the similar neural phenotypes observed following knockout of 
individual Nfi genes [4,8,10]. Despite this, our analyses revealed that the role of Nfia 
and Nfix may not be entirely overlapping. Indeed, there were a number of genes 
identified as NFIA targets that were not identified as NFIX targets (Fig. 6A). Although 
care needs to be taken when interpreting the differences in our targetomes, as 
experimental conditions may underlie this (e.g. variations in antibody affinity for ChIP-
seq), the fact that the Nfia cKO mutant cerebellum exhibited increased foliation (Fig. 
4I), whereas the Nfix mutant does not [20], provides a morphological indication of some 
distinct functions between these transcription factors. Potential differences in the 
targets of NFIA and NFIX (and, potentially, NFIB) could relate to the capacity of 
different family members to bid to co-factors. The C-terminal region of each family 
member is less well conserved [43], indicative of potentially different affinity for 
protein-binding partners. There is surprisingly little known regarding other proteins that 
the NFIs interact with. One recent study performed in HEK298T cells used tandem 
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 affinity purification followed by mass spectrometry to reveal an interaction between 
NFIX and CREB1 [50] In future, the use of sophisticated approaches like this, in 
conjunction with specific cellular populations like GNPs, could be ways in which 
proteins that interact with NFIs could be identified. In conclusion, our study has 
enhanced our understanding of neural development specifically, and NFI biology more 
broadly, using molecular and transcriptomic assays to reveal that the NFI family share 
a large number of targets during the differentiation of the postnatal cerebellum.  
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 Tables 
 
 
Table 1: Antibodies used in this study. 
 
 
Gene Forward Rev 
Id3 CTGTCGGAACGTAGCCTGG GTGGTTCATGTCGTCCAAGAG 
Wnt5a CAACTGGCAGGACTTTCTCA
A 
CCTTCTCCAATGTACTGCATG
TG 
Gas6 GACCCCGAGACGGAGTATTT
C 
TGCACTGGTCAGGCAAGTTC 
Kalrn AAGACCTACGGAAACTTGTG
ACG 
CCCCGCATGTCGATGATGAC 
Etv5 TCAGTCTGATAACTTGGTGCT
TC 
CTACAGGACGACAACTCGGA
G 
FoxO6 TCATGGACAGTGACGAAATG
G 
ACCCAGCTCTGGTTAGGGG 
Gapdh GCACAGTCAAGGCCGAGAAT 
 
GCCTTCTCCATGGTGGTGAA 
 
 
Table 2: qPCR primers used in this study. 
 
 
  
Antibody Source 
species 
Company Catalogue 
number 
Dilution 
used 
NFIX Mouse Sigma-
Aldrich 
SAB1401263 1/200 
NFIA Rabbit Sigma-
Aldrich 
HPA008884 1/400 
NFIB Rabbit Sigma-
Aldrich 
HPA003956 1/400 
S100-Alexa647 Rabbit ABCAM AB196175 1/400 
PAX6 Rabbit DAKO Z0334 1/400 
Ki67 Mouse BD 
Pharmigen 
550609 1/400 
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 Figure legends 
 
Figure 1. NFIX and NFIA are co-expressed by various cellular populations in the 
developing mouse postnatal cerebellum. 
Sagittal cerebellar sections showing the nuclear marker DAPI (blue), NFIX (green), 
NFIA (red) and s100 expression (magenta) in P3 (A-E), P7 (F-J) and P15 (K-O) wild-
type mice. NFIX and NFIA are co-expressed by GNPs within the external granule layer 
(EGL; arrows in B-E, G-J, L-O). NFIX and NFIA are also co-expressed by s100-
positive glial cells (double-headed arrows in B-E, G-J, L-O). These transcription factors 
are also expressed by cells leaving the EGL (arrowheads in G-J, L-O); these are likely 
immature neurons migrating to the internal granule layer (IGL). ML = molecular layer. 
Scale bar (in A): 20 m. 
 
Figure 2. NFIX and NFIA are co-expressed in Bergmann glia and astrocytes in the 
developing cerebellum. 
High magnification sagittal cerebellar sections showing the nuclear marker DAPI 
(blue), NFIX (green), NFIA (red) and s100 expression (magenta) in P3 (A-J), P7 (K-
T) and P15 (U-DD) wild-type mice. NFIX and NFIA are co-expressed in IGL white 
matter astrocytes at these ages (arrows in B-D, L-O, V-Y). NFIX and NFIA are also 
co-expressed in Bergmann glia at P3, P7 and P15 (arrowheads in G-J, Q-T, AA-DD). 
The NFI factors are also co-expressed in mature granule neurons within the IGL 
(double-headed arrows in B-D, L-O, V-Y). IGL = inner granule layer, ML = molecular 
layer. Scale bar (in A): 10 m. 
 
Figure 3. PAX6-positive EGL progenitors express NFIA. 
(A-D) Expression of the nuclear marker DAPI (blue, A), PAX6 (green, B), and NFIA 
(red, C) reveals NFIA expression in PAX6-positive EGL progenitor cells (arrows in B-
D). NFIA is also expressed in IGL granule neurons (double-headed arrows in B-D) and 
migrating cells exiting the EGL (arrowheads in B-D). (E-H) Expression of the nuclear 
marker DAPI (blue, E), Ki67 (green, F), and NFIA (red, G) also shows NFIA 
expression in proliferating EGL progenitor cells (arrows in F-H). EGL = external 
granule layer, ML = molecular layer, IGL = inner granule layer. Scale bar (in A): 20 
m. 
190 APPENDIX B. NFIX AND NFIA PAPER
  
Figure 4. Conditional ablation of NFIA from EGL progenitors using Atoh1-cre. 
(A) Sagittal cerebellar section in a P7 Nfiafl/fl; Atoh1-cre+ mouse (Nfia cKO). Co-
expression of PAX6 and NFIA was examined in different cerebellar lobes  and is shown 
in the respective high-magnification panels (B-D).  (B-D) DAPI (blue), PAX6 (green) 
and NFIA (red) expression revealed that cells at the margin of the molecular layer and 
IGL expressed NFIA (arrowheads in B-D). Importantly, the majority of cells in the 
EGL of lobes VI and IX were immunopositive for PAX6, but did not express NFIA 
(arrows in B, C). Within lobe X, there were more cells within the EGL that had not 
undergone Cre-mediated ablation, and hence retained NFIA expression (double 
arrowheads in D). (E-G) Quantification of the percentage of cells within the EGL of 
lobes VI (E), IX (F) and X (G) that expressed NFIA. (H, I) Hematoxylin staining of 
Nfia control and Nfia cKO cerebella at P15. The cerebellum of mice lacking Nfia was 
dysmorphic, with elevated foliation of the cerebellar lobes evident. Expression of 
DAPI, PAX6 and Ki67 in Nfia control (J) and Nfia cKO (K) cerebella at P15 revealed 
significantly more PAX6-positive cells within the EGL of the mutant (L), although the 
number of proliferating cells (M), and the width of the EGL (N), was not significantly 
different between sample groups . * p < 0.05, t-test. Scale bar (in A): 250 m, A; 400 
m, H, I; 30 m, B-D; 25 m, J, K. 
 
Figure 5. Transcriptomic profiling of GNPs in Nfiafl/fl; Atoh1-cre+ mice.  
(A) Volcano plot of misregulated genes following RNA-seq in P7 Nfia cKO mice GNPs 
in comparison to Nfia controls. Red dots represent the 2,267 genes misregulated in Nfia 
mutant GNPs. (B) Gene Ontology (DAVID 6.8) analysis identifying Biological 
processes, Cellular components, KEGG pathways and Molecular functions as 
misregulated in P7 Nfia cKO mice GNPs in comparison to controls. Only the top five 
items for each category are shown; full details can be found in Supp. Table 2. (C) To 
narrow the list of potential NFIA target genes, we performed ChIP-seq on wild-type P7 
GNPs with an anti-NFIA antibody. This revealed 14,025 NFIA binding peaks (green 
circle). We compared this with a published DNase I hypersensitivity analysis of P7 
cerebellar tissue (red circle [36]). Of the 14,025 NFIA ChIP peaks, 12,539 were in 
regions of accessible chromatin. (D) We then compared the 7,870 genes (yellow circle) 
associated with these 12,539 NFIA peaks with our RNA-seq data (blue circle). This 
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 analysis identified 1,232 potential direct NFIA target genes. (E) DAVID Gene 
Ontology analysis was performed again following refinement of our target gene list. 
The top five categories for the NFIA targetome from each of Biological processes, 
Cellular components, KEGG pathways and Molecular functions identified are shown; 
full details can be found in Supp. Table 2. 
 
Figure 6. Identification of coregulated targets of NFI family members in GNP 
development.   
(A) Cross comparison of our NFIA targetome (red circle) with a similar analysis 
performed against NFIX (blue circle; [20]) revealed that there were 304 coregulated 
genes (i.e. identified in both datasets). Of these, 283 demonstrated coordinated 
regulation (i.e. either upregulated in RNA-seq experiments from P7 GNPs in both Nfia 
cKO GNPs and Nfix-deficient GNPs, or downregulated in both). Of these 283 
coordinated targets, 282 also possessed an associated NFIB ChIP-seq peak (Supp. 
Table 3), indicative of shared regulatory roles for all three NFI family members in GNP 
biology. (B) DAVID Gene Ontology analysis was performed on these 282 genes. The 
top five categories from each of Biological processes, Cellular components, KEGG 
pathways and Molecular functions identified are shown; full details can be found in 
Supp. Table 2. (C) Curated list of genes from DAVID analysis (Biological Processes), 
highlighting downstream NFI targets (upwards pointing arrow denotes mRNA 
upregulation in mutant GNPs, downwards pointing arrow denotes mRNA 
downregulation in mutant GNPs). (D) Analysis of ChIP-seq binding events for NFIA, 
NFIB and NFIX, showing the proportion of distal, promoter and genic binding. (E-J) 
Validation of potential NFI targets using qPCR. * p < 0.05; ** p < 0.01; *** p < 0.001, 
t-test. 
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Figure B.1: Figure 1. NFIX and NFIA are co-expressed by various cellular populations in the
developing mouse postnatal cerebellum. Sagittal cerebellar sections showing the nuclear marker DAPI
(blue), NFIX (green), NFIA (red) and s100β expression (magenta) in P3 (A-E), P7 (F-J) and P15
(K-O) wild-type mice. NFIX and NFIA are co-expressed by GNPs within the external granule layer
(EGL; arrows in B-E, G-J, L-O). NFIX and NFIA are also co-expressed by s100β -positive glial cells
(double-headed arrows in B-E, G-J, L-O). These transcription factors are also expressed by cells
leaving the EGL (arrowheads in G-J, L-O); these are likely immature neurons migrating to the internal
granule layer (IGL). ML = molecular layer. Scale bar (in A): 20 µm.
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Figure B.2: Figure 2. NFIX and NFIA are co-expressed in Bergmann glia and astrocytes in the
developing cerebellum. High magnification sagittal cerebellar sections showing the nuclear marker
DAPI (blue), NFIX (green), NFIA (red) and s100β expression (magenta) in P3 (A-J), P7 (K-T) and
P15 (U-DD) wild-type mice. NFIX and NFIA are co-expressed in IGL white matter astrocytes at these
ages (arrows in B-D, L-O, V-Y). NFIX and NFIA are also co-expressed in Bergmann glia at P3, P7
and P15 (arrowheads in G-J, Q-T, AA-DD). The NFI factors are also co-expressed in mature granule
neurons within the IGL (double-headed arrows in B-D, L-O, V-Y). IGL = inner granule layer, ML =
molecular layer. Scale bar (in A): 10 µm.
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Figure B.3: Figure 3. PAX6-positive EGL progenitors express NFIA. (A-D) Expression of the nuclear
marker DAPI (blue, A), PAX6 (green, B), and NFIA (red, C) reveals NFIA expression in PAX6-positive
EGL progenitor cells (arrows in B-D). NFIA is also expressed in IGL granule neurons (double-headed
arrows in B-D) and migrating cells exiting the EGL (arrowheads in B-D). (E-H) Expression of the
nuclear marker DAPI (blue, E), Ki67 (green, F), and NFIA (red, G) also shows NFIA expression in
proliferating EGL progenitor cells (arrows in F-H). EGL = external granule layer, ML = molecular
layer, IGL = inner granule layer. Scale bar (in A): 20 µm.
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Figure B.4: Figure 4. Conditional ablation of NFIA from EGL progenitors using Atoh1-cre. (A)
Sagittal cerebellar section in a P7 Nfiafl/fl; Atoh1-cre+ mouse (Nfia cKO). Co-expression of PAX6 and
NFIA was examined in different cerebellar lobes and is shown in the respective high-magnification
panels (B-D). (B-D) DAPI (blue), PAX6 (green) and NFIA (red) expression revealed that cells at the
margin of the molecular layer and IGL expressed NFIA (arrowheads in B-D). Importantly, the majority
of cells in the EGL of lobes VI and IX were immunopositive for PAX6, but did not express NFIA
(arrows in B, C). Within lobe X, there were more cells within the EGL that had not undergone Cre-
mediated ablation, and hence retained NFIA expression (double arrowheads in D). (E-G) Quantification
of the percentage of cells within the EGL of lobes VI (E), IX (F) and X (G) that expressed NFIA.
(H, I) Hematoxylin staining of Nfia control and Nfia cKO cerebella at P15. The cerebellum of mice
lacking Nfia was dysmorphic, with elevated foliation of the cerebellar lobes evident. Expression of
DAPI, PAX6 and Ki67 in Nfia control (J) and Nfia cKO (K) cerebella at P15 revealed significantly
more PAX6-positive cells within the EGL of the mutant (L), although the number of proliferating cells
(M), and the width of the EGL (N), was not significantly different between sample groups . * p ¡ 0.05,
t-test. Scale bar (in A): 250 µm, A; 400 µm, H, I; 30 µm, B-D; 25 µm, J, K.
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Figure B.5: Figure 5. Transcriptomic profiling of GNPs in Nfiafl/fl; Atoh1-cre+ mice. (A) Volcano
plot of misregulated genes following RNA-seq in P7 Nfia cKO mice GNPs in comparison to Nfia
controls. Red dots represent the 2,267 genes misregulated in Nfia mutant GNPs. (B) Gene Ontology
(DAVID 6.8) analysis identifying Biological processes, Cellular components, KEGG pathways and
Molecular functions as misregulated in P7 Nfia cKO mice GNPs in comparison to controls. Only
the top five items for each category are shown; full details can be found in Supp. Table 2. (C) To
narrow the list of potential NFIA target genes, we performed ChIP-seq on wild-type P7 GNPs with an
anti-NFIA antibody. This revealed 14,025 NFIA binding peaks (green circle). We compared this with
a published DNase I hypersensitivity analysis of P7 cerebellar tissue (red circle [36]). Of the 14,025
NFIA ChIP peaks, 12,539 were in regions of accessible chromatin. (D) We then compared the 7,870
genes (yellow circle) associated with these 12,539 NFIA peaks with our RNA-seq data (blue circle).
This analysis identified 1,232 potential direct NFIA target genes. (E) DAVID Gene Ontology analysis
was performed again following refinement of our target gene list. The top five categories for the NFIA
targetome from each of Biological processes, Cellular components, KEGG pathways and Molecular
functions identified are shown; full details can be found in Supp. Table 2.
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Figure B.6: Figure 6. Identification of coregulated targets of NFI family members in GNP development.
(A) Cross comparison of our NFIA targetome (red circle) with a similar analysis performed against
NFIX (blue circle; [20]) revealed that there were 304 coregulated genes (i.e. identified in both datasets).
Of these, 283 demonstrated coordinated regulation (i.e. either upregulated in RNA-seq experiments
from P7 GNPs in both Nfia cKO GNPs and Nfix-deficient GNPs, or downregulated in both). Of
these 283 coordinated targets, 282 also possessed an associated NFIB ChIP-seq peak (Supp. Table 3),
indicative of shared regulatory roles for all three NFI family members in GNP biology. (B) DAVID
Gene Ontology analysis was performed on these 282 genes. The top five categories from each of
Biological processes, Cellular components, KEGG pathways and Molecular functions identified are
shown; full details can be found in Supp. Table 2. (C) Curated list of genes from DAVID analysis
(Biological Processes), highlighting downstream NFI targets (upwards pointing arrow denotes mRNA
upregulation in mutant GNPs, downwards pointing arrow denotes mRNA downregulation in mutant
GNPs). (D) Analysis of ChIP-seq binding events for NFIA, NFIB and NFIX, showing the proportion
of distal, promoter and genic binding. (E-J) Validation of potential NFI targets using qPCR. * p ¡ 0.05;
** p ¡ 0.01; *** p ¡ 0.001, t-test.
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Table C.1: Atoh1 significant DAVID terms
Nearest Gene CisMapper Common
GO:0005737 cytoplasm 8.5E-03 GO:0005515 protein binding 1.8E-13 GO:0005515 protein binding 3.6E-10
GO:0005874 microtubule 8.9E-03 GO:0007275 multicellular organ-
ism development
9.2E-09 GO:0007399 nervous system de-
velopment
5.9E-10
GO:0005634 nucleus 1.2E-02 GO:0016020 membrane 3.5E-08 GO:0045202 synapse 1.0E-07
GO:0005515 protein binding 1.7E-02 GO:0007411 axon guidance 1.2E-07 GO:0030054 cell junction 2.5E-07
GO:0007399 nervous system de-
velopment
1.6E-07 GO:0043005 neuron projection 2.1E-06
GO:0005737 cytoplasm 2.0E-07 GO:0043025 neuronal cell body 1.7E-05
mmu04360:Axon guidance 5.3E-07 GO:0014069 postsynaptic den-
sity
2.6E-05
GO:0043005 neuron projection 2.4E-06 GO:0016020 membrane 3.0E-05
GO:0043025 neuronal cell body 2.8E-06 GO:0007420 brain development 3.4E-05
GO:0031175 neuron projection
development
1.4E-05 GO:0007155 cell adhesion 3.8E-05
GO:0030154 cell differentiation 3.5E-05 GO:0030154 cell differentiation 5.6E-05
GO:0001764 neuron migration 4.1E-05 mmu05200:Pathways in cancer 6.1E-05
GO:0014069 postsynaptic den-
sity
6.5E-05 GO:0002062 chondrocyte differ-
entiation
6.8E-05
GO:0005634 nucleus 8.6E-05 GO:0045944 positive regulation
of transcription from RNA poly-
merase II promoter
1.5E-04
GO:0007155 cell adhesion 2.6E-04 GO:0045211 postsynaptic mem-
brane
1.7E-04
GO:0030424 axon 2.8E-04 GO:0030425 dendrite 1.9E-04
GO:0030425 dendrite 3.3E-04 GO:0030424 axon 1.9E-04
GO:0030426 growth cone 4.3E-04 GO:0007275 multicellular organ-
ism development
3.1E-04
GO:0030054 cell junction 7.1E-04 GO:0005737 cytoplasm 3.1E-04
GO:0005509 calcium ion bind-
ing
8.0E-04 GO:0005604 basement mem-
brane
3.4E-04
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GO:0000122 negative regulation
of transcription from RNA poly-
merase II promoter
9.8E-04 GO:0005578 proteinaceous ex-
tracellular matrix
6.5E-04
GO:0042995 cell projection 1.0E-03 mmu04390:Hippo signaling
pathway
2.5E-03
GO:0045211 postsynaptic mem-
brane
1.1E-03 GO:0000122 negative regulation
of transcription from RNA poly-
merase II promoter
2.6E-03
GO:0005794 Golgi apparatus 1.2E-03 GO:0008021 synaptic vesicle 2.8E-03
GO:0043204 perikaryon 1.8E-03 GO:0044295 axonal growth cone 3.2E-03
GO:0045202 synapse 1.9E-03 GO:0001764 neuron migration 5.4E-03
GO:0006351 transcription,
DNA-templated
2.3E-03 GO:0007411 axon guidance 5.6E-03
GO:0005667 transcription factor
complex
3.8E-03 mmu04360:Axon guidance 9.7E-03
GO:0002116 semaphorin recep-
tor complex
4.1E-03 mmu04151:PI3K-Akt signaling
pathway
1.5E-02
GO:0048471 perinuclear region
of cytoplasm
1.1E-02 GO:0042995 cell projection 1.5E-02
GO:0005925 focal adhesion 1.1E-02 mmu05205:Proteoglycans in
cancer
1.7E-02
GO:0043197 dendritic spine 1.2E-02 GO:0005829 cytosol 2.0E-02
GO:0005911 cell-cell junction 1.3E-02 GO:0031594 neuromuscular
junction
2.1E-02
GO:0070062 extracellular exo-
some
1.7E-02 GO:0001725 stress fiber 2.5E-02
GO:0046983 protein dimeriza-
tion activity
2.0E-02 GO:0043197 dendritic spine 2.8E-02
GO:0043565 sequence-specific
DNA binding
2.0E-02 GO:0007269 neurotransmitter
secretion
2.9E-02
GO:0030334 regulation of cell
migration
2.2E-02 GO:0001701 in utero embryonic
development
2.9E-02
GO:0003714 transcription core-
pressor activity
2.4E-02 GO:0001525 angiogenesis 3.0E-02
GO:0030175 filopodium 2.4E-02 GO:0035556 intracellular signal
transduction
3.2E-02
GO:0003677 DNA binding 2.5E-02 GO:0007409 axonogenesis 3.3E-02
GO:0007612 learning 2.6E-02 GO:0060291 long-term synaptic
potentiation
3.3E-02
GO:0010976 positive regulation
of neuron projection develop-
ment
2.6E-02 GO:0045893 positive regulation
of transcription, DNA-templated
3.4E-02
GO:0015629 actin cytoskeleton 2.6E-02 GO:0045599 negative regulation
of fat cell differentiation
3.4E-02
GO:0005856 cytoskeleton 2.7E-02 mmu04724:Glutamatergic
synapse
3.8E-02
GO:0032587 ruffle membrane 2.7E-02 mmu04512:ECM-receptor inter-
action
4.1E-02
GO:0030496 midbody 2.8E-02 GO:0047485 protein N-terminus
binding
4.1E-02
205
GO:0051015 actin filament bind-
ing
2.9E-02 GO:0000978 RNA polymerase II
core promoter proximal region
sequence-specific DNA binding
4.2E-02
GO:0016301 kinase activity 3.0E-02 mmu04510:Focal adhesion 4.2E-02
mmu04014:Ras signaling path-
way
3.8E-02 GO:0033268 node of Ranvier 4.5E-02
GO:0005578 proteinaceous ex-
tracellular matrix
4.7E-02 GO:0043234 protein complex 4.5E-02
GO:0045944 positive regulation
of transcription from RNA poly-
merase II promoter
4.8E-02 GO:0001077 transcriptional acti-
vator activity, RNA polymerase
II core promoter proximal region
sequence-specific binding
4.6E-02
mmu04015:Rap1 signaling path-
way
4.9E-02
Table C.2: Nfia significant DAVID terms
Nearest Gene CisMapper Common
GO:0005578 proteinaceous ex-
tracellular matrix
4.3E-11 GO:0016020 membrane 6.7E-06 GO:0045202 synapse 1.5E-13
GO:0016020 membrane 1.6E-09 GO:0045202 synapse 1.6E-02 GO:0005578 proteinaceous ex-
tracellular matrix
2.1E-12
GO:0005886 plasma membrane 8.4E-09 GO:0016020 membrane 1.9E-11
GO:0005576 extracellular region 4.3E-08 GO:0043025 neuronal cell body 2.2E-11
GO:0009986 cell surface 1.3E-07 GO:0030054 cell junction 3.5E-10
GO:0005515 protein binding 1.4E-07 GO:0009986 cell surface 9.9E-09
GO:0007155 cell adhesion 6.2E-07 GO:0007155 cell adhesion 6.0E-08
GO:0030154 cell differentiation 1.3E-05 GO:0005515 protein binding 7.3E-08
GO:0007275 multicellular organ-
ism development
1.4E-05 GO:0030425 dendrite 7.7E-08
GO:0030424 axon 3.6E-05 GO:0031012 extracellular ma-
trix
8.5E-08
GO:0043005 neuron projection 3.7E-05 GO:0043005 neuron projection 9.9E-08
GO:0030335 positive regulation
of cell migration
1.7E-04 GO:0042734 presynaptic mem-
brane
1.1E-07
GO:0031012 extracellular ma-
trix
2.0E-04 GO:0005604 basement mem-
brane
2.9E-07
mmu04360:Axon guidance 2.5E-04 GO:0030424 axon 3.0E-07
mmu04512:ECM-receptor inter-
action
2.8E-04 GO:0014069 postsynaptic den-
sity
5.2E-07
GO:0005911 cell-cell junction 4.0E-04 GO:0005576 extracellular region 3.3E-06
GO:0043025 neuronal cell body 4.3E-04 GO:0007399 nervous system de-
velopment
5.3E-06
GO:0009897 external side of
plasma membrane
4.7E-04 GO:0043197 dendritic spine 7.8E-06
mmu04510:Focal adhesion 5.0E-04 GO:0005886 plasma membrane 1.6E-05
GO:0005615 extracellular space 1.4E-03 GO:0005509 calcium ion bind-
ing
2.0E-05
GO:0007399 nervous system de-
velopment
2.3E-03 mmu04713:Circadian entrain-
ment
2.4E-05
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GO:0007411 axon guidance 2.7E-03 mmu04512:ECM-receptor inter-
action
2.7E-05
GO:0030054 cell junction 2.8E-03 GO:0043204 perikaryon 4.5E-05
GO:0016477 cell migration 3.0E-03 mmu04720:Long-term potentia-
tion
5.1E-05
GO:0005737 cytoplasm 3.0E-03 mmu04724:Glutamatergic
synapse
5.3E-05
GO:0005509 calcium ion bind-
ing
3.2E-03 GO:0005516 calmodulin binding 5.3E-05
GO:0005604 basement mem-
brane
3.4E-03 mmu04911:Insulin secretion 6.7E-05
GO:0005887 integral component
of plasma membrane
3.7E-03 mmu04921:Oxytocin signaling
pathway
1.0E-04
GO:0005581 collagen trimer 4.3E-03 GO:0060076 excitatory synapse 1.5E-04
GO:0030027 lamellipodium 4.5E-03 mmu04261:Adrenergic signal-
ing in cardiomyocytes
1.9E-04
GO:0005518 collagen binding 4.7E-03 mmu04510:Focal adhesion 2.0E-04
GO:0045211 postsynaptic mem-
brane
7.8E-03 mmu05200:Pathways in cancer 2.1E-04
GO:0042995 cell projection 8.0E-03 GO:0045211 postsynaptic mem-
brane
2.3E-04
mmu05412:Arrhythmogenic
right ventricular cardiomyopathy
(ARVC)
8.5E-03 GO:0044295 axonal growth cone 2.8E-04
GO:0048812 neuron projection
morphogenesis
9.1E-03 GO:0043195 terminal bouton 2.8E-04
GO:0030425 dendrite 9.3E-03 GO:0030315 T-tubule 2.9E-04
GO:0005794 Golgi apparatus 9.4E-03 GO:0042383 sarcolemma 4.1E-04
GO:0001666 response to hy-
poxia
9.5E-03 mmu04010:MAPK signaling
pathway
4.1E-04
mmu04151:PI3K-Akt signaling
pathway
9.7E-03 GO:0043198 dendritic shaft 4.2E-04
mmu04024:cAMP signaling
pathway
1.0E-02 mmu04728:Dopaminergic
synapse
4.4E-04
mmu05414:Dilated cardiomy-
opathy
1.0E-02 mmu05146:Amoebiasis 5.6E-04
mmu05200:Pathways in cancer 1.0E-02 mmu04723:Retrograde endo-
cannabinoid signaling
8.4E-04
GO:0007507 heart development 1.1E-02 GO:0007269 neurotransmitter
secretion
8.6E-04
GO:0007157 heterophilic cell-
cell adhesion via plasma mem-
brane cell adhesion molecules
1.1E-02 mmu05414:Dilated cardiomy-
opathy
8.9E-04
GO:0042383 sarcolemma 1.1E-02 GO:0007420 brain development 1.1E-03
GO:0045121 membrane raft 1.2E-02 mmu04360:Axon guidance 1.1E-03
GO:0045202 synapse 1.2E-02 GO:0048471 perinuclear region
of cytoplasm
1.1E-03
GO:0070062 extracellular exo-
some
1.2E-02 GO:0001525 angiogenesis 1.3E-03
GO:0043292 contractile fiber 1.4E-02 mmu04020:Calcium signaling
pathway
1.3E-03
207
GO:0048471 perinuclear region
of cytoplasm
1.4E-02 GO:0030198 extracellular ma-
trix organization
1.4E-03
mmu05205:Proteoglycans in
cancer
1.9E-02 GO:0042391 regulation of mem-
brane potential
1.5E-03
GO:0005925 focal adhesion 2.2E-02 mmu04151:PI3K-Akt signaling
pathway
1.7E-03
GO:0005178 integrin binding 2.6E-02 GO:0008076 voltage-gated
potassium channel complex
2.5E-03
GO:0048663 neuron fate com-
mitment
2.8E-02 mmu04916:Melanogenesis 2.5E-03
GO:0050998 nitric-oxide syn-
thase binding
2.8E-02 mmu05410:Hypertrophic car-
diomyopathy (HCM)
2.6E-03
GO:0007160 cell-matrix adhe-
sion
3.1E-02 GO:0030018 Z disc 2.7E-03
GO:0030315 T-tubule 3.2E-02 mmu05205:Proteoglycans in
cancer
3.5E-03
GO:0030175 filopodium 3.3E-02 GO:0030154 cell differentiation 3.5E-03
GO:0008305 integrin complex 3.4E-02 mmu04925:Aldosterone synthe-
sis and secretion
4.1E-03
GO:0032332 positive regulation
of chondrocyte differentiation
3.4E-02 mmu05031:Amphetamine addic-
tion
4.5E-03
GO:0001755 neural crest cell mi-
gration
3.7E-02 GO:0030314 junctional mem-
brane complex
5.0E-03
GO:0040037 negative regulation
of fibroblast growth factor recep-
tor signaling pathway
3.8E-02 mmu04725:Cholinergic synapse 5.1E-03
GO:0030018 Z disc 3.9E-02 mmu04930:Type II diabetes mel-
litus
5.1E-03
GO:0007346 regulation of mi-
totic cell cycle
4.3E-02 mmu04310:Wnt signaling path-
way
6.1E-03
GO:0043204 perikaryon 4.3E-02 mmu04970:Salivary secretion 8.7E-03
GO:0045666 positive regulation
of neuron differentiation
4.3E-02 GO:0005887 integral component
of plasma membrane
9.1E-03
GO:0008201 heparin binding 4.5E-02 GO:0007275 multicellular organ-
ism development
9.1E-03
GO:0007219 Notch signaling
pathway
4.6E-02 GO:0044224 juxtaparanode re-
gion of axon
9.7E-03
mmu04924:Renin secretion 4.9E-02 GO:0016529 sarcoplasmic retic-
ulum
1.1E-02
GO:0008021 synaptic vesicle 1.1E-02
GO:0046982 protein het-
erodimerization activity
1.2E-02
mmu04730:Long-term depres-
sion
1.3E-02
GO:0005891 voltage-gated cal-
cium channel complex
1.3E-02
GO:0060291 long-term synaptic
potentiation
1.3E-02
GO:0005244 voltage-gated ion
channel activity
1.3E-02
GO:0030672 synaptic vesicle
membrane
1.4E-02
208 APPENDIX C. CHAPTER 3 APPENDICES
GO:0030426 growth cone 1.4E-02
GO:0007528 neuromuscular
junction development
1.6E-02
mmu05214:Glioma 1.7E-02
GO:0003151 outflow tract mor-
phogenesis
1.7E-02
GO:0005829 cytosol 1.8E-02
GO:0045165 cell fate commit-
ment
1.8E-02
GO:0051966 regulation of
synaptic transmission, gluta-
matergic
2.0E-02
GO:0005178 integrin binding 2.0E-02
GO:0034765 regulation of ion
transmembrane transport
2.1E-02
GO:0005216 ion channel activity 2.3E-02
GO:0032281 AMPA glutamate
receptor complex
2.6E-02
GO:0042995 cell projection 2.6E-02
mmu04971:Gastric acid secre-
tion
2.7E-02
mmu05014:Amyotrophic lateral
sclerosis (ALS)
2.8E-02
mmu04390:Hippo signaling
pathway
2.9E-02
GO:0001764 neuron migration 3.0E-02
GO:0042493 response to drug 3.2E-02
mmu04015:Rap1 signaling path-
way
3.4E-02
GO:0048306 calcium-dependent
protein binding
4.1E-02
GO:0030165 PDZ domain bind-
ing
4.1E-02
GO:2000311 regulation of
alpha-amino-3-hydroxy-5-
methyl-4-isoxazole propionate
selective glutamate receptor
activity
4.3E-02
GO:0005242 inward rectifier
potassium channel activity
4.4E-02
GO:0043524 negative regulation
of neuron apoptotic process
4.4E-02
GO:0006811 ion transport 4.5E-02
GO:0045599 negative regulation
of fat cell differentiation
4.5E-02
GO:0009887 organ morphogene-
sis
4.6E-02
GO:0005737 cytoplasm 4.6E-02
GO:0007612 learning 4.7E-02
mmu05202:Transcriptional mis-
regulation in cancer
4.8E-02
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mmu04666:Fc gamma R-
mediated phagocytosis
4.8E-02
GO:0043235 receptor complex 4.9E-02
mmu04024:cAMP signaling
pathway
4.9E-02
GO:0005605 basal lamina 4.9E-02
Table C.3: Nfix significant DAVID terms
Nearest Gene CisMapper Common
GO:0016020 membrane 4.76E-09 GO:0016020 membrane 6.24E-05 GO:0043005 neuron projection 1.30E-05
GO:0005576 extracellular region 1.95E-08 GO:0045202 synapse 4.89E-04 GO:0030424 axon 2.91E-04
GO:0007155 cell adhesion 5.02E-08 GO:0030424 axon 0.00272585 GO:0016020 membrane 5.88E-04
GO:0005578 proteinaceous ex-
tracellular matrix
2.91E-06 GO:0005244 voltage-gated ion
channel activity
0.002854815 GO:0005578 proteinaceous ex-
tracellular matrix
9.45E-04
GO:0005509 calcium ion bind-
ing
8.82E-06 GO:0008076 voltage-gated
potassium channel complex
0.003549398 GO:0005886 plasma membrane 0.001248749
GO:0005886 plasma membrane 9.85E-06 GO:0043025 neuronal cell body 0.006330119 GO:0043025 neuronal cell body 0.001319849
GO:0005216 ion channel activity 3.33E-05 GO:0005216 ion channel activity 0.006594439 GO:0045121 membrane raft 0.003486674
GO:0043025 neuronal cell body 4.47E-05 GO:0005886 plasma membrane 0.007401441 GO:0045202 synapse 0.007565897
GO:0007275 multicellular organ-
ism development
1.19E-04 GO:0016021 integral component
of membrane
0.008709109 mmu04024:cAMP signaling
pathway
0.012654705
GO:0030425 dendrite 3.80E-04 GO:0034765 regulation of ion
transmembrane transport
0.010630566 GO:0030315 T-tubule 0.016705352
GO:0007399 nervous system de-
velopment
4.49E-04 GO:0043005 neuron projection 0.013435453 GO:0030425 dendrite 0.017178632
GO:0009986 cell surface 4.55E-04 GO:0042734 presynaptic mem-
brane
0.015773298 mmu04925:Aldosterone synthe-
sis and secretion
0.018321474
GO:0045202 synapse 5.13E-04 GO:0043204 perikaryon 0.026781817 mmu04261:Adrenergic signal-
ing in cardiomyocytes
0.020105428
GO:0045211 postsynaptic mem-
brane
5.84E-04 GO:0030054 cell junction 0.037961937 GO:0005516 calmodulin binding 0.020799662
GO:0005615 extracellular space 0.001345478 GO:0005251 delayed rectifier
potassium channel activity
0.047072156 mmu04020:Calcium signaling
pathway
0.023028317
GO:0030154 cell differentiation 0.001791303 GO:0031012 extracellular ma-
trix
0.024087168
GO:0008076 voltage-gated
potassium channel complex
0.003246114 GO:0042383 sarcolemma 0.027146047
GO:0005581 collagen trimer 0.00405804 mmu04720:Long-term potentia-
tion
0.030189725
GO:0030424 axon 0.006180416 mmu04022:cGMP-PKG signal-
ing pathway
0.03283228
GO:0043005 neuron projection 0.007262002 mmu04970:Salivary secretion 0.045363591
GO:0009897 external side of
plasma membrane
0.011185876
GO:0016021 integral component
of membrane
0.011550622
GO:0030175 filopodium 0.012538299
GO:0006811 ion transport 0.017796585
GO:0007411 axon guidance 0.019771909
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GO:0043204 perikaryon 0.020858242
GO:0030054 cell junction 0.022394372
GO:0005515 protein binding 0.029527764
GO:0005201 extracellular ma-
trix structural constituent
0.030411886
GO:0014069 postsynaptic den-
sity
0.031063348
GO:0046982 protein het-
erodimerization activity
0.037070978
GO:0005887 integral component
of plasma membrane
0.039857315
GO:0007596 blood coagulation 0.042874118
GO:0030335 positive regulation
of cell migration
0.043515016
GO:0030501 positive regulation
of bone mineralization
0.045798754
Table C.4: Nfia and Nfix significant DAVID terms from temporal analysis
Nfia Nfix
GO:0043025 neuronal cell body 2.86E-16 GO:0007155 cell adhesion 3.42E-10
GO:0007399 nervous system de-
velopment
1.21E-12 GO:0007399 nervous system de-
velopment
1.28E-09
GO:0016020 membrane 9.82E-12 mmu04360:Axon guidance 8.15E-09
GO:0045202 synapse 3.42E-11 GO:0016020 membrane 9.62E-09
mmu04360:Axon guidance 6.69E-11 GO:0043025 neuronal cell body 1.40E-07
GO:0005886 plasma membrane 3.04E-10 GO:0043005 neuron projection 2.92E-06
GO:0030054 cell junction 4.17E-10 GO:0045202 synapse 3.03E-06
GO:0030424 axon 6.45E-10 GO:0030424 axon 3.69E-06
GO:0009986 cell surface 8.15E-10 GO:0005578 proteinaceous ex-
tracellular matrix
6.11E-06
GO:0005578 proteinaceous ex-
tracellular matrix
1.32E-09 GO:0005886 plasma membrane 2.55E-05
GO:0030425 dendrite 7.28E-09 GO:0007411 axon guidance 2.86E-05
GO:0043005 neuron projection 9.43E-09 GO:0009986 cell surface 2.01E-04
GO:0007155 cell adhesion 3.22E-08 GO:0030425 dendrite 2.64E-04
GO:0045211 postsynaptic mem-
brane
8.99E-08 GO:0042734 presynaptic mem-
brane
2.75E-04
GO:0014069 postsynaptic den-
sity
3.07E-07 GO:0005576 extracellular region 3.31E-04
GO:0005515 protein binding 3.37E-07 GO:0045211 postsynaptic mem-
brane
3.33E-04
GO:0042734 presynaptic mem-
brane
5.69E-07 GO:0030054 cell junction 8.19E-04
GO:0007411 axon guidance 1.27E-06 GO:0005887 integral component
of plasma membrane
0.001316479
mmu04724:Glutamatergic
synapse
2.15E-06 GO:0007275 multicellular organ-
ism development
0.001357189
GO:0005516 calmodulin binding 1.08E-05 GO:0001764 neuron migration 0.001577529
GO:0007507 heart development 1.36E-05 GO:0007612 learning 0.001691699
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GO:0005216 ion channel activity 1.47E-05 GO:0007269 neurotransmitter
secretion
0.00176017
GO:0001764 neuron migration 1.71E-05 GO:0007156 homophilic cell ad-
hesion via plasma membrane ad-
hesion molecules
0.001851404
GO:0043197 dendritic spine 3.03E-05 GO:0014069 postsynaptic den-
sity
0.002603653
GO:0007275 multicellular organ-
ism development
3.44E-05 GO:0016021 integral component
of membrane
0.00789915
GO:0008076 voltage-gated
potassium channel complex
6.75E-05 GO:0048812 neuron projection
morphogenesis
0.008197276
GO:0051966 regulation of
synaptic transmission, gluta-
matergic
1.17E-04 GO:0048471 perinuclear region
of cytoplasm
0.009774644
mmu04723:Retrograde endo-
cannabinoid signaling
1.31E-04 GO:0043197 dendritic spine 0.009870987
GO:0048812 neuron projection
morphogenesis
1.58E-04 GO:0043204 perikaryon 0.01011765
mmu04921:Oxytocin signaling
pathway
2.02E-04 GO:0008013 beta-catenin bind-
ing
0.011734769
GO:0005887 integral component
of plasma membrane
2.16E-04 GO:0008076 voltage-gated
potassium channel complex
0.013795334
GO:0008045 motor neuron axon
guidance
2.90E-04 GO:0010976 positive regulation
of neuron projection develop-
ment
0.013928002
GO:0007269 neurotransmitter
secretion
2.90E-04 GO:0051966 regulation of
synaptic transmission, gluta-
matergic
0.015094593
mmu05412:Arrhythmogenic
right ventricular cardiomyopathy
(ARVC)
2.98E-04 GO:1903561 extracellular vesi-
cle
0.015858452
mmu05414:Dilated cardiomy-
opathy
3.01E-04 GO:0008021 synaptic vesicle 0.018227875
mmu04713:Circadian entrain-
ment
3.05E-04 GO:0050806 positive regulation
of synaptic transmission
0.018674766
mmu04720:Long-term potentia-
tion
3.51E-04 GO:0060291 long-term synaptic
potentiation
0.01886311
GO:0030165 PDZ domain bind-
ing
6.44E-04 GO:0008045 motor neuron axon
guidance
0.020051019
mmu04510:Focal adhesion 8.68E-04 mmu04510:Focal adhesion 0.021277258
mmu04261:Adrenergic signal-
ing in cardiomyocytes
0.001071093 GO:0004714 transmembrane re-
ceptor protein tyrosine kinase ac-
tivity
0.025329088
GO:0060291 long-term synaptic
potentiation
0.001268977 GO:0044295 axonal growth cone 0.026259837
GO:0022029 telencephalon cell
migration
0.00127637 mmu04512:ECM-receptor inter-
action
0.026286316
mmu04024:cAMP signaling
pathway
0.001590322 GO:0005516 calmodulin binding 0.026998582
GO:0005737 cytoplasm 0.001661359 GO:0005604 basement mem-
brane
0.028184527
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GO:0007420 brain development 0.001966331 GO:0031012 extracellular ma-
trix
0.028229262
GO:0048471 perinuclear region
of cytoplasm
0.001987313 mmu04151:PI3K-Akt signaling
pathway
0.029352893
GO:0030175 filopodium 0.002148958 GO:0030165 PDZ domain bind-
ing
0.030072478
GO:0051965 positive regulation
of synapse assembly
0.00215305 mmu04724:Glutamatergic
synapse
0.031728141
mmu04728:Dopaminergic
synapse
0.002183175 mmu04720:Long-term potentia-
tion
0.032293054
mmu04725:Cholinergic synapse 0.002184971 mmu04024:cAMP signaling
pathway
0.03255964
mmu04020:Calcium signaling
pathway
0.002211989 GO:0048666 neuron develop-
ment
0.033339502
GO:0050806 positive regulation
of synaptic transmission
0.00231917 GO:0031594 neuromuscular
junction
0.033841609
mmu05033:Nicotine addiction 0.002482465 mmu05200:Pathways in cancer 0.03474591
mmu04151:PI3K-Akt signaling
pathway
0.002493393 GO:0008328 ionotropic gluta-
mate receptor complex
0.041873826
GO:0005576 extracellular region 0.00259342 GO:0005515 protein binding 0.044199198
GO:0008021 synaptic vesicle 0.002597828 GO:0060076 excitatory synapse 0.045799354
GO:0030018 Z disc 0.002619578 GO:0043195 terminal bouton 0.045824697
GO:0043204 perikaryon 0.002653904 GO:0060079 excitatory postsy-
naptic potential
0.046621813
GO:0042995 cell projection 0.0027317 GO:0030154 cell differentiation 0.04986421
GO:0031012 extracellular ma-
trix
0.003093252
GO:0007162 negative regulation
of cell adhesion
0.003094576
mmu05410:Hypertrophic car-
diomyopathy (HCM)
0.003254198
GO:0035556 intracellular signal
transduction
0.004067225
GO:0007156 homophilic cell ad-
hesion via plasma membrane ad-
hesion molecules
0.004280611
GO:0005509 calcium ion bind-
ing
0.005285391
mmu04540:Gap junction 0.005487132
mmu04512:ECM-receptor inter-
action
0.006067527
GO:0007612 learning 0.006883951
GO:0071526 semaphorin-plexin
signaling pathway
0.007239647
GO:0005249 voltage-gated
potassium channel activity
0.008317418
mmu05200:Pathways in cancer 0.008605365
GO:0060076 excitatory synapse 0.008672954
GO:0072102 glomerulus mor-
phogenesis
0.00906423
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GO:0008328 ionotropic gluta-
mate receptor complex
0.012386271
GO:0043198 dendritic shaft 0.013410238
GO:0030672 synaptic vesicle
membrane
0.013410238
GO:0021772 olfactory bulb de-
velopment
0.013957252
GO:0042391 regulation of mem-
brane potential
0.015025648
GO:0030154 cell differentiation 0.015399216
GO:0048843 negative regulation
of axon extension involved in
axon guidance
0.015501403
GO:0045499 chemorepellent ac-
tivity
0.01554073
GO:0006816 calcium ion trans-
port
0.015983958
GO:0006811 ion transport 0.016719691
GO:0005546
phosphatidylinositol-4,5-
bisphosphate binding
0.016720148
mmu04730:Long-term depres-
sion
0.017465125
GO:0043195 terminal bouton 0.018441633
mmu04666:Fc gamma R-
mediated phagocytosis
0.018852399
mmu04015:Rap1 signaling path-
way
0.019225246
GO:0071560 cellular response to
transforming growth factor beta
stimulus
0.019726695
mmu04911:Insulin secretion 0.019763293
GO:0044295 axonal growth cone 0.020826383
GO:0045121 membrane raft 0.020984044
GO:0042383 sarcolemma 0.021923394
mmu05031:Amphetamine addic-
tion
0.023623312
GO:0030335 positive regulation
of cell migration
0.023668482
GO:0005244 voltage-gated ion
channel activity
0.024412638
GO:0048786 presynaptic active
zone
0.024530962
GO:0004970 ionotropic gluta-
mate receptor activity
0.026003414
GO:0005234 extracellular-
glutamate-gated ion channel
activity
0.026003414
GO:0005604 basement mem-
brane
0.026891242
GO:0043234 protein complex 0.028827368
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GO:0032279 asymmetric
synapse
0.029093735
GO:0060048 cardiac muscle con-
traction
0.030746027
GO:0071313 cellular response to
caffeine
0.030931375
GO:0010881 regulation of car-
diac muscle contraction by reg-
ulation of the release of se-
questered calcium ion
0.030931375
GO:2000311 regulation of
alpha-amino-3-hydroxy-5-
methyl-4-isoxazole propionate
selective glutamate receptor
activity
0.031667129
GO:0034765 regulation of ion
transmembrane transport
0.032468488
mmu05014:Amyotrophic lateral
sclerosis (ALS)
0.033549683
mmu04070:Phosphatidylinositol
signaling system
0.034193211
mmu04916:Melanogenesis 0.034401393
mmu04390:Hippo signaling
pathway
0.035063458
mmu04071:Sphingolipid signal-
ing pathway
0.035925641
GO:0004714 transmembrane re-
ceptor protein tyrosine kinase ac-
tivity
0.036665812
mmu05231:Choline metabolism
in cancer
0.037057907
GO:0030215 semaphorin recep-
tor binding
0.039378534
GO:0016021 integral component
of membrane
0.040764378
GO:0043087 regulation of GT-
Pase activity
0.040844483
GO:0007157 heterophilic cell-
cell adhesion via plasma mem-
brane cell adhesion molecules
0.041774589
GO:0007165 signal transduction 0.042576745
GO:0003151 outflow tract mor-
phogenesis
0.046928158
GO:0060079 excitatory postsy-
naptic potential
0.047194509
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Figure D.1: ChIP-R’s workflow is separated into six main stages: (i) peak and pseudo fragment
generation (ii) fragment ranking within replicates, (iii) rank product calculation, (iv) significance
calculation, (v) thresholding based on a binomial test (ChIP-R threshold), and (vi) peak filtering. The
tool requires processed ChIP-seq data in the BED or BIGBED peak format. After all test fragments
have been filtered and/or collapsed into output peaks, three output files are produced: “T1” for peaks
with p≤ 0.05, “T2” for peaks p≤ θ (where θ is the threshold suggested by the binomial test) and
“ALL” containing all peaks regardless of p.
215
216 APPENDIX D. CHAPTER ?? APPENDICES
0
1
2
5
10
20
50
50
0
1-union 2-union 3-union 4-union MSPC_c1 MSPC_c2 MSPC_c3 MSPC_c4 MACS2CR_m1 CR_m2 CR_m3 CR_m4 IDR_p6 CR_p6_m1 CR_p6_m2
1
2
5
10
20
50
20
0
50
0
1-union 2-union 3-union 4-union MSPC_c1 MSPC_c2 MSPC_c3 MSPC_c4 MACS2CR_m1 CR_m2 CR_m3 CR_m4 IDR_p4 CR_p4_m1 CR_p4_m2
20
0
SR
F
M
A
X
5.5% 21% 34% 39%48% 40% 38% 40% 19%38% 48% 5.5% 21% 35% 40%41%
30% 32% 29% 30% 32% 29% 29% 27%26% 28% 30% 30% 28% 27% 29% 29%
R
ea
d 
de
pt
h 
at
 m
ot
if 
m
at
ch
1-union 2-union 3-union 4-union MSPC_c1 MSPC_c2 MSPC_c3 MSPC_c4 MACS2CR_m1 CR_m2 CR_m3 CR_m4 IDR_p1 IDR_p1_rlxd IDR_p3
R
ea
d 
de
pt
h 
at
 m
ot
if 
m
at
ch
74% 72% 83% 87%96% 72% 75% 73% 90%92% 95% 89% 72% 83% 87%93%
IDR_p3_rlxd
70%
1
5
10
50
50
0
20
0
2
20
1
5
10
50
10
0
10
00
1-union 2-union 3-union 4-union MSPC_c1 MSPC_c2 MSPC_c3 MSPC_c4 MACS2CR_m1 CR_m2 CR_m3 CR_m4 IDR_p1 IDR_p1_rlxd IDR_p3
R
ea
d 
de
pt
h 
at
 m
ot
if 
m
at
ch
50% 52% 58% 53%62% 62% 63% 48% 55%54% 60% 53% 52% 58% 54%57%
IDR_p3_rlxd
50%
1
5
10
50
50
0
20
0
1-union 2-union 3-union 4-union MSPC_c1 MSPC_c2 MSPC_c3 MSPC_c4 MACS2CR_m1 CR_m2 CR_m3 CR_m4 IDR_p1 IDR_p1_rlxd IDR_p3
R
ea
d 
de
pt
h 
at
 m
ot
if 
m
at
ch
48% 42% 48% 51%62% 43% 44% 46% 54%56% 61% 53% 42% 48% 51%59%
IDR_p3_rlxd
37%
2
20
R
ea
d 
de
pt
h 
at
 m
ot
if 
m
at
ch
C
TC
F
C
EB
PB
FO
XA
1
Figure D.2: ChIP-R (CR) reproducible peaks for SRF, MAX, CTCF, CEBPB and FOXA1 recover sites
with greater supporting read depth in motif positive peaks, here compared with IDR, m-union, MSPC
and MACS2. Motif matches identified by FIMO across the genome were annotated with the absolute
read depth at their genomic location. Greater read depth indicates motif- and sequencing-based support
of a true binding event. The read depths at motif matches that overlapped peaks reported by each tool
are shown as linearly scaled density-beans. Percentages indicate the proportion of output peaks that
overlapped a motif. Where available (SRF and MAX), the green horizontal line represents the mean
read depth at motifs in peaks from the true positive set. The red horizontal line represents the mean
read depth at motifs in peaks from the true negative set. IDR and ChIP-R were run on the same pair of
replicates (noted as p*, where * is a replicate pair identifier) while ChIP-R and all other tools were run
on all four replicates for each TF with increasing m or c (for MSPC) settings.
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Figure D.3: ChIP-R (CR) reproducible peaks as originally called with SPP recover sites with greater
supporting read depth in motif positive peaks. Motif matches identified by FIMO across the genome
were annotated with the absolute read depth at their genomic location. Greater read depth indicates
motif- and sequencing-based support of a true binding event. IDR analyses used peaks sourced directly
from ENCODE, and from pooling peaks together to emulate IDR being performed on all four replicates
at once. The read depths at motif matches that overlapped peaks reported by each tool are shown as
linearly scaled density-beans. Percentages indicate the proportion of output peaks that overlapped
a motif. The green horizontal line represents the mean read depth at motifs in peaks from the true
positive set. The red horizontal line represents the mean read depth at motifs in peaks from the true
negative set.
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Figure D.4: The distribution of rank-product p-values as calculated by ChIP-R using a range of
different peak callers. The data set is a CTCF ChIP-seq experiment containing three biological
replicates. Each distribution is truncated at p≤ θ . m1, m2, and m3 indicate the setting of m.
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Table D.1: Each tool’s performance when evaluated on REST, SRF and MAX, which are associated with true positive and true negative data: the area
between the positive and negative peak accumulation curves (ABC value), Top-N ABC values where N equals the smallest number of peaks produced
for a TF across all tested methods, output peak count, the mean width ± standard deviation of output peaks and the mean motif score (read depth) across
all motifs overlapping a peak. An ABC value approaching 1 represents ideal performance, and an ABC value around 0 indicates that true positives and
negatives are included at similar rates. Where an ABC value of NA is recorded, no true positive or negative peaks were identified by the tool. An asterisk *
indicates cases where lack of precision prevented accurate ranking of peaks. If two ABC values are equal, the tool with better performance is the one to
achieve the ABC value by calling fewer and narrower peaks with lower variation while maintaining high motif scores. IDR and ChIP-R were run on the
same pair of replicates (noted as p) while ChIP-R and all other tools were run on all four replicates for each TF with increasing m or c settings.
REST SRF MAX
Setting ABC ABC
Top-N
Count Mean
Width
Mean
Score
ABC ABC
Top-N
Count Mean
Width
Mean
Score
ABC ABC
Top-N
Count Mean
Width
Mean
Score
IDR p Global
<0.05
0.01* 0.011* 807 797±259 1,104 NA* 0* 1,789 246±125 108 -0.06* -0.047* 8,001 452±267 109
ChIP-R p m1 NA 0.000 2,200 555±408 1,057 0.73 0.550 2,199 204±128 101 0.33 0.320 10,420 437±278 106
ChIP-R p m2 0.32 0.138 1,782 483±263 1,190 0.68 0.505 1,579 207±111 119 0.32 0.318 6,509 459±236 123
ChIP-R m1 0.57 0.155 7,716 389±290 632 0.67 0.522 3,179 194±113 83 0.17 0.223 23,291 389±318 70
ChIP-R m2 0.51 0.155 3,964 456±322 806 0.73 0.531 1,700 200±113 117 0.22 0.229 15,163 426±319 84
ChIP-R m3 0.43 0.157 2,559 489±312 970 0.64 0.537 845 228±116 158 0.25 0.239 9,855 464±314 99
ChIP-R m4 0.30 0.154 1,599 486±229 1,217 0.54 0.532 566 229±92 187 0.25 0.249 5,905 439±229 117
MSPC C1 0.24 0.143 126,598 264±201 165 0.02 0.360 103,518 136±56 29 -0.11 0.014 192,071 268±285 16
MSPC C2 0.44 0.143 43,183 411±252 244 0.53 0.361 13,232 215±91 47 -0.05 0.014 86,768 410±373 27
MSPC C3 0.59 0.139 16,865 541±318 361 0.62 0.361 3,807 271±120 76 0.00 0.014 48,203 549±444 43
MSPC C4 0.60 0.143 7,463 668±399 511 0.66 0.362 2,242 299±134 97 0.02 0.016 27,032 728±504 59
1-union 0.25 0.153 127,038 264±201 164 0.02 0.510 103,626 136±56 29 -0.10 0.254 192,834 267±285 16
2-union 0.45 0.153 43,207 411±252 244 0.56 0.510 13,258 215±92 47 -0.03 0.254 86,794 410±373 27
3-union 0.58 0.154 17,811 543±316 348 0.67 0.511 3,960 274±122 75 0.04 0.254 49,114 550±441 41
4-union 0.62 0.155 9,001 671±383 457 0.72 0.513 2,325 301±137 96 0.08 0.254 29,015 724±494 55
MACS2 q-val
<0.05
0.41 0.152 63,654 357±242 219 0.47 0.373 15,580 152±74 60 -0.09 0.165 185,234 286±308 61
TP - - 107 196±54 1565 - - 111 182±42 222 - - 226 242±120 146
TN - - 99 175±147 114 - - 45 147±55 36 - - 63 211±89 40
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Table D.2: Each tool’s performance when evaluated on CTCF, CEBPB and FOXA1: output peak count, the mean width ± standard deviation of output
peaks and the mean motif score (read depth) across all motifs overlapping a peak. IDR was run on two pairs of replicates (noted as p*) while ChIP-R and all
other tools were run on all four replicates for each TF with increasing m or c settings.
CTCF CEBPB FOXA1
Setting Count Mean Width Mean Score Count Mean Width Mean Score Count Mean Width Mean Score
IDR p1 Global<0.05 9,286 361±161.96 27 24,285 201±74.35 15 20,421 287±136.64 24
IDR p1 rlxd Global<0.4 14,679 373±154.27 29 39,334 206±70.06 16 27,138 289±129.88 25
IDR p3 Global<0.05 11,139 316±165.74 23 15,183 280±169.71 26 26,921 266±116.64 16
IDR p3 rlxd Global<0.4 17,451 327±157.09 25 26,323 288±161.74 28 32,679 270±113.80 17
ChIP-R m1 27,330 272±121.78 103 21,503 225±127.76 86 28,928 290±133.45 70
ChIP-R m2 21,467 278±117.20 114 13,700 240±124.86 110 20,674 311±131.72 82
ChIP-R m3 16,905 278±97.73 123 8,969 253±117.15 135 16,181 320±123.62 92
ChIP-R m4 13,374 266±68.37 132 6,087 244±89.93 160 12,327 316±103.20 104
MSPC C1 91,078 379±200.23 53 166,533 218±132.54 24 136,515 263±141.73 28
MSPC C2 64,979 452±187.65 61 84,429 280±154.19 34 82,954 321±150.36 37
MSPC C3 53,901 486±180.12 68 42,634 342±178.86 56 60,069 353±156.99 45
MSPC C4 44,256 518±173.52 76 24,931 394±200.01 78 43,617 381±163.61 53
1-union 91,078 379±200.23 53 166,533 218±132.54 24 136,516 263±141.73 28
2-union 64,986 452±187.68 61 84,447 280±154.19 34 82,965 321±150.36 37
3-union 53,979 487±181.38 68 42,932 344±180.93 55 60,234 354±158.73 44
4-union 44,411 520±176.44 75 25,318 399±203.39 76 43,936 384±168.06 53
MACS2 q-val < 0.05 89,478 353±178.05 56 126,343 221±118.84 30 146,137 269±144.84 30
220 APPENDIX D. CHAPTER ?? APPENDICES
Table D.3: MEME suite analysis of ChIP-R outputs from analysing all TFs. ChIP-R was run on
all four replicates from each TF with m set from 1 to 4. Outputs were separated into a foreground
of peaks p ≤ θ and a background of remaining peaks. MEME suite was used to perform motif
discovery and differential enrichment. The Motif E-value is sourced from MEME and represents
enrichment of the discovered target motif in the foreground set of peaks. A smaller value indicates
a greater enrichment of the target motif which you would expect from true TF peaks. The Fisher
E-value produced by MEME-ChIP indicates whether a significant difference of motif occurrence
exists between the foreground and background sets of peaks. A smaller value here represents a greater
enrichment of the discovered target motif in the foreground compared to the background set of peaks
indicating background peaks carry less biologically relevant sequence content.
Setting Value REST SRF MAX CTCF CEBPB FOXA1
m1 Motif E-value 6.2E-538 6.3E-611 N.S. 3.7E-3892 2.1E-1189 2.1E-573
Fisher E-value 1.1E-282 5.7E-520 N.S. 8.9E-1671 8.3E-67 1.5E-140
m2 Motif E-value 9.0E-452 5.6E-413 N.S. 2.2E-1528 1.1E-504 7.4E-132
Fisher E-value 5.2E-128 1.2E-59 N.S. 4.3E-104 1.5E-17 5.8E-10
m3 Motif E-value 1.8E-340 3.8E-18 3.2E-03 2.6E-154 7.8E-164 6.2E-90
Fisher E-value 9.1E-04 3.6E-10 N.S. 4.9E-04 N.S. N.S.
m4 Motif E-value 5.3E-26 N.S. 7.8E-06 5.6E-278 1.4E-55 2.2E-66
Fisher E-value N.S. N.S. N.S. N.S. N.S. N.S.
D.2 Chapter 4 supporting data
Table D.5: ChIP-R processed Nfia and Nfix individual targetomes and pair targetome sig-
nificant DAVID terms
Nfia targetome Nfix targetome Pair targetome
GO:0045202 synapse 4.59E-19 GO:0045202 synapse 8.79E-09 GO:0030424 axon 7.92E-08
GO:0016020 membrane 4.55E-16 GO:0030424 axon 1.25E-08 GO:0045202 synapse 3.30E-06
GO:0030424 axon 4.09E-14 GO:0016020 membrane 1.57E-08 GO:0043025 neuronal cell body 4.74E-06
GO:0005578 proteinaceous ex-
tracellular matrix
6.13E-14 GO:0043005 neuron projection 5.50E-07 GO:0008076 voltage-gated
potassium channel complex
1.72E-05
GO:0043025 neuronal cell body 7.35E-14 GO:0005576 extracellular region 3.14E-06 GO:0007411 axon guidance 2.34E-05
GO:0043005 neuron projection 1.02E-13 GO:0005886 plasma membrane 3.28E-06 GO:0043197 dendritic spine 6.26E-05
GO:0030054 cell junction 1.63E-13 GO:0005578 proteinaceous ex-
tracellular matrix
3.55E-06 GO:0005578 proteinaceous ex-
tracellular matrix
7.00E-05
GO:0042734 presynaptic mem-
brane
9.60E-13 GO:0042734 presynaptic mem-
brane
4.13E-06 GO:0005576 extracellular region 7.08E-05
GO:0005515 protein binding 2.80E-11 GO:0008076 voltage-gated
potassium channel complex
5.78E-06 GO:0042734 presynaptic mem-
brane
1.11E-04
GO:0014069 postsynaptic den-
sity
1.05E-10 GO:0007411 axon guidance 2.40E-05 GO:0043005 neuron projection 1.22E-04
GO:0007155 cell adhesion 1.42E-10 GO:0045211 postsynaptic mem-
brane
2.84E-05 GO:0016020 membrane 2.46E-04
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GO:0007399 nervous system de-
velopment
1.85E-10 GO:0030054 cell junction 3.14E-05 mmu04360:Axon guidance 2.46E-04
GO:0005886 plasma membrane 1.27E-09 GO:0005216 ion channel activity 3.34E-05 GO:0005886 plasma membrane 2.59E-04
mmu04360:Axon guidance 1.78E-09 GO:0043025 neuronal cell body 4.20E-05 GO:0009986 cell surface 0.001109682
GO:0045211 postsynaptic mem-
brane
9.95E-09 GO:0007399 nervous system de-
velopment
5.07E-05 GO:0030175 filopodium 0.00119579
GO:0030425 dendrite 1.03E-08 GO:0030425 dendrite 1.67E-04 GO:0030425 dendrite 0.001717556
GO:0005576 extracellular region 1.55E-08 GO:0007155 cell adhesion 3.74E-04 GO:0007155 cell adhesion 0.002442466
GO:0005216 ion channel activity 4.32E-08 mmu04360:Axon guidance 3.99E-04 GO:0030054 cell junction 0.003068192
GO:0009986 cell surface 7.02E-08 GO:0005244 voltage-gated ion
channel activity
6.75E-04 GO:0051966 regulation of
synaptic transmission, gluta-
matergic
0.003119156
GO:0005516 calmodulin binding 1.21E-07 GO:0043197 dendritic spine 6.87E-04 GO:0005887 integral component
of plasma membrane
0.003178171
GO:0043197 dendritic spine 2.45E-07 GO:0006811 ion transport 8.72E-04 GO:0000187 activation of
MAPK activity
0.003342897
GO:0007275 multicellular organ-
ism development
3.15E-07 GO:0000187 activation of
MAPK activity
9.01E-04 GO:0045211 postsynaptic mem-
brane
0.003385575
mmu04724:Glutamatergic
synapse
3.22E-07 GO:0034765 regulation of ion
transmembrane transport
0.001015063 GO:0007399 nervous system de-
velopment
0.003563112
GO:0005509 calcium ion bind-
ing
5.18E-07 GO:0005516 calmodulin binding 0.001120274 GO:0008066 glutamate receptor
activity
0.004976962
GO:0030154 cell differentiation 1.39E-06 GO:0051966 regulation of
synaptic transmission, gluta-
matergic
0.001394979 GO:0030141 secretory granule 0.004984863
GO:0043204 perikaryon 7.82E-06 mmu04713:Circadian entrain-
ment
0.001437203 GO:0005216 ion channel activity 0.00766277
GO:0008076 voltage-gated
potassium channel complex
8.32E-06 mmu04724:Glutamatergic
synapse
0.003048926 GO:0005249 voltage-gated
potassium channel activity
0.009427921
GO:0005604 basement mem-
brane
1.49E-05 GO:0030175 filopodium 0.003326305 GO:0005515 protein binding 0.017973037
GO:0043195 terminal bouton 1.71E-05 GO:0004714 transmembrane re-
ceptor protein tyrosine kinase ac-
tivity
0.003485934 GO:0005509 calcium ion bind-
ing
0.018696444
GO:0031012 extracellular ma-
trix
2.72E-05 GO:0030141 secretory granule 0.003685235 GO:0010811 positive regulation
of cell-substrate adhesion
0.019980132
GO:0042383 sarcolemma 2.84E-05 mmu04080:Neuroactive ligand-
receptor interaction
0.00388279 GO:0007275 multicellular organ-
ism development
0.020207646
GO:0042995 cell projection 3.05E-05 GO:0005004 GPI-linked ephrin
receptor activity
0.004069298 GO:0007413 axonal fascicula-
tion
0.020801145
GO:0001657 ureteric bud devel-
opment
6.19E-05 mmu04720:Long-term potentia-
tion
0.004525567 GO:0005615 extracellular space 0.021744343
GO:0030315 T-tubule 7.50E-05 GO:0014069 postsynaptic den-
sity
0.004740847 GO:0048471 perinuclear region
of cytoplasm
0.021792808
GO:0007411 axon guidance 1.96E-04 GO:0005515 protein binding 0.005063946 GO:0005604 basement mem-
brane
0.022231441
GO:0005887 integral component
of plasma membrane
2.06E-04 GO:0008066 glutamate receptor
activity
0.005995625 GO:0014069 postsynaptic den-
sity
0.022336362
GO:0006811 ion transport 2.92E-04 GO:0005245 voltage-gated cal-
cium channel activity
0.006561788 GO:0004714 transmembrane re-
ceptor protein tyrosine kinase ac-
tivity
0.022466081
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GO:0048471 perinuclear region
of cytoplasm
3.83E-04 GO:0005509 calcium ion bind-
ing
0.007251965 GO:0030154 cell differentiation 0.02787709
GO:0030314 junctional mem-
brane complex
6.18E-04 GO:0005615 extracellular space 0.007354507 GO:0005251 delayed rectifier
potassium channel activity
0.029123418
GO:0005249 voltage-gated
potassium channel activity
6.65E-04 GO:0007413 axonal fascicula-
tion
0.0082483 GO:0005004 GPI-linked ephrin
receptor activity
0.029376352
GO:0001525 angiogenesis 8.90E-04 mmu04921:Oxytocin signaling
pathway
0.009605884 GO:0032279 asymmetric
synapse
0.029775736
GO:0004970 ionotropic gluta-
mate receptor activity
9.01E-04 mmu04925:Aldosterone synthe-
sis and secretion
0.011017322 GO:0004713 protein tyrosine ki-
nase activity
0.02994113
GO:0005234 extracellular-
glutamate-gated ion channel
activity
9.01E-04 mmu04911:Insulin secretion 0.011017322 GO:0005267 potassium channel
activity
0.035938666
GO:0060076 excitatory synapse 0.001056392 GO:0005267 potassium channel
activity
0.012621306 GO:0005244 voltage-gated ion
channel activity
0.037642001
GO:0051966 regulation of
synaptic transmission, gluta-
matergic
0.001282206 GO:0005003 ephrin receptor ac-
tivity
0.015256749 GO:0001786 phosphatidylserine
binding
0.038833461
mmu04713:Circadian entrain-
ment
0.001358759 GO:0004713 protein tyrosine ki-
nase activity
0.016493391 GO:0043198 dendritic shaft 0.040085063
GO:0030198 extracellular ma-
trix organization
0.001849009 GO:0005262 calcium channel ac-
tivity
0.016925799 GO:0031594 neuromuscular
junction
0.043922788
GO:0060079 excitatory postsy-
naptic potential
0.001994544 mmu04723:Retrograde endo-
cannabinoid signaling
0.018071469 GO:0007409 axonogenesis 0.047760458
GO:0048786 presynaptic active
zone
0.002419358 GO:0043195 terminal bouton 0.019015802
GO:0008328 ionotropic gluta-
mate receptor complex
0.002435359 mmu04020:Calcium signaling
pathway
0.019033316
GO:0030018 Z disc 0.002864349 GO:0005887 integral component
of plasma membrane
0.019432588
GO:0005911 cell-cell junction 0.002952191 GO:0009986 cell surface 0.019525493
GO:0007269 neurotransmitter
secretion
0.002966497 mmu05033:Nicotine addiction 0.019845937
GO:0008045 motor neuron axon
guidance
0.002966497 mmu05031:Amphetamine addic-
tion
0.02091969
GO:0016529 sarcoplasmic retic-
ulum
0.003002957 GO:0042383 sarcolemma 0.02152291
GO:0005244 voltage-gated ion
channel activity
0.003274959 GO:0005891 voltage-gated cal-
cium channel complex
0.023346568
GO:0004713 protein tyrosine ki-
nase activity
0.004064869 GO:0007169 transmembrane re-
ceptor protein tyrosine kinase
signaling pathway
0.024215435
GO:0022029 telencephalon cell
migration
0.004791938 GO:0005234 extracellular-
glutamate-gated ion channel
activity
0.030474956
mmu04720:Long-term potentia-
tion
0.004866288 GO:0004970 ionotropic gluta-
mate receptor activity
0.030474956
GO:0007162 negative regulation
of cell adhesion
0.004875169 GO:0005249 voltage-gated
potassium channel activity
0.031151542
GO:0043268 positive regulation
of potassium ion transport
0.004904859 GO:0004672 protein kinase ac-
tivity
0.032730665
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mmu04723:Retrograde endo-
cannabinoid signaling
0.005335032 GO:0060291 long-term synaptic
potentiation
0.0342
GO:0008066 glutamate receptor
activity
0.005984088 mmu05414:Dilated cardiomy-
opathy
0.035857694
mmu04911:Insulin secretion 0.006284501 GO:0007275 multicellular organ-
ism development
0.038536811
GO:0051965 positive regulation
of synapse assembly
0.006400257 GO:0006468 protein phosphory-
lation
0.0407054
GO:0005267 potassium channel
activity
0.006816212 GO:0008201 heparin binding 0.042144936
GO:0001786 phosphatidylserine
binding
0.006969591 mmu04512:ECM-receptor inter-
action
0.042496864
GO:0050680 negative regulation
of epithelial cell proliferation
0.007291389 GO:0043198 dendritic shaft 0.0433652
GO:0045165 cell fate commit-
ment
0.007291389 GO:0005604 basement mem-
brane
0.043439503
GO:0045666 positive regulation
of neuron differentiation
0.007437814 GO:0016301 kinase activity 0.044024712
GO:0034765 regulation of ion
transmembrane transport
0.007513326 GO:0031594 neuromuscular
junction
0.04935243
GO:0030165 PDZ domain bind-
ing
0.007597723 GO:0042995 cell projection 0.049822104
GO:0005615 extracellular space 0.00766759
GO:0004714 transmembrane re-
ceptor protein tyrosine kinase ac-
tivity
0.007855598
GO:0071805 potassium ion
transmembrane transport
0.009269099
GO:0045599 negative regulation
of fat cell differentiation
0.009508182
GO:0007420 brain development 0.009658478
mmu05200:Pathways in cancer 0.010058724
GO:0016021 integral component
of membrane
0.010113593
GO:0008021 synaptic vesicle 0.011120552
GO:0044295 axonal growth cone 0.01129951
GO:0006813 potassium ion
transport
0.011738153
mmu04080:Neuroactive ligand-
receptor interaction
0.012117684
GO:0071300 cellular response to
retinoic acid
0.013299286
GO:0005251 delayed rectifier
potassium channel activity
0.013303295
GO:0007612 learning 0.014394375
GO:0005737 cytoplasm 0.014838869
GO:0030175 filopodium 0.015647724
GO:0045121 membrane raft 0.015767406
GO:0043198 dendritic shaft 0.016539993
GO:0007268 chemical synaptic
transmission
0.016654414
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GO:0016477 cell migration 0.016941778
GO:0007169 transmembrane re-
ceptor protein tyrosine kinase
signaling pathway
0.017224267
mmu05033:Nicotine addiction 0.017441245
GO:0010595 positive regulation
of endothelial cell migration
0.017822843
GO:0003151 outflow tract mor-
phogenesis
0.018055248
GO:0010811 positive regulation
of cell-substrate adhesion
0.018156194
mmu04512:ECM-receptor inter-
action
0.019294291
GO:0045893 positive regulation
of transcription, DNA-templated
0.019921285
mmu04921:Oxytocin signaling
pathway
0.021229751
GO:0044224 juxtaparanode re-
gion of axon
0.021866576
GO:0007417 central nervous sys-
tem development
0.023218021
GO:0043524 negative regulation
of neuron apoptotic process
0.023688005
GO:0001764 neuron migration 0.023844538
GO:0007156 homophilic cell ad-
hesion via plasma membrane ad-
hesion molecules
0.02624475
GO:0010628 positive regulation
of gene expression
0.026302731
GO:0001964 startle response 0.027239222
mmu04730:Long-term depres-
sion
0.027724172
GO:0043679 axon terminus 0.02842272
GO:0034705 potassium channel
complex
0.028638556
GO:0045334 clathrin-coated en-
docytic vesicle
0.028638556
mmu05205:Proteoglycans in
cancer
0.029920752
GO:0030334 regulation of cell
migration
0.029958777
GO:0060048 cardiac muscle con-
traction
0.031939991
GO:0001658 branching involved
in ureteric bud morphogenesis
0.031939991
GO:0048812 neuron projection
morphogenesis
0.031998027
GO:0042493 response to drug 0.032060288
GO:0045778 positive regulation
of ossification
0.032188346
mmu04510:Focal adhesion 0.033447987
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GO:0060291 long-term synaptic
potentiation
0.033820062
GO:0042391 regulation of mem-
brane potential
0.03496866
GO:0005004 GPI-linked ephrin
receptor activity
0.035359678
GO:0005768 endosome 0.037922895
GO:0070062 extracellular exo-
some
0.039286984
GO:0030141 secretory granule 0.040322876
mmu04727:GABAergic synapse 0.043518547
GO:0046982 protein het-
erodimerization activity
0.043552442
GO:0050840 extracellular ma-
trix binding
0.04486688
GO:0005245 voltage-gated cal-
cium channel activity
0.046215188
GO:0032590 dendrite membrane 0.046396888
GO:0001656 metanephros devel-
opment
0.04640583
GO:0007528 neuromuscular
junction development
0.04640583
GO:0005783 endoplasmic reticu-
lum
0.047144622
GO:0030426 growth cone 0.047735088
Table D.6: Significant DAVID terms of genes excluded due to loss of Nfix binding and
terms of genes excluded due to loss of both Nfia and Nfix binding
Genes excluded due to loss of
Nfix binding
Genes excluded due to loss of
Nfia and Nfix
GO:0043204 perikaryon 0.005139913 GO:0005576 extracellular region 4.90E-04
GO:0005515 protein binding 0.014642121 GO:0009986 cell surface 0.015195086
GO:0043025 neuronal cell body 0.016655547 GO:0005578 proteinaceous ex-
tracellular matrix
0.025899035
GO:0043005 neuron projection 0.023894548 GO:0005886 plasma membrane 0.05270466
GO:0030424 axon 0.029323629 GO:0031012 extracellular ma-
trix
0.068243162
Table D.7: ChIP-R run on all four data sets to generate a pair targetome and the resulting
significant DAVID terms
GO:0043025 neuronal cell body 2.04E-10 GO:0005516 calmodulin binding 0.003154407
GO:0045202 synapse 4.66E-10 GO:0032590 dendrite membrane 0.003907298
GO:0030424 axon 4.82E-10 GO:0007275 multicellular organ-
ism development
0.004552735
GO:0043005 neuron projection 5.74E-10 GO:0005251 delayed rectifier
potassium channel activity
0.004580553
GO:0005576 extracellular region 6.47E-10 GO:0030175 filopodium 0.005685269
GO:0005578 proteinaceous ex-
tracellular matrix
1.48E-09 GO:0005267 potassium channel
activity
0.006215756
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GO:0009986 cell surface 1.73E-07 GO:0030141 secretory granule 0.007221698
GO:0008076 voltage-gated
potassium channel complex
2.15E-07 GO:0030154 cell differentiation 0.008153512
GO:0005886 plasma membrane 7.07E-07 GO:0008066 glutamate receptor
activity
0.010362617
GO:0030425 dendrite 9.05E-07 GO:0043198 dendritic shaft 0.011761103
GO:0016020 membrane 8.54E-06 GO:0042995 cell projection 0.011895468
GO:0043197 dendritic spine 1.22E-05 mmu04360:Axon guidance 0.012437761
GO:0042734 presynaptic mem-
brane
1.29E-05 mmu04724:Glutamatergic
synapse
0.015969898
GO:0031012 extracellular ma-
trix
3.45E-05 GO:0007413 axonal fascicula-
tion
0.02110625
GO:0043204 perikaryon 8.34E-05 GO:0000187 activation of
MAPK activity
0.021784326
GO:0005604 basement mem-
brane
8.55E-05 GO:0005244 voltage-gated ion
channel activity
0.022071499
GO:0045211 postsynaptic mem-
brane
1.22E-04 GO:0045121 membrane raft 0.023163858
GO:0030054 cell junction 1.37E-04 GO:0043195 terminal bouton 0.033514828
GO:0007155 cell adhesion 1.87E-04 GO:0051966 regulation of
synaptic transmission, gluta-
matergic
0.036721402
GO:0007411 axon guidance 2.20E-04 GO:0048839 inner ear develop-
ment
0.037987811
GO:0014069 postsynaptic den-
sity
2.39E-04 GO:0007162 negative regulation
of cell adhesion
0.038171754
GO:0005515 protein binding 3.28E-04 GO:0010811 positive regulation
of cell-substrate adhesion
0.038171754
GO:0005509 calcium ion bind-
ing
3.57E-04 GO:0042493 response to drug 0.039589931
GO:0005887 integral component
of plasma membrane
4.23E-04 GO:0006813 potassium ion
transport
0.041419797
GO:0005249 voltage-gated
potassium channel activity
4.74E-04 GO:0071805 potassium ion
transmembrane transport
0.04182107
GO:0005216 ion channel activity 4.77E-04 GO:0008201 heparin binding 0.043137631
GO:0048471 perinuclear region
of cytoplasm
0.001566721 GO:0046676 negative regulation
of insulin secretion
0.046548626
GO:0005615 extracellular space 0.001869974 GO:0016525 negative regulation
of angiogenesis
0.048570953
GO:0007399 nervous system de-
velopment
0.002496542
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Table D.4: ENCODE data identifiers for assays used in this analysis and JASPAR motif annotations.
TF Cell type Source BAM IDs Read Type Assembly
REST (MA0138.2) K562 ENCSR137ZMQ ENCFF686NWE Paired End hg19
ENCFF541OZF
ENCSR000BMW ENCFF294HHJ Single End hg19
ENCFF520WAB
MAX (MA0058.2) K562 ENCSR000BLP ENCFF825FLR Single End hg19
ENCFF112YUX
ENCSR000EFV ENCFF938QJA Single End hg19
ENCFF543CKI
SRF (MA0083.2) GM12878 ENCSR000BGE ENCFF187ZGJ Single End hg19
ENCFF210YHD
ENCSR000BMI ENCFF941CFE Single End hg19
ENCFF059RHP
CTCF (MA0139.1) MCF-7 ENCSR560BUE ENCFF565WPL Single End hg19
ENCFF534AFH
ENCSR000AHD ENCFF754DME Single End hg19
ENCFF335UKS
A549 ENCSR035OXA ENCFF810IXF Single End GRCh38
ENCFF774IBY
ENCFF713UMA
CEBPB (MA0466.1) A549 ENCSR000DYI ENCFF940YYO Single End hg19
ENCFF644WIF
ENCSR000BUB ENCFF000MWY Single End hg19
ENCFF000MWW
FOXA1 (MA0148.2) HepG2 ENCSR000BMO ENCFF587IJL Single End hg19
ENCFF793JQM
ENCSR000BLE ENCFF074KQO Single End hg19
ENCFF994UGO
Input K562 ENCSR173USI ENCFF581ZJL Paired End hg19
ENCFF051LWI
Input GM12878 ENCSR237VSG ENCFF991WDT Single End hg19
Input MCF-7 ENCSR511PAE ENCFF423QHQ Single End hg19
Input A549 ENCSR949BZP ENCFF863STQ Single End hg19
ENCFF425JYG
ENCSR139PCE ENCFF097CSC Single End GRCh38
ENCFF987XCE
ENCFF653HKQ
Input HepG2 ENCSR476TKW ENCFF929OSU Single End hg19

Appendix E
A review of available approaches to predict
transcription factor binding sites in vivo
E.1 Introduction
HTS technologies, specifically ChIP-seq, have allowed improved identification of transcription factor
binding sites in vivo. However, there are two major limitations to studying transcription factors with
ChIP-seq. First, the experiment is dependent on access to an antibody specific to the target transcription
factor, something that does not exist for every transcription factor. Second, there are thousands of
transcription factors operating in the human genome with each one binding different sites across
different cell types, at different stages of development and during response to invasion or disease. To
assay all of these combinations is not possible due to time, expense, and ability to isolate specific
cellular conditions and transcription factors. To address these limitations, approaches to predicting
transcription factor binding sites in vivo have been developed. A review of the currently available tools
and approaches is provided to explore their scope, limitations and avenues for improvement.
Transcription factor binding in vivo is influenced by many features both genetic and epigenetic.
Identifying these features and incorporating them into predictive models is an active area of research.
Previous tools and approaches to predict transcription factor binding in vivo have explored a wide
variety of features that can assist in identifying binding sites. These include sequence, evolutionary
conservation, DNA shape, histone modification patterns, chromatin accessibility data and, DNase I
hypersensitivity (DHS) footprints [58, 68, 42, 181, 27, 131, 122, 4, 187, 141, 149, 133, 129, 106].
These tools can be broken into three subgroups based on the features they use to predict binding:
sequence specific, sequence with local epigenetic environment and, sequence combined with DHS
footprints. All tools except one used sequence specific binding motifs as a feature to predict binding
with the sequence specific subset relying on motif scanning alone. The second subset of tools explore
features relating to sequence, histone modifications and regions of accessible chromatin. The tools
using sequence combined with DHS footprints focus more explicitly on the advantages provided by
footprinting while still considering sequence. Only one tool did not take into account sequence motifs
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as they focused on patterns of co-occupancy which cannot be explicitly captured by sequence [106].
E.2 Sequence specific tools
Transcription factors are known to bind to DNA at specific sequences. The DNA sequences recognized
by transcription factors, referred to as motifs, are between 4 and 20 base pairs (bps) and derived from
merging sequences detected by both in vivo and in vitro techniques as bound by the transcription factor
[7, 83, 113]. A motif can be represented as a consensus sequence, position weight matrix (PWM) or
tables of affinities (or relative affinities) to individual sequences as seen in Figure E.1. A consensus
sequence represents the DNA sequence bound by the transcription factor with the highest affinity
for that sequence while ignoring low affinity or uncommon sequences. No ’gold standard’ exists to
represent sequence preferences of a transcription factor [76].
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Figure E.1: This schematic represents a hypothetical transcription factor, its potential interactions with
DNA and how these binding events are represented as a motif. Three examples of the DNA sequence
that is bound by this transcription factor are shown demonstrating variations that must be reflected in
the motif. The PWM representation is based on the frequency of each letter for each position in the
three DNA sequences. A visual representation is provided in the form of a sequence logo captured
from the values in the PWM.
Motif scanning is utilised in many transcription factor binding site prediction tools and the body of
literature behind motif scanning is extensive. A number of tools exist that are capable of scanning the
genome for putative transcription factor binding sites based on their sequence motif to predict binding
[58] with FIMO a popular and effective choice [58]. PWM motif representations are most common
for motif scanning but other tools have attempted to improve PWM scans using machine learning
techniques such as hidden Markov models and support vector machines [112, 4]. All approaches
relying on a standalone motif scan fail to take into account additional factors such as flanking sequence,
sequence polymorphism, chromatin accessibility, transcription factor interactions or cell type, all
of which have been shown to influence binding [76, 177, 83, 53, 59]. Additionally, only a small
proportion of these motif predicted binding sites will be occupied in vivo.
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It is also important to note that not all transcription factors bind directly to DNA. Many transcription
factors contain effector domains which can interact with transcription machinery, other transcription
factors, and indirectly recruit histone and chromatin modifying enzymes. Effector domains are less
conserved than DNA binding domains allowing a single transcription factor to play a range of roles in
transcriptional regulation depending on its interactions [53, 156]. If a transcription factor is operating
through interactions with other transcription factors and not DNA directly, it will not have an associated
sequence motif making it impossible to predict all true binding events based on sequence alone. Motif
scanning or sequence based approaches will not be explored beyond their contribution to tools which
incorporate more informative features into their predictions.
E.3 Tools combining sequence with local epigenetic environment
Ernst et al. [42] was one of the first papers to explore the impact of 29 genetic and epigenetic features
that could be combined with sequence scanning to improve prediction of binding. The genetic features
included conservation (PhastCons) and GC content while also taking into account the location of a site
relative to CpG islands, low information content sequence regions (e.g. repeats), transcribed regions
and gene features (TSS, exon, intron, 3’UTR, 5’UTR). The epigenetic features were retrieved from
human genome-wide data sets describing histone modifications and chromatin accessibility as well
as insulator protein CTCF, histone variant H2A.Z and RNA polymerase II. The information from all
29 features was reduced to a single, base pair specific general binding preference (GBP) learned by a
logistic regression classifier and represents the probability of binding for any transcription factor. This
is combined with a PWM scanning motif score to determine the probability of a specific transcription
factor binding event.
They were able to show that high GBP scores increase closer to a TSS and overlap accessible
chromatin regions and validated their predictive performance on experimental ChIP-chip data. They
also showed that combining their GBP classifier with a PWM score from motif scanning improved
overall predictions of transcription factor binding compared to a PWM score alone. This improvement
was not observed across all transcription factors, with STAT1 binding better predicted by GBP score
alone. Even using a coarse measure of the local epigenetic environment, [42] were able to improve
predictions of transcription factor binding beyond what can be achieved using sequence motif scanning
alone.
Ernst et al. [42] identified two features describing histone modifications as having the highest
individual predictive power while features related to sequence conservation, represented by distance to
PhastCons elements, also had reasonable individual performance. The use of sequence conservation
limits this approach to genomes where this information is available. GC content and the distance to the
nearest TSS also have comparable performance to conservation features supporting research showing
that a transcription factor’s genomic location relative to genes and GC content around the binding
motif influence the likelihood of in vivo binding [117, 198, 12, 36].
Won, Ren, and Wang [181] present a tool called Chromia to explore histone modifications and
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sequence features to predict transcription factor binding using hidden Markov models (HMMs).
Windows of 100bps were defined by a PWM score, sequence read counts of eight histone modifications
and P300 binding then split into promoter data (strong H3K4me3), enhancer data (P300 binding
and strong H3K4me1/2) and background (chromosome 1) groups. A HMM was trained for each
data set and predictions were made by comparing log-odds scores of promoter to background and
enhancer to background. The model performance varied significantly across transcription factors when
validated using ChIP-seq experiments with positive predictive values ranging from 96.0% to 0.3%. It
was noted that certain transcription factors do not match characterised histone modification patterns
preventing the model from making realistic predictions of binding. They also found that using multiple
histone modifications outperformed models trained using only single histone modifications limiting the
application of Chromia to cases where extensive, cell-type specific data is available. Chromia can also
only function given a transcription factor known to bind at locations with common epigenetic patterns:
requirements that significantly limit the applications of Chromia to novel cell types and transcription
factors.
Arvey et al. [4] implemented two support vector machines (SVMs) to both improve detection of
sequence motifs and introduce chromatin accessibility to predict transcription factor binding in vivo.
The sequence SVM uses flexible k-mer signals and shows improved performance in identifying binding
sites compared to PWM scans allowing detection of DNA-binding preference and co-factor binding
signals. To interpret chromatin accessibility, a spatial SVM was constructed comparing read counts of
histone modifications and DHS sequencing at fifty 100bp windows centered around a ChIP-seq peak
(one positive) to read counts at multiple distances away from the peak (six negatives). Considering
multiple windows in a feature vector improves accuracy when compared to using a single window
as in Ernst et al. [42]. Of most interest, the model trained on DNase I hypersensitivity sequencing
alone showed better accuracy than any combination of histone modifications. As in Ernst et al. [42],
combining sequence and chromatin models improved overall performance with sequence specific
transcription factors better predicted by sequence and transcription factors that don’t directly interact
with DNA better predicted by chromatin accessibility. The features extracted for training both SVMs
are from ChIP-seq data limiting the transcription factors that can be explored in this way. Arvey et al.
[4] also showed that transcription factors show strong cell-type-specific binding patterns.
E.4 Tools combining sequence with DHS footprints
Hesselberth et al. [68] first described digital genomic footprinting (DGF) as a method of identifying
protein binding sites in the genome. Using high resolution DNase I hypersensitivity sequencing data,
protected footprints of DNA (DNase I hypersensitivity sequencing footprints) can be identified and
linked to transcription factor binding sites through identification of motifs. DNase I makes single
incisions in the DNA, so each read generated by DNase-seq represents a cleavage of DNA at the 5’
end. Footprints are short regions (6-40bps) with low cleavage rates compared to surrounding locations.
This approach does not rely on a motif to identify binding sites and can therefore be applied to a much
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larger range of transcription factor binding events.
Neph et al. [122] detected 45 million transcription factor binding events across 41 diverse cell and
tissue types by scanning per nucleotide cleavage patterns in 6-40 nucleotide stretches and identify
windows with low cleavage rates relative to the flanking regions. They found DNase I hypersensitivity
sequencing footprints are enriched for transcription factor motifs, lack methylation, show distinct pro-
files matching crystal structures of motifs and occurred in regions of high conservation. There was also
a good correlation between footprints containing transcription factor specific motifs and corresponding
ChIP-seq transcription factor peaks. This approach does not allow detection of transcription factor
specific footprint patterns, which they have shown to exist, instead detecting generic footprints across
the genome.
CENTIPEDE uses a PWM scan to identify locations of interest then applies an unsupervised
Bayesian mixture model to determine the probability of in vivo binding given DNase I hypersensitivity
sequencing, histone modification, conservation and genetic features [131]. The requirement of a motif
match to predict binding is a significant limitation of this approach as many transcription factors bind
without the presence of a sequence match. CENTIPEDE uses the depth of sequence reads for DNase I
hypersensitivity sequencing and their own detection of DNase I hypersensitivity sequencing footprints
modeled as a multinomial distribution capturing the ’shape’ of reads across a putative transcription
factor binding site. Similar to Arvey et al. [4], they found that DNase I hypersensitivity sequencing
data provided a better prediction of binding than presence or absence of seven histone modifications.
The tool also looked at sequence conservation using PhastCons scores and showed that true binding
sites tended to have higher conservation scores but that the feature itself did not significantly influence
predictive power.
Sherwood et al. [149] developed a tool protein interaction quantitation (PIQ) which combines
sequence scanning with profiles of DNase I hypersensitivity sequencing represented as a Gaussian
Process, using machine-learning to predict in vivo binding sites. One disadvantage of PIQ is its use of
motifs to first identify sites of interest as it limits the application to transcription factors with known
motifs. It will also fail in detecting events with diverse sequence specificities such as co-factor binding.
By exploring single transcription factors, PIQ is able to detect footprints with patterns specific to
a transcription factor. They showed that PIQ had higher accuracy than DGF (e.g. [68, 122, 27])
and CENTIPEDE however, at the time of publishing; the tool had only been tested on a handful of
transcription factors. When validating predictions, PIQ was able to correctly identify 50− 60% of
ChIP-seq peaks for a given transcription factor.
A second iteration of the CENTIPEDE tool, msCentipede, improved representation of the read
’shape’ of DNase I hypersensitivity sequencing after noting that the original model did not effectively
capture the heterogeneity in the ’shape’ profiles across the genome [133]. However, multiple biolog-
ical replicates are required to detect the heterogeneity msCentipede is attempting to model. When
comparing CENTIPEDE and msCentipede to PIQ, msCentipede has the best performance only when
biological replicates are available; otherwise, the three tools perform comparably.
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E.5 Single event limitation
One limitation shared by all tools discussed thus far is their focus on single transcription factor binding
events. A transcription factor often interacts with other transcription factors cooperatively or as co-
factors, competitors, dimers or through recruitment. Of particular concern is the lack of consideration
for binding sites occupied by multiple transcription factors. These sites do not have typical sequence
motifs and also have distinct chromatin features. To explore these features, Liu, Zhao, and Zhou [106]
trained four different models (SVM, Random Forest, Naive Bayes and Linear Discriminative Analysis)
using tag density profiles of histone modifications and DNase I hypersensitivity sequencing in 100bp
windows and comparing sites occupied by a single transcription factor and sites with evidence of
transcription factor-transcription factor binding according to overlapped ChIP-seq data sets. The SVM
trained on DNase I hypersensitivity sequencing data was most accurate when predicting co-occupied
sites. It is also noted that models trained on histone modifications are cell-type dependent while
DNase I hypersensitivity sequencing models are consistent in their accuracy across cell types. They
showed that all explored chromatin features, as well as GC content, showed significant differences
when comparing different types of binding sites. Although this study addresses a different question,
it is valuable to consider as the frequency of such events are high and could influence prediction of
individual transcription factor binding sites in vivo.
E.6 Validation limitation
Of the tools reviewed, only two ([4, 106]) performed validation across cell types. One of the key issues
that transcription factor binding site prediction is attempting to address is the inability to perform
ChIP-seq across multiple conditions. Therefore, an important feature of a prediction tool would be the
ability to make accurate predictions in a cell type other than the one used for training. This is a major
oversight in the body of literature surrounding transcription factor binding site prediction in vivo.
E.7 Conclusions
A number of genetic and epigenetic features have been identified which allow prediction of transcription
factor binding sites in vivo. Of these features, DNase I hypersensitivity sequencing footprints appear
most informative when incorporated into a model. The tools currently available to perform in vivo
prediction have significant limitations leaving room for improvement and scope for new tools to be
developed. Many of the tools are only able to predict binding sites where a motif is present which
limits their application to transcription factors with no known motif or transcription factors which do
not directly bind DNA. Others rely on numerous experimental data sets requiring time and money to
generate. Many of the data sets required are histone modifications and when attempting to predict
transcription factor binding in a cell type that cannot be isolated and assayed, tools which rely on these
inputs cannot be used. Weaknesses are also present in data representation as HTS data is information
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rich and therefore difficult to compress into a format that can be interpreted by a model without losing
essential detail. A number of tools showed that different transcription factors are better detected by
different approaches depending on sequence specificity and binding mode, a feature that could be
explored in future prediction models. Finally, most approaches have not had performance tested across
cell type, an essential step for future predictors of transcription factor binding.
We hypothesise that a Bayesian network approach to combining multiple features, represented
with greater detail, across a large number of cell types will improve prediction of transcription factor
binding sites and explore this in Chapter 5. A Bayesian network will allow exploration of how features
are related and their influence on binding. The existing approaches tend to use machine learning
approaches (e.g. SVMs or Random Forests) which only provide a prediction of binding with no
opportunity to explore the contributing features.

Appendix F
Bayesian Network Prediction supporting
data
237
238 APPENDIX F. BAYESIAN NETWORK PREDICTION
Transcription factor Motif Cell type/s Source
ARID3A MA0151.1 HepG2 [113]
Atf3 MA0605.1 H1-hESC, HepG2, K562 [113]
Atf7 MA0834.1 GM12878, HepG2, K562 [113]
CEBPB MA0466.2 H1-hESC, HeLa-S3, HepG2, K562 [113]
CREB1 MA0018.2 GM12878, H1-hESC, HepG2, K562 [113]
CTCF MA0139.1 H1-hESC, HeLa-S3, HepG2, K562 [113]
E2F1 MA0024.3 GM12878, HeLa-S3 [113]
E2F6 MA0471.1 H1-hESC, HeLa-S3 [113]
EGR1 MA0162.2 GM12878, H1-hESC [113]
FOXA1 MA0148.3 HepG2 [113]
FOXA2 MA0047.2 HepG2 [113]
GABPA MA0062.2 GM12878, H1-hESC, HeLa-S3, HepG2 [113]
HNF4A MA0114.3 HepG2 [113]
JUND MA0491.1 HeLa-S3, HepG2, K562 [113]
MAFK MA0496.1 GM12878, H1-hESC, HeLa-S3, HepG2 [113]
MAX MA0058.3 GM12878, H1-hESC, HeLa-S3, HepG2 [113]
MYC MA0147.2 HeLa-S3, K562 [113]
NANOG NANOG HUMAN.H10MO.A H1-hESC [95]
REST MA0138.2 H1-hESC, HeLa-S3, HepG2 [113]
RFX5 MA0510.2 GM12878, HeLa-S3 [113]
SPI1 MA0080.4 GM12878 [113]
SRF MA0083.3 GM12878, H1-hESC, HepG2, K562 [113]
STAT3 MA0144.2 HeLa-S3 [113]
TCF12 MA0521.1 GM12878, H1-hESC [113]
TCF7L2 MA0523.1 HeLa-S3 [113]
TEAD4 MA0809.1 H1-hESC, HepG2, K562 [113]
YY1 MA0095.2 GM12878, H1-hESC, HepG2 [113]
ZNF143 MA0088.2 GM12878, H1-hESC, HeLa-S3, HepG2 [113]
Table F.1: Motif sources
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